0001019687-14-002672.txt : 20140708 0001019687-14-002672.hdr.sgml : 20140708 20140708085350 ACCESSION NUMBER: 0001019687-14-002672 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20140531 FILED AS OF DATE: 20140708 DATE AS OF CHANGE: 20140708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SIMULATIONS PLUS INC CENTRAL INDEX KEY: 0001023459 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 954595609 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32046 FILM NUMBER: 14964160 BUSINESS ADDRESS: STREET 1: 42505 10TH STREET WEST STREET 2: * CITY: LANCASTER STATE: CA ZIP: 93534-7059 BUSINESS PHONE: 661-723-7723 MAIL ADDRESS: STREET 1: 42505 10TH STREET WEST CITY: LANCASTER STATE: CA ZIP: 93534-7059 10-Q 1 simulations_10q-053114.htm SIMULATIONS PLUS, INC.

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

xQuarterly Report Pursuant to Section 13 or 15(d) of the Security Exchange Act of 1934 for the quarterly period ended May 31, 2014
   
  OR
   
 oTransmission Report Pursuant to Section 13 or 15(d) of the Security Exchange Act of 1937 for the transition period from ______ to ______

 

Commission file number: 001-32046

 

Simulations Plus, Inc.

(Name of registrant as specified in its charter)

 

California 95-4595609
(State or other jurisdiction of Incorporation or Organization) (I.R.S. Employer identification No.)

 

42505 10th Street West

Lancaster, CA 93534-7059

(Address of principal executive offices including zip code)

 

(661) 723-7723

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filings requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes x No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):

 

o  Large accelerated filer o  Accelerated filer
o  Non-accelerated filer (Do not check if a smaller reporting company)   x   Smaller reporting company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

 

The number of shares outstanding of the registrant’s common stock, par value $0.001 per share, as of July 8, 2014 was 16,342,804; no shares of preferred stock were outstanding.

 

 
 

 

Simulations Plus, Inc.

FORM 10-Q

For the Quarterly Period Ended May 31, 2014

 

Table of Contents

 

 

  PART I. FINANCIAL INFORMATION  
     
Item 1. Condensed Financial Statements Page
     
  Condensed Balance Sheets at May 31, 2014 (unaudited) and August 31, 2013 (audited) 2
     
Condensed Statements of Operations for the three months and nine months ended May 31, 2014 and, 2013 (unaudited) 3
     
Condensed Statements of Cash Flows for the nine months ended May 31, 2014 and 2013 (unaudited) 4
     
Notes to Condensed Financial Statements (unaudited)  5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Result of Operations 15
     
    General  15
     
  Result of Operations 22
     
  Liquidity and Capital Resources 26
     
Item 3.   Quantitative and Qualitative Disclosures about Market Risk 26
     
Item 4.   Controls and Procedures 26
     
PART II. OTHER INFORMATION  
     
Item 1.   Legal Proceedings 28
     
Item 1A.   Risk Factors 28
     
Item 2.   Changes in Securities 28
     
Item 3.   Defaults upon Senior Securities 28
     
Item 4.   Mine Safety Disclosures 28
     
Item 5.   Other Information 28
     
Item 6.   Exhibits 28
     
Signature   30

 

 

1
 

 

SIMULATIONS PLUS, INC.

CONDENSED BALANCE SHEETS

at May 31, 2014 (Unaudited) and August 31, 2013

(Audited)

 


   (Unaudited)   (Audited) 
   May 31,   August 31, 
   2014   2013 
ASSETS
Current assets          
Cash and cash equivalents  $7,757,972   $10,179,298 
Prepaid income taxes   946,518    301,573 
Accounts receivable, net of allowance for doubtful accounts of $0   3,219,743    1,910,615 
Contracts receivable   124,270    203,913 
Prepaid expenses and other current assets   119,180    192,173 
Deferred income taxes   217,655    184,258 
Total current assets   12,385,338    12,971,830 
Long-term assets          
Capitalized computer software development costs, net of accumulated amortization of $6,385,815 and $5,801,578   3,358,632    2,891,169 
Property and equipment, net (note 3)   103,596    117,987 
Intellectual property, net of accumulated amortization of $41,875 and $11,250   6,033,125    63,750 
Other assets   18,445    18,445 
Total assets  $21,899,136   $16,063,181 
           
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities          
Accounts payable  $177,356   $146,011 
Accrued payroll and other expenses   349,464    311,209 
Accrued bonuses to officers   90,000    60,000 
Other Current Liabilities   19,859    19,859 
Current portion -  Contract payable (Note 4)   750,000     
Deferred revenue   234,671    89,227 
Total current liabilities   1,621,350    626,306 
           
Long-term liabilities          
Deferred income taxes   2,529,371    1,146,389 
Payments due under Contract payable (Note 4)   1,750,000     
Other long-term liabilities   33,099    47,993 
Total liabilities   5,933,820    1,820,688 
           
Commitments and contingencies (note 5)          
           
Shareholders' equity (note 6)          
Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding        
Common stock, $0.001 par value 50,000,000 shares authorized 16,335,804 and 16,030,894 shares issued and outstanding   4,807    4,502 
Additional paid-in capital   6,021,432    4,842,794 
Retained earnings   9,939,077    9,395,197 
           
Total shareholders' equity   15,965,316    14,242,493 
           
Total liabilities and shareholders' equity  $21,899,136   $16,063,181 

 

The accompanying notes are an integral part of these financial statements.

 

2
 

 

SIMULATIONS PLUS, INC.

CONDENSED STATEMENTS OF OPERATIONS

For the three and nine months ended May 31,

(Unaudited)

 


   Three months ended   Nine months ended 
   2014   2013   2014   2013 
                 
Net sales  $3,740,567   $3,094,779   $9,463,059   $8,502,994 
Cost of sales   227,600    451,935    1,168,219    1,337,583 
Gross profit   3,512,967    2,642,844    8,294,840    7,165,411 
Operating expenses                    
Selling, general, and administrative   1,204,312    903,589    3,378,950    2,689,632 
Research and development   234,685    206,424    750,808    634,281 
Total operating expenses   1,438,997    1,110,013    4,129,758    3,323,913 
                     
Income from operations   2,073,970    1,532,831    4,165,082    3,841,498 
                     
Other income (expense)                    
Interest income   8,017    9,203    25,000    40,005 
Interest expense                
Miscellaneous income       4,694        35,488 
Gain on currency exchange   7,340    (980)   35,477    96,662 
Total other income (expense)   15,357    12,917    60,477    172,155 
                     
Income  before provision for income taxes   2,089,327    1,545,748    4,225,559    4,013,653 
                     
Provision for income taxes   (781,778)   (552,518)   (1,422,991)   (1,371,862)
Net Income  $1,307,549   $993,230   $2,802,568   $2,641,791 
                     
Earnings per share                    
Basic  $0.08   $0.06   $0.17   $0.17 
Diluted  $0.08   $0.06   $0.17   $0.16 
                     
Weighted-average common shares outstanding                    
Basic   16,193,976    16,024,467    16,117,198    15,984,819 
Diluted   16,455,078    16,335,608    16,361,695    16,307,618 

 

The accompanying notes are an integral part of these financial statements.

 

3
 

 

SIMULATIONS PLUS, INC.

CONDENSED STATEMENTS OF CASH FLOWS

For the nine months ended May 31,

(Unaudited)

 


   2014   2013 
Cash flows from operating activities          
Net income  $2,802,568   $2,641,791 
Adjustments to reconcile net income to net cash provided by operating activities          
Depreciation and amortization of property and equipment   35,730    31,411 
Amortization of intellectual property   30,625    5,625 
Amortization of capitalized computer software development costs   584,237    532,106 
Excess tax benefits from share-based arrangements       (70,806)
Stock-based compensation   103,498    98,494 
Deferred income taxes   1,349,585    99,402 
(Increase) decrease in          
Accounts receivable and Contracts receivable   (1,229,485)   (1,611,838)
Prepaid income taxes   (644,945)   153,896 
Prepaid expenses and other assets   72,993    13,284 
Increase (decrease) in          
Accounts payable   31,345    44,206 
Accrued payroll and other expenses   38,255    24,973 
Accrued Bonus   30,000    (15,000)
Accrued income taxes       (403,735)
Other liabilities   (14,894)    
Deferred revenue   145,444    35,324 
Net cash provided by operating activities   3,334,956    1,579,133 
           
Cash flows from investing activities          
Purchases of property and equipment   (21,339)   (19,259)
Purchase of intellectual property   (2,500,000)    
Capitalized computer software development costs   (1,051,700)   (833,965)
Net cash used in investing activities   (3,573,039)   (853,224)
           
Cash flows from financing activities          
Excess tax benefits from share-based arrangements       70,806 
Proceeds from the exercise of stock options   75,445    27,985 
Dividends paid   (2,258,688)   (3,520,285)
Net cash (used in) financing activities   (2,183,243)   (3,421,494)
           
Net increase (decrease) in cash and cash equivalents   (2,421,326)   (2,695,585)
Cash and cash equivalents, beginning of year   10,179,298    12,701,075 
Cash and cash equivalents, end of period  $7,757,972   $10,005,490 
           
Supplemental disclosures of cash flow information          
Interest paid  $   $ 
Income taxes paid  $572,192   $1,382,545 
           
Non-Cash Investing and Financing          
Purchase of intellectual property with shares and notes payable   3,500,000     

 

The accompanying notes are an integral part of these financial statements.

 

4
 

 

Simulations Plus, Inc.

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

May 31, 2014 and 2013

(Unaudited)

 

Note 1: GENERAL

 

This report on Form 10-Q for the quarter ended May 31, 2014, should be read in conjunction with the Company's annual report on Form 10-K for the year ended August 31, 2013, filed with the Securities and Exchange Commission (“SEC”) on November 18, 2013. As contemplated by the SEC under Article 8 of Regulation S-X, the accompanying financial statements and footnotes have been condensed and therefore do not contain all disclosures required by generally accepted accounting principles. The interim financial data are unaudited; however, in the opinion of Simulations Plus, Inc. ("we", "our", "us"), the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Results for interim periods are not necessarily indicative of those to be expected for the full year.

 

 

Note 2: SIGNIFICANT ACCOUNTING POLICIES

 

Estimates

Our condensed financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. Actual results could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized computer software development costs, valuation of stock options, and accounting for income taxes.

 

Revenue Recognition

We recognize revenues related to software licenses and software maintenance in accordance with Financial Accounting Standard Board (“FASB”) Accounting Standard Codification (“ASC”) 985-605, “Software - Revenue Recognition”. Software product revenue is recorded when the following conditions are met: 1) evidence of arrangement exists, 2) delivery has been made, 3) the amount is fixed, and 4) collectability is probable. Post-contract customer support ("PCS") obligations are insignificant; therefore, revenue for PCS is recognized at the same time as the licensing fee, and the costs of providing such support services are accrued and amortized over the obligation period.

 

As a byproduct of ongoing improvements and upgrades for the new programs and new modules of software, some modifications are provided to customers who have already purchased software at no additional charge. Other software modifications result in new, additional cost modules that expand the functionality of the software. These are licensed separately. We consider the modifications that are provided without charge to be minimal, as they do not significantly change the basic functionality or utility of the software, but rather add convenience, such as being able to plot some additional variable on a graph in addition to the numerous variables that had been available before, or adding some additional calculations to supplement the information provided from running the software. Such software modifications for any single product have typically occurred once or twice per year, sometimes more, sometimes less. Thus, they are infrequent. The Company provides, for a fee, additional training and service calls to its customers and recognizes revenue at the time the training or service call is provided.

 

5
 

 

Generally, we enter into one-year license agreements with customers for the use of our pharmaceutical software products. We recognize revenue on these contracts when all the criteria are met.

 

Most license agreements have a term of one year; however, from time to time, we enter into multi-year license agreements. We generally unlock and invoice software one year at a time for multi-year licenses. Therefore, revenue is recognized one year at a time.

 

We recognize revenue from collaboration research and revenue from grants equally over their terms. However, we recognize contract study revenue using the percentage-of-completion method, depending upon how the contract studies are engaged, in accordance with ASC 605-35, “Revenue Recognition – Construction-Type and Production-Type Contracts”. To recognize revenue using the percentage-of-completion method, we must determine whether we meet the following criteria: 1) there is a long-term, legally enforceable contract, 2) it is possible to reasonably estimate the total project costs, and 3) it is possible to reasonably estimate the extent of progress toward completion.

 

Cash and Cash Equivalents

For purposes of the statements of cash flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.

 

Accounts Receivable

We analyze the age of customer balances, historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability of the Company’s trade accounts receivable balances. If we determine that the financial conditions of any of its customers deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable are written off when all collection attempts have failed.

 

Capitalized Computer Software Development Costs

Software development costs are capitalized in accordance with ASC 985-20, “Costs of Software to Be Sold, Leased, or Marketed”. Capitalization of software development costs begins upon the establishment of technological feasibility and is discontinued when the product is available for sale.

 

The establishment of technological feasibility and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues, estimated economic life, and changes in software and hardware technologies. Capitalized software development costs are comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in our software products.

 

Amortization of capitalized software development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the products (not to exceed five years, although all of our current software products have already been on the market for 7-15 years except for our newest MedChem Designer™ program, and we do not foresee an end-of-life for any of them at this point). Amortization of software development costs amounted to $584,237 and $532,106 for the nine months ended May 31, 2014 and 2013, respectively, and amortization of software development costs was $200,585 and $173,094 for the three months ended May 31, 2014 and 2013, respectively. We expect future amortization expense to vary due to increases in capitalized computer software development costs.

 

6
 

 

We test capitalized computer software development costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:

 

Equipment 5 years
Computer equipment 3 to 7 years
Furniture and fixtures 5 to 7 years
Leasehold improvements Shorter of life of asset or lease

 

Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.

 

Fair Value of Financial Instruments

Assets and liabilities recorded at fair value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The categories, as defined by the standard are as follows:

 

Level Input:   Input Definition:
Level I   Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II   Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III   Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

 

The following table summarizes fair value measurements by level at May 31, 2014 for assets and liabilities measured at fair value on a recurring basis:

 

   Level I   Level II   Level III   Total 
Cash and cash equivalents  $7,757,972   $   $   $7,757,972 
                     
Total  $7,757,972   $   $   $7,757,972 

 

For certain of our financial instruments, including accounts receivable, accounts payable, contract payable, accrued payroll and other expenses, and accrued bonus to officer, the amounts approximate fair value due to their short maturities.

 

Research and Development Costs

Research and development costs are charged to expense as incurred until technological feasibility has been established. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased software and databases which were developed by other companies and incorporated into, or used in the development of, our final products.

 

Income Taxes

We utilize FASB ASC 740-10, “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.

 

7
 

 

Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.

 

Intellectual property

On February 28, 2012, we bought out the royalty agreement with Enslein Research of Rochester, New York. The cost of $75,000 is being amortized over 10 years under the straight-line method. Amortization expense for each of the nine months periods ended May 31, 2014 and 2013 was $5,625 and was $1,875 for each three month period ended May 31, 2014 and 2013. Accumulated amortization as of May 31, 2013 was $16,875.

 

On May 15, 2014, we acquired intellectual property from TSRL, Inc of Ann Arbor, Michigan. The cost of $6,000,000 is being amortized over 10 years under the straight-line method. Amortization expense for the period of May 15, 2014 to May 31, 2014 was $25,000. Accumulated amortization as of May 31, 2014 was $25,000. (See Note 4)

 

Total amortization expense for intellectual property agreements for each of the nine months periods ended May 31, 2014 and 2013 was $30,625 and $ 5,625, respectively, and was $26,875 and $1,875 respectively for the three month periods ended May 31, 2014 and 2013. Accumulated amortization as of May 31, 2014 was $41,875.

 

Earnings per Share

We report earnings per share in accordance with FASB ASC 260-10. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted earnings per share for the three and nine months ended May 31, 2014 and 2013 were as follows:

 

   Three months ended   Nine months ended 
   05/31/2014   05/31/2013   05/31/2014   05/31/2013 
Numerator:                    
Net income attributable to common shareholders
  $1,307,549   $993,230   $2,802,568   $2,641,791 
                     
Denominator:                    
Weighted-average number of common shares outstanding during the period   16,193,976    16,024,467    16,117,198    15,984,819 
Dilutive effect of stock options   261,102    311,141    244,497    322,799 
                     
Common stock and common stock equivalents used for diluted earnings per share    16,455,078    16,335,608    16,361,695    16,307,618 

 

8
 

 

Stock-Based Compensation

Compensation costs related to stock options are determined in accordance with FASB ASC 718-10, “Compensation-Stock Compensation”, using the modified prospective method. Under this method, compensation cost is calculated based on the grant-date fair value estimated in accordance FASB ASC 718-10, amortized on a straight-line basis over the options’ vesting period. Stock-based compensation was $103,498 and $98,495 for the nine months ended May 31, 2014 and 2013, respectively, and was $32,411 and $28,241 for the three months ended May 31, 2014 and 2013, respectively. This expense is included in the condensed statements of operations as Selling, General and Administration (SG&A), and Research and Development expense.

 

Recently Issued Accounting Pronouncements

In July 2012, the FASB issued ASU 2012-02, “Testing Indefinite-Lived Intangible Assets for Impairment”, which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September 15, 2012 and earlier adoption is permitted. We adopted this standard in the first quarter of fiscal year 2013. We believe adoption did not have a material effect on our financial statements.

 

In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity’s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.

 

In May 2014, FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. The standard will eliminate the transaction- and industry-specific revenue recognition guidance under current U.S. GAAP and replace it with a principles-based approach for determining revenue recognition. ASU 2014-09 is effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The revenue recognition standard is required to be applied retrospectively, including any combination of practical expedients as allowed in the standard. We are evaluating the impact, if any, of the adoption of ASU 2014-09 to our financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

 

9
 

 

Note 3: Property and Equipment

 

Property and equipment as of May 31, 2014 consisted of the following:

 

Equipment  $124,042 
Computer equipment   145,893 
Furniture and fixtures   51,466 
Leasehold improvements   23,646 
Sub total   345,047 
Less: Accumulated depreciation and amortization   (241,451)
Net Book Value  $103,596 

 

 

Note 4: CONTRACT PAYABLE

 

On May 15, 2014 the Company entered into an agreement (the “Agreement”) with TSRL, Inc., a Michigan corporation (“TSRL”). Under the terms of the Agreement, the Company and TSRL agreed to transfer the rights of the intellectual property under the Exclusive Software Licensing Agreement dated June 30, 1997 (the “License Agreement”), under which TSRL licensed to the Company certain Software Technology and Databases (as defined in the License Agreement), and pursuant to which the Company paid royalties to TSRL to the Company.

 

The Agreement calls for the Company to pay TSRL total consideration of $6 million. The Company paid $3.5 million on May 20, 2014, comprised of cash in the amount of $2.5 million and the issuance of $1 million worth of the Company’s common stock-- 164,745 shares of the Company’s common stock based upon the April 25, 2014 closing price per share of $6.07. Future payments under the Agreement, which is non-interest- bearing, are due as follows:

 

April 25, 2015  $750,000 
April 25, 2016   750,000 
April 25, 2017   1,000,000 
Total  $2,500,000 
Less Current portion   (750,000)
Contract payable, net of current portion  $1,750,000 

 

 

Note 5: COMMITMENTS AND CONTINGENCIES

 

Employment Agreement

On July 22, 2012, the Company entered into an employment agreement with its President/Chief Executive Officer that expired in August 2013. The employment agreement provided for an annual base salary of $300,000 per year, and a performance bonus in an amount not to exceed 10% of Employee’s salary, or $30,000 per year, at the end of each fiscal year. The specific amount of the bonus to be awarded to be determined by the Compensation Committee of the Board of Directors, based on the financial performance and achievements of the Company for the previous fiscal year. The agreement also provided for Employee stock options, exercisable for five years, to purchase fifty (50) shares of Common Stock for each one thousand dollars ($1,000) of net income before taxes at the end of each fiscal year up to a maximum of 120,000 options over the term of the agreement at an exercise price equal to ten percent (10%) over the market value per share as of the date of grant (the number of shares to be adjusted accordingly for any stock splits or reverse splits after the date of the agreement). The agreement allows the Company to terminate the agreement upon 30 days written notice, if termination is without cause, the Company's only obligation would be to pay its President the greater of a) 12 month’s salary or b) the remainder of the term of the employment agreement from the date of notice of termination.

 

10
 

 

For fiscal year 2013, the Compensation Committee awarded a $30,000 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was paid in September 2013.

 

On August 22, 2013, effective as of September 1, 2013, the CEO’s employment agreement was renewed for another year by the Compensation Committee and provides for an annual bonus of up to five percent (5%) of the Company’s net income before taxes of the previous fiscal year not to exceed $60,000. In addition, at the CEO’s request, the agreement calls for a reduced granting of ten (10) options to purchase shares of the Company’s common stock for each $1,000 of net income before taxes that the Company earns at the end of each fiscal year (up to a maximum of twenty thousand (20,000) options over the term of the agreement) at an exercise price equal to ten percent (10%) over the market value per share as of the date of grant (the number of shares to be adjusted accordingly for any stock splits or reverse splits after the date of the agreement). A copy of the agreement is attached to the Company’s 2013 Form 10-K filed with the SEC on November 18, 2013 as Exhibit 10.9.

 

Litigation

The Company is a party to litigation. Management does not believe the outcome of such litigation will have a material impact on the Company’s financial position.

 

 

Note 6: SHAREHOLDERS’ EQUITY

 

Dividend

The Board of Directors declared cash dividends during fiscal year 2013. The details of dividends paid are in the following table:

 

Record Date  Distribution Date  Number of Shares Outstanding on Record Date   Dividend per Share   Total Amount 
11/8/2012  11/13/2012   15,927,806   $0.05   $796,390 
12/24/2012  12/28/2012   16,021,309   $0.14   $2,242,983 
5/7/2013  5/10/2013   16,030,433   $0.03   $480,913 
8/12/2013  8/15/2013   16,030,894   $0.03   $480,926 
Total               $4,001,212 

 

The Board of Directors has also declared cash dividends during fiscal year 2014. The details of dividends paid are in the following table:

 

Record Date  Distribution Date  Number of Shares Outstanding on Record Date   Dividend per Share   Total Amount 
11/08/2013  11/15/2013   16,073,894   $0.04   $642,956 
2/17/2014  2/24/2014   16,149,460   $0.05   $807,473 
5/09/2014  5/16/2014   16,165,171   $0.05   $808,259 
Total               $2,258,688 

 

11
 

 

Stock Option Plan

In September 1996, the Board of Directors adopted, and the shareholders approved, the 1996 Stock Option Plan (the "Option Plan") under which a total of 1,000,000 shares of common stock had been reserved for issuance. In March 1999, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 2,000,000. In February 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 4,000,000. In December 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 5,000,000. Furthermore, in February 2005, the shareholders approved an additional 1,000,000 shares, resulting in the total number of shares that may be granted under the Option Plan to 6,000,000. The 1996 Stock Option Plan terminated in September 2006 by its term.

 

On February 23, 2007, the Board of Directors adopted and the shareholders approved the 2007 Stock Option Plan under which a total of 1,000,000 shares of common stock had been reserved for issuance. On February 25, 2014 the shareholders approved an additional 1,000,000 shares increasing the total number of shares that may be granted under the Option Plan to 2,000,000.

 

Qualified Incentive Stock Options (Qualified ISO)

As of May 31, 2014, employees hold Qualified ISO to purchase 466,000 shares of common stock at exercise prices ranging from $1.00 to $5.61 which were granted prior to May 31, 2014.

 

Transactions in FY14  Number of Options   Weighted-Average Exercise Price
Per Share
   Weighted-Average Remaining Contractual Life 
             
Outstanding, August 31, 2013   532,000   $1.82    3.95 
Granted   100,000   $5.61      
Exercised   (160,000)  $1.36      
Cancelled/Forfeited   (6,000)  $1.00      
Outstanding, May 31, 2014   466,000   $2.80    3.57 
Exercisable,  May 31, 2014   314,000   $1.78    3.31 

 

The fair value of the options, including both ISO and NQSO options, granted during the nine months ended May 31, 2014 is estimated at $130,781. The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions for FQE May 31, 2014: dividend yield of 3.14%, pre-vest forfeiture rate of 6.25%, expected volatility of 38.95%, risk-free interest rate of 1.36%, and expected life of 5.0 years.

 

12
 

 

Non-Qualified Stock Options (Non-Qualified ISO)

As of May 31, 2014, the outside members of the Board of Directors hold options to purchase 45,600 shares of common stock at exercise prices ranging from $1.67 to $6.68, which were granted prior to May 31, 2014.

 

Transactions in FY14  Number of Options  

Weighted-Average Exercise Price

Per Share

   Weighted-Average Remaining Contractual Life 
             
Outstanding, August 31, 2013   48,600   $3.79    7.85 
Exercised   (3,000)  $1.80      
Outstanding, May 31, 2014   45,600   $3.92    7.29 
Exercisable,  May 31, 2014   25,200   $3.45    6.12 

 

The weighted-average remaining contractual life of options outstanding issued under the Plan, both Qualified ISO and Non-Qualified SO, was 4.19 years at May 31, 2014. The exercise prices for the options outstanding at May 31, 2014 ranged from $1.00 to $6.68, and the information relating to these options is as follows:

 

Exercise Price   Awards Outstanding   Awards Exercisable 
Low   High   Quantity   Weighted Average Remaining Contractual Life   Weighted Average Exercise Price   Quantity   Weighted Average Remaining Contractual Life   Weighted Average Exercise Price 
$1.00   $1.50    212,500    3.54   $1.05    212,500    3.54   $1.05 
$1.51   $3.00    21,600    5.86   $2.28    11,600    5.83   $2.11 
$3.01   $4.50    141,900    3.38   $3.28    103,500    3.24   $3.23 
$4.51   $6.68    136,000    4.70   $5.49    12,000    3.27   $5.59 
           511,600    3.90   $2.90    339,200    3.52   $1.90 

 

 

NOTE 7: RELATED PARTY TRANSACTIONS

 

As of May 31, 2014, included in bonus expenses to officers was $120,000, of which $45,000 was accrued bonus representing an estimated quarterly amount of bonus payable to the Corporate Secretary, Virginia Woltosz, as part of the terms of the sale of Words+ to Simulations Plus in 1996, and $45,000 accrued bonus representing an estimated quarterly amount of bonus payable to our President/Chief Executive Officer, Walter Woltosz as part of his 2014 employment agreement The other $30,000, paid in September 2013, was FY2013 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was approved by the compensation committee in September 2013.

 

 

NOTE 8: CONCENTRATIONS AND UNCERTAINTIES

 

Revenue concentration shows that International sales accounted for 53% and 42% of net sales for the nine months ended May 31, 2014 and 2013, respectively. Three customers accounted for 14% (a dealer account in Japan representing various customers), 9% and 5% of sales for the nine months ended May 31, 2014 compared to three customers who accounted for 10% (a dealer account in Japan representing various customers) 9% and 7% of net sales during the nine months ended May 31, 2013.

 

13
 

 

Accounts receivable concentration shows that three customers comprised 23%, 18% (a dealer account in Japan representing various customers) and 10% of accounts receivable at May 31, 2014 compared to three customers comprising 18%, 13% and 11% (a dealer account in Japan representing various customers) of accounts receivable at May 31, 2013.

 

We operate in the computer software industry, which is highly competitive and changes rapidly. Our operating results could be significantly affected by our ability to develop new products and find new distribution channels for new and existing products.

 

The majority of our customers are in the pharmaceutical industry. During the current economic downturn, we have seen consolidations in the pharmaceutical industry, especially in this first fiscal quarter of 2013. Although we have not seen any significant reduction in total revenues to date, our growth rate has been affected. Continued consolidation and downsizing in the pharmaceutical industry could have an impact on our revenues and earnings going forward.

 

NOTE 9: Geographic Reporting

 

We allocate revenues to geographic areas based on the locations of our customers. Geographical revenues for the nine months ended May 31, 2014 and 2013 were as follows (in thousands):

 

Nine month ended   North America   Europe   Asia   South America   Total 
                      
 May 31, 2014   $4,480   $2,684   $2,273   $26   $9,463 
 May 31, 2013   $4,413   $2,673   $1,416   $1   $8,503 

 

 

Note 10: EMPLOYEE BENEFIT PLAN

 

We maintain a 401(K) Plan for all eligible employees, and we make matching contributions equal to 100% of the employee’s elective deferral, not to exceed 4% of total employee compensation. We can also elect to make a profit-sharing contribution. Our contributions to this Plan amounted to $89,784 and $76,317 for the nine months ended May 31, 2014 and 2013, respectively, and $28,028 and $25,772 for the three months ended May 31, 2014 and 2013, respectively.

 

 

Note 11: SUBSEQUENT EVENT

 

On or about June 26, 2014, the Company was served with a complaint in a civil action entitled Sherri Winslow v. Incredible Adventures, Inc., et al. (Los Angeles Superior Court Case No. BC545789) alleging wrongful death and seeking unspecified damages arising out of a May 18, 2012 plane crash in the State of Nevada (the “Complaint”). In the Complaint, Plaintiff alleges that the Company was the owner of the subject aircraft.   The Company denies all material allegations against it, including that it owns or has ever owned any interest in the subject aircraft, and intends to vigorously defend itself.

 

14
 

 

Item 2. Management's Discussion and Analysis or Plan of Operations

 

Forward-Looking Statements

 

This document and the documents incorporated in this document by reference contain forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact contained in this document and the materials accompanying this document are forward-looking statements.

 

The forward-looking statements are based on the beliefs of our management, as well as assumptions made by and information currently available to our management. Frequently, but not always, forward-looking statements are identified by the use of the future tense and by words such as “believes,” expects,” “anticipates,” “intends,” “will,” “may,” “could,” “would,” “projects,” “continues,” “estimates” or similar expressions. Forward-looking statements are not guarantees of future performance and actual results could differ materially from those indicated by the forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by the forward-looking statements.

 

The forward-looking statements contained or incorporated by reference in this document are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”) and are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements include declarations regarding our plans, intentions, beliefs or current expectations.

Among the important factors that could cause actual results to differ materially from those indicated by forward-looking statements are the risks and uncertainties described under “Risk Factors” in our Annual Report and elsewhere in this document and in our other filings with the SEC.

Forward-looking statements are expressly qualified in their entirety by this cautionary statement. The forward-looking statements included in this document are made as of the date of this document and we do not undertake any obligation to update forward-looking statements to reflect new information, subsequent events or otherwise.

 

General

 

BusinesS

 

Simulations Plus, Inc., incorporated in 1996, develops and produces software for use in pharmaceutical research and for education, as well as provides contract research services to the pharmaceutical industry. Two recent in-house developments take advantage of the artificial neural network ensemble modeling engine in our ADMET Predictor™ software for new markets. AEROModeler™ predicts missile aerodynamic force and moment coefficients and MRIModeler™ classifies patients as either likely to experience some form of autism or not. These are discussed further below under ADMET Predictor.

 

We currently offer five software products for pharmaceutical research: ADMET Predictor™, MedChem Designer™, MedChem Studio™, DDDPlus™, and GastroPlus™. We call the combination of ADMET Predictor, MedChem Studio, and MedChem Designer our ADMET Design Suite™.

 

15
 

 

ADMET Predictor™

ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts about 145 different properties for them at the rate of over 100,000 compounds per hour on a fast laptop computer. This capability allows chemists to get estimates for a large number of important properties without the need to synthesize and test the molecules. ADMET Predictor has been consistently top-ranked for predictive accuracy in peer-reviewed, independent comparison studies, while generating its results at a very high throughput rate. Although the state-of-the-art of this type of software does not enable finding the best molecule in a series, it does allow identifying molecules that are highly likely to fail as potential drug candidates (the worst molecules, which is usually the majority of a chemical library) before synthesizing and testing them. Thus, millions of “virtual” compounds can be created and screened in a day, compared to potentially months or years of work to actually synthesize and test a much smaller number of actual compounds.

 

The ADMET Modeler™ subprogram that is integrated into ADMET Predictor enables scientists to use their own experimental data to quickly create high-quality, proprietary predictive models using the same powerful modeling methods we use to build our top-ranked property predictions. Pharmaceutical companies expend substantial time and money conducting a wide variety of experiments on new molecules each year, resulting in large databases of experimental data. Using this proprietary data to build predictive models can provide a second return on their investment; however, model building has traditionally been a difficult and tedious activity performed by specialists. The automation in ADMET Modeler makes it easy for a scientist to create very powerful models with a minimum of training.

 

We are now examining a very different application of this modeling engine – building predictive models for missile aerodynamic force and moment coefficients as a function of missile geometry, Mach number, and angle of attack. This problem was identified by the Aerospace Engineering department at Auburn University, and working with them, we have done some preliminary testing of the modeling engine in ADMET Modeler for this type of problem. Results have been very encouraging, and we believe there are government agencies and industrial aerospace companies that will find such a capability to be highly useful. We have developed a prototype AEROModeler™ program to test this concept and to use as a demonstrator for proposal efforts to potential funding agencies. Our proposed joint scientific poster on this subject with Auburn University’s Aerospace Engineering Department was selected for presentation at the NSMMS/CRASTE (National Space and Missile Material Symposium/Commercial and Government Responsive Access to Space Technology Exchange) conference in Huntsville, Alabama in June 2014, and received significant attention and positive feedback from both government agencies and aerospace contractors, not only for aerodynamic coefficient predictions, but for several other problems of interest to the industry.

 

We have also begun a preliminary investigation of applying this powerful modeling engine to the analysis of MRI (magnetic resonance imaging) data in cooperation with the MRI facility at Auburn University. This state-of-the-art facility has two MRIs – one a 3-Tesla machine and one a very powerful 7-Tesla machine, both built in the last few years. We are examining data from a series of subjects in four groups: healthy, PDD (Pervasive Developmental Disorder), ADHD (Attention Deficit Hyperactivity Disorder), and Asperger’s Syndrome, to determine whether we can discriminate between the groups from the MRI imaging data. The amount of data is massive (“big data”), requiring us to modify our code to handle much larger data arrays than our previous applications have required. Our current goal is to show the potential of our modeling technology to provide useful classification of a patient into one of the four groups based only on MRI imaging, so that we could go to various agencies (such as the National Institutes of Health) to obtain funding to develop a commercial product. Preliminary results exceed published classification accuracies from other groups by a substantial margin. We will be presenting a scientific poster at the Fourth Biennial Conference on Resting State/Brain Connectivity hosted by the Massachusetts Institute of Technology (MIT) in Cambridge, MA on September 10-13, 2014. We believe our artificial neural network ensemble modeling engine has wide-ranging applications and we intend to pursue funding to develop customized tools based on the engine for a number of potential applications.

 

16
 

 

During this reporting period, we released version 7.0 of ADMET Predictor. This new version incorporates a powerful new model for predicting ionization constants (pKa’s), developed in a collaboration with Bayer AG that enabled us to more than double the size of our data set from about 16,000 pKa values to more than 35,000, and to expand the chemical space it covers to include a larger number of molecules more like those of interest to the pharmaceutical industry today. We believe the resulting improvement in pKa prediction puts our already best-in-class model well in front of any competitor. Predicting ionization is critical to predicting most other properties, so all of our models (approximately 144) were retrained based on this new capability for version 7.0. We are currently finalizing version 7.1, which incorporates several new capabilities that we expect to release during our 4th fiscal quarter.

 

MedChem Designer™

MedChem Designer was launched in 2011. It was initially a molecule drawing program, or “sketcher”, but now has capabilities exceeding those of other molecule drawing programs because of its integration with both MedChem Studio and ADMET Predictor. We provide MedChem Designer for free because we believe that in the long run it will help to increase demand for ADMET Predictor and MedChem Studio, and because most other existing molecule drawing programs are also free. Our free version includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures and then see a few key properties very quickly. The chemist also sees that with a paid ADMET Predictor license, the entire 140+ predictions would be available.

 

When coupled with a license for ADMET Predictor, MedChem Designer becomes a de novo design tool for medicinal chemists. With it, they can draw one or more molecular structures, then click on the ADMET Predictor icon and have over 140 properties for each structure calculated in seconds, including our proprietary ADMET Risk™ index. Scientists can also click on an icon to generate the likely metabolites of a molecule and then predict all of the properties of those metabolites from ADMET Predictor, including their ADMET Risk scores. This is important because a metabolite of a molecule can be harmful even though the parent molecule is not.

 

ADMET Risk provides a single number that tells the chemist how many default threshold values for 24 predicted properties were crossed (or violated) by each structure. The rules can be modified and new rules added by the user to include any desired rule set based on any combination of calculated descriptors, predicted properties, and user inputs. Thus, in a single number, the chemist can instantly compare the effects of different structural changes in many dimensions. As chemists attempt to modify structures to improve one property, they often cause others to become unacceptable. Without ADMET Risk, the chemist would have to individually examine many key properties for each new molecule (and its metabolites) to check whether any of them became unacceptable as a result of changing the structure.

 

17
 

 

During this reporting period, we released version 3.0 of MedChem Designer, which added the ability to capture the image of a molecular structure from a variety of publication files with a new snapshot tool, and then have the program automatically convert the graphic image into any of several computer-based chemical structure files. Converting from lines and letters on the screen to an exact chemical representation of the molecule (Optical Structure Recognition, or OSR) is a complex task. Although a few OSR programs are in existence, we are not aware of any that can accurately convert as many varieties of images to chemical representation as the OSR tool within MedChem Designer. Such a capability allows chemists to quickly capture molecular structures from the scientific literature to use for various purposes, including in our simulation and modeling software.

 

MedChem Studio™

While MedChem Designer can be used to refine a small number of molecules, MedChem Studio can be used to create and screen (with ADMET Predictor) a very large number of molecules down to a few promising lead candidates. MedChem Studio has features that enable it to generate new molecular structures using a variety of de novo design methods. Coupled with ADMET Predictor and MedChem Designer, we believe the programs provide an unmatched capability for chemists to search through large libraries of compounds that have undergone high-throughput screening experiments to find the most promising classes (groups of molecules with a large part of their structures the same) and molecules that are active against a particular target. In addition, MedChem Studio can take an interesting (but not acceptable) molecule and, using a variety of design algorithms, very quickly generate many thousands to millions of high quality analogs (similar new molecules). These molecules can then be screened using ADMET Predictor to find molecules that are both active against the target as well as acceptable in a variety of ADMET properties.

 

MedChem Studio version 4.0 was released during the current reporting period.

 

NCE Projects

During late 2012, based on our strong belief in the exceptional capabilities of our ADMET Design Suite (MedChem Studio/MedChem Designer/ADMET Predictor), we initiated a new molecule (NCE, or New Chemical Entity) design project. After considering various targets, we selected the malaria parasite Plasmodium falciparum, both because of the unmet need for a very low-cost cure, and because we believed that external funding opportunities might exist if we were successful in generating high-quality lead compounds using our software. Our goal was to demonstrate how well the ADMET Design Suite worked to generate new lead molecules in a fraction of the time and cost normally required in the pharmaceutical industry. We completed the design process in September 2012 and we announced that we had requested quotations from chemical synthesis companies for the cost and time to make a small set of molecules. Five molecules of our own design and two precursors (almost the final designed structures, but a step away in synthesis) were synthesized and tested for inhibition of the parasite at the University of California at Riverside. We were hoping that at least one would show inhibition of the growth cycle of the parasite.

 

We were excited to learn that every molecule showed activity against the parasite at less than micromolar concentrations, with two showing activity at less than 100 nanomolar concentration (high potency) against the drug-sensitive strain of the parasite. They were then tested against the newer drug-resistant strain of the parasite, and again potency was observed, with two molecules showing nanomolar activity. We believe this exercise – a software company using its own products to design novel molecules and have them synthesized and tested – is unprecedented. New software license sales resulting from presenting our results have already more than recovered our investment.

 

18
 

 

During previous reporting periods, we announced that we had completed the design of a number of new molecules for a different target – the cyclo-oxygenase-2 (COX-2) enzyme that is the target for Celebrex®. Celebrex is the only COX-2 inhibitor remaining on the market, after the withdrawal of other approved drugs (such as Vioxx®) due to cardiac toxicity. It appears from the scientific research that was conducted after the withdrawal of other COX-2 inhibitors from the market that it is important to inhibit both COX-2 and COX-1 at a certain ratio in order to provide the benefits of COX-2 inhibition without the cardiotoxicity risk that has been associated with inhibiting COX-2 alone. We designed our new molecules based on activity models for both COX-2 and COX-1 built from public data, with the goal of providing an acceptable ratio of COX-2 to COX-1 inhibition. This is more challenging than designing for a single target, as we did for the earlier malaria NCE project. Results reported during this reporting period showed that we were once again very successful, with all four molecules that were synthesized inhibiting both the COX-2 and COX-1 enzymes, and one of them providing the desired characteristic of higher affinity for COX-2 than COX-1. We believe this is a remarkable and unique achievement among software companies, and clearly demonstrates that our ADMET Design Suite can save considerable time and money in developing new lead compounds for particular targets.

 

DDDPlus

DDDPlus simulates in vitro laboratory experiments used to measure the rate of dissolution of the drug and, if desired, the additives (excipients) contained in tablets and capsules under a variety of experimental conditions. This software program is used by formulation scientists in industry and the U.S. Food and Drug Administration (FDA) to (1) understand the physical mechanisms affecting the dissolution rate for various formulations, (2) reduce the number of cut-and-try attempts to design new drug formulations, and (3) to design in vitro dissolution experiments to better mimic in vivo conditions.

 

GastroPlus

Our flagship product and largest source of revenues is GastroPlus. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs administered to humans and animals, and is currently in widespread use at pharmaceutical companies, the FDA, the U.S. National Institutes of Health (NIH), and other government agencies in the U.S. and other countries. Because of the widespread use of GastroPlus, we were the only non-European company invited to join the European Innovative Medicines Initiative (IMI) program for Oral Bioavailability Tools (“OrBiTo”). OrBiTo is an international collaboration among 27 industry, academic, and government organizations working in the area of oral absorption of pharmaceutical products. Because we are outside of Europe, our participation in this project is at our own expense, while other members are compensated for their work; however, we are a full member with access to all of the data and discussions of all other members. We believe participation in this initiative enables us to benefit from and to contribute to advancing the prediction of human oral absorption from preclinical data, and ensures that we are in front of the audience of member pharmaceutical companies and regulatory agencies.

 

Version 8.5 of GastroPlus was released during the previous reporting period, adding a number of important new capabilities requested by customers as well as improvements we have identified in-house, including:

 

A new model for precipitation based on classical nucleation theory

Infant physiologies, including for babies born as much as 16 weeks premature

A unique method for using transporter data from preclinical experiments to predict transporter effects in human and other animals

A number of additional expression levels of enzymes and transporters in human and animal physiologies

 

19
 

 

An interim release (8.6) is planned for the 4th fiscal quarter (June 1 – August 31) to enable certain customers to take advantage of a new physiological model for minipig, which has become a more frequently used animal species in preclinical development, and to add the ability to simulate populations within the Drug-drug interaction Module.

 

The next major release, version 9.0, is already well along in development. This version will add the ability to simulate dermal (through the skin) drug absorption from patches, creams, and ointments. This capability was developed through a funded collaboration with a top-5 pharmaceutical company, and is already in use at the customer’s sites at this time. A number of other improvements will be included in version 9.0 that will be announced with the release of the product.

 

MembranePlus™

MembranePlus is a new product that has been under development for a number of years, but was put on hold for several years due to other priorities. It was revived in the past year and is now nearing commercial release. Like DDDPlus, MembranePlus simulates laboratory experiments, but in this case, the experiments are for measuring permeability of drug-like molecules through various membranes, including several different cell cultures (Caco-2, MDCK) as well as artificially formulated membranes (PAMPA). The value of such a simulation results from the fact that when the permeabilities of the same molecules are measured in different laboratories, results are often strikingly different. These differences are caused by a complex interplay of factors in how the experiment was set up and run. MembranePlus simulates these experiments with their specific experimental details, and this enables the scientist to better interpret how results from specific experimental protocols can be used to predict permeability in human and animals, which is the ultimate goal. MembranePlus is unique and our customers have expressed significant interest in the new capability.

 

Priorities for developing material for our May training workshops as well as numerous conferences and on-site customer trainings required us to delay development of MembranePlus. We now plan to release version 1.0 of MembranePlus in the fourth fiscal quarter.

 

Contract Research and Consulting Services

Our expertise in oral absorption and pharmacokinetics is evidenced by the fact that our staff members have been speakers or presenters at over 150 scientific meetings worldwide in the past four years. We frequently conduct contracted studies for large customers (including the largest five pharmaceutical companies) who have particularly difficult problems and who recognize our expertise in solving them, as well as for smaller customers who prefer to have studies run by our scientists rather than to license our software and train someone to use it. The demand for our consulting services has been steadily increasing, and we have expanded our Simulations Studies team to meet the increased workload. Long-term collaborations and shorter-term consulting contracts serve both to expand and showcase our technologies, and to build and strengthen customer relationships.

 

During the current reporting period, we continued to work on our 5-year Research Collaboration Agreement (RCA) with the Center for Food Safety and Applied Nutrition (CFSAN) of the FDA. FDA scientists and our scientists are using ADMET Predictor/Modeler to build predictive models for likely toxicities of food additives and contaminants. During the first part of this collaboration, we analyzed FDA databases and worked with FDA scientists to ensure that the FDA data to be used for building new predictive models is as accurate as we can reasonably make it. Both FDA scientists and our scientists are building a series of models to classify new compounds as toxic or nontoxic from FDA datasets. Included early on in this effort was a special modification to ADMET Predictor to allow the user to set a minimum value for specificity or sensitivity when building a model, and this is now a standard part of the program available to all users. Sensitivity refers to how well a model identifies toxic (or any other property) compounds. A model that determined all compounds are toxic would have 100% sensitivity, because all toxic compounds would be labeled as such; however, all nontoxic compounds would also be labeled toxic. Specificity refers to how well a model distinguishes between toxic and nontoxic compounds. Increasing one usually results in decreasing the other. Depending on the purpose of the model, some scientists will prefer to train models that emphasize one statistic over the other.

 

20
 

 

Also during this reporting period, we began another five-year RCA, this time with the Office of Generic Drugs (OGD) within the FDA. This RCA is directed toward the FDA’s evaluation of mechanistic IVIVCs (in vitro-in vivo correlations), an approach to determine whether mechanistic absorption modeling (MAM) correlates laboratory (in vitro) dissolution experiments with the in vivo behavior of a dosage form better than traditional empirical methods. We have proposed this method for about 15 years and believe in it, so we are pleased to see the FDA giving it serious consideration with this RCA.

 

STRATEGY

 

Our business strategy is to do the things we need to do to promote growth both organically (by expanding our current products and services through in-house efforts) and by acquisition. We believe in the “Built to Last” approach - that the fundamental science and technologies that underlie our business units are the keys both to improving our existing products and to expanding the product line with new products that meet our various customers’ needs.

 

With our significant cash reserves, seeking suitable acquisitions is a priority. Because we had been unable to identify suitable acquisitions and our cash continued to accumulate, the board of directors declared a $0.05 per share per quarter cash dividend that began in February 2012 and was paid in May, August, and November 2012. The board declared an accelerated cash dividend consisting of the February, 2013 dividend of $0.05 per share per quarter plus $0.03 per share from each of the expected May, August, and November 2013 dividends of $0.05 per share per quarter for a total of $0.14 per share, which was distributed on December 28, 2012, in order to provide our shareholders with the income tax benefits from lower capital gains rates in 2012 over 2013. We declared a $.04 per share dividend in November 2013 and $.05 per share dividends in February and May 2014. We anticipate the dividend to continue to be $0.05 per share per quarter, however there can be no assurances that such dividends will be distributed, or if so, whether the amounts will be more, less, or the same as expected. The Board of Directors must approve each quarterly dividend distribution and may decide to increase, decrease, or eliminate dividend distributions at any time.

 

 

21
 

 

Results of Operations

 

Comparison of Three Months Ended May 31, 2014 and 2013.

 

The following table sets forth our condensed statements of operations (in thousands) and the percentages that such items bear to net sales (because of rounding, numbers may not foot):

 

   Three Months Ended 
   05/31/14   05/31/13 
Net sales  $3,741    100.0%  $3,095    100.0%
Cost of sales   228    6.1    452    14.6 
Gross profit   3,513    93.9    2,643    85.4 
Selling, general and administrative   1,204    32.2    904    29.2 
Research and development   235    6.3    206    6.7 
Total operating expenses   1,439    38.5    1,110    35.9 
Income from operations   2,074    55.4    1,533    49.5 
Other income   15    0.4    13    0.4 
Income from operations before taxes   2,089    55.9    1,546    49.9 
(Provision for) income taxes   (781)   (20.9)   (553)   (17.8)
Net income  $1,308    35.0%  $993    32.1%

 

Net Sales

Net sales Increased $646,000, or 20.9%, to $3,741,000 in the third quarter of Fiscal Year 2014 (“3QFY14”) from $3,095,000 in the third fiscal quarter of Fiscal Year 2013 (“3QFY13”), setting a new record for revenues for any quarter in our history. Software sales increased $692,000 during the quarter. This increase included approximately $300,000 of sales to a major customer that decided in 2QFY14 to move the timing of their global renewal order to our third quarter to synchronize purchases for their internal budget timelines. We expect this long-time customer will now continue to renew in the third quarter going forward. Analytical study revenues decreased by $66,000 during the quarter, mainly due to 3QFY13 collaboration revenues that were not replaced in 3QFY14. Within analytical study revenues, we distinguish between consulting services and collaborations; it was the completion of the funded collaboration to develop the dermal dosing capability within GastroPlus that results in reduced analytical study revenues. Training revenues increase by $20,000.

 

Cost of Sales

Cost of sales decreased by $224,000 or 49.5%, to $228,000 in 2QFY14 from $452,000 in 2QFY13. The majority of this decrease is due to the absence of royalty expense as a the result of the agreement with TSRL discussed in Note 4. As sales of GastroPlus increase, we anticipate this agreement will have a significant impact on earnings as we will no longer be paying royalties on that growth. Instead, starting May 15, 2014, the Company will incur amortization expense in the fixed amount of $150,000 per quarter. Amortization expense under this agreement for 3QFY14 was $25,000 because the agreement was only in effect for one-half of one month. We continue to pay royalties to Accelrys on a portion of the ADMET Predictor Metabolism Module. Total expense under the Accelrys agreement was $9,000 during the quarter.

 

22
 

 

Another significant portion of cost of sales for pharmaceutical software products is the systematic amortization of capitalized software development costs. Amortization cost increased approximately $27,000, or 16%, in 3QFY14 compared with 2QFY13. Workshop/Training costs increased by $24,000, as we did more workshop programs and more onsite training in 3QFY14 compared to 3QFY13.

 

Gross Profit

Gross profit increased $870,000, or 32.9%, to $3,513,000 in 3QFY14 from $2,642,000 in 2QFY13. We attribute this change to increased revenues, and the absence of royalties in this quarter.

 

Selling, General and Administrative Expenses

Selling, general and administrative (SG&A) expenses increased $300,000, or 33.3%, to $1,204,000 in 3QFY14 from $904,000 in 3QFY13.

 

The major changes in SG&A expenses for 2QFY14 vs 2QFY13 were:

 

·Commission expense - increased by $75K, we incurred increased commissions to our Japanese and Chinese dealers as we recorded significantly increased sales in our Asian markets
·Marketing labor costs - increased by $24K, substantive employee time was incurred in conjunction with updating of training material, conference, trade shows
·Travel expenses - increased $21K as the company continued its’ strategy of an increased presence at a number of trade shows and conferences in 3QFY14, in addition, a higher percentage of travel was at international destinations
·Consulting Fees - increased by $44K, we used consultants in 3QF14 for review of contracts and other strategic issues
·Professional fees - increased by $118K, due to the timing of accounting fees and legal fees associated with negotiation of the TSRL agreement (See Note 4) and other corporate matters

 

Research and Development

We incurred approximately $552,000 of research and development costs during 3QFY14. Of this amount, $317,000 was capitalized and $235,000 was expensed. In 3QFY13, we incurred $458,000 of research and development costs, of which $252,000 was capitalized and $206,000 was expensed. The increase of $94,000, or 20%, in total research and development expenditures from 3QFY13 to 3QFY14 was due to an expansion of staff as well as increases in salaries and stock-based compensation for existing employees. In addition, the company incurred $14K of costs associated with its COX-2/COX-1 NCE initiative (see NCE discussion in Business section above).

 

Other income (expense)

Net other income in 3QFY14 decreased by $2,000 to $15,000 in 3QFY14 from $13,000 in 3QFY13.

 

Provision for Income Taxes

The provision for income taxes increased by $229,000, or 41.5%, to $782,000 in 3QFY14 from $553,000 in 3QFY13 due to increased income before taxes. The Company’s effective tax rate for 3QFY14 was 37.4.

 

Net Income

Net income increased by $315,000, or 31.6%, to $1,308,000 in 3QFY14 from $993,000 in 3QFY13. We attribute this increase to the sales increase in excess of increased research and development costs and operating expenses.

 

23
 

 

Comparison of Nine Months Ended May 31, 2014 and 2013.

 

The following table sets forth our condensed statements of operations (in thousands) and the percentages that such items bear to net sales (because of rounding, numbers may not foot):

 

 

 

   Nine Months Ended 
   05/31/14    05/31/13 
Net sales  $9,463    100.0%  $8,503    100.0%
Cost of sales   1,168    12.4    1,338    15.7 
Gross profit   8,295    87.6    7,165    84.3 
Selling, general and administrative   3,380    35.7    2,690    31.6 
Research and development   750    7.9    634    7.5 
Total operating expenses   4,130    43.6    3,324    39.1 
Income from operations   4,165    44.0    3,841    45.2 
Other income   61    0.6    172    2.0 
Income from operations before taxes   4,226    44.6    4,014    47.2 
(Provision for) income taxes   (1,423)   (15.0)   (1,372)   (16.1)
Net income  $2,803    29.6%  $2,642    31.1%

 

Net Sales

Net sales increased $960,000 or 11.3%, to $9,463,000 in the first 9 months of fiscal 2014 (“9moFY14”) from $8,503,000 in the first 9 months of fiscal 2013 (“9moFY13)”. The increase in revenues is due to an approximately $1,204,000 increase in software sales. Analytical studies and workshop/training revenues decreased by $244,000, primarily due to approximately $213,000 of funded collaboration revenues in 9moFY13 that were not replaced in 9moFY14.

 

Cost of Sales

Cost of sales decreased by $170,000, or 12.7%, to $1,168,000 in 9moFY14 from $1,338,000 in 9moFY13. As a percentage of revenue, cost of sales decreased in 9moFY14 by 3.4% mainly due to decreased royalty costs associated with the TRSL agreement. A significant portion of cost of sales for pharmaceutical software products is the systematic amortization of capitalized software development costs. Amortization cost increased approximately $27,000, or 15.9%, in 9moFY14 compared with 9moFY13.

 

Gross Profit

Gross profit increased $1,130,000, or 15.8%, to $8,295,000 in 9moFY14 from $7,165,000 in 9moFY13. We attribute this change to increased revenues and the current-year effect on royalties of the TSRL Agreement.

 

Selling, General and Administrative Expenses

Selling, general and administrative (SG&A) expenses increased $690,000, or 25.6%, to $3,379,000 in 9moFY14 from $2,690,000 in 9moFY13.

 

The major changes in SG&A expenses for 9moFY14 vs 9moFY13 were:

 

·Commission expense – increased by $139K, we incurred increased commissions to our Japanese and Chinese dealers as we recorded significantly increased sales in our Asian markets
·Marketing labor costs – increased by $43K, as substantial employee time was incurred in conjunction with updating of training materials, trade shows, and visiting our Asian dealers and customers

 

24
 

 

 

·Travel expenses - increased $72K as the company continued its increased presence at trade shows and conferences in 9moFY14. In addition, a higher percentage of travel was at international destinations
·Bonus expense - increased by $45K, due to the changes in 2014 compensation plan for the company’s Chief Executive Officer (see Notes to Financial statements above)
·Consulting fees – increased by $54K as we used consultants in 9moFY14 for the TSRL analysis and review of contracts and other strategic issues
·Professional fees – increased by $148K, primarily due to increased legal costs associated with review of proxy issues, legal expense associated with the company’s amendment of its 2007 Stock Option Plan, negotiation of the TSRL agreement (See Note 4), and other corporate matters
·Investor relations – increased by $28K due to a change in stock transfer agents which occurred in the 3QFY13
·Salaries and wages – increased $90K due to annual salary review increases and some duplicated salaries associated with the transition of the company’s CFO. In addition the Life Science staff spent more time on G&A activities (marketing, sales, and support) in 9moFY14 compared to 9moFY13, resulting in more expense allocated to SG&A

 

Research and Development

We incurred approximately $1,803,000 of research and development costs during 9moFY14. Of this amount, $1,052,000 was capitalized and $751,000 was expensed. In 9moFY13 we incurred $1,468,000 of research and development costs, of which $834,000 was capitalized and $634,000 was expensed. The increase of $335,000, or 22.8%, in total research and development expenditures from 9moFY13 to 9moFY14 was due to expansion of staff and increases in salaries and stock-based compensation for existing employees. In addition, the company incurred $40K of costs associated with its NCE initiative (See NCE discussion in Business section above).

 

Other income (expense)

Net other income decreased by $111,000, or 65%, to $61,000 in 9moFY14 from $172,000 in 9moFY13. This is due to lower interest income and lower currency exchange gain in 9moFY14 compared with 9moFY13. In addition 9moFY14 did not include any sublease income, while $36K was included in 9moFY13.

 

Provision for Income Taxes

Provision for income taxes increased by $51,000 or 15%, to $1,423,000 in 9moFY14 from $1,372,000 in 9moFY13 due to increased income before taxes. The Company’s effective tax rate was 33.7%, which differs from statutory rates for the quarter mainly due to R&D tax credits recognized during the period.

 

Net Income

Net income increased by $161,000 or 29.6%, to $2,803,000 in 9moFY14 from $2,642,000 in 9moFY13. We attribute this increase to the sales increase in excess of increased decrease to increased research and development costs and operating expenses.

 

25
 

 

Liquidity and Capital Resources

 

Our principal sources of capital have been cash flows from our operations. We have achieved continuous positive cash flow from operations for the last fourteen fiscal years. We believe that our existing capital and anticipated funds from operations will be sufficient to meet our anticipated cash needs for working capital and capital expenditures for the foreseeable future. Thereafter, if cash generated from operations is insufficient to satisfy our capital requirements, we may open a revolving line of credit with a bank, or we may have to sell additional equity or debt securities or obtain expanded credit facilities. In the event such financing is needed in the future, there can be no assurance that such financing will be available to us, or, if available, that it will be in amounts and on terms acceptable to us. If cash flows from operations became insufficient to continue operations at the current level, and if no additional financing was obtained, then management would restructure the Company in a way to preserve its pharmaceutical business while maintaining expenses within operating cash flows.

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Our risk from exposure to financial markets is limited to foreign exchange variances and fluctuations in interest rates. We may be subject to some foreign exchange risks. Most of our business transactions are in U.S. dollars, although we generate significant revenues from customers overseas. The exception is that we have been compensated in Japanese yen by Japanese customers and PRC Yuan by Chinese customers. In the future, if foreign currency transactions increase significantly, then we may mitigate this effect through foreign currency forward contracts whose market-to-market gains or losses are recorded in "Other Income or expense" at the time of the transaction. To date, exchange rate exposure has not resulted in a material impact.

 

 

Item 4. Controls and Procedures

 

We are responsible for maintaining disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Disclosure controls and procedures are controls and other procedures designed to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

Based on management’s evaluation (with the participation of our chief executive officer and chief financial officer) of our disclosure controls and procedures as required by Rule 13a-15 under the Exchange Act, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective.

 

26
 

 

Management's Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal controls over financial reporting, as defined in Exchange Act Rule 13a-15(f). Our internal controls over financial reporting are designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of condensed financial statements for external purposes in accordance with generally accepted accounting principles.

 

No changes were made in our internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during our most recent fiscal quarter that have materially affected or are reasonably likely to materially affect, our internal controls over financial reporting.

 

Our management, including our CEO and CFO, does not expect that our disclosure controls or internal controls over financial reporting will prevent all errors or all instances of fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and any design may not succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitation of a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

27
 

 

Part II. Other Information

 

Item 1. Legal Proceedings
  On or about June 26, 2014, the Company was served with a complaint in a civil action entitled Sherri Winslow v. Incredible Adventures, Inc., et al. (Los Angeles Superior Court Case No. BC545789) alleging wrongful death and seeking unspecified damages arising out of a May 18, 2012 plane crash in the State of Nevada (the “Complaint”).   In the Complaint, Plaintiff alleges that the Company was the owner of the subject aircraft.   The Company denies all material allegations against it, including that it owns or has ever owned any interest in the subject aircraft, and intends to vigorously defend itself.
 
Item 1A. Risk Factors
  Not applicable.
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
   
Item 3. Defaults Upon Senior Securities
  None.
   
Item 4. Mine Safety Disclosures
  Not applicable.
   
Item 5. Other Information
None.

 

Item 6. Exhibits

 

 

EXHIBIT

NUMBER

DESCRIPTION
  
3.1Articles of Incorporation of the Company. (5)
3.2Amended and Restated Bylaws of the Company. (5)
4.1Articles of Incorporation of the Company. (incorporated by reference to Exhibit 3.1 hereof)
4.2Bylaws of the Company. (incorporated by reference to Exhibit 3.2 hereof)
4.3Form of Common Stock Certificate (1)
4.4Share Exchange Agreement (1)
10.1The Company’s 1996 Stock Option Plan (the “Option Plan”) and forms of agreements relating thereto (1)
10.2Exclusive License Software Agreement by and between the Company and Therapeutic Systems Research Laboratories dated June 30, 1997. (2)
10.3 The Company’s 2007 Stock Option Plan. (3)
10.4Notice of Election to Extend Term of Lease by and between the Company and Crest Development LLC formerly Freeway Ventures LLC, dated July 29, 2010.(4)
10.5 Employment Agreement by and between the Company and Walter S. Woltosz, dated as of July 22, 2011. (5) (†)
10.6Employment Agreement by and between the Company and Walter S. Woltosz, dated as of August 22, 2013. (6) (†)

 

 

28
 

 

10.7 The Company’s Amended 2007 Stock Option Plan. (7).
10.8Termination and Non-Assertion Agreement with TSRL, Inc. (8)
31.1 Section 302 – Certification of the Principal Executive Officer. (9)
31.2Section 302 – Certification of the Principal Financial Officer. (9)
32.1Section 906 – Certification of the Chief Executive Office and Chief Financial Officer. (9)
101.INSXBRL Instance Document.
101.SCHXBRL Taxonomy Extension Schema Document.
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.
101.LABXBRL Taxonomy Extension Label Linkbase Document.
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.

 

 

------------------------------------------------------------------------------------------------------------------------

 

(1)Incorporated by reference to the Company’s Registration Statement on Form SB-2 (Registration No. 333-6680) filed on March 25, 1997.
(2)Incorporated by reference to the Company’s Form 10-KSB for the fiscal year ended August 31, 1997.
(3)Incorporated by reference to the Company’s Form 10-K for the fiscal year ended August 31, 2009.
(4)Incorporated by reference to the Company’s Form 10-K for the fiscal year ended August 31, 2010.
(5)Incorporated by reference to the Company’s Form 10-K for the fiscal year ended August 31, 2011.
(6)Incorporated by reference to the Company’s Form 8-K filed September 22, 2011.
(7)Incorporated by reference to the Company’s Form 10-Q filed April 9, 2014.
(8)Incorporated by reference to the Company’s Form 8-K filed May 19, 2014.
(9)Filed herewith.

 

29
 

 

SIGNATURE

 

In accordance with Section 13 or 15 (d) of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Lancaster, State of California, on July 8, 2014.

 

 

 Simulations Plus, Inc.
Date: July 8, 2014 
  
 By: /s/ John R Kneisel
John R. Kneisel
Chief Financial Officer

 

 

30

 

EX-31.1 2 simulations_10q-ex3101.htm CERTIFICATIONS

Exhibit 31.1

RULE 13A-14(A) CERTIFICATION

 

SIMULATIONS PLUS, INC.

a California corporation

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

I, Walter S. Woltosz, certify that:

 

 1. I have reviewed this Quarterly Report on Form 10Q of Simulations Plus, Inc., a California corporation;
   
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its condensed subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

  5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

  (a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and
     
  (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Dated: July 8, 2014 By: /s/ Walter S. Woltosz
   

Walter S. Woltosz

Chief Executive Officer

(Principal Executive Officer)

 

 

EX-31.2 3 simulations_10q-ex3102.htm CERTIFICATIONS

Exhibit 31.2

 

RULE 13A-14(A) CERTIFICATION

 

SIMULATIONS PLUS, INC.

a California corporation

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

I, John R. Kneisel, certify that:

 

 1. I have reviewed this Quarterly Report on Form 10Q of Simulations Plus, Inc., a California corporation;
   
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its condensed subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

  5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

  (a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and
     
  (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Dated: July 8, 2014 By: /s/ John R. Kneisel
   

John R. Kneisel

Chief Financial Officer

(Principal Financial Officer)

 

 

EX-32 4 simulations_10q-ex32.htm CERTIFICATIONS

Exhibit 32

 

CERTIFICATIONS PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

In connection with the Quarterly Report of Simulations Plus, Inc., a California corporation (the “Company”), on Form 10-Q for the quarter ended May 31, 2014, as filed with the Securities and Exchange Commission, Walter S. Woltosz, Chief Executive Officer of the Company and John R. Kneisel, Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. § 1350, that to his/her knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

 

/s/ Walter S. Woltosz

Walter S. Woltosz

Chief Executive Officer

(Principal Executive Officer)

July 8, 2014

 

 

/s/ John R. Kneisel

John R. Kneisel

Chief Financial Officer

(Principal Financial Officer)

July 8, 2014

 

(A signed original of this written statement required by Section 906 has been provided to Simulations Plus, Inc. and will be retained by Simulations Plus, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.)

 

 

 

 

EX-101.INS 5 simu-20140531.xml XBRL INSTANCE FILE 0001023459 2013-09-01 2014-05-31 0001023459 2014-07-08 0001023459 simu:RecordDate8Member 2013-09-01 2014-05-31 0001023459 simu:RecordDate9Member 2013-09-01 2014-05-31 0001023459 simu:RecordDate10Member 2013-09-01 2014-05-31 0001023459 simu:RecordDate4Member 2012-09-01 2013-08-31 0001023459 simu:RecordDate5Member 2012-09-01 2013-08-31 0001023459 simu:RecordDate6Member 2012-09-01 2013-08-31 0001023459 simu:RecordDate7Member 2012-09-01 2013-08-31 0001023459 2012-09-01 2013-08-31 0001023459 simu:QualifiedISOMember 2013-09-01 2014-05-31 0001023459 simu:QualifiedISOMember 2013-08-31 0001023459 simu:QualifiedISOMember 2014-05-31 0001023459 simu:NonQualifiedISOMember 2013-09-01 2014-05-31 0001023459 simu:NonQualifiedISOMember 2013-08-31 0001023459 simu:NonQualifiedISOMember 2014-05-31 0001023459 2014-05-31 0001023459 simu:StockOptionsOneMember 2013-09-01 2014-05-31 0001023459 simu:StockOptionsOneMember 2014-05-31 0001023459 simu:StockOptionsTwoMember 2013-09-01 2014-05-31 0001023459 simu:StockOptionsTwoMember 2014-05-31 0001023459 simu:StockOptionsThreeMember 2013-09-01 2014-05-31 0001023459 simu:StockOptionsThreeMember 2014-05-31 0001023459 simu:StockOptionsFourMember 2013-09-01 2014-05-31 0001023459 simu:StockOptionsFourMember 2014-05-31 0001023459 simu:InternationalSalesMember 2013-09-01 2014-05-31 0001023459 simu:InternationalSalesMember 2012-09-01 2013-05-31 0001023459 simu:Customer1Member us-gaap:SalesMember 2013-09-01 2014-05-31 0001023459 simu:Customer2Member us-gaap:SalesMember 2013-09-01 2014-05-31 0001023459 simu:Customer3Member us-gaap:SalesMember 2013-09-01 2014-05-31 0001023459 simu:Customer1Member us-gaap:SalesMember 2012-09-01 2013-05-31 0001023459 simu:Customer2Member us-gaap:SalesMember 2012-09-01 2013-05-31 0001023459 simu:Customer3Member us-gaap:SalesMember 2012-09-01 2013-05-31 0001023459 simu:CustomerAMember 2014-05-31 0001023459 simu:CustomerBMember 2014-05-31 0001023459 simu:CustomerCMember 2014-05-31 0001023459 simu:CustomerAMember 2013-05-31 0001023459 simu:CustomerBMember 2013-05-31 0001023459 simu:CustomerCMember 2013-05-31 0001023459 us-gaap:NorthAmericaMember 2013-09-01 2014-05-31 0001023459 us-gaap:EuropeMember 2013-09-01 2014-05-31 0001023459 us-gaap:AsiaMember 2013-09-01 2014-05-31 0001023459 us-gaap:SouthAmericaMember 2013-09-01 2014-05-31 0001023459 us-gaap:NorthAmericaMember 2012-09-01 2013-05-31 0001023459 us-gaap:EuropeMember 2012-09-01 2013-05-31 0001023459 us-gaap:AsiaMember 2012-09-01 2013-05-31 0001023459 us-gaap:SouthAmericaMember 2012-09-01 2013-05-31 0001023459 2012-09-01 2013-05-31 0001023459 2014-03-01 2014-05-31 0001023459 2013-03-01 2013-05-31 0001023459 us-gaap:EquipmentMember 2013-09-01 2014-05-31 0001023459 us-gaap:ComputerEquipmentMember 2013-09-01 2014-05-31 0001023459 us-gaap:FurnitureAndFixturesMember 2013-09-01 2014-05-31 0001023459 us-gaap:LeaseholdImprovementsMember 2013-09-01 2014-05-31 0001023459 us-gaap:FairValueInputsLevel1Member 2014-05-31 0001023459 us-gaap:FairValueInputsLevel2Member 2014-05-31 0001023459 us-gaap:FairValueInputsLevel3Member 2014-05-31 0001023459 2013-08-31 0001023459 us-gaap:EquipmentMember 2014-05-31 0001023459 us-gaap:ComputerEquipmentMember 2014-05-31 0001023459 us-gaap:FurnitureAndFixturesMember 2014-05-31 0001023459 us-gaap:LeaseholdImprovementsMember 2014-05-31 0001023459 us-gaap:MinimumMember 2014-05-31 0001023459 us-gaap:MaximumMember 2014-05-31 0001023459 2012-08-31 0001023459 2013-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SIMULATIONS PLUS INC 0001023459 10-Q 2014-05-31 false No No Yes Smaller Reporting Company Q3 2014 16342804 --08-31 <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">This report on Form 10-Q for the quarter ended May 31, 2014, should be read in conjunction with the Company's annual report on Form 10-K for the year ended August 31, 2013, filed with the Securities and Exchange Commission (&#147;SEC&#148;) on November 18, 2013. As contemplated by the SEC under Article 8 of Regulation S-X, the accompanying financial statements and footnotes have been condensed and therefore do not contain all disclosures required by generally accepted accounting principles. The interim financial data are unaudited; however, in the opinion of Simulations Plus, Inc. (&#34;we&#34;, &#34;our&#34;, &#34;us&#34;), the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Results for interim periods are not necessarily indicative of those to be expected for the full year.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Estimates</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Our condensed financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management&#146;s application of accounting policies. Actual results could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized computer software development costs, valuation of stock options, and accounting for income taxes.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize revenues related to software licenses and software maintenance in accordance with Financial Accounting Standard Board (&#147;FASB&#148;) Accounting Standard Codification (&#147;ASC&#148;) 985-605, &#147;<i>Software - Revenue Recognition&#148;</i>. Software product revenue is recorded when the following conditions are met: 1) evidence of arrangement exists, 2) delivery has been made, 3) the amount is fixed, and 4) collectability is probable. Post-contract customer support (&#34;PCS&#34;) obligations are insignificant; therefore, revenue for PCS is recognized at the same time as the licensing fee, and the costs of providing such support services are accrued and amortized over the obligation period.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As a byproduct of ongoing improvements and upgrades for the new programs and new modules of software, some modifications are provided to customers who have already purchased software at no additional charge. Other software modifications result in new, additional cost modules that expand the functionality of the software. These are licensed separately. We consider the modifications that are provided without charge to be minimal, as they do not significantly change the basic functionality or utility of the software, but rather add convenience, such as being able to plot some additional variable on a graph in addition to the numerous variables that had been available before, or adding some additional calculations to supplement the information provided from running the software. Such software modifications for any single product have typically occurred once or twice per year, sometimes more, sometimes less. Thus, they are infrequent. The Company provides, for a fee, additional training and service calls to its customers and recognizes revenue at the time the training or service call is provided.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Generally, we enter into one-year license agreements with customers for the use of our pharmaceutical software products. We recognize revenue on these contracts when all the criteria are met.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Most license agreements have a term of one year; however, from time to time, we enter into multi-year license agreements. We generally unlock and invoice software one year at a time for multi-year licenses. Therefore, revenue is recognized one year at a time.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize revenue from collaboration research and revenue from grants equally over their terms. However, we recognize contract study revenue using the percentage-of-completion method, depending upon how the contract studies are engaged, in accordance with ASC 605-35, &#147;<i>Revenue Recognition &#150; Construction-Type and Production-Type Contracts&#148;</i>. To recognize revenue using the percentage-of-completion method, we must determine whether we meet the following criteria: 1) there is a long-term, legally enforceable contract, 2) it is possible to reasonably estimate the total project costs, and 3) it is possible to reasonably estimate the extent of progress toward completion.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and Cash Equivalents</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For purposes of the statements of cash flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We analyze the age of customer balances, historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability of the Company&#146;s trade accounts receivable balances. If we determine that the financial conditions of any of its customers deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable are written off when all collection attempts have failed.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Capitalized Computer Software Development Costs</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Software development costs are capitalized in accordance with ASC 985-20,&#160;<i>&#147;Costs of Software to Be Sold, Leased, or Marketed&#148;</i>. Capitalization of software development costs begins upon the establishment of technological feasibility and is discontinued when the product is available for sale.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The establishment of technological feasibility and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues, estimated economic life, and changes in software and hardware technologies. Capitalized software development costs are comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in our software products.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of capitalized software development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the products (not to exceed five years, although all of our current software products have already been on the market for 7-15 years except for our newest MedChem Designer&#153; program, and we do not foresee an end-of-life for any of them at this point). Amortization of software development costs amounted to $584,237 and $532,106 for the nine months ended May 31, 2014 and 2013, respectively, and amortization of software development costs was $200,585 and $173,094 for the three months ended May 31, 2014 and 2013, respectively. We expect future amortization expense to vary due to increases in capitalized computer software development costs.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We test capitalized computer software development costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Property and Equipment</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 8pt/115% Times New Roman, Times, Serif">Equipment</td> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 8pt/115% Times New Roman, Times, Serif; text-align: right">5 years</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font: 8pt/115% Times New Roman, Times, Serif">Computer equipment</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font: 8pt/115% Times New Roman, Times, Serif; text-align: right">3 to 7 years</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font: 8pt/115% Times New Roman, Times, Serif">Furniture and fixtures</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font: 8pt/115% Times New Roman, Times, Serif; text-align: right">5 to 7 years</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font: 8pt/115% Times New Roman, Times, Serif">Leasehold improvements</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font: 8pt/115% Times New Roman, Times, Serif; text-align: right">Shorter of life of asset or lease</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value of Financial Instruments</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Assets and liabilities recorded at fair value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The categories, as defined by the standard are as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: bottom; width: 14%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><b>Level&#160;Input:</b></td> <td style="vertical-align: top; width: 1%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; width: 85%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><b>Input Definition:</b></td></tr> <tr style="vertical-align: top"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Level I</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</td></tr> <tr style="vertical-align: top"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Level II</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</td></tr> <tr style="vertical-align: top"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Level III</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Unobservable inputs that reflect management&#146;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes fair value measurements by level at May 31, 2014 for assets and liabilities measured at fair value on a recurring basis:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Level I</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Level II</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Level III</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Total</b></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%; padding-left: 5.4pt; line-height: 115%">Cash and cash equivalents</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 11%; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right; line-height: 115%">7,757,972</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 11%; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 10%; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%">$</td> <td style="width: 10%; border-bottom: black 1pt solid; text-align: right; line-height: 115%">7,757,972</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="background-color: #EEEEEE"> <td style="vertical-align: top; padding-left: 25.4pt; line-height: 115%">Total</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; text-align: right; line-height: 115%">7,757,972</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; padding-left: 25.4pt; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; padding-left: 25.4pt; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; padding-left: 25.4pt; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right; line-height: 115%">7,757,972</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain of our financial instruments, including accounts receivable, accounts payable, contract payable, accrued payroll and other expenses, and accrued bonus to officer, the amounts approximate fair value due to their short maturities.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Research and Development Costs</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are charged to expense as incurred until technological feasibility has been established. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased software and databases which were developed by other companies and incorporated into, or used in the development of, our final products.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We utilize FASB ASC 740-10,&#160;<i>&#147;Income Taxes&#148;</i>&#160;which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Intellectual property</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 28, 2012, we bought out the royalty agreement with Enslein Research of Rochester, New York. The cost of $75,000 is being amortized over 10 years under the straight-line method. Amortization expense for each of the nine months periods ended May 31, 2014 and 2013 was $5,625 and was $1,875 for each three month period ended May 31, 2014 and 2013. Accumulated amortization as of May 31, 2013 was $16,875.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 15, 2014, we acquired intellectual property from TSRL, Inc of Ann Arbor, Michigan. The cost of $6,000,000 is being amortized over 10 years under the straight-line method. Amortization expense for the period of May 15, 2014 to May 31, 2014 was $25,000. Accumulated amortization as of May 31, 2014 was $25,000. (See Note 4)</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Total amortization expense for intellectual property agreements for each of the nine months periods ended May 31, 2014 and 2013 was $30,625 and $ 5,625, respectively, and was $26,875 and $1,875 respectively for the three month periods ended May 31, 2014 and 2013. Accumulated amortization as of May 31, 2014 was $41,875.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Earnings per Share</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We report earnings per share in accordance with FASB ASC 260-10. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted earnings per share for the three and nine months ended May 31, 2014 and 2013 were as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Three months ended</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Nine months ended</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2014</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2013</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2014</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2013</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">Numerator:</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 42%; padding-left: 15.4pt; text-align: justify; line-height: 115%; text-indent: -10pt">Net income attributable to common shareholders&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">1,307,549</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">993,230</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">2,802,568</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">2,641,791</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 115%">Denominator:</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 15.4pt; text-align: justify; line-height: 115%; text-indent: -10pt">Weighted-average number of common shares outstanding during the period</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,193,976</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,024,467</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,117,198</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">15,984,819</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 115%">Dilutive effect of stock options</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">261,102</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">311,141</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">244,497</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">322,799</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 15.4pt; text-align: justify; line-height: 115%; text-indent: -10pt">Common stock and common stock equivalents used for diluted earnings per share</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,455,078</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,335,608</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,361,695</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,307,618</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-Based Compensation</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Compensation costs related to stock options are determined in accordance with FASB ASC 718-10,&#160;<i>&#147;Compensation-Stock Compensation&#148;,</i>&#160;using the modified prospective method. Under this method, compensation cost is calculated based on the grant-date fair value estimated in accordance FASB ASC 718-10, amortized on a straight-line basis over the options&#146; vesting period. Stock-based compensation was $103,498 and $98,495 for the nine months ended May 31, 2014 and 2013, respectively, and was $32,411 and $28,241 for the three months ended May 31, 2014 and 2013, respectively. This expense is included in the condensed statements of operations as Selling, General and Administration (SG&#38;A), and Research and Development expense.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recently Issued Accounting Pronouncements</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2012, the FASB issued ASU 2012-02, &#147;<i>Testing Indefinite-Lived Intangible Assets for Impairment&#148;,</i>&#160;which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September 15, 2012 and earlier adoption is permitted. We adopted this standard in the first quarter of fiscal year 2013. We believe adoption did not have a material effect on our financial statements.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2013, the FASB issued ASU 2013-11,&#160;<i>Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists</i>, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity&#146;s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. The standard will eliminate the transaction- and industry-specific revenue recognition guidance under current U.S. GAAP and replace it with a principles-based approach for determining revenue recognition. ASU 2014-09 is effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The revenue recognition standard is required to be applied retrospectively, including any combination of practical expedients as allowed in the standard. We are evaluating the impact, if any, of the adoption of ASU 2014-09 to our financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment as of May 31, 2014 consisted of the following:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 77%; padding-left: 5.4pt; text-align: justify; line-height: 115%">Equipment</td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">124,042</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Computer equipment</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">145,893</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Furniture and fixtures</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">51,466</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Leasehold improvements</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">23,646</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 22pt; text-align: justify; line-height: 115%">Sub total</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">345,047</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Less: Accumulated depreciation and amortization</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">(241,451</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 22pt; text-align: justify; line-height: 115%">Net Book Value</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">103,596</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 15, 2014 the Company entered into an agreement (the &#147;Agreement&#148;) with TSRL, Inc., a Michigan corporation (&#147;TSRL&#148;). Under the terms of the Agreement, the Company and TSRL agreed to transfer the rights of the intellectual property under the Exclusive Software Licensing Agreement dated June 30, 1997 (the &#147;License Agreement&#148;), under which TSRL licensed to the Company certain Software Technology and Databases (as defined in the License Agreement), and pursuant to which the Company paid royalties to TSRL to the Company.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Agreement calls for the Company to pay TSRL total consideration of $6 million. The Company paid $3.5 million on May 20, 2014, comprised of cash in the amount of $2.5 million and the issuance of $1 million worth of the Company&#146;s common stock-- 164,745 shares of the Company&#146;s common stock based upon the April 25, 2014 closing price per share of $6.07. Future payments under the Agreement, which is non-interest- bearing, are due as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 77%; padding-left: 5.4pt; text-align: justify; line-height: 115%">April 25, 2015</td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">750,000</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">April 25, 2016</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">750,000</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">April 25, 2017</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Total</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2,500,000</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Less Current portion</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">(750,000</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Contract payable, net of current portion</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,750,000</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Employment Agreement</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 22, 2012, the Company entered into an employment agreement with its President/Chief Executive Officer that expired in August 2013. The employment agreement provided for an annual base salary of $300,000 per year, and a performance bonus in an amount not to exceed 10% of Employee&#146;s salary, or $30,000 per year, at the end of each fiscal year. The specific amount of the bonus to be awarded to be determined by the Compensation Committee of the Board of Directors, based on the financial performance and achievements of the Company for the previous fiscal year. The agreement also provided for Employee stock options, exercisable for five years, to purchase fifty (50) shares of Common Stock for each one thousand dollars ($1,000) of net income before taxes at the end of each fiscal year up to a maximum of 120,000 options over the term of the agreement at an exercise price equal to ten percent (10%) over the market value per share as of the date of grant (the number of shares to be adjusted accordingly for any stock splits or reverse splits after the date of the agreement). The agreement allows the Company to terminate the agreement upon 30 days written notice, if termination is without cause, the Company's only obligation would be to pay its President the greater of a) 12 month&#146;s salary or b) the remainder of the term of the employment agreement from the date of notice of termination.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For fiscal year 2013, the Compensation Committee awarded a $30,000 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was paid in September 2013.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 22, 2013, effective as of September 1, 2013, the CEO&#146;s employment agreement was renewed for another year by the Compensation Committee and provides for an annual bonus of up to five percent (5%) of the Company&#146;s net income before taxes of the previous fiscal year not to exceed $60,000. In addition, at the CEO&#146;s request, the agreement calls for a reduced granting of ten (10) options to purchase shares of the Company&#146;s common stock for each $1,000 of net income before taxes that the Company earns at the end of each fiscal year (up to a maximum of twenty thousand (20,000) options over the term of the agreement) at an exercise price equal to ten percent (10%) over the market value per share as of the date of grant (the number of shares to be adjusted accordingly for any stock splits or reverse splits after the date of the agreement). A copy of the agreement is attached to the Company&#146;s 2013 Form 10-K filed with the SEC on November 18, 2013 as Exhibit 10.9.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><u>Litigation</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a party to litigation. Management does not believe the outcome of such litigation will have a material impact on the Company's financial position.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Dividend</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board of Directors declared cash dividends during fiscal year 2013. The details of dividends paid are in the following table:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Record Date</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Distribution Date</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Number of Shares Outstanding on Record Date</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Dividend per Share</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Total Amount</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 14%; padding-left: 5.4pt; text-align: right; line-height: 115%">11/8/2012</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 14%; padding-left: 5.4pt; text-align: right; line-height: 115%">11/13/2012</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 28%; padding-left: 5.4pt; text-align: right; line-height: 115%">15,927,806</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 15%; padding-left: 5.4pt; text-align: right; line-height: 115%">0.05</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">796,390</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">12/24/2012</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">12/28/2012</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">16,021,309</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">0.14</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2,242,983</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">5/7/2013</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">5/10/2013</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">16,030,433</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">0.03</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">480,913</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">8/12/2013</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">8/15/2013</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">16,030,894</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">0.03</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">480,926</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><b>Total</b></td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><b>$</b></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>4,001,212</b></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board of Directors has also declared cash dividends during fiscal year 2014. The details of dividends paid are in the following table:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Record Date</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Distribution Date</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Number of Shares Outstanding on Record Date</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Dividend per Share</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Total Amount</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 14%; padding-left: 5.4pt; text-align: right; line-height: 115%">11/08/2013</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 15%; padding-left: 5.4pt; text-align: right; line-height: 115%; text-indent: 15pt">11/15/2013</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 27%; padding-left: 5.4pt; text-align: right; line-height: 115%">16,073,894</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 15%; padding-left: 5.4pt; text-align: right; line-height: 115%">0.04</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">642,956</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">2/17/2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">2/24/2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">16,149,460</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">0.05</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">807,473</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">5/09/2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">5/16/2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">16,165,171</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">0.05</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: justify; line-height: 115%">$</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">808,259</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><b>Total</b></td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><b>$</b></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>2,258,688</b></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock Option Plan</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In September 1996, the Board of Directors adopted, and the shareholders approved, the 1996 Stock Option Plan (the &#34;Option Plan&#34;) under which a total of 1,000,000 shares of common stock had been reserved for issuance. In March 1999, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 2,000,000. In February 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 4,000,000. In December 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 5,000,000. Furthermore, in February 2005, the shareholders approved an additional 1,000,000 shares, resulting in the total number of shares that may be granted under the Option Plan to 6,000,000. The 1996 Stock Option Plan terminated in September 2006 by its term.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 23, 2007, the Board of Directors adopted and the shareholders approved the 2007 Stock Option Plan under which a total of 1,000,000 shares of common stock had been reserved for issuance. On February 25, 2014 the shareholders approved an additional 1,000,000 shares increasing the total number of shares that may be granted under the Option Plan to 2,000,000.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><u>Qualified Incentive Stock Options (Qualified ISO)</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of May 31, 2014, employees hold Qualified ISO to purchase 466,000 shares of common stock at exercise prices ranging from $1.00 to $5.61 which were granted prior to May 31, 2014.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Transactions in FY14</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Number of Options</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted-Average Exercise Price&#160;<br /> Per Share</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted-Average Remaining Contractual Life</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 58%; padding-left: 5.4pt; text-align: justify; line-height: 115%">Outstanding, August 31, 2013</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 11%; padding-left: 5.4pt; text-align: right; line-height: 115%">532,000</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 10%; padding-left: 5.4pt; text-align: right; line-height: 115%">1.82</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%">3.95</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Granted</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">100,000</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">5.61</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Exercised</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">(160,000</td> <td style="line-height: 115%">)</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">1.36</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Cancelled/Forfeited</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">(6,000</td> <td style="line-height: 115%">)</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">1.00</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Outstanding, May 31, 2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">466,000</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">2.80</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">3.57</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Exercisable, &#160;May 31, 2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">314,000</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">1.78</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">3.31</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the options, including both ISO and NQSO options, granted during the nine months ended May 31, 2014 is estimated at $130,781. The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions for FQE May 31, 2014: dividend yield of 3.14%, pre-vest forfeiture rate of 6.25%, expected volatility of 38.95%, risk-free interest rate of 1.36%, and expected life of 5.0 years.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Non-Qualified Stock Options (Non-Qualified ISO)</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of May 31, 2014, the outside members of the Board of Directors hold options to purchase 45,600 shares of common stock at exercise prices ranging from $1.67 to $6.68, which were granted prior to May 31, 2014.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Transactions in FY14</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Number of Options</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; padding-bottom: 1pt"> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Weighted-Average Exercise Price</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Per Share</p></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted-Average Remaining Contractual Life</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 58%; padding-left: 5.4pt; text-align: justify; line-height: 115%">Outstanding, August 31, 2013</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 11%; padding-left: 5.4pt; text-align: right; line-height: 115%">48,600</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 10%; padding-left: 5.4pt; text-align: right; line-height: 115%">3.79</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%">7.85</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Exercised</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">(3,000</td> <td style="line-height: 115%">)</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">1.80</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Outstanding, May 31, 2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">45,600</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">3.92</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">7.29</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Exercisable, &#160;May 31, 2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">25,200</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">3.45</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">6.12</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 1in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted-average remaining contractual life of options outstanding issued under the Plan, both Qualified ISO and Non-Qualified SO, was 4.19 years at May 31, 2014. The exercise prices for the options outstanding at May 31, 2014 ranged from $1.00 to $6.68, and the information relating to these options is as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Exercise Price</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Awards Outstanding</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Awards Exercisable</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Low</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">High</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Quantity</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted Average Remaining Contractual Life</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Quantity</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted Average Remaining Contractual Life</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 10%; text-align: right; line-height: 115%">1.00</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 10%; text-align: right; line-height: 115%">1.50</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%">212,500</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 16%; text-align: right; line-height: 115%">3.54</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 10%; text-align: right; line-height: 115%">1.05</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%">212,500</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 8%; text-align: right; line-height: 115%">3.54</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 3%; text-align: right; line-height: 115%">1.05</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1.51</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">3.00</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">21,600</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">5.86</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2.28</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">11,600</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">5.83</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2.11</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">3.01</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">4.50</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">141,900</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">3.38</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">3.28</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">103,500</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">3.24</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">3.23</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">4.51</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">6.68</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">136,000</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">4.70</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">5.49</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">12,000</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">3.27</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">5.59</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>511,600</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>3.90</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><b>$</b></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>2.90</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>339,200</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>3.52</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><b>$</b></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>1.90</b></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of May 31, 2014, included in bonus expenses to officers was $120,000, of which $45,000 was accrued bonus representing an estimated quarterly amount of bonus payable to the Corporate Secretary, Virginia Woltosz, as part of the terms of the sale of Words+ to Simulations Plus in 1996, and $45,000 accrued bonus representing an estimated quarterly amount of bonus payable to our President/Chief Executive Officer, Walter Woltosz as part of his 2014 employment agreement The other $30,000, paid in September 2013, was FY2013 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was approved by the compensation committee in September 2013.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue concentration shows that International sales accounted for 53% and 42% of net sales for the nine months ended May 31, 2014 and 2013, respectively. Three customers accounted for 14% (a dealer account in Japan representing various customers), 9% and 5% of sales for the nine months ended May 31, 2014 compared to three customers who accounted for 10% (a dealer account in Japan representing various customers) 9% and 7% of net sales during the nine months ended May 31, 2013.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable concentration shows that three customers comprised 23%, 18% (a dealer account in Japan representing various customers) and 10% of accounts receivable at May 31, 2014 compared to three customers comprising 18%, 13% and 11% (a dealer account in Japan representing various customers) of accounts receivable at May 31, 2013.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We operate in the computer software industry, which is highly competitive and changes rapidly. Our operating results could be significantly affected by our ability to develop new products and find new distribution channels for new and existing products.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The majority of our customers are in the pharmaceutical industry. During the current economic downturn, we have seen consolidations in the pharmaceutical industry, especially in this first fiscal quarter of 2013. Although we have not seen any significant reduction in total revenues to date, our growth rate has been affected. Continued consolidation and downsizing in the pharmaceutical industry could have an impact on our revenues and earnings going forward.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">We allocate revenues to geographic areas based on the locations of our customers. Geographical revenues for the nine months ended May 31, 2014 and 2013 were as follows (in thousands):</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Nine month ended</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">North America</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Europe</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Asia</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">South America</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Total</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 20%; text-align: right; line-height: 115%">May 31, 2014</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">4,480</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">2,684</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">2,273</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">26</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">9,463</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">May 31, 2013</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">4,413</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2,673</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1,416</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">8,503</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain a 401(K) Plan for all eligible employees, and we make matching contributions equal to 100% of the employee&#146;s elective deferral, not to exceed 4% of total employee compensation. We can also elect to make a profit-sharing contribution. Our contributions to this Plan amounted to $89,784 and $76,317 for the nine months ended May 31, 2014 and 2013, respectively, and $28,028 and $25,772 for the three months ended May 31, 2014 and 2013, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On or about June 26, 2014, the Company was served with a complaint in a civil action entitled Sherri Winslow v. Incredible Adventures, Inc., et al. (Los Angeles Superior Court Case No. BC545789) alleging wrongful death and seeking unspecified damages arising out of a May 18, 2012 plane crash in the State of Nevada (the &#147;Complaint&#148;). In the Complaint, Plaintiff alleges that the Company was the owner of the subject aircraft.&#160;&#160; The Company denies all material allegations against it, including that it owns or has ever owned any interest in the subject aircraft, and intends to vigorously defend itself.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Our condensed financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management&#146;s application of accounting policies. Actual results could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized computer software development costs, valuation of stock options, and accounting for income taxes.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize revenues related to software licenses and software maintenance in accordance with Financial Accounting Standard Board (&#147;FASB&#148;) Accounting Standard Codification (&#147;ASC&#148;) 985-605, &#147;<i>Software - Revenue Recognition&#148;</i>. Software product revenue is recorded when the following conditions are met: 1) evidence of arrangement exists, 2) delivery has been made, 3) the amount is fixed, and 4) collectability is probable. Post-contract customer support (&#34;PCS&#34;) obligations are insignificant; therefore, revenue for PCS is recognized at the same time as the licensing fee, and the costs of providing such support services are accrued and amortized over the obligation period.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As a byproduct of ongoing improvements and upgrades for the new programs and new modules of software, some modifications are provided to customers who have already purchased software at no additional charge. Other software modifications result in new, additional cost modules that expand the functionality of the software. These are licensed separately. We consider the modifications that are provided without charge to be minimal, as they do not significantly change the basic functionality or utility of the software, but rather add convenience, such as being able to plot some additional variable on a graph in addition to the numerous variables that had been available before, or adding some additional calculations to supplement the information provided from running the software. Such software modifications for any single product have typically occurred once or twice per year, sometimes more, sometimes less. Thus, they are infrequent. The Company provides, for a fee, additional training and service calls to its customers and recognizes revenue at the time the training or service call is provided.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Generally, we enter into one-year license agreements with customers for the use of our pharmaceutical software products. We recognize revenue on these contracts when all the criteria are met.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Most license agreements have a term of one year; however, from time to time, we enter into multi-year license agreements. We generally unlock and invoice software one year at a time for multi-year licenses. Therefore, revenue is recognized one year at a time.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize revenue from collaboration research and revenue from grants equally over their terms. However, we recognize contract study revenue using the percentage-of-completion method, depending upon how the contract studies are engaged, in accordance with ASC 605-35, &#147;<i>Revenue Recognition &#150; Construction-Type and Production-Type Contracts&#148;</i>. To recognize revenue using the percentage-of-completion method, we must determine whether we meet the following criteria: 1) there is a long-term, legally enforceable contract, 2) it is possible to reasonably estimate the total project costs, and 3) it is possible to reasonably estimate the extent of progress toward completion.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For purposes of the statements of cash flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We analyze the age of customer balances, historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability of the Company&#146;s trade accounts receivable balances. If we determine that the financial conditions of any of its customers deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable are written off when all collection attempts have failed.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Software development costs are capitalized in accordance with ASC 985-20,&#160;<i>&#147;Costs of Software to Be Sold, Leased, or Marketed&#148;</i>. Capitalization of software development costs begins upon the establishment of technological feasibility and is discontinued when the product is available for sale.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The establishment of technological feasibility and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues, estimated economic life, and changes in software and hardware technologies. Capitalized software development costs are comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in our software products.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of capitalized software development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the products (not to exceed five years, although all of our current software products have already been on the market for 7-15 years except for our newest MedChem Designer&#153; program, and we do not foresee an end-of-life for any of them at this point). Amortization of software development costs amounted to $584,237 and $532,106 for the nine months ended May 31, 2014 and 2013, respectively, and amortization of software development costs was $200,585 and $173,094 for the three months ended May 31, 2014 and 2013, respectively. We expect future amortization expense to vary due to increases in capitalized computer software development costs.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We test capitalized computer software development costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Equipment</td> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">5 years</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Computer equipment</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">3 to 7 years</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Furniture and fixtures</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">5 to 7 years</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Leasehold improvements</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">Shorter of life of asset or lease</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Assets and liabilities recorded at fair value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The categories, as defined by the standard are as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: bottom; width: 14%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><b>Level&#160;Input:</b></td> <td style="vertical-align: top; width: 1%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; width: 85%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><b>Input Definition:</b></td></tr> <tr style="vertical-align: top"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Level I</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</td></tr> <tr style="vertical-align: top"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Level II</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</td></tr> <tr style="vertical-align: top"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Level III</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Unobservable inputs that reflect management&#146;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes fair value measurements by level at May 31, 2014 for assets and liabilities measured at fair value on a recurring basis:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Level I</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Level II</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Level III</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Total</b></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%; padding-left: 5.4pt; line-height: 115%">Cash and cash equivalents</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 11%; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right; line-height: 115%">7,757,972</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 11%; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 10%; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%">$</td> <td style="width: 10%; border-bottom: black 1pt solid; text-align: right; line-height: 115%">7,757,972</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="background-color: #EEEEEE"> <td style="vertical-align: top; padding-left: 25.4pt; line-height: 115%">Total</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; text-align: right; line-height: 115%">7,757,972</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; padding-left: 25.4pt; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; padding-left: 25.4pt; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; padding-left: 25.4pt; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right; line-height: 115%">7,757,972</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain of our financial instruments, including accounts receivable, accounts payable, contract payable, accrued payroll and other expenses, and accrued bonus to officer, the amounts approximate fair value due to their short maturities.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are charged to expense as incurred until technological feasibility has been established. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased software and databases which were developed by other companies and incorporated into, or used in the development of, our final products.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We utilize FASB ASC 740-10,&#160;<i>&#147;Income Taxes&#148;</i>&#160;which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 28, 2012, we bought out the royalty agreement with Enslein Research of Rochester, New York. The cost of $75,000 is being amortized over 10 years under the straight-line method. Amortization expense for each of the nine months periods ended May 31, 2014 and 2013 was $5,625 and was $1,875 for each three month period ended May 31, 2014 and 2013. Accumulated amortization as of May 31, 2013 was $16,875.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 15, 2014, we acquired intellectual property from TSRL, Inc of Ann Arbor, Michigan. The cost of $6,000,000 is being amortized over 10 years under the straight-line method. Amortization expense for the period of May 15, 2014 to May 31, 2014 was $25,000. Accumulated amortization as of May 31, 2014 was $25,000. (See Note 4)</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Total amortization expense for intellectual property agreements for each of the nine months periods ended May 31, 2014 and 2013 was $30,625 and $ 5,625, respectively, and was $26,875 and $1,875 respectively for the three month periods ended May 31, 2014 and 2013. Accumulated amortization as of May 31, 2014 was $41,875.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We report earnings per share in accordance with FASB ASC 260-10. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted earnings per share for the three and nine months ended May 31, 2014 and 2013 were as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Three months ended</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Nine months ended</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2014</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2013</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2014</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2013</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">Numerator:</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 42%; padding-left: 15.4pt; text-align: justify; line-height: 115%; text-indent: -10pt">Net income attributable to common shareholders&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">1,307,549</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">993,230</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">2,802,568</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">2,641,791</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 115%">Denominator:</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 15.4pt; text-align: justify; line-height: 115%; text-indent: -10pt">Weighted-average number of common shares outstanding during the period</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,193,976</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,024,467</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,117,198</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">15,984,819</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 115%">Dilutive effect of stock options</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">261,102</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">311,141</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">244,497</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">322,799</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 15.4pt; text-align: justify; line-height: 115%; text-indent: -10pt">Common stock and common stock equivalents used for diluted earnings per share</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,455,078</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,335,608</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,361,695</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,307,618</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Compensation costs related to stock options are determined in accordance with FASB ASC 718-10,&#160;<i>&#147;Compensation-Stock Compensation&#148;,</i>&#160;using the modified prospective method. Under this method, compensation cost is calculated based on the grant-date fair value estimated in accordance FASB ASC 718-10, amortized on a straight-line basis over the options&#146; vesting period. Stock-based compensation was $103,498 and $98,495 for the nine months ended May 31, 2014 and 2013, respectively, and was $32,411 and $28,241 for the three months ended May 31, 2014 and 2013, respectively. This expense is included in the condensed statements of operations as Selling, General and Administration (SG&#38;A), and Research and Development expense.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2012, the FASB issued ASU 2012-02, &#147;<i>Testing Indefinite-Lived Intangible Assets for Impairment&#148;,</i>&#160;which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September 15, 2012 and earlier adoption is permitted. We adopted this standard in the first quarter of fiscal year 2013. We believe adoption did not have a material effect on our financial statements.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2013, the FASB issued ASU 2013-11,&#160;<i>Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists</i>, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity&#146;s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. The standard will eliminate the transaction- and industry-specific revenue recognition guidance under current U.S. GAAP and replace it with a principles-based approach for determining revenue recognition. ASU 2014-09 is effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The revenue recognition standard is required to be applied retrospectively, including any combination of practical expedients as allowed in the standard. We are evaluating the impact, if any, of the adoption of ASU 2014-09 to our financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Level I</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Level II</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Level III</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><b>Total</b></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%; padding-left: 5.4pt; line-height: 115%">Cash and cash equivalents</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 11%; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right; line-height: 115%">7,757,972</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 11%; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 10%; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1pt solid; line-height: 115%">$</td> <td style="width: 10%; border-bottom: black 1pt solid; text-align: right; line-height: 115%">7,757,972</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="background-color: #EEEEEE"> <td style="vertical-align: top; padding-left: 25.4pt; line-height: 115%">Total</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; text-align: right; line-height: 115%">7,757,972</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; padding-left: 25.4pt; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; padding-left: 25.4pt; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-left: 25.4pt; text-align: right; line-height: 115%">&#150;</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; padding-left: 25.4pt; line-height: 115%">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right; line-height: 115%">7,757,972</td> <td style="vertical-align: bottom; line-height: 115%">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Three months ended</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Nine months ended</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2014</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2013</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2014</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">05/31/2013</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">Numerator:</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 42%; padding-left: 15.4pt; text-align: justify; line-height: 115%; text-indent: -10pt">Net income attributable to common shareholders&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">1,307,549</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">993,230</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">2,802,568</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 11%; text-align: right; line-height: 115%">2,641,791</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 115%">Denominator:</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 15.4pt; text-align: justify; line-height: 115%; text-indent: -10pt">Weighted-average number of common shares outstanding during the period</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,193,976</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,024,467</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,117,198</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">15,984,819</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; line-height: 115%">Dilutive effect of stock options</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">261,102</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">311,141</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">244,497</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">322,799</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 15.4pt; text-align: justify; line-height: 115%; text-indent: -10pt">Common stock and common stock equivalents used for diluted earnings per share</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,455,078</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,335,608</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,361,695</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">16,307,618</td> <td style="line-height: 115%">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Equipment</td> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">5 years</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Computer equipment</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">3 to 7 years</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Furniture and fixtures</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">5 to 7 years</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Leasehold improvements</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">Shorter of life of asset or lease</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 77%; padding-left: 5.4pt; text-align: justify; line-height: 115%">Equipment</td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">124,042</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Computer equipment</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">145,893</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Furniture and fixtures</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">51,466</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Leasehold improvements</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">23,646</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 22pt; text-align: justify; line-height: 115%">Sub total</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">345,047</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Less: Accumulated depreciation and amortization</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">(241,451</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 22pt; text-align: justify; line-height: 115%">Net Book Value</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">103,596</td> <td style="line-height: 115%">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 77%; padding-left: 5.4pt; text-align: justify; line-height: 115%">April 25, 2015</td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">750,000</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">April 25, 2016</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">750,000</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">April 25, 2017</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Total</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2,500,000</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Less Current portion</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">(750,000</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Contract payable, net of current portion</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,750,000</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board of Directors declared cash dividends during fiscal year 2013. The details of dividends paid are in the following table:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Record Date</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Distribution Date</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Number of Shares Outstanding on Record Date</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Dividend per Share</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Total Amount</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 14%; padding-left: 5.4pt; text-align: right; line-height: 115%">11/8/2012</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 14%; padding-left: 5.4pt; text-align: right; line-height: 115%">11/13/2012</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 28%; padding-left: 5.4pt; text-align: right; line-height: 115%">15,927,806</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 15%; padding-left: 5.4pt; text-align: right; line-height: 115%">0.05</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">796,390</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">12/24/2012</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">12/28/2012</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">16,021,309</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">0.14</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2,242,983</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">5/7/2013</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">5/10/2013</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">16,030,433</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">0.03</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">480,913</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">8/12/2013</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">8/15/2013</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">16,030,894</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">0.03</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">480,926</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><b>Total</b></td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><b>$</b></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>4,001,212</b></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board of Directors has also declared cash dividends during fiscal year 2014. The details of dividends paid are in the following table:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Record Date</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Distribution Date</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Number of Shares Outstanding on Record Date</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Dividend per Share</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Total Amount</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 14%; padding-left: 5.4pt; text-align: right; line-height: 115%">11/08/2013</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 15%; padding-left: 5.4pt; text-align: right; line-height: 115%; text-indent: 15pt">11/15/2013</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 27%; padding-left: 5.4pt; text-align: right; line-height: 115%">16,073,894</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 15%; padding-left: 5.4pt; text-align: right; line-height: 115%">0.04</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">642,956</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">2/17/2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">2/24/2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">16,149,460</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">0.05</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">807,473</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">5/09/2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">5/16/2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">16,165,171</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">0.05</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: justify; line-height: 115%">$</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">808,259</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: center; line-height: 115%"><b>Total</b></td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><b>$</b></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>2,258,688</b></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Exercise Price</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Awards Outstanding</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Awards Exercisable</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Low</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">High</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Quantity</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted Average Remaining Contractual Life</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Quantity</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted Average Remaining Contractual Life</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 10%; text-align: right; line-height: 115%">1.00</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 10%; text-align: right; line-height: 115%">1.50</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%">212,500</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 16%; text-align: right; line-height: 115%">3.54</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 10%; text-align: right; line-height: 115%">1.05</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%">212,500</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 8%; text-align: right; line-height: 115%">3.54</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 3%; text-align: right; line-height: 115%">1.05</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1.51</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">3.00</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">21,600</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">5.86</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2.28</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">11,600</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">5.83</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2.11</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">3.01</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">4.50</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">141,900</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">3.38</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">3.28</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">103,500</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">3.24</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">3.23</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">4.51</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">6.68</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">136,000</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">4.70</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">5.49</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">12,000</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">3.27</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%">5.59</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>511,600</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>3.90</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><b>$</b></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>2.90</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>339,200</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>3.52</b></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><b>$</b></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><b>1.90</b></td> <td style="line-height: 115%">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Nine month ended</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">North America</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Europe</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Asia</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">South America</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Total</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 20%; text-align: right; line-height: 115%">May 31, 2014</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">4,480</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">2,684</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">2,273</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">26</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">9,463</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">May 31, 2013</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">4,413</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">2,673</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1,416</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">8,503</td> <td style="line-height: 115%">&#160;</td></tr> </table> 2013-11-08 2014-02-17 2014-05-09 2012-11-08 2012-12-24 2013-05-07 2013-08-12 2013-11-15 2014-02-24 2014-05-16 2012-11-13 2012-12-28 2013-05-10 2013-08-15 16073894 16149460 16165171 15927806 16021309 16030433 16030894 0.04 0.05 0.05 0.05 0.14 0.03 0.03 2258688 642956 807473 808259 796390 2242983 480913 480926 4001212 3520285 532000 466000 48600 45600 511600 212500 21600 141900 136000 100000 -160000 -3000 -6000 314000 25200 339200 212500 11600 103500 12000 1.82 2.80 3.79 3.92 2.90 1.05 2.28 3.28 5.49 5.61 1.36 1.80 1.00 1.78 3.45 1.90 1.05 2.11 3.23 5.59 P3Y11M12D P7Y10M6D P3Y6M25D P7Y3M14D P3Y3M22D P6Y1M13D 1.00 1.51 3.01 4.51 1.50 3.00 4.50 6.68 P4Y2M9D P3Y6M14D P5Y10M10D P3Y4M17D P4Y8M12D P3Y6M7D P3Y6M14D P5Y9M29D P3Y2M27D P3Y3M7D 120000 0.53 0.42 0.14 0.09 0.05 0.10 0.09 0.07 0.23 0.18 0.10 0.18 0.13 0.11 89784 76317 28028 25772 5 years 3 to 7 years 5 to 7 years Shorter of life of asset or lease 7757972 7757972 0 0 7757972 7757972 0 0 2802568 2641791 1307549 993230 16117198 15984819 16193976 16024467 16361695 16307618 16455078 16335608 -584237 -532106 200585 173094 30625 5625 30625 5625 41875 11250 32411 28241 103498 98495 345047 124042 145893 51466 23646 241451 103596 117987 750000 750000 1000000 2500000 130781 Black-Scholes option-pricing model 0.0314 0.0625 0.3895 0.0136 P5Y 466000 1.00 5.61 45600 1.67 6.68 1.00 6.68 7757972 10179298 12701075 10005490 946518 301573 3219743 1910615 124270 203913 119180 192173 217655 184258 12385338 12971830 3358632 2891169 6033125 63750 18445 18445 21899136 16063181 177356 146011 349464 311209 90000 60000 19859 19859 750000 234671 89227 1621350 626306 2529371 1146389 1750000 33099 47993 5933820 1820688 4807 4502 6021432 4842794 9939077 9395197 15965316 14242493 21899136 16063181 0 0 6385815 5801578 0.001 0.001 10000000 10000000 0 0 0 0 0.001 0.001 50000000 50000000 16335804 16030894 16335804 16030894 9463059 8502994 3740567 3094779 1168219 1337583 227600 451935 8294840 7165411 3512967 2642844 3378950 2689632 1204312 903589 750808 634281 234685 206424 4129758 3323913 1438997 1110013 4165082 3841498 2073970 1532831 25000 40005 8017 9203 35488 4694 35477 96662 7340 -980 60477 172155 15357 12917 4225559 4013653 2089327 1545748 1422991 1371862 781778 552518 0.17 0.17 0.08 0.06 0.17 0.16 0.08 0.06 35730 31411 70806 103498 98494 1349585 99402 1229485 1611838 644945 -153896 -72993 -13284 31345 44206 38255 24973 30000 -15000 -403735 -14894 145444 35324 3334956 1579133 21339 19259 2500000 1051700 833965 -3573039 -853224 70806 75445 27985 -2183243 -3421494 -2421326 -2695585 572192 1382545 -3500000 9463000 4480000 2684000 2273000 26000 4413000 2673000 1416000 1000 8503000 <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><u>Qualified Incentive Stock Options (Qualified ISO)</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of May 31, 2014, employees hold Qualified ISO to purchase 466,000 shares of common stock at exercise prices ranging from $1.00 to $5.61 which were granted prior to May 31, 2014.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Transactions in FY14</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Number of Options</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted-Average Exercise Price&#160;<br /> Per Share</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted-Average Remaining Contractual Life</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 58%; padding-left: 5.4pt; text-align: justify; line-height: 115%">Outstanding, August 31, 2013</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 11%; padding-left: 5.4pt; text-align: right; line-height: 115%">532,000</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 10%; padding-left: 5.4pt; text-align: right; line-height: 115%">1.82</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%">3.95</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Granted</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">100,000</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">5.61</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Exercised</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">(160,000</td> <td style="line-height: 115%">)</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">1.36</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Cancelled/Forfeited</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">(6,000</td> <td style="line-height: 115%">)</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">1.00</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Outstanding, May 31, 2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">466,000</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">2.80</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">3.57</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Exercisable, &#160;May 31, 2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">314,000</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">1.78</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">3.31</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Non-Qualified Stock Options (Non-Qualified ISO)</u></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of May 31, 2014, the outside members of the Board of Directors hold options to purchase 45,600 shares of common stock at exercise prices ranging from $1.67 to $6.68, which were granted prior to May 31, 2014.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Transactions in FY14</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Number of Options</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; padding-bottom: 1pt"> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Weighted-Average Exercise Price</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Per Share</p></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%">Weighted-Average Remaining Contractual Life</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 58%; padding-left: 5.4pt; text-align: justify; line-height: 115%">Outstanding, August 31, 2013</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 11%; padding-left: 5.4pt; text-align: right; line-height: 115%">48,600</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">$</td> <td style="width: 10%; padding-left: 5.4pt; text-align: right; line-height: 115%">3.79</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%">7.85</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Exercised</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">(3,000</td> <td style="line-height: 115%">)</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">1.80</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Outstanding, May 31, 2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">45,600</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">3.92</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">7.29</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; text-align: justify; line-height: 115%">Exercisable, &#160;May 31, 2014</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">25,200</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">$</td> <td style="padding-left: 5.4pt; text-align: right; line-height: 115%">3.45</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">6.12</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 1in">&#160;&#160;</p> 244497 322799 261102 311141 EX-101.SCH 6 simu-20140531.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - 1. GENERAL link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 3. PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 4. CONTRACT PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 5. COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 6. SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 7. RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 8. CONCENTRATIONS AND UNCERTAINTIES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 9. GEOGRAPHIC REPORTING link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 10. EMPLOYEE BENEFIT PLAN link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 11. SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 3. PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 4. CONTRACT PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 6. SHAREHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 9. GEOGRAPHIC REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Details - Property and Equipment) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Details-Fair Value Measurements) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Details-Earnings Per Share) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 3. PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 4. CONTRACT PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 6. SHAREHOLDERS' EQUITY (Details-Dividends) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 6. SHAREHOLDERS' EQUITY (Details-Options Outstanding) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 6. SHAREHOLDERS' EQUITY (Details-Options Outstanding and Exercisable) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 6. SHAREHOLDERS' EQUITY (Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - 7. RELATED PARTY TRANSACTIONS (Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - 8. CONCENTRATIONS AND UNCERTAINTIES (Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - 9. GEOGRAPHIC REPORTING (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - 10. EMPLOYEE BENEFIT PLAN (Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 simu-20140531_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 simu-20140531_def.xml XBRL DEFINITION FILE EX-101.LAB 9 simu-20140531_lab.xml XBRL LABEL FILE Record Date 11/08/2013 StatementClassOfStock [Axis] Record Date 2/17/2014 Record Date 5/09/2014 Record Date 11/08/2012 Record Date 12/24/2012 Record Date 05/07/2013 Record Date 08/12/2013 Qualified ISO PlanName [Axis] Non-Qualified SO Stock Options One AwardType [Axis] Stock Options Two Stock Options Three Stock Options Four International Sales MajorCustomers [Axis] Customer 1 Net Sales Income Statement Location [Axis] Customer 2 Customer 3 Customer A Customer B Customer C North America StatementGeographical [Axis] Europe Asia South America Equipment PropertyPlantAndEquipmentByType [Axis] Computer equipment Furniture and fixtures Leasehold improvements Level I FairValueByFairValueHierarchyLevel [Axis] Level II Level III Minimum [Member] Range [Axis] Maximum [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer Is Entity a Voluntary Filer Is Entity's Reporting Status Current Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents Prepaid income taxes Accounts receivable, net of allowance for doubtful accounts of $0 Contracts receivable Prepaid expenses and other current assets Deferred income taxes Total current assets Long-term assets Capitalized computer software development costs, net of accumulated amortization of $6,385,815 and $5,801,578 Property and equipment, net (note 3) Intellectual property, net of accumulated amortization of $41,875 and $11,250 Other assets Total assets LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities Accounts payable Accrued payroll and other expenses Accrued bonuses to officers Other current liabilities Current portion - Contract payable (Note 4) Deferred revenue Total current liabilities Long-term liabilities Deferred income taxes Payments due under Contract payable (Note 4) Other long-term liabilities Total liabilities Commitments and contingencies (note 5) Shareholders' equity (note 5) Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding Common stock, $0.001 par value 50,000,000 shares authorized 16,335,804 and 16,030,894 shares issued and outstanding Additional paid-in capital Retained earnings Total shareholders' equity Total liabilities and shareholders' equity Allowance for doubtful accounts Accumulated amortization of computer software development costs Accumulated amortization on intellectual property Preferred stock par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock par value Common stock shares authorized Common stock shares issued Common stock shares outstanding Income Statement [Abstract] Net sales Cost of sales Gross profit Operating expenses Selling, general, and administrative Research and development Total operating expenses Income from operations Other income (expense) Interest income Interest expense Miscellaneous income Gain on currency exchange Total other income (expense) Income before provision for income taxes Provision for income taxes Net Income Earnings per share - Basic Earnings per share - Diluted Weighted-average common shares outstanding Basic Diluted Statement of Cash Flows [Abstract] Cash flows from operating activities Net income Adjustments to reconcile net income to net cash provided by operating activities Depreciation and amortization of property and equipment Amortization of intellectual property Amortization of capitalized computer software development costs Excess tax benefits from share-based arrangements Stock-based compensation Deferred income taxes (Increase) decrease in Accounts receivable and Contracts receivable Prepaid income taxes Prepaid expenses and other assets Increase (decrease) in Accounts payable Accrued payroll and other expenses Accrued bonus Accrued income taxes Other liabilities Deferred revenue Net cash provided by operating activities Cash flows from investing activities Purchases of property and equipment Purchase of intellectual property Capitalized computer software development costs Net cash used in investing activities Cash flows from financing activities Excess tax benefits from share-based arrangements Proceeds from the exercise of stock options Dividends paid Net cash (used in) financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of period Supplemental disclosures of cash flow information Interest paid Income taxes paid Non-Cash Investing and Financing Purchase of intellectual property with shares and notes payable Organization, Consolidation and Presentation of Financial Statements [Abstract] Note 1. GENERAL Accounting Policies [Abstract] Note 2. SIGNIFICANT ACCOUNTING POLICIES Property, Plant and Equipment [Abstract] Note 3. PROPERTY AND EQUIPMENT Contract Payable Note 4. CONTRACT PAYABLE Commitments and Contingencies Disclosure [Abstract] Note 5. COMMITMENTS AND CONTINGENCIES Equity [Abstract] Note 6. SHAREHOLDERS' EQUITY Related Party Transactions [Abstract] Note 7. RELATED PARTY TRANSACTIONS Concentrations And Uncertainties Note 8. CONCENTRATIONS AND UNCERTAINTIES Geographic Reporting Note 9. GEOGRAPHIC REPORTING Compensation Related Costs [Abstract] Note 10. EMPLOYEE BENEFIT PLAN Subsequent Events [Abstract] Note 11. SUBSEQUENT EVENTS Estimates Revenue Recognition Cash and Cash Equivalents Accounts Receivable Capitalized Computer Software Development Costs Property and Equipment Fair Value of Financial Instruments Research and Development Costs Income Taxes Intellectual property Earnings per Share Stock-Based Compensation Recently Issued Accounting Pronouncements Property and Equipment estimated useful lives Assets and liabilities recorded at fair value Components of basic and diluted earnings per share Property and equipment Contract Payable Tables Future payments Details of dividend paid Summary of the stock option transactions Exercise prices for the options outstanding Geographical revenues Statement [Table] Statement [Line Items] Property, Plant and Equipment, Type [Axis] Estimated useful lives Fair Value, Hierarchy [Axis] Cash and cash equivalents Total assets Numerator Net income attributable to common shareholders Denominator Weighted-average number of common shares outstanding during the period Dilutive effect of stock options Common stock and common stock equivalents used for diluted earnings per share Significant Accounting Policies Narrative Amortization of capitalized computer software development costs Accumulated amortization of intellectual property Stock-based compensation Property and equipment, gross Less accumulated depreciation and Amortization Net Book Value Contract Payable Details 25-Apr-15 25-Apr-16 25-Apr-17 Total Less Current portion Contract payable, net of current portion Class of Stock [Axis] Record Date Distribution Date Number of Shares Outstanding on Record Date Dividend per Share Total Amount Plan Name [Axis] Number of Options Awards Outstanding, beginning balance Granted Exercised Expired Canceled/Forfeited Awards Outstanding, ending balance Exercisable, end of period Vested and Expected to Vest, end of period Weighted-Average Exercise Price Per Share Outstanding Granted Exercised Canceled/Forfeited Expired Outstanding Exercisable, end of period Vested and Expected to Vest, end of period Weighted-Average Remaining Contractual Life Outstanding, beginning of period Outstanding, end of period Exercisable Vested and Expected to Vest Award Type [Axis] Exercise price low Exercise price high Awards Outstanding Weighted average remaining contractual life - awards outstanding Weighted average exercise price - awards outstanding Awards Exercisable Weighted average remaining contractual life - awards exercisable Weighted average exercise price - awards exercisable Fair value of options granted Assumptions used Pricing model Dividend yield Pre-vest forfeiture rate Expeceted volatility Risk-free interest rate Expected life Qualified incentive stock options Exercise prices Non-qualified stock options Exercise prices of Non-qualified stock options Weighted-average remaining contractual life of options outstanding Exercise prices for the options outstanding Bonuses paid Customer [Axis] Net sales concentration percentage Accounts receivable concentration percentage Geographical [Axis] Revenues Compensation and Retirement Disclosure [Abstract] Contribution by employer in benefit plan Custom Element. CONCENTRATIONS AND UNCERTAINTIES Intellectual property policy text block Property and Equipment estimated useful lives Details of dividends paid Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Weighted average number of shares outstanding basic and diluted at record date Qualified ISO Member Non-Qualified ISO Member Weighted average remaining contractual life abstract Weighted average remaining contractual life outstanding, beginning balance Custom Element. Custom Element. Custom Element. Stock options 4 Member Custom Element. Customer 1 Member Customer 2 Member Customer 3 Member Customer A Member Customer B Member Customer C Member Accounts receivable concentration percentage Numerator Denominator Weighted-average common shares outstanding Pre-vest forfeiture rate Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Weighted-average common shares outstanding IncreaseDecreasePrepaidIncomeTaxes Increase (decrease) in Custom Element. Custom Element. Assets, Current Assets Liabilities, Current Deferred Tax Liabilities, Net, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Other Income Income Tax Expense (Benefit) Share-based Goods and Nonemployee Services Transaction, Tax Benefit Deferred Income Tax Expense (Benefit) Increase (Decrease) in Accounts Receivable IncreaseDecreasePrepaidIncomeTaxes Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Employee Related Liabilities Increase (Decrease) in Deferred Revenue Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment PurchaseOfIntellectualProperty Payments to Develop Software Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash and Cash Equivalents, Period Increase (Decrease) PurchaseOfIntellectualPropertyWithSharesAndNotesPayable Cash and Cash Equivalents, Fair Value Disclosure Allocated Share-based Compensation Expense Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price ExercisePricesForOptionsOutstanding EX-101.PRE 10 simu-20140531_pre.xml XBRL PRESENTATION FILE ZIP 11 0001019687-14-002672-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001019687-14-002672-xbrl.zip M4$L#!!0````(`,)&Z$1@V$@VQ7L``+NQ!0`1`!P`82`(5RF3X;.]CKWG>N[BZ MVF/_?/Z__\/@?T__UFRR2RFB\)2]5$'S*AFH,_:6Q^*4_2@2H7FF]!G[-X]R MN/+SKU=)!M>"3-X(N&K)G++#5H>S9G.-.7LJUX$H)C0RSB.>P23FMT[[C^\/ M7K:/NIW.8>MV`%1?\@S&'+0[AWCCF/[XT#D^/3R`_Z])+^-9;@IZ[=N3=OME M&_YG'W]ZV]>1/,4_&0@N,:>W1C[;&V59>KJ_/QZ/6^-N2^GA_D&[W=G_]?RJ2R:=%SW6>/'FR3W?]T+F12-S3Z.[C[3XWY&RH5#']NAT@\-Q%@\,N.G38'=C`3-P1ZM(F(7/ MT)T%#R4J2?)X,5]AIO>S22KV85`31@DM@^*YSS\T_0!:0/%$Q1Q:@8J1KT,T MB#V/=$3'J2$,OA<#1L`Z'9&X\=FF?Z!U:\(]=QNITNTT`I3L^ZDL\@,%!GV; M,1D^V[O4*K:2>`+"R!1.UFP?-4OZQ6,BR60V*:X6UV6(=P92:$9-!< M7/VT]QQLL-,^Z!X>/7FZ/_MP26Y_(3U'+05!JG">"[`(G:'S>%XNQ\]4WIM[ M3"2A?\BMNR0?3CWBKT\QX"\ZD2Z7\[EY-[`TCIOMDWLF6^MOLN?E`@H2[L[7 M$=)R,/X6Y"93\6_O1:`TZ>7DC8C[0F]-DB7PQ#`6%1$4MT)@YC:-9"`SRRL+ M)8RT0=JYKE.,50*?OXBX`8ST,A5\.K^59N\Y&O?IW(*?[B^X:V`YO`-8.?@2 MK#C=;1$K1[N&E:,:*U^*E<>[AI7'-58VP\I['0VC5LZ!IJB.RH:QAIL2-!H;+4VCULZAYJF.RLB[A4N=X-U9N(>=+ M#WYL\S"Y%V['"NHW)_G?=@%$,VO_/'8VH7J5!#!W<4+LM0H(K99\<8#LCB#W MSOJ\-9![L,/(/:B1>X^1V]UAY'9KY-Y5Y*[(,^MLHNP9RZVRA1N[] M1&Z=+=3(O4O(7=R]]AH[WQ%DGC_LIO5J);_8$26_V&4E7^R(DB]V0LE+DHO: M77_#L_[;4G+MKG=`R;6[?A!*7M%%]@7@6Z6ST3E]NI$_#*47M=B/0@TU3T>P MLFBZ'IM?=-W$W10XKW*MT@=R[G`-R%276X-E4["<&[D[WJ5<;`V438'24_GN MA:/Y1=?`6;>_7>WEYMR+G!X#G[I?(>5MO8!1I[!^Y3-&#/HQH8Z MD5FN!4C\4M[BKP=RPG`C/"T70PVI32'U6G`C1BH*K^)4JQLJ0W814ROD4(-J MU6FTPC=QJ>F?S+Q*P-F;U^)&1)V'`:1B:2\FQ<]_`1VN@]&$%CKCGY:+8HO' M(;[E$<55H#BH03$CBAH44;<&Q8PH'C@H[N>_([*E;T+7G8BM=R*V[#/K-L*= M:2-L.WK6/8"[U0/8,A[J`O[.%?!;1L0;F<@XCQ\&!M[S9#BCZ:GU[9IN^>W# MUFUU?0]\A"7WLO9P32PQ1$%*AY]*HPX/. M\2F,\9/Y6],D<+8E\_=&')*JI22%\U:(?I2)"J6R>?(?EXNLW073>SO3TEA#8%>`YG/J"R%G^LK M+!3R]!6!_[T82I-I0"_^&T[,@?.]&*S::-I[WKMZ\_'U^8>K=V][[/KUQQZ[ M>GOQ='_9M/-D+\#T-(^NDE#<_B0F:].MFO?2V:KD7JH@QRB"N>7:5#KMYL]V M_NKCBZ:])@M_9?=BUIZ_&HN6SE8E=PYW0QQQ&?'AVF0&/#+"4IB:8%X=OX@H M^BE1XZ0'T%&)"*^,R<';KDOIK:JJ8\EL\V3_K:(\R;B>7,I(:/.%Y&9F60"V M7&M8^GN1*IW)9(A',_/UJ?T'3?YSL\U3)6XN0)%#I=<'>"_F$3S'BND9=DAX M,JFR,#7U(EA>2A/PR,+I$JZMO]B?N].0G)MI.;G_"*XW(X:_%Y$K9EJ@2Q7' M*J&/F-L0\R[/,/B&**HJW3+7/H:,9H^A^Z,;+C*Q4`02A&V>[5V]O02;?]P] M/#AI'TZI>@6Q*FL.$B7SFSJ$ID^Z5LWF*?JT^IT>\D3^2=]/NE")49$,[<>4 MDO`:F(4YZ*_O!I<0AY)`\J@XE&Q>PNR1,K;7TI/#!#*D`"OR(%!@3;#`:X7I MN3`?8`$O(A#!VJOY(.F4G:;:?*`WR9A^@9C#LK1BS]RKF M2<->:+`>8&QPQF*NAS(Y9>TSAL2:/`+F3MGON8$D;K+WPS`[^S"2AFDR$*82 M=@GS,G39;*`TRT:"_9%SG0G]P]\[W3/P>R)D;_B$=3L-AFPVF!FI/`I97\`L M/&0RP:7]GBYD\%S0DHBEEBY_D0N/7TN@WB M8P`V&Y9S]T20:YF!?&'RD+VZ#498."'-6!HLJ=@_?N!Q>O;WSN'Q6>_5A?_+ MR=DC9.`M=D.P!.N<6"HM=NX,+TXCT#(L;V(IO;H`\($J0$X MF6$>$498K_EK@X9S```M&PUJX($#VO3((7X'2F6)RH#[$;\1($E!,H14VP!E M'`%S:0'"$2Q4#(82;QQ$#?X-ZD://D/<:/%'+K7E>2@22-BB:(*LB!17P@M0 MLE1+8"B-A&FQ#\"NQ&^2R[C"*=@`9V"LL&B>AQ*>/V,C-18W0C=0U;A(EKY\A6*"#+]Y4!,S=)F*!!XL*3D\"?!$>(GV\#`!`9 M903+%)H5U/8B0,UY>H,<%HLFTD+GL)^B&3_=WY8GF_6D]\S_X?PY_G@%UV*0 M@R&AYOZ>%2^IR_[Q%_/S+M<5XU_F,XB5*>]B'0BB*P7/RM'^T3_`$!W"%,)Z MRX7&O\A+.-O^F*#-,P*(06"Z-VQ:[)JHP$3.(2_@TSDB`\M.^-":$$`ZYI\` MU%[:Y-\XY+2Q_6=4@"S/&!\,`//.VC!.H..*D77B`L8+M-=(\KZ,R/,WG%W? MB"07#9H5#0>D:)V;6443Q69)6K=9,NPCQ>,S&)5BD\VZ>&2B(DL';X@;0987 M/L9Z@8#B8RAA?LT&`'5GW04[+5:QF473DN5#*NB\'7.KA/\&"AY$AAK5YW!X MP%.9`;[^%!8L@=L;9$8-LC$N.,2S%(JV"X!'@_*\X5%>K,]@J@;>G41D)3I# M0]+W)UG&;V$1W]A8W$6)E@+3MEM',K$&;37VN+T5\RWECK;K6'XI M\/)G@2"T49O?@%UZ8!`W`#RR'5)[`9F88SA+R)\L\"Y%0&&EYT??D81>]%-1-;\!#Q<`1*%.)B^_Y M%339(L44LY!BZ`DP2O],JE68@S?R9D<),Z[1S2C) M"2(+`WDKPD81#`X?`5&H=H/,NL0)C@'.^[P?"7#78.!-C+F:PTH"]PDJ9O*4 MLO`R.[N^Z)49%U-]`!(O%R(AJ2I3`>5A_;K`U M!IX/UF+H@H4:^13A/#=>)I>$@L+-2DDEJ#C4/19G] M)D`;QL'5V'H+O!##9)'-&+SS@$H1@T5<,6:?KZ!^K0_RP#1L/%*V'.(1UI43 MEN8:RCKCU%JX)$!5HB"+M^8&$H%!>@B(?X?@K+BN*;HV-J,/`VX;4X\#[`KV M*1>!-,)C[O\@CXMGJ!B2:^,JS8)^1SKA!&2GUN9#"]`H9I16:] MQ M9_0"-X4/-P*?(R3A[H*"/,>/=P(9\=!Z0G[#9403]9W74<2<9V*6;L"CP->C M%.'`=40N#Z6Z;8!&9%V"%S@E:#I/$K2`:=7VR/TL!A3,Y$QDPM"71678(!1G MDQ3?6<="-,#2$R@I"@0`@S$`!7T2U7363#(RZUAYL[%_!XE0,HM%->G*4HM(7!*3U\(@<4CAS4T1 M#)U7)X=./]R4UCKTU*PN))&@O[7WG?6TV_*YRZ/`%N3QHR_\&FP,!0FV*K!A MH0";HDE-..?$++:'6KC2CM*]$AL^%N2&4AL%-6P*#BOF@0#_$F!9.)-,&7*% MHB,/*C/53`2"&IT>5?'`BVQI\)]:E4'KZ,I&47A,QZ`< M:Y>)[;%6FGFV,"4K5O3?64C$$##E%"@J1$B;91LA3ZC'@RY#)C<*[;\``-`F M'F@F#'>6*D)HGH2MW6=RS)F\TB^FG*P&Q-**S^H9*P7>5YJ"EV]6"'P'P[GY MRM@A;CP;!B'&AB^73TM-B`(%__-3YL;'50AX`?8BAZ*I M!DUL3T2B8`>L>J2@N@E%*NQV5)Z":P"TNMJ@,KET-8!(AC!9V%A4F4*IR!YC M1W%Q>;B@)O3#CMIG+J0F)M,Y)4]-V@!'25U;;U9:W%)^4$MT,CG1<*\ M.,;6=&+<$0D%RE\"^,%!4IHV1F\HLME2U'E+*D"I8$/[X2R"-+^)4S0@KQB2 M;@4F1(&@#,N+F(I2215GJHR1?;?GD>%2<$<:1D^*7I9-`50&^`5'_SOV\%QK M":75G9V)K9@%0.UZ[E1=0.H#H_'?8&:E8&I#GVXZ77!C+9A^X&G@&QY1^;;5 MUM,E^'8HWT#KMB2DM+KL$\.5`/BUK0-`K2%74I1)F#B.Y'`$`(DD+(EBBG![ M-F59:`U=:0G<`->`([\G2!0A4D$^G60C@SEW9.&$Q1221N_F155C:AI3KBMG MT#D*$!(Z@&TW,CEH>/*G]1/@+0E!OJ75YQ'Z?;QI!:[&J!IE*Z?ZF/R]T7KM=)ZQ"YC0J7] M5"E'?-`<$E,`#)D^A(2YJ+9AFB85`5:Y:#,NO6,0P/`T7@".W.2"!(4[`>C' MA=\WXAA]*/S&?$(M"UA;BYW/+\Y6%A"4QF"MX/&!VT&1\GL!8@SD&>[&^WQV MP/$(0&VKL_Z_V/1A_F6PLH_]LMSP<2F-V79DZ"W=C**4;G83:TEFAYW_@W9C M6@FRHA?(]2Y\.[D@"3A_(>"O$>"?WHT)J9_TANM/8!OAX@RND'"Y35;=-IE? M1E^`#(Q-7RFM@<#7CZ09%2<*1#!*5*2&Y*0&P(AT#7PJGPR=[U"X+8(-[F*O MP7>7,)?S;;&B^6X@E-6VX;%!:*.H#VQA MZ?PC.1!S,;+LRL/U$>3JUM`*^AC"+M83%ID_N#`M?H^&&Q7&-0(9GGN'W#]K1ICNV#JX MZ$&P);ATZ9=#C=4>^P>:!:A9W`:"3M;E>*]B4IDJ\M9EI$3._^%-VW@E. M<>;.$:$X;O!LH$N2??0_H`IW[K)1R`=>:CO2YLQY80:'Q]T5)IT[O9DL? M_RJ\/0'NWX/?;G4SQ9/P/%%JXP\0@:]VQ_-,UK!M*:AP\MC%R%"D,%):/S3K M,EL0.5;$::AHAK9MM%<2IWT1' MV%KL1X[-39PD4H9V]Q+L5Z;*\,B?&*9W%HHW2OQ;$5AFI\*>0*C+H9ED%K]Z MR>BSERBG\EC]%9U!*(UR:YGM.;V`8Q5?OH-3S6KIW3GBY8;6X=1_4;S:],)N M:K'>2(BBW4]O85/YU:<]W:)M'F'=A<(H^J5@\0I3W^J+H)(^$FK;>'ADR7Z[ MP1\<`YG2"WW$D'WCT5.D;2P#Z?8`ER2OB MQVP([*LL4W%)Z+"@<\I>@)?ZQ#HIMN8B&6Z4J&+%TP0@T$",/X79]6WX`Y"5 M0J5/SEIE]\M0LBH.+@CEY2)*6<'E!>MP-]TREMVVHEE;#`OAM$0,TVC::*$S M"CLYVLIBOT3GI&0HI,'P:==\B;Z_9@;W7Z[=W;>+_/J2(2-@5Y_'P)I\+EOF M-\7K7\+K!D*U7Z_V;]+3*^>XW?Q'KC!^I9I>9*)7*ND#6[A/QVV(Q92V$F%I M!YS>$K>[#<8?P'>QCD)C"%&MM=/HK>'[%\"WP10=$LI&/)F!;C7+=RIHE&\S MJ3Z^!4*IB-^M*>LUZ;OFV4C3)ARDD%KYP\DVMW,[:_9K%#7>%^"]!OQ7%>O' MI()95U40G+48X(&T)5\(Z.,F4G&*6>%!-IYY]*97P.;"A3'=JI?O+C=ZI<(NPS5[G>3*A_*4F#-(!+<`0@9_!WW\R?MI@WFY6 M[5>-,13VKL)MK[A;?3Y+T6^?,/,I;9X4LLIE00&J)R8D3JR1^IX9-3B1F.L->H)1C]Y9>RP:[*C4=X^U=G3^MD[RNP=9:(Z M9`X;6GP?[KR$;5MZ=\IF)[8DC;505^O.9F`]:WK6/$O6;#64>^U&2B_%BW;2 MV+H$9KNRO>ZDV[OM+EW_C(%APQ(X#99^[ONY?]YS?Y)9[JH9+_$GCA!^W>TX7\1#DLG\(MTXPV_QLAA?GBF;9O>7 M8<.HV9<+]Y%_DZ*CI=](>&21(4^'O#R60V+DI_CN]-Q-&"P)'RF%5-V3_6`0A6G`@ M):&O"+I!%1NRM(<\"\.9FNJ\W\-+;-".][RXQ#?*9'"4(/93-F.D5HG[8U-DBHRO MRXH&<4`#?`5UB9"B)Z)2%"*A\`QU@;,MJT^M)NV4EG?!GJ#5B$$'?0I/%RD2 MH6P<:]Z+E0Q550A2OH`+$2-3TP6T;HJML2(]*!="L"C7D:23"MSPGV]8\L`$ M4!6^RZUJ6KAG36H%1H](&,JD+4H+-Z9^1Z(P%_0$N[U@@!D?`3\J<%>I-A>,BK0P]7;R8R*(6:E5\*(L4>3^ M$$&"R,H!96V)]'N)@2?>S98XE<-XI=7&5(Z#"LL`2^>&TY`INB!58$+D">&5 M]PBT@BDRRB'5XD/` ML`I&J3<-JRM;P@C6<,F7?\*(..T2]SE0WK&;:(GP-@8O@F@0"NL-AF2#R[), M4D2E*'QT?0Q+E>C?/$;[;1#[#`0B]1RQ)F(X`5\N07!HI.[/,/I+Y-TA5CD\ M\//(5C5-0V0HJB61%6_A($^Z)@S,4E@Q3D(9A$41YBAU1U&LR6((X,T\9)'4 M^RUH01QXR%:'!H<=HC]UU1G9W%3)UG/H0U(YMK1*2)@IR$<1M(/L9.XM08(^ MQ$Y[59+BBAS2;5F$]`&!4T792R^G7GQ;(&%8",_\V_77#U23DLK9!8%R&=V$ M(*`?P?![MVZP(J!#E,^:,EJ$6!$AQSMD-&=5Q?S+T:&-+T@1Q\(BQ:DJ2$3# M^LLOKD%H/X6PA[=>]I*5WC65PW_):I[ELI4KN-"(R3&UU.;\K)#]64%12U=H M/J-D'@0R&GW,/UP&DE:%E"KB13049=/2>UM54F#4C;`P#LF`0B6P3[ZM%368 M69ZR^([#-N20=KF8484_N?\UAKC_'2BOJ:I460.Q1%"CDY.I)VJX"7&.*SP;B%G$(!3@4N(%7I%"6M!*6%$F-Y MHJE=G@Z4;<##7"%VCUN118CU$+S5]XF$M$(607+S,GCBM8W]\M,M9!.8"+GH MS1=A(#'Y.4/X$=M&9@K#(K8*$>,G:15Q(3D-/;!")W)E&LS>:R+.?]A"G/^W M-8C0C@<%ML1`HCZM:_L8-/N5J;]"8WDN$MHJ%\R>"[TLM",+>YBI M/;.R:@3]?\)*J.A@_MKQ*>]*U&IW6^A9T[/F#%G3D%G>&RJAJF=AG=':JPMWAFJHQFJ/72Z-N`SX=[0TM716&]MP)WTC/N%O",# MZUG3L^99LN98GG$-H_@FNY'J#PS.O86>-3UKSI`UI_(6&SHF^+X29Z!LBC'( MW\RO!<0^,5G1AZH.&]SQ:'@>`SLN:S3#4JWAZ#P&=F2IT4<@.14V]ET8V#%9 M8ZMCQU(=O<)IV[G[I"*R2&$\3P+3]I)P\I<2+JCDSQ.;66.HJ[I6(:>Z"Z,Z M(E],'?AB53BDZL*HCBDO%BP>XW[Q6),7PU!'XVZ:QWU/,KL79?=TMAW=;:%G M3<^:,V3-:5S)AG;Q5V*K3HXF(5GGO\@A6G-L!@Q>WQS;_L0$!K9EEFVKVJC? MEI6PQC1M=:CUK"EC#6QMAF/[/`9V9-9H(W6H-RPU)1;X.2-F=8^BG^0T4>K> M-:XM%Z\I^PLKP;,@I@Q)(NIDR7UY2@24DD1%2L*5DQBDQR6HHX1%Q.LER,?_B;+$:2R,A*,`:*9JC1T^99CK.W;@ M;SO-[ZV8>%>22BRRC@W5TG6>1FPXJF'I9:G#,E\(J:C0/B87`A-D'K47K^$+ M3=*JT'E\H7R%<,P2O&8^\/1657YG`7SOIQG0EU.06@\93YQZ?-<(T05;9#@T;G8/\V\&%'].`+,)"XCP`/'! MW%F"N>YL`3J-MZD"TL*@#N`-WX,OW2FWBD2$1^W/O21!-*/OC/]*'(2?TH+L M*2Y9!.;]GTLW2OA=;8X:`6#P'3.JH9][EG8$>[ZI$H0"\,Q%A$H8*;S&^4%T M(/T%6,[,,/6F8E7US(VJ9U[H>IFGL`J-I[SX%BZ\"<+JO?P5+`QA5+D2^`[D M^H\@!TL&KRBO80V8>8GR'9&T7`7#_#_SU0*D[T,8Q\J5&T6/(*(/(#"P""C7 M(M1$08&E`9.`_EC(F7I*U))`W;@@"9!8B'B2/F;L$)L;UJQ#V' M@!,N+-K/2:(B'H,;@*\52EP&T0:B$.4X)0Q/89B]Q9$6![U-COA4,#:9QZ-"ZFJH^5Q[8/L2H\[#-$8(TA;>CQPMT?V'K,B$Z(M%;'M`S=0J#\?GGYA9J+V,)WT640(&LN`N'"@K3P62PV"83$C&A#=)HIMG#( MBI).!]Q=YN*&C%A7GA(/0"K%+E4:END'KK,Y'?DF0>1*.)*M[K'$094`AX39 MR)`?2;8)Q)U+#AP[>,0-TPU.CM`K88YQ90@=C%^SY< MBXFM")V]P7T0\\KWHF!#)V"]EQ&B)-)*!(U>$;XP1T=&]CV"H8N9SP$?72YS MG&-\RPL/1?0P2$EN#T\PL&GP17Z0:&0\LL:W(0XP)5-,C0#=S)F=O[U:QA>W MKKOX]1K4$N4:MLV9VGT)?6_BL?@;:.YK'S:P__C?_PL/P?XFW_HB8+*^^/A> M,'T+LTO[KSE=:;8-DUJ^&XT_-1^SC^M0!I.T4\?-CY M<$C;H(AQV]N#0J%M MM#UN?XG(PE^RSI+D$="!)''[P!# M$020J\/P`A_-[C@OY0_95>5+?HR88N`/\"I!(M\KLI`57:)G[>#3N2:RH`N\ MIXSFL3CPX&>+LD^U0#>:5FR&$TNG>G2,-1/MD)C)A@HHZVF!C!R\_ML?$W\9 MXXGEM:S?]<&;L`##1HI48$TOZ.X_E@%33$U5]/%XM,HF_BI3RMBEBE[YM0^- MP.>/3V5%%CE$6=!/DL2/\V3I,\Z"-VF%L1=NK-"];A8$L4:'"%U8+*-XZ>+U M:RCHR'>[<+VIPDMR8"4=>(:HY,01#>+)_A*!>L<#UDP\8)'QLZ)9DJ="MQ:@ MA8*9"<%G@X!-14`*KPVAS#W?I\NN;ZM3\K,YL.7/>-[*;RYDO0J,[(F\F!\6 M3MSX3@J!J.^#K1L#7F-$-B**)-&EA[QS^UE/^W@`QR4M.2!(R5^4\+`Q?NVP7(@(JDL8B*\8TEJA[:5XI@CO03.@<.+70!L- ME'>\(+^O.UU?.U`Y>"-L[7CG"5NEJK MGF(?9VD\U*EEI9L';^JQW(;\T=O6X[/5B!],Q?42VN%=!E-\"\2$!1@EU.68 M'VR?5VN;+_R0=JBY@R'_E+D.GV7`M:'F\AU63@9%3!O6)PX4EHUAI5@K1G]A ME+6'&]=75W<>FREO?[`)A^SY/)O!YCWB@;_LQT*4U50NE[=`CPBLQQ./T@ZH M_+!,#^(AA3*J$(\.E-CUL8WI`F3>6E(A>'?N^%0"\?'=&0C3";.]>/PW0" MZ6W)UF+.H`K,9]'$B]/2T3,4'(J2IFK6BV4TN##,__AL%KLK+U]IE4E@NJV0UZ M]@.LV!R?T0UN0DDX^+"R1#VIF@8,!J4H=_P;'KM+A0Q%?X4QOLSB4/-B@:=K*V>D"I=R M&0J=/4U'@Z8&[3_&RD.$Q4U) M`^$-6$21"4FI"#>4R(!GM`5C)K(ZF2LR@MR7,-$\;7'=,B![;E[R&P@V=STZ MB103WH(_ZZ8I9'+(=IB*:61=?-V?&69 M`(GX[OHX]=]#/PGC?ZD4A[USJ9,'SI@$2\?W>)$CT]9DC*_9Q7D\C2,B/0'N MBL#<94D$W*85F:>K^2E^^SFOB>5.BHLI``%[$*N0&_`<1Y*6DD55R8D)7IGQ M%2Q6"NX'OST@.0$*^8I`RU9JM.U?7FZY"=FT](@W5M983FO15?EY2(++3>S[ M("W.FCHB*[S!+`@6B[M4M^36RA697%.^:(B44;2WL`"]E*MU84$N7/CD+P@W M719EBS-?AK>MPFF1W-0M=:-@Y^+\8KD@0E97Z.0!1ON8^0,O^(J=C6O[X6>Z">,E:24'T=FS\5@3>^\&R^!=P?C9V4BBSO&#Z#* MMQV`_LA?1>/TPX*&X1,P^WY*X4#YZ`;NK8B1"!E/-)*)TH14L4Q(O65N9O8N MSX-;S9WF"5+"7RLZ2I!0Z:.HO\(]<`;RY`JU?&2YM&.)TNBC)O0A_@\@Q6!<0;5OKY+=: M)/=3ZGY<<_?CTM>W?498#VVR@VZ9E4NZ7#S7*\GI=FT MJ@0;;;]:T5\Y6&:Z>I9CLR4L&QF!;IYR")M&T%@/AG,XDVQU;(Q41ZL03]16 MW=-VF51S&FH$L=D'X(SG]E6%5-'N' M3_;AM%9=95JB]>0LP`)*6'RZX5H/IV?!WLI_J$W5K3-FY3%B\`S+4,?.TX4U MV)[O_VJ$%J?AT;=#J:Z=EM13,8!F=<05?Y_1V[6F;R],SHOU,@'TCN_=)`"`;;#P1 MQ)T2D=M^#(V-W>"'+.WG)AO!B:URI\KV==(P=W4`Y]5LS^X#LG!2"_)S'>O1 M:&).2H*E:IJN&N*`KP5#5F+7GW.5J&T1+'<$^1R':2@+$4.H&[M"6:P^E*4/ M9>E#6?I0EJZRJ0]ER5/0A[(4SDKT5YI3\;BHE4"0@P(%5M8SW18U?C&\I>HA M6%>#+?8)7*B$H[3S[&QD5CL[.]_8BP['O#QIOA\WYF6(5[EV>\%;#=G[EJ\N MC%J>[N*_!JD\.N><8Q0.-K^Z-5:M8<.H':=GP>EN*8Y2E?QL+W4=;:1: MHVY>ZAXAWD4;GXEMM%_IP]XV#FU5'U5`ES^]97O:!O/TC&CK\&S'+=XQ[WH= MS5$-N^'8U\XXK?U-[Q.VU5T=P'DUV[/[B=ST&F#''77H.&T9LA*K_IQO>C=3 M=%PZTCX)L('#V'WFQ8"Q)@U1C)4-Z`,$C54Q9A-U;3$!('7 M""P-7F#Z'G_&G[`Q96VT^9HJIO5;G@_RNY>%4BJN**J!.'PIRC72DL$3%3"( M[EQ$?&,!5J!GT;V`A9*E,`8*U0:/H&&@;ZQN'@3B`7G!),("@/+B?A6TA^@@ M)*.Y^XCP/03P@S4OTDH5^:$GH6+((1`A[]A-M$1T.0._W9.6/#-JT6(5:$EK M=.]-"Q&2`S2J0XN=T?)N&2&"USR,$`2PR"1[!V$2)DM`>*4"(VA242B6/J%? M"=*Y<*VC,=4A?I@1_ZT@^$1$X6$)A%C$C<.A#1&M#"&<\)EG!8ZT%3\NFWT3 M<:2T417[M-T\T2_85(EUVF5YE!U6AZC88'D*H\G7[*H@SNL4"!V49>?S?7YYV";_,EYD79:.8 M`..-%2I>FY)+!`')!:`_:SC<)ML$[9P'QHL5D*);"H)#5-.?]0&\#`W^;`^& MNL3'9%$F;?`6P@N'DDBB@H+FSD?(^M"WE0@:K,KG3K@^X#+]9\NGTD<*(A,J M?HQ#FZXRXSM]P:87ER!@[BV6413J_P75OTC@3:2\2BG\TL>6E;#O*R%&H[V4 M-1$05_2#-VN837N M58FY+;S!4\5TMA]+MK&+ZO?IIM%JX<0.1-NU$^6H'1YC.G"JP\XUROQ1)\U0ZP[0VZS`L*ID0^G-$4J%;O7FJ$'7:.2<,2N/ M:X[,AL_,2LS1$:+;Y2@[&1^)T:8SUXM$Z5%1TS.MO.X%$W^)@D3$@(6^PV@U M"H[\])_P(7U0QFD):#,*Z869X<6P8ZS&"C_F[2F6BV1`QYQ"6=U$^5DW-77D MZ#P"=HVFF->/E=58L6AOX?7U(JG+-++Q-49B7%Q/[D(?@].HB0N,0\,'YN&4 M^4I:?#1#5G/C>#D7W6$8YKO_?$LDY$?Q:XK1ICQZS*=X4G.@6[^H6*+WXAY( MQ'=Q3[V,F!()`H<#P_X%Z]HOV`3IOP]]-_%\+Z&JJJ8S&.//D1?_=3&+&`9) M@P1A6]B`C,W$\YU?>!Q]VI#OS:@#>Z`1KEQ\1N%QSRJ'XQ-(8!8!NA(:6OA1 MQEMV,$14U&[%\U.:_3X.]_2QG]V,W.R'V_(P7,O!_4.M,?51N(U$ MX9J#405HH3X*MVX4[FC@]%&X?2S<"[./1SG\TJ6_`^[C4?IXE#U=*[N::W5> MPS^1*3('XW.NPW[,^]_1P'BJF)5].,K^\5RV:O36J#%K9#T]5/-VK-%PH#=L MN$NLT:FB4?137T&FL2@/\L3=%2?N47KB/LE.W(D<&>L@KY/#7-$NA,PJ8%0A M.)6J4`!+`7B)A[(4+^,_JQ1>8@WT,0^BP/OGPI4QAJ@0#:NWTA@GD@N@*="T MT@C=8"/"5Q$`B2ZP4_0Q+Y@A=PE?*V(8)((A+2$/B)&]$"4>4!F+Z)7XV/4` M5X7GJ4,AI>?=PQ8NG4KN`<_@Y%_76F#%Y8,;30OE^'IVQ$K./3RY?[Q=/=JX MD_T0/IR+$+0Q_'^'OY_S^&&=#A(O>7S./)!A"ZH=I/7/KV M:6Q8AXGFP#Y1;=VSU]\J%>'.F'&]_IZF,:=7W[W4U^R,]C;D]NV\F-V;8W6< ME*,`_;750I.\,(\$`]2%%FK8\&-%TW2AA1H`F,Y$AK96.DKK+BW8LK*6KX][$EBB. M>=;+<;-&I'=-UA5',ZL=RW1A5$=5'.,H<5&GA3IWU-L-L'DTQ-PNM-`8WZS!Z$R8MFO(>RMF8[RT!U;#V4K=;:$YQ:U8 M.ZT+@^X0V\"9:!BH^3GKK=W-+,.]#XW.*C&\NRWTK*FG?,;`L$'_IN'RQFNZBU\)91P1N%D4O_WGTDL> M/X4)>^/%$S^,EQ'[!H-Z[<,S__C?_PL)^IM\\2MF'K/I%S=*'O-8QR6O4I8V M_/&5S?[^T[LHG"-NX84VOM#T),2TYPO-OC#UG_Z!1!X;KYQ7,V!3Q&B^"8,E MSYQ&\/P@9H1''LYFW@380PG@/^L&E:%4L24.)_ZS9>,W]+,[F4289$XM*1%; M1"QF`65HNT&N.,$_E\`W%OF/BCL'!S_!UO@["_>19@FIX$G=RE48+4(J$W#- M)A%+W.A15?[+P^%ZKO(]]),P_I>*J=X+:%76:X#FY['\(W9]RHO_#G(<_W\X MJFMOOO1=GI'^Q5\21K4^'@]YGKD8$U'1V)B(F/5,^`8\A5'(*#F M4286BRB\1P8^TEQ,PCD*%T_@1TA[+TFHGL,*>3D0^DQ?:ZB=U-@89OK7JS#` ME)Z(S_AE,/T#_HX2UX.)9''W5/4KNV?!$IF5HUN)[\('F)@[-U'>8WY20%\+ M[`>4<=)`%#X$40@CQ39_(7FVC%]0<`*6*/PQ"R]59HY+!5\E^?RCJ9\P[YZC-+0U*N`4J)]`OBL#,@#*@3%D+7#Z&2KPRE%*Y@O)Q:TCM0 M6X1Z_XY0-8R\&F"R7!>7N-S&X2QY@/F#'Z;P!G@[1!%?46'IOP,'&+P,6D<3 MCY9=G,')'8+G8!68A3=%(_T95FK>!TX:3-_23U``ECZLQ>`3`4T>K-9ND*#/ M,IOQS MY,LZT!(PG]ML_)579()'D!390'=$0>Y(5F3BYE0V"'VXN?L_823*7^&,Y%9; MDHUT95G;$$F44Y08'"EL,$6HNX8T3N*=8VRYS2VRA\2.YX M/;$[\#MOJ$4AU@/*7_<"=.0+8R3)1&;$WK\()6OKB(7V$-5@%3VPLQ-PR8.4 MB)0\$G@WPM3Y6+D-J2Q3&"%83<&OK>.R.4*].O_64E@V$ M(9S@/.1GZY:%MV";P(JA`.,$N;A&AISA]$**W+4J\@/E]_3MO!#4=&-YZ:L, M$TQY0=,-:QD\$;]L'R)LGU7HJ>""M5*7*9UW/NT=/[UKEQ=@!>Z42U`7F)GG MS(BWRPC]82U4@/Q)]IM8/UIM:%TY?'^D8L_OT@BCZ0?:# M[`=Y;*O:%LC7'L@;1BW(EGJ8_6U5)VNLL490@VKACEBJ5:5XS_/@G%$++4@= M.CW4S7Z<,T;5BRWVG,MQK@*(1\^VM7;'JC5L3^`:6F_WS!1L)>8Z?\G6<0]L M:PN-IE&J5L^,W.)7Q80_#V;H(!D]NI)D1L\(WI:CVEK[.>FE@:B[+_-6[_^N MTE5B.@>S_5]A<%+ MG@QKX=&-#/O`"[P'?/LO_$\RN4N+'XF(@UAA_T1D\B2D*RT9]RF;$%-C#7^# M!WT>QZ9,V8Q%P"B5+J#A3?9CPMA4L?CK='2:IZ,0N3A08#03(-WUXY"WB4T0 MA2Y&.,R\Y"*^R'#\K]0'D?3"(V12U1 M+J?(%[`10#1\/5`5EH!`#I07'\)8N0QN&08B7B\7,*`P(C*NPF64*%=NS)1/ MX4!Y?65;]L@9OT3U8[XD#3YE*/ZJH+Q@C,9MQZIF(C?96Q'3'G='S[C)G&)2`L6#D71?-(BG@P$Y$0D9^`\C/G`9>H>G',$F"K[_'@ M/1!6'ATEPF54$87'4SNH8%^\K4]D6SXL,",XOYRZBX7O\=B=7(PJ\3*$'SSL MZ3*K4%@,0YR"[H(J4+V_Y"[,DS-0KG.18"7-TFI%B1N4P2*#@C#T-(07D2`U M_QX^/G$7'BSKWK]$>/AZS*4(=J1IF>`BI2KWKK],QQ=CPI"L,L@YNM('T!/. M80UU?["X5!F+.K:>6$3#^)J-X@L.^+%[B]_WE-?_RD5Z17R!1YF63"56PQAX M2A$M*)+=Y`^R@'2Q1#/?I1ITF3'Y&NO>N=%4>1WB?U]DZ\:[R^O7N26C["6Q M"$Y)L&A2<^]?7E_E7Q\[]L50L]7A0PC;?^4Q'JR[BEX7%JPH6<>IE>SAGN/%["2H)Y.!-:2]V(RF>2 MZ%*L+K%L+M$R2JZ;UVY>KZ_3S2R6\`4%RLX'`BIFI M^6](4<1`BY@JF<,M*>@5M",912(W5<12'[NH;B"]BECKN:B1/C*6%0XE=49& M83Z21XMSO)SW0+$O^9DNHRTU7HEZ]K:,.`6K7P.HA=2CZMX[`$2YF<+8,)?PXK MCXG05Q)JT8U% M++J!E[P`5B,?DRAE6#FXE2&/S"[D"?`L`^KIQHV]27$$Z.#"GM878>OY@:@* M['8Q.AN9".Q!JN_1HP;KI7)%)/LDG2>9,0E[[X1/=(ZGF(%"#V``MT*!P;1\ MB"=$.6`E6,+,8Z:*?%XPY,Z=BO#P>]?SJ:$;875"(DX2L=KOQ/4G:=HHKG!@ M.GSAPZV4)DX93LY-M`P"&8N?3>TUF9]R@9J)#1N/B0]N_6S9("E.'A=X1P%3 M$DXHNA]#J7$A`#%X`$%!FT2EFKF:)*36\U"J#?\;.$*.X#*F#>NC,,FSB&\6 MLJ+.<@\D1@6/TY&-,+`9@V`UX.7B^+:1#"IRS2=V>4F<3V.`1U)K'J>+H;#J M9-#I@VB2:T=4:%4L2<3H8UO?54O;D=2Y8E;+L?GQN]PT45X)Q?#AIC4$V607 M*(W2B''9EDG+,7?W,MF0:\$R9C+_924E(UYQIF(RA6L.J<@OB%E:*QU7`E1] MWY>F3IE$'NWGI6O5+^3\1A%7+C%?2FZN^"I*&?8P.5PO`T;&YC?E+GS`XPU5 M;.I(BT/Z=U4DYK!@>@6AR'5"LYEMP9%1]SQ:^4@\D:ZP5BXXZ/SS,EC-R$/(5);O2!A9,[8>9SS\)RC5)$ M!_:X?`E_VHLX9L-`^7T+YF*W])I;4($XBGM]V\>UQP;,XOW!KEGXGRZ[&Y5O*;V')C.QFB2+9 M\F,A(]CT8+!EH MX#M_.=UC<:T)(P^H<>D`?1G1$27O,7??!-3X?&YP9X)=HZF03"R_8*K"[]5) M^H:[3GB+MG4RZ?]KFK?.W^[,)&%6)3#N\5]+`]\Z# MKR-RDVY@JS-E-[3IA,[X;BM]C6Z2D@?,'`.]CX56R4QR,'OIDPN7X\QP6!WR MH.8N70IE!\A"=HJG1OE-K;P/RQT?)S@+I;@! MPY.P@+:?A>T&T4%M>`0FA,9/F+GIDN6/"B[$)=<$15&X(%GBM!?'2WXEC2>] M:&O2#'Y,>WV@)6+N/M*V&L8V4$H`);CW"X;S(4+T&SQ9GJ5NJ60@92?#K_.% M]+EFL%METU(5J"3-ZV?-?(U^DQUZHQJ)0W%Y7-E5NW6]\5N_5L_X-BS@> M\AJ:6G2LO)RO1?>1XN0P[1+$Y36#/WT0HP\H`U,Z.OCH1G\QA,$I7:RO)$79 M;4+^A'Q]&#=X(QMS3X56L!@C1[SX;BX6LH1-[H+0#V])UV=`B"?.:LE3CA&5 M89(FOJ?'RO(@`9=M>0*2GK,B>DWO[Z8P#-5YGIYHTN&P./+$2[DXIG>1N>BL M8F6VZAY+5ANNZ2B?R?Y92BAE9NY^@*`>5;1&:0<>.``N0$1;@" MS\`5"Z,XNZGF!W1XXN=[V9+#$-`#(8X/-*<%6-6:3^$H6'B("/,-^>_RC@I."S MN(J:`E>!1;"^16!V+^3UE6A(S*9T8_#M%,8DSAF#&SJJH!MB/*M8/YSH%8JN M!OA-2FK_RH1_@RT$6R5/7SEJA"N9>W'S>"$M&IY)QQ)3(L:CP]N[Y,*G,"G: M\J3;366#7`HO1DB-0+IY48P0FV'X&)X0H!\@T4QPY4YQ*SC:RIH8%"\@Z`A: MT#JGE8-LQ.A"MWGK7']^8/0!_8)M!^P!*%<^LNG5'9LK;QB>S[-(;B[-W^3= M21HU)\[Q\<0C9H1;`CM@W`_2<.D<-Y#']7-^_$H[*B](7H+WDILRZ$?.=D6\-PB>,8($R$6Y!$3MN]"A]3>DZ-XL/8/=]^1X7]F!=-EG-P27!GA+!$WH0?;X@=T<2-(HI\ M$M?ZN!%!Y;]A63\%]RY_RK''9F!U1_$%H3>BY!$C6?%UW(Y34UW=1$B">6R4 MI)8\"!F2`291!`O%B7GXM5L=FY7 MMG(5@P^RU0O\#HS6Q""/.(=MU#Z846-6XAP0CI)P42&KVL:^!-$7$<\/L`?6 M(LF^]=DL^W(#@(T4P\KI;W7[K5X*1C@B^Z;.[6#;P:R2YBE3W=T\:X-/)B[J MHXXSZ]TR"CSNHA!RXP\*'3\-P^QS8!B=["`Z?#%RZ20,N[X+)8RBW*90P"\_ M+P]=Y?. M22C*9J#\CF'^U(@?QG1G$N`YVR*,75\&-6:@^CQ:FP<]X_:0`[*&0?E-1E7_ M:=7O>N=ZT7^Y_I)]GJ4QL^_I?G&>785TQNFZI$AUSL(L6#WO<.%1-X]_PNCK M](3]*LT!>,UO!S`_AJ4'O@F[#2-RP#FV9'IPZJ-/B^Q/3\Q`=T+TRN3-%`_? M@K4DY@AA=D0/>QC%-V"Z"3O6.V MEV.VQ=QNRM>7'5EI/[\JKU?!U`Y>))"6&[Y:@)!E3'V/TL0G^R8SRMN6C9+E M+1M$QBOXNF0[Y:!BG1N&N91Y;456FLP]3U?F'`=60;N%$>& M%X[_7(:X?BTBREJ@W".T\713PY/!R#G,K;!T!TK)S_R\.9;1MF*MHZ418;4' MSUIZ>_%M07Q5494HN7.#%='-^\MB"M0L=2&\P9!O7VV\_'20@5W$5W# M@`L9A3(2D?MVXFX%Y-KMY;U4WGN!;Y2M?P0YF16["A+GB,T(*:(\E?8&KQ'2 MD$4JL.8F4GJQ^!==MU.T/&7/+GGH$2J1/#@N48P]);[-\X*N'0Y\*\2W\EU/ MO)QCQ`!FIF3;/A%*G'(RQKT>WURN%N&A>]7R?:YH(-WG\K;YG3;L@9<1@8;0 M57:_63Q6G8*N8E"WB@]>W+L*M[WB;O7Y<*5G2SE;>KX4^9*A[;?`DUI.:1,( MT9;U2[VK.(S4IYB^E9#]RK>8C8,+[YKC&J.K`7.Z=\^5[X)&ZL@>J>.148L; MC8)`USDLZR>OA!WV*:%\G^KL:?WL'67VCC)1'3*'#2V^.^&B=\IF)[8DQ\>V M/K>!]:SI6?,L6;/54.ZU&RF]%"_:26/K$EBQ!MHF*][>;7?I^F<,#!N6P&FX MO/%9O8%66'Z;)Z6-1?KX4U&'S?W4M^DS]W/?S_WSGON3S')7S7B)/W&$0.;. M)K[Q,'Y,"1/IW"+A-`/"\+*@7YXKF2&1EX!LJ-F7"_>1?Y-"(:7?2"Q4D2-- MA[P\ED."2:=`R/3<31@L";\EG,T\H%25(;0I6K6[6$3A#W[/G;L!%S:6/`[W+_A%W.UIP;!FD`D9^,4SK3/`"7P% M19/P2B>,9\PC2`-/GA5HK_>,2_=J7D8I0#_V!*U&##H(^F3KSB1;=X4.$>'% M\9:]6,F0!848YPL`$#$RF5C`2Z:@`RNRBU(IQ)K2XD@WJ$`"__F&)0],(/C@ MN]Q$IH4?UG1&@)>(/)I,UB-98RI;CA.%N:"EV.T%EA+AZ3-4A\8E=#LBR3,'KDBL*+1_`R$`*"3V`/>N&41D4V('4"\F,BF$6IT_"B+''A_A"Q M<\C*@?)?:0F&%&-+O)NM5RK'-PK`N8EC-WI4.18@V'26S@VG(3,S@E21+)\G MA!+F>38_S_6A+.T825@M\H`,16@-;G#XW`C?*9UKSHP46Y]2]3F2]G09Y=`: M\2%@6`636+I,;5ISY-H4>_,E/)0P`AA;NGZ:;T;/)YU;HSX'RCMV$RT1.L,0 M184(?_`&@WT3JCHDT5JB\-'U,>!1@LCRZ-^W0>PSX&GJ28'&?`TGX-LDB#&* MU/T91G^)C"Z$O(4'?A[9JJ9IB#I#D.19#0`.(*-K0D>7PA!P$LKR]HL0*JE[ MAI)!2B>P\?)P*%)UMB"1<%`36QT:'-*$_M159V1S;9>MYY!-I'QM:97`ZE)D M@R)2`9F:?)%1T><0.^V722FN5/[*EE7`'A#;D%P?7KQ)ZAUWDR7V!,'B?KO^ M^H'*>%%%H2!0+B/8N:O*1["=WJT;K`CH$.6SIHP6<25$,.L.&>3UWOH`SF&-Z(R*W;-!*!LI8"*8'VAW-PF1-1 MAL.+4\RNJ0#PHJICHLR(H+10]B5/-+7+LS:R[2@X+Y0C3ASC*KD($:/:6WV? M2$BKEA`$+2]-)%[;V"\_.D$V@;[)%62^"`,)[:9&;/8GK$Z'#N:O'9_RK@07 M=K>%GC4]:\Z0-0V9Q9UI#3*C<#UQ3*\%!+&RE;O0M47"32E+TC.')(F\FV6R MY=AASY2W1C-L&DE4JRQ`NFIJ(]6VQ@W0^/RX-QZ;JF%JI^'=D1IKBW>&ZFB& M:@^=K@WX3+@WM'1U--9;&W`G/>-^(>_(P'K6]*QYEJPYEF=Q\". MRQK-L%1K.#J/@1U9:O012$Z%C7T7!G9,UMCJV+%41Z]PVG;N/JF(+%(8C]O' MG+`$P]_"!=4X>6(S:PQU5=7%@L5CW"\> M:_)B&.IHW$WSN.])9O>B[)[.MJ.[+?2LZ5ESAJPYC2O9T"[^2FS5R=$DP.'\ M%SG@89[XC\'KFV/;GYC`P+;,LFU5&_7;LA+6F*:M#K6>-66L@:W-<&R?Q\". MS!IMI`[UAJ6FQ`)GP$990O>.-+/5K#1ZYC7F*&%A9!;$E!/WF3;CE\'T?8#A MM[!?Q_*B72L*FJ=8@,Y(_)@D7#E60):Y!`J3L&CN!1S2(\ME4XIY;"/=V8EJ MDN_^XIIZRW\E'W1^4VFN5E!.LM+M\W#JS3P!-;"(0IGLF&:#ET!'3%:'3NEK MKC\1"8XI'`-V*6>M4=T9)"\U+EHOQ M#W]3[K$O&"T_#1\HQ*P+3F-A)#P_7#-A#^SP*<,LT+$#?]MIYF?%++*2)%.1 MCVJHEJ[S!%/#40U++TLJE`TZ9I)6HLU#Q^3K^V+* MVS7S@:>WJO(["^![/\V-O9R"U'K(>.+4B^O?.8--Y[?+EWQT!>2G'.B0I*H4 M`&(/`[!J0T"'+SDH&%#^)0H#^"A*)/,7NIKJ^CY0_F/I/PJ,")PD$GR1+7EY M_0?]&VP#AP#R9US^28E7GK<4($X"1IA/ MA'D98:ZH^)@5V;L-P^F#Y_L\0SPE=I#GA7+#,&PV%B>XT"C10-6K@F#)19;2 MRR-OGFN$J"(_&AZ="S=[YL6(+,91!VX83%A`A`<(JN3.L'SY-5N`MN"EFX`1 M,*@#>,/WX$MWRNT-$>%1^W,O21"$Y3OCOQ('X:>TO'(*YA2!X?SGTI5ETG/4 MB*3Q[YAX"_W_*E\XM(XKT<)`KO\(56N14HXOHT/$$Z<*VE0KB(V MA?;R;REO?X"]CC/U5@4Z'0@4A>4`X5-0GRA&0#TJRX>E5D'%4Q2-]9$L\R,A M3"<^$B+D@8\FP()^Z6BPY#RX!L71I`GNB-*$#^!@.+X4'TC^!5S-"HGY`B-) M0!?E<)>X\$<%0*-<(CNO:L_!2Z9>G"(ST=CX2V%,:>F#O`@(C"<@,O`?2QD3 M+\E:$C85-P0!,@M7KN0Q>&*F?(MIDD;HS>L$G!%ID%8R=Q M*-"7]+A%`GQ<+\)5Q417NC02VR.D!4EG0ZX(\K%#1FQKCPE'H!4 MBEVJ-"S3#UQGX5[@AS4;8#[VOD- M3H[0*V&.<64'_WGJD<,.+CJ9K10Q5*`D\;X/UV)B*P+A;G`?Q+SR71[8T`E8 M[V6$X&ZT$D&C5X1QRA%:D7V/8.ABYG.<.I?+'.<8WTS"0Q$]#%*2VQT3=F9Z M1Y\?)!H9CZSQ;8@#3,D44R.P`DMW&W6W"FO'%9,[6'M\!.^5.+[D_?8A3P_9X^G#)6`?-_BA+U:ZA2L]6\K9TO.E MR)>^6&E?K%2D(_;%2OO)Z\M=]L5*G^CL'66B.F0.3Q/!]:SI6?,L M6;/54/;%2I]QU<*^6.FSG?HZ/G,_]_W=2]CK8?&/QHT>%K^[5U0]%'J!"STL?B\+/2Q^!Z>\ M*\=8W6VA9TW/FC-D34-FL8?%KW^7VTA(1`^+?Q3N];#X^_.NA\4_C'L]+'Z_ MD)]S"SUK>M:<(6N.Y1GWL/CG*)X]:WK6/$O6G,I;[&'QVY.5'A:_A\7?3VIZ M6/QRUO2P^#TL_NE'=42^]+#X&^2EA\4OEY<>%O])SNNY#:QG3<^:9\F:T[B2 M/2S^,;9E/2S^1M;TL/B;6=/#XF]DS0EA\??,01'GX+ MQI&PM=]*%/4_8C9;^@C^_-11YI)P42%&S=9R,6H1GTJQ;-4X%TGYO%MH]NRW ML@#;',5U[]5_!]L.9A7B/BX16)-5YUD;?#(Q6'#4<6:]6X(12)81([]GYOW` MSQ5.V=H1K#-@V`?FQA3VB5BF47C/,3M/P[#KNU`BMOO>C*-'8SHD@EC[2&>- M]>$`P[Z:2"E;P4H)2;ZII[L4-`'$-QIMPGRJ<1)4?YTP.Q?0Z-0*1#8L5;.> M`234CHG?9]4[+[_9LE5G_+32N&K,[[X+]5G-L:VKUK#AJ(%S4>!]'8O#IV<_ M%,`F>ZA^_V6J0ZN;`E+;!AA&30FY7MZ`>UL)Y>JLM-X$RZY9#5]JGH_:Q_&O M6'IC.1=X,;W>'N0[?6%8L&38>P<*O#Q+0X#)B:_# M\"^%$'!.)A)-`1HU"ER$11/MS#YU^QII/_ MQ7TD'^!=&*4UN.H'JYW935\N(L]7#%Z7I\)5QM/84H]L3=6T]K)3SV5I M+LS^F<0R-S_)Y^!*'SBW1XFG.R.O2D?)Z*QTM*[W%9&$VU+W"F:]1KJWW>&9 M/(*>X_9*N1)%`:D@6[^'6MU#';@4M+&'.L)Q.:]5*:NSJKQ8["PM('EJ6>GF MYDH]EMNP`_UU_\U2(9`E:_&-=^]-63"-O[C>M'L%VK&>Y>N0:D[.E#=>Q"9) M&,7*E$U\%\M[8BTNXMU4CD-F&:Z7\L:VIBQQ/3_&UK(W%C!T*MHIRX*'6."3 M4A61A3Q'_"S*YY[/)G>;C6L.!?$KFT!;RALW.=UIT5Z$O_%B#KZ%9Z&MD]\J M$N6G-#/XFJ<$?\ZE!,/HCCQ'7663-,044'U]!@'5K7*#MB+*)15T/U<77IK- MC74FJ[L?^BL'L5RK1WLTBQ/7R`AT\Y1#:+VLG.$*B:XV=PEKXC2.^5854T>X=/]N&T5EUE M6J+UY"Q`E!)$>&TXH?KT+-A;^0^UJ<=!X3\J(F:SY]2&9:ACY^F&=VZ/>WPU M.EJ]BD,IU;73DGIJ#J!Q-#75,I\<"TYF'+5S9F7[QM%R-'7?NYS24XVV'@BF0C M-AXT=H,?LM"8FVP$)[;*G<+&ZJ1A[NH`SJO9GMT'1*JD%N3G.M:CT>"5E`1+ MU31=-<0!7PN&K,2N9_$L'0Z;.$$$RYT;*ZX?AVDH"QS*KE`6JP]EZ4-9 M^E"6/I2EJVSJ0UGR%/2A+(6S$OV5YE0\+FHE$.2@0(&5]4RW!9`FAK=4/03K M:K#%/H$+E7(-=YZ=C*LA>]_RU87Q M2J=+W=-=_-<@E4?GG'.,PL'F5[?&JC5L.+/E]"PXW2W%4:!_S_92U]%&JC7J MYJ7N$>)=M/&9V$;[E3[L;>/05O51!92=TUNVIVTP3\^(M@[/=MSB'?.NU]$< MU;"[64SH<*>UO^E]PK:ZJP,XKV9[=C^1FUX#[+BC#AVG+4-68M4[>M,K$-YW M(1YL!JB3-4+8%*&F61`3'B6_`+I<)G=AY/V+3?\`8J)KK)OTF0IV(A1>_/KQ M[0\63;R8?8F\"?OJ!K=/'KVN=(U.+UB&+5RP2!XKQ.1C+(%-7#7I6@NLN'QP MHVGA6K)G1ZP(`2'S=&K?=KMZM''_^"%\.!7S. M//A.7["I<@E*Z=XRY2N;NQX6`5,D'M82G)(/WNQLEH^CL.D\5]9>BWHMZA*; MVM2BAD[7:H0`-7&KKM4J=#1H$9*Y"XVUQSC[:3-NG\9J<=#0"4?V*8R[T<:& M=9AH#NP3Q1B=O?Z>"I"HPXWU^GMX8[6*(O3J6RAOT0WM;Q[W9H#='`:HY#[W1&UY[CW<<=935N/=,1%M6I:.D[O*B'0MKZ>JX-[$EBF.> M]7+AA>84U^CU=@^V@3-QE%+'ST-O M.YHAN/>A42N^_+GI6L^:8VOUP4E>=NZ(_R;3I*XSHZOL-`?CL^/E$\E6/$/. M=U:*S;%J]$:A.:-@MX:6W!N%;23H+1J%$H]S>]WUMG*`-V<=?V7W+%BR&!.# MW_Y(6!2X_M4R!@ZS*+X,IA_"X/:#=\^FEW',$NCE=Q;>1N[B#IWERXBY*^7? MGV6V<2L8P/"M,H,\FD:5MXYXTUUD@N8JUL)DNUG!/ET76/TJ=%6EW@.>MT?Y&U(%NS1[J]G;:-Q!P"MK7[.$N M0>\0[>OV4!]V@?B:]E`WNT_TNCW<8<2[0/2:/=2UKA)=P1X>9E.H,H/$2Q5P MJ;S&M@BYBG-(]J_=V)M``V\\?XF/)QE=!QM)91EX_&W>[4_*E$V\N>O'?__I M_:=W/_T#7.R1Z8PM44VB`9H[PX-Q=1[HUM@::D^0!ZG1KL*$H:V/]/-B0C7C MOWOP]M@8.=KP*0W>KF$"#-W$SAGTA%ZMKT[3-A=F<0%6QSJV.!G-`UV2X;M#)WT,KE[6,L5XBQ'&^M'HZV: M$2PAT6A%?4M(W$Z)!N_DS\E;(V6GW35M0S,7OX\NO'[!'1 M'I49Y"E_><>?[P@*`[F$KG-3_9]+U_=F'IN^O_Y<=1=BFX:FY;2X<8)/PI$5 MJ[L/8ZSA\`DR1HK*IS#8BRG.\.GQ9$58]F6-_7194\&,Z/K3';Z4C%PN=OPY M8%4E`Y8O^UGQYMM#6)TWSTMLOMU%K++@Z)8^?E;<>1=N[#APLT-`5&U*;RZ./Z($R\RZ,9LQ+EM"?%)QCS'BS]J%D M$$WS*5=8OM6MC:E;C;)FC>XN,&9/Y3%@D_]465-!,LSQTQU^Q]SXSO.FAAO? M\.ZO^ZRIY<9KYO,2G%IN?+/'CZWS)K=-6(G8*."R[7U,N^5"4A\X1BO[G6T# MZ1#_ZG@^6]AH#)QVMHUGPL:J1\!;6&@.1N/GS,*:KN963HY[G5Z]=]NLN>-G MK;DU_=BM2TD^8JKGY`ZO=ZM,YK-$>D[N=)*W&L.>EW5-!NTVK0[3];3E85NR9WFV?+ MK,[M-I\4)VOO-O4Z_N>SXN0>NTVSYV5#NTV[P=UF3592]FQNA_J5S5TO@`]7 M,.;(G22P6'[P9@UX?__X8OZIZQ]UXXW(V:W0:\M4ECL#__@R^E/7/@[WH+,P MB3>KD\CG?T>)HO4"1;G^Q1RO3&P95=]8-#>:F;3A1\-^LR*@IQ_;TV#Y9@DT M/^K6,^-ZSG2=1-#-CX;1%LOW']O38/DF01_^"4N">29<7UN6]R3K0_C`(O[) MFWM)358>MI?8N2MK9DQGPK^:.PA]8._<03PO_M7?-V@]!P_9+5A/0P3_6"Q. M90+MMDS@RIC.A'\U3:#9WA)RIORK:P*M7@(/,X'#P7#GE4:+#%QS3M#*VW]:7P<[_2D6R7V?/BU?27AQQX5-N`]-RNL*__X8N.!FJ[U[&QF MF4'QM#[JHYZ?C2PZ:#H=?C#]A-BY^2)@$PEZ];4&S6.3XK<'L>?#KZ.O-<^. MF\6U9OS1:-(/>G[<7%EJC(]&K^M-+35XS=`Q;GZ>S6#_$\5Y`IJ`VJ3LQ-Q6 MMZR?=033`$N_1_3C5R_^ZPL,#[Z`\=2=@O]HA2IP)R':S!%=A=.&/1H9#1#])0H7+$H> M\97D,IB^_>?26^#N[6V<0&^P3_LC9K.EC[5\*V,9RA4V;4SN*VWED;E1G(/7 MKM/]46G'[=\2=C=K8S"5)%1&YS.0=\LHH-0R:/B=]X.2S++Y.*^Q?&!NS.Y" M?_I^OHC">YY;)P=S?1=&,&%*.%-\C+*&?UTL/JV$D>+CBPV-\,J-L2HA_H/O MW8,;"52\<[WHOUQ_R=YX\<0/8V!SY?2D52LZLD?CO'97[K$-4C-!DJ^]#T`S MX@_LGOEZE2(2YS,FB"E>=D^';DU9?=TA-:4 MS[K.M/&T-)'8[VI[NNZQ;JIC>P\ MPLAAW==U<,=CTS"UBKW7*JQ87S0V!6D.=7VDCW,"4HN.Q@>Q7<`V#<(>.Y:C MC[LRB.UBNGDFQN9X-.S*(+8+^\9!:(9E#4?M#D+4%%UKHT&M,(?Z<&SO',8F M2EH8R'Z:,00+.-1WJ_<1![*G=EBVK8TZ-9`]-<0T[:'6W$"NW(67N#Z&WLK] M_G4X2Q[@M3EY= M8;6/2EU=N3PR\^H*X2',>^=!NPQ/RJ:KCUY.)LOYTL?SM(UJ4^-LP-*=48[, M^AVW0WJ5$ISIR:^^R-=/*[R"/36_M;;ECY5W[_/R^7C&KAGDP+5NS<@[6]EX: MHVGC;=?VH$-+RX?`'9O63;=;6VFV;&=LGH[F+1=96]`''2O2E?54B;V_] MM:L0U"*L^GL,7@EB;T)W/GOSU=1&3H-@BAL);(P3Z347;`:6<][K1Y;.V[D[\NKB>P[K!8":F=BT7D3?`T;AY.F=\`4[;3VBI+T*^ M[R6/C7+*=,9-@.-6I[Q59F&4[+N(,4K^87'2K%#IM>H#'$IW8RE[V^:F9M:R M_6<#>7<[Z2F8G0STCJ*AO7N6SPQL[&H0-F+D553HLT!>`0&ETJ[KHQ?`B_/Z MJ',E_1U*BONC+BF\!,DN4CZ%P3\E#]N9+GN8LF139UN8\WE6B<(F9Q`OSVM1 MTA[Y]6>=`P8U13ZLGNM>Z[%5IY2(5HAND-U;B=X>,7F97+E1]`C/'[1OJ1@Q MN]);8R16.I70]-'8R)]<'Y=&HPJ-QDC3M9%]0CY6VOK;UGAG+.X.&K]$;.%Z MTV_NCZV+TO:C?6MHYZ-=\FW6[:^*")F:;H_,:OU=3B;A$MCPE4T8L`1+_[+D M:AE%!QQ2FH8^'EEFX91R8R>'$E1)I\:Z-M3MI@AZ[?D^[:(^A,$M^GSR$"?^ M''V)PMO(G>\M*[IA@7)MH[1*[^V-H0J[#HGF5J+G#9LQ$&!4<_[`X8H,Q`SMG-ILZ>)` M:BHQQ[$,V]F+&O[[@=S0#=.Q33-_IYQOMG:?E<9LC$>Z8ZY%[6_HLZ\/QOD2M1H?`(V]_3/PENJ2_A^'T`2S4OOP: M:J:IY^-^JG36%(%5>#V\"*IJ6V@0< MMO(8NC,>%X[D-H2H';:>#+6AJ>=O:C;T(E;H+^XC+L^'&LK1R+2'Z^M_L?7] M::@TX-&OQPY=.TP+-@&YRX^='35"6:7-@JX; M>2R9VI0!9Z,EF\KW1*;\H0P;%Z])MW=R.$F5K.8A))%):4Z>]+&3KQJVH?4# MB*CFK=8A0J*"K%]W'\@+&8.PLX--/NI7=L^"Y:%6SS"MX4A?=T^+K>]/0Y49 M<<:&,:I+0H-2.31T,^]9[!;)YJ1Q:`S-?$[%[KYS&XC[,X9MC,TR4=C4 M41.$58MXLH:F,ZY/V&;5^G2P^NJ[]??31A5>M3F'3YYI:N,M1FV'0]KH=%FC M<3XLM#HIN8?V98,]AIVN4:[*-;NKYH`;VM!Q*G4'N[NYEU"X)Q[G0H>P3V'! MI-YH?\3>KX'G__VG!%;QGY17!_:R89"[>OD2"0VDRZ>Z=QL-M;XG[Z^5TZG$PUB^N-WT?B,.&_4\(#-W*GZAL:/\` M,BKQP+&,43Y'KB(97UGB(BK66S="@.&X$(4\\R;>_F[_V!QKHYPX[.ZJ&>*J ML`MHL_7Q0<21A&'0.HMBO(1*'O=>-NWQT#;U?$S/6MO[]5YM>VW`__.KT^[> MQ=&;\+E33);^NO7*0=Z8/E- M;9W^&B>V"D^;(G9;.G"SV97@!ELM,D\46OY(L; M?8ZN$WR)5MXOT![&E53F]J8P%&V@Y6M-5NNU.5I+F7M$6E3MLZ^(Y+V/HZ7!W)L!SV\A\-HJU:S+H0[N` MX+-_U[4MBZT;X[QEV;_KVO41AI;A6%:EKJ^9[V,,&0M8Y/J(13&=>X$74U60 M>]8DEI(Y(,9VR*L9-">Y(UMS\L";6SL\F+JZ8CHT0=OU8U%7>W4TK6$> ME+)=ZFI;2@U,I;4G=9\7#.4RN!6_-X(T:6$X>3Z$?JV7O:D!?",BID$93U=`!!=:7& MPI3/-@FJ*SN.EB_:UCP]M5TB0S/WINOD4!F%1_]N=H5K]U3;XMI6/_MO8UT%$-3"U=9E>[U!EF#^OK,R#=V'$O%L1 M(3MY_!:Y0>Q.\.;]=]<+<%%XS6;PS#?W1R-;;=O*!VC5Z+UAPNO*V'@X'!I= M(+SN,C(R\P=&;J]FF>X M5\^U]SJV:3HKK28]M&`1RG(D4RY%J&D>Q9@&YK*$O><)7VMS=1 M.R7I%$3ME*4M03].6T3M%*#R#L$,G:PJ_#"6M)N@XG MK"4)VT!8%93^9G9IHSQJ3)5NFR*U]MY?+]RB[T-JAE4K0Q!@]\Q$9KZ,1LCM M.&!Y.K^-0BH''J:Y\X.%;^1.<@XF6J=ILN-/"Z4.1O1Y\-D%B; MHV,KG[99DT!X+,*J,6\8__=]L)XNU`@C#8Q**EQ%[.ZX*6)K[U*&NNZ8SG[$ M4L[^Z@L"M2Z=E&8NKX<6*)/$Q=_=90,4UB[KJ=NF@Q5N:I*XF?'B'2GFN[$& M]ZVA.C(*4`/[4=+>>.K/A&DX5OOC64&5:L1Q`RM03L+>,NNUE2B!FC2T,H@]+'O; MHQ!P8KGEX3"CLON2^B`*:G/0TLR1N^Q81]$-NU;OBRCR1UH`14H9[[/"(Q-OMM8X&"* M^+:]OP-):\!N9FP44=L2[J*9\RU;'Q7`"S;U=A!9M9,G0?Z']AY4;=#P]\$] MBYNWC!=TRIU7U>K]-TMY;7?(@24HOP;M3SB\,F&,CG7?_IBP.,Z.;Y&X\D)G M+3F5C=%RX(GW7G1L&@R]D:L-)8L:-9(2.[(+R.,[^VR$R-I[T-'8.83(#<+] MS@O<8%(0[JL0<1:7\)UP"O8JNU:B;X;N@,^WVQ>I2%/[(ZQM44S+T`O7#>%TU8%N9L9@/*:14^HZ%#1-?>W9,(9CNW"7<@CU,J`<01E;CK_? MU$4S&]!L8[_W0(K!0R,#G-Z2X"'>Q1X4U(_Q<@Q[Y<"VC(0*_NMW+[D3F"]X M0YL<>@*TZBI5=[HW4M+6:!J0+K%5/WRUN#`%?DG>+9>M']AK6E;Q4Q@E=Y=S MT/Z)6U9;<94@RW*T5@EZN\1YJT**,72L5DFYC+U*/#&,4;N3=!TN:TV2,3R8 MG!)%.$!F],/YLXV@.C+3P%1M(Z6JS.B6WNXDU949O0UJMG?IV%JUR;B>W+'I MTL=XE=)RX7G?7SB3C]_0Q'\#$E_[\&-58_R/_^,GORV4.'GTV=]_FL%+ORK. M(GD5A!'0K7SSYC#V3^Q!^1K.W4#E7ZC*-;!Y]ILR=Z-;+_A5T7Y3L+,+U_=N MX<__6<+.>?;XT_^Y37[#]E\MZ-._Z:;X3R-]ILTO\4-:>UM)BV\KQ"9%ECA^ MD7OD^O-+(FS9+HF;V7(9*^%,^>@^*J:N*C@AJB(#PV(%D8F5E%PB"$A6DE!9 MB*5?L89#%61)B6FEQ\8FA#P&-..@W41A8E.H+'AA;RRPCNFL,Y`&Y6"B-\0A!)5""A@R/S2WSI!5.&S6H#VPOX MW+OSQ6__!F9EXPPFW.T!%RE>N+CS0H^,_EZXTZG\>Y7J7>0^>-/D[E<%#,@O MORDW831ET<4D]'UW$;-?%?GIIXPCO`F3))QG3Z,AH#>F M\@W1!7\07O!=F&`=Z(Q#WYL6>8:BSZ+?%-\+V,4=\V[O8$RZ;O]"'>1"#6/% M"Y1W?^H6\2Z9;NF_O*T5[I>W`,P`S@=__\GXJ?G1?%JBE4?1%RK>ZE`ZSHSO M]`6;7ER"@+FW3)%G0@J5`"\2>!,IKU(*82>LT#+3LR_'OJ]L[GH85Z[@&8TH MC*-\\&8-LXD^1HW9BE+[V;5IZQZ1_3#/>IA[*!&LW&`L;J-P&4QQ]0ZC7Y5_ M>TO_VZ9?8NVW'5CZA0]QX;,9D&@/K$6RP8$I'TL.&595+I>W\+3T!LW=_!&4 M&+\TP6SITFP:57,];.PBS[@(.]K4JVT:Z/G6&E1C]!OM#S]7;U@[F/7Z MP#%.P_$M5.;4^3MEAUJ>-'SBC`7F,&UY`9T<8GQ> M=FO<)[(Y^L`_Y\6PMSR'6YZS=AQ[ MRW-$;Z=P[)2_@3QC`3I,>\1=ZE,;_XELD3%PSIF5S=JB7><^]JB39JAU!TAL MN?!^7E6RH?3F"*5"MWISU*!K-'+.F)7'-4=FPV=F)>;H%07E%+YJ.G!(CG+O MN*'S#(AK.GKJZ!2=:#8H"/!3&%QD`8(KD8.%'V4X7@,<^SC'AKV&XS)#.D_R`?BI*"FR^79#, M1>94/:79[\,T3Q\:V,W`OGZ8K0QSNY*=_Q%Y'Z5Y\BA-R\']0ZTQ]4&:C01I MFH/1^#1\?]I!FJ.!TP=I]J%2+\P^7.'P,_G^BK`/5^C#%?9TK>QJKM5Y#?]$ MIL@\'AP-C`J.Y1/V>OIHA;)P'ULU>FO4F#6R*NPQ.LO*8UJC MX4!OV'"76*-3!2OHZU>0)9>1N4)C!P,&E<+!(_2PZU_1S:^`E$N2R+M9$EN^ MA5>N[\M6LYI:]8'@-M3Y,RS+&H]6X.+WHZGEX6V'@MHP/-,P1N/Q.0QO>PG) M3;,WU'7-.(?A;2]$N6GV=%VW]*:&][=7/VXBW_L5_PM__O]02P,$%`````@` MPD;H1-$;/K[@#@``6*X``!4`'`!S:6UU+3(P,30P-3,Q7V-A;"YX;6Q55`D` M`^SINU/LZ;M3=7@+``$$)0X```0Y`0``U5WK<]I($O]^5?<_Z+QU=7L?>!EG MDWB3VY)!.%1A8`'O;CZE9&G`4RLD,A)^[%]_/8/$@J1Y"!`:NU*Q+4_W=/>O MI[OGH>'3+R]+SWA"),2!__FB56]>&,AW`A?[B\\7]].:.>WT^Q=&&-F^:WN! MCSY?^,'%+__[YS\,^/KTKUK-Z&'DN==&-W!J?7\>_&P,[26Z-FZ1CX@=!>1G MXS?;6\.37__H^Q$\LHU:38'G-%@3!VT9AGBY]NP(F(3? M6LWO_[[L-M^U6ZVK^LL<>NW:$;2Y;+:NZ!_>L_]FK??75Y?P3[&_R([6X;:_ MYLN'9K/;A*\-^2T_\>[!`98$H_O'X)\>>+QRA:73<:S\_/]>=V/2"+ MQF6SV6K\<3>8.H]H:=>P3TWJH(N$BG+)HVM]_/BQP?Z:-,VT?'D@7M)'NY&( ML^4,?\6"]CN2A/@Z9.(-`H>95:$;@]N"_E9+FM7HHUKKLM9NU5]"]R(Q/K,@ M"3PT07.#?K^?]+>][N!;=X)E@_Z]`1BME\B/3-^U_`A'KQ0PLF3-0`?&\)&@ M^><+2EZC^%.OH+W^H$(;O:X0HUUY8)/&X8)V`M]%?HC<&]NC!IX^(A2%,A'% M5"4+-[8)6.<11=BQO<,DS65Q>K'IR$04RG`T'ZUHH*$-E446DY M\'R8M!GJDPF["=A2V%/-3M;]=+U-R,N'')``OBEYI8/F^QBL*EDQ4$="B4*QB5ZE?L>E.)E0$P2/D`L! M-GJ=$=L/:2&E$/1D=*?T-0=1_V'/`:1[^)U$-@:H5/!5H3YAM`L6Q%X]8F>" M5@&ASB2/?%R2DXEE`8?@%:$;B+)S'(TAL\K$$I"<,#@_A.C[&O"QGN@(E(?A M_/9GSA:GS1JE90^U[FI:9!-;'EE&6E1#7YA$0EYAU%T"5TIQ,0 M+>+Y4TXP5)15G<69!U@70;;QPMHAQ=SI>JA(Z9Z-"5OFN$-VN":;Z<9IM19V M49':EDU\>!R.$6&#Z+0:\[B?6=FA36A9]70B[3+L2LT?L2T/22`ITK(RB**$ M8JH2D$RZ+,X@]6K&FHW7$5J$5"O5#>%6B"'76%T0<'*I, MSH_G7**2ZC%&3EKZE%E96&4&9YI$*PM>D$V9TVK%\"BG+'.2K6Q8%5J1H([M M.;%$`_A]CP*]1!!;D9OPH<(>OQD"CRF;YN:K9=2,A&KW1P@;QH:%L<>C3.DE M>QU['4ZAHWYL`<=BQC^L6R9M-D9RF1V`N]4`^-L-Y$5A\H0Z1+O6;,5[63_$C[^980CB M=]:$[)3SGOV`/-;MM[A=JEFC.H'I7@)=2X5O-!(_V1Y;78TZX-"O,/Y8L".#YG$,0("F>#S1:O93'JRB;/G.]FMQ;A%(Z3U*F54P^`8"?V(Q`_DJ1C(OT<((;ZBN0]BSBAZ1&1C"#[$8BHU(*\J!E)%<^W@ZJ(Y`J7_@OY':"Y6H=(3(-YM&S36@%)*K:Q72ZE'W<.EU%;>W02I:GZ7I! MM+M&+<1*3*5+]<8-67*5M<.I[T>VO\!08VZ3GO7B>&NZIGH;!.XS5)Y\O-2H M=2G6.+@5,8%V^.U4E,/`=V1U&J>Y+A4:!R&ADMI!,L#V`_8P77>6ULUY;368 MI\=;=LH+*NGVU1<\?!`XD^U\E;5SKF0Y/MZH*>)K"J35UT+*N"D;0CL(P>/( M&KFIC16%=70)7?7E49%!IV`"[9!+E@@FZ`GY:WEXY+6OOB!21DJLLG8(L4JA M2%#D$E1?$BEC)%'ZA"!EMX?IDV_):O3:]D8/'EXPY?BFIS1BDNK7J.3&EVNA MZ1C944VI,-6LG.,,@C=4`.RL-.](K3)]DU-J5<')5]J%^FL'7#K0*L^XCP+K M3!6;8G(I%:8B^65X4(H9%LXR9RK#E--+5F_MQLDT"IP_U\BKX.&_@JJ&1;5I\4E2'AJ:D='J;K8JJW M[8UM[/;]>)]*L'S!(Z@^"RJC(U%:.Y`F]$"QC]SDO1S3<=;L7"IRH0C##A84 M+BJTU6=09>C43:$=BCM5@NF[19*KG++Z;*6J'7^^5PRX2F=$1304-!0J^JF1 MUG,`OY_]6'O^Q3A[9]S;BF?;YVVN6@3A!&HSD]#L%B&")/V$'A%**3J!#GTU0?E>78R'7.@:E6\1+5)D[Y MB_C0L6")-Z=IE<,<>1X]<+.Y;0OL;;I+[.,PVKQJ%LLH&/V*]-4'!2Y$Z=!0 MR"+:18P)"A&(0U\RZD)\\P)V%DZ*HX2L^KBA"I^2_MJAMM6N[T-!A`80(Q4B MR&YCC0985H<41GDY0--)A+I2?`?5+UO1S86-0I(=E*11M4=E$4%AM!%E:V6^ MX%P"#89(UO#94[$B;;4+7,/`#_:'B#35"$@T&.]2A*0::X=1+R`@1[Q]Y>Q> M,'%K8Y^&M!LTAS8S^X6/6B$FU:\MRW$\P"K:(9M$"^F8RS2L?@E9/1;*QU?% M^713RHB+MMTVU2>BK,2\:B:G[M&T5)/KE.-QNHWH(8I4I@"I9I6&("H&!,EX ME,:'BD6AB$-0_:C(-7XF*`GU50Q.YQ\=*KKEC"!-MSS$5]7O;1&\4]PBZ)C3 M+T9O,/J]RBT"^O([J`-`T`OPW)O7>U"V[V^CL4D_U$1RAK0(CSB;HFHBU8$.9@9!'[V$#.Q[YI+>FG:7WM7?^6=F%6AUB(J'@=F$3-I MA_&ND*-Y^H5C7%!8^DW[V1W MG-[8H':R6SH,?!2_W9=LG.XL;$#5*BW/C^%9_YTA5C2.=J""O`1!F.JBS?>^G[V^4+@&HT"M!N\'G>$M8J93!F[.&U5I M<>+KUK;.ESNMIY0JA&IP?=02+E4=M4VQ&3^+I4_B2\%K.`_EI[P\HJ,3'*G[ MV_&-U.4WA\3I+:DBXEJOB"E;Z`VD8?X%.45@%G%11%SK9;-#[/8&P&?QZ#0> M(&6EZ`9:K[(=;,$WX`OQ94L[Y^7!\6<`QHS^/ MA2+J6J^Q%;;8&\`\=6%7$:PSI(H8Z[UTIFHA[;#EJ-[WGU!XY!9\+H\JSZW9 MK^P,Q2PPG>]K3!#W+F7!N;8"/+3=O!>`FSXB4]AD^DU(_]8A?D,FV?5203E# MHNTF_B&@<@QRAJ7!\9HXCQ`HV68S\CS$[A]*O(NS+"@CTG8C7@$;%?UT'6$< MK7O8MWUG3VMZUQ3VU_`L^ZJ[N=A58$HY'\\SG`/,STUYC;7/2D3#S M#:-?#$Q\DCD@W3Z//STX_KQ@)+C!0(%4V\QVFH$L-9IV@S;_@RW'B.#`34\& M1L5COA>C:UT M>^]J_$0_*AJ'CA>$:X+@EU;=N+6&UL0^'B.'3J9W^Q! M@E''@8>=79_;$_I]6NC+NC'MWP[[O7['',X,L],9W0]G_>&M,1X-^IV^-2U7 MF61^E+L:L2?ZA[3H[;HQGM#+LF9?#7/8-:Q?[_MC^HI,Z7=_L1MWTVO]>\)^ M3`M[5:/07L3. M!*WH5--O1E,31[M,(E71;L.P9-WRB@&1 M)IDLRRT)SJ1`JC80R'Z92;LNO:+:"VO*9?-E)E>KC/:X&VB==&38OFMLN]+*%CT;$W81_AW, M3T'')3=!76:R?P%CL'X,UI&QVY-6MDBN+H>Y.QO5^6;(5!5%S)!T84`?!NM$ M"PL,Z=M.]-++?)4SI8F*REN>%>2]V-SYVF0*%$'BBQF=-_,)I<\4(+FI[SQR M9W-?XN?9;8L])3*U!S<-9AA6IE*\0#]:1V$$\9PW26IG:A.I;C%G8X>U1EJR MK4:V*<%=L6FKES4"G3=9\N^NSFX#<11L9VH>KI+G"GV\A1.)(IFJ1KB"`L``00E#@``!#D!``#M76US MXCJ6_KY5^Q^\F=J:G0\0($FGD[F]4PXX::H(<('T3'^B'!")]QJ+ZY=TF%^_ MDL'$QI8E&\L2P5VW;J<=O3SG.4=OYQS+O_WC?6DJ;\!V#&A].VO6&V<*L&9P M;E@OW\Z>QC5UW.YVSQ3'U:VY;D(+?#NSX-D__O<__T-!?W[[KUI-N3>`.;]5 M.G!6ZUH+^'>EKR_!K?(`+&#K+K3_KOS030\]^?U?7L.T!! M5%K.[;MC?#M[==W5[?GYKU^_ZK\NZM!^.6\U&LWS?SWVQK-7L-1KAH4IG8&S MH!9N):E>\^;FYMS_;5`T5O+]V3:#/B[.`SB[EM%OY^ZN0KCPU?GFE^&B1DK3 M(=".<>OXDO3@S-<``R*%6`+_JQ84J^%'M6:K=M&LOSOSLT!//MDV-,$(+!3\ M]].HN^LU9`KU&5R>X]^?(W5Z2V"YJC77+-=PUUBW]M(OAF3P&WRUP>+;&:Y> MPZ:"#0CW^A>6NNYZ!?RZ*Q-Q?UWH2_\J&- MU2X,[&9NIZI]KUAAW8^]Y5*WUX/%V'BQC`4R'S1.9S/HH8%JO0RA:L<+*HD%-JU.D!;IX<1[J:_T9MT4UN:3B!<)9+@W7 M-V4D-NX-:07M31@TRU"U.%M\1;/8*S3G:#>#=>.NJ79'K%$8J!%`C\`<3;#N M>F+KEH/W7`R3'JU>D;8V`]A^_.=(24_HW[:K&TA5+/IEJ5W@;`=?;'WU:LQ& M8`5M;$STF8]8I3!8&FH!K@&X0[/LPG"':&6EP4JI4N#D_.R`/SVD'^T-CT#Z M-)Q@U<9T:GDV<\7U($CH>]VP?8_((]`=S]X<-XJ5 M.K4+06)KNFVAQ\X0V/X@*E9B4NLE"]O7;;RM>BM(NEAS7->/+9=Y%I"]JKQ6 M$$:$Z;4XKB&!-7:,-V,.K'F.Y8381`FP!RN_Z,!S?8&P',X/;YFCD.QS#+TJ]R,S,UCF!DHZ1#,#S]@,SV,UX_1(K\GSD,U,+$O= M-*"Z/0NP)A4.=TZ(K`0!'AQ2N?(QO:(F[)GW#&IS`ZU[CA_-V'84)F/7"K*" M.T2$/L]U99@^0SLC'"C5?ECU4TS&T*_ M`G]<%G35K-"".J7:)%CHGNGF-LJ@>A0S>FQ8!IZ0>NB?$=S@W45;*S`/D.,& M#X^%HL>XF<;F3U.I*4&M\(]HUZ!LFE`B;7`$3XET1F"W$-9=%`S]W![T.UI_ MK'64.[6G]MN:,OZN:9.Q`,#)`<\(^@M&],K_1!K[6SG24&*A$4DNB9*,)^I$ M>]3Z2(K!O3(8:B-UTAWT2])(>H0T(L(5HPAM=?Q=N>\-_LE7A/UP:@3K%SQ$ M#6=F0NPO0?]HUI4'K8^X[7$%E3&*&L%\O8^Y55?&W8=^][[;5OL316VW!T_] M2;?_H`P'O6Z[J_$E.-77%D'^=1_Y15T9CK`I3WXJ:K^C:+\_=8?80'@;=6(, M-H+U9A_K91U;\F2DMB?*4/VIWO4TSBCIX=@PXF9C'_$51OSXV)ULAAPF&$N` M#$/K<[>*E'AM!'5S'_479,W?U9'V?=#K:*/Q7WVCF/SD"I8:P8U`;NU#OJXK M(ZV'YK8.L@QLR\A*^F-D*&7,SRPQW0C\BWWX7WW+;FO8N'W(OJD\H2>CB=I% M!L/95-+"OA'DE_O(;_!L/7@8J`Z18$U, M71N;.=9&M"?<-LEW.Y@K;AP1+K9\L@BW:9"O:`RQY8@@L;65N`\H!W]Z[#D, MO15;9!.V!>6`IH:D([A9E]F2L&<(44?$B"V]A!6@)#&*BTE'I(RMT"P#?=L- M*AUTM/$Y!%W]+4@)#Z@PX2PBOXESTJ&=Z-;QW3$+W7GV?3*>4WO1]=5Y"VTF MSH'I.L$3[,F]J#6:VR3TOVP?3W?'040ZZ*(?=^HU]6=@^GU/MX63RIY+`'T2 M/BNDP-Z6VX?\87BJ'8#?^K08'8<;1]KM#$U6R%0UT^_MVYFS&4L!LH4-EU0^ MM]S!5`G"!",@9PJTT5SS[:S9^,""+!3,OYVYMI<@[\;<\`"[6T]0 MW^J[D6)Q3)4+U6=B.("FOZA:8'81B`J54W48>&<;>,BLNG#E0E47#XH0])9% M)8S*C#,25V:K\:FU.6TFR%>40H.`0LZ9EJO&?<%)2K\0J_0=W,=M[(VDX+V" MT\)U&0T!9M53POB"-/QR3JIMN%QY+K"9-4.HP&&X<591FB!$78E5UKUG(SK1 M3A\)>F^\XY\\@3RGAJ1FIE=BE,M\^,LN#4F[ M(4%_.T_PNDS-B/&5Y-14P0U9R%* M.L>-"'7+[,PISR1D]NSL,'(""+A34A^)W(D-:4ORERHC$L810%HEW;9:?;[C_*FM$F%A::$K"X;:ARC]7 M^><^K7^N2I>JTJ6J="D)O&Y5NE25+E6E2PF?5*MTJ2I=ZFA45J5+5>E2,FQ1 M'FSHY#DF^/6F7R3W>C'`E]0W.9MYOL\$S#M@98.9X;M/T,\F\*FUYNH2OVGW M;_\Y4NH,)+;RK$&*[]MY;?]M'[;'?:VJ3O.8#%VX>R/ M=&]M2A6Y?;14665;2L,X::Z[I+)B_*YTFB$5N:3.U<,4(K/K]'"E\?&/QF_S MQ4^F(S!#+>,O2WXEGOAQP5@Y01[/%!N'%+1%3TU41F\8&;T1ZZ',2ND-3S\D ME=1F@Y'5H*`H+V)66B-X"_<44GF]9*1U6VYZ>1RLAN&22+WD1NH5(ZG;S;9N4<"#Q*"/5@$(JP?T?X3)^7^!'I*-"9#(VC=EMP+F%D8.;W]26)TP,S4 M;7"88@F-'*=B4X4I:,&0+8 M,4P/%W<_)AK"Q%E`RQ*KM5`)&5S[8M)/EM#:K#<[Z]WFHP>FFYJ+0JTML7XS M2T'T6H@-I.EK/Z`_6,1B&PGQLWAA^35$!$T\\HA[!23/]^G"$:B+V#V_U`C4 MMF4EU'05BZIB49\V%K7Y,-N2]K)`I)3<$:^4$)?4G,9I, MNN2QI'R\RQQ#RJR;4D-&OWNZ:2P,,.^.!ZE>HWA!46GRR88,:5!+.G[VH<7, M:6)98;GM5%[)<`N/'!6TP<';4W16!7.KA\KZ@`JZ3M<:`MN`<\K[!APZJVSR,.KD]+;Z/L:NXWA@WO%L?".& M#WOC3/9_N15+>T?G2\-)\[UF;^MD;"H?,W(Z=P\E3WM?&=MO-`:CA-]$EM#9 MR1@=)^H8/-Q':)6(S@7PWR0MP2H3.JNL\C#J2%9Y==16N5T/L)^6]R$DUE5E MD8<01[+'ZZ.VQQ_`P:D$UAPM#F"&?IQ`_*A$,V5%4%DO!SY)1OWUJ(TZ1/E> M;DVP'1_:Q@Q@=2Q*]"XR8CDESV,62DBV>G,*MBK<0#_!])O#V(08?KK/4W(G MO)/)F\;)Y(L#49E]^70?:UR31D,@J6CKSX2C&@!"&">.`<'1A4.92/#V"!H% M&9%4XT`0Y\21('G0A#XGQ+SQPM:#3$BJD2"(<^)(..Y`3<@S)>8$S`B@LOMR MJ2::^Y>C-G>Z?U;,*#@,5S4XI-``<X[`EA7B,/@*D=/-WO&`JC/ MCO]/0B9VQE9.VL;R\D6TB+PA'H)%A,-.J"<)PAO/ M^[:_R7-3/?<5VL:_P?S)0EA#:6_XK08G:MQXK(2XV`X-!HXGP%ZV*,N>>(!' M:J$2DDA,JY4@\%$41:$E7]+S[C71P^#SO)=^)$;N9H%G$SAX+^4D)=53=U5#=U M?-J;.OSY9O^3>@F?=8D6D_NNCD29CN[]1V(,Y$,\:\YZ]02?WL1<')*LWJ(B M3'1VY3Q<';4IR7P7BBAS*_5*E?!+EP,+I-X`DEA6T,4J7,V"1%%7T[?AC#/?1L M9CU]%!;V'3L!:MJ3FJ2EW#?#\]P#Y70]]N`O8&]^,I9&RK<.>?8Z;0JZ5.O` M-YF*E)YD;#+NMW/*_;1:";"UO5Y/S-82I3]2-X',UW8=J54=+#)QRRG>E`X( M1Y`3<0J+MW(%PLO!QV&891%!/`<>M3$*O;KFTQL80622 M*4EP"](!T[Q4R1YYLA&.PQQ%D$+TKH@WV%-X1^DX#+,L(DC&&'H;0GB^4%^W M\8N`;X2$H!9S0M"NH2K=ITKW^;3I/K[3*SW5)U1$[C2?F"RR^>Y\@,3H4EB* MH)"8A)HXD0E$1^60+@?))%B5/*(N%QZ2YI2(L5$I2DDF3BD MP"P\L:`@VO5W)MK#Q:9)IB('[3&81&O_-(&:+CH9&F@JF?W03:\<]V2TR^G5 M)S\&I4M^3%%G!IGO=8TN M(P=R;F8+E7XC^I.3^OD4/AT*,[-RK8>CZ>YQ*7&PNRB)@_?O@F];C]",49+A M)G5=F3`W5HL.A)-24'D(\W$](,$^_HGBXRG2?\#8N>_:;AK M`9-MM//3LN>2>94X0E^4]"/#^>/>!@"=-($-'+=$@T[JNC)G;JQ*'+W/D\R0 M-I1Y9950^SQ=\^5')T.@OXA=[\>'V*T9`FB\@?![1H0-:WJET[(&1CY(ZBSX MSL)(Q@A)?=%"IZ>N!/E)ZLE[52%!/7UH_1G8"L,X(Q4_/96E,I&6[,%O<`T6 M&;7)6OWTM)N)&:*V)?#%G_*;/"=EM8)Y)HZ!O`Y^IAGO'MIQW$R376+-T[*8 M+*00U1MR>9>UP`TF2[W9?I: M5]J#?EOK(UDVYRF4^A5QF=`"&2_`A*NX)4YV: MW9Q:2>Y\9P9Y94L:(4"F73%'J28F2YJ%?B:%27Z;(`^=R9QM7;!>9<[('NLF M<&B)P:%"HK*QV08.3(5-'%UB\Y(>]?^#=MMS7"2@[:2O54EEY5ZBR-+)EA^& M[S\;+")X:3-<2A4Q*U(*VY`5N:2+4)'JD7GQ.5R%I5X3ZT>\+7\RULWTU027 M)Q47=%DL?1A`-NQ%;[8);`<@FZDD[Y42M69G(C<),W$FXL1JBXG5EM@7I'*Q MVN+YMA2%U0LF5B_$WG:;B]4P9A*K15]5&_2M,K&Z+27J0X^Y6`UC)K'ZE1.K M=TRL;DM-;XZ(U3!F$JLWG%AM,[':WKV_?$2T1D"37:5B?6Z1>`-.51RB,QYZ MH+^`E(2]M%K3INROYM'1D[15\`8Y!4A2"-TWKI0J$C//!IUAIUQR1NKP>[>MC+3A8#3I]A]VGQ2K M8FY5S.W3QMQVV#^&D6ZF>S%3JLCMS*3**ENT;;RQT#!;I*%Y6 ME),[JRX(R`MW=1=T,R%X`Y:7^(+4MDA00O[KAZ-(&7PJ)1_NM>7*A&L`[H"% MFG4W'SI+3;#]LG^\;S;JBO8X[`U^:IIRI_6U^^Y$&?;4?CQA>"L<_A].ND=/ M_A]02P,$%`````@`PD;H1(4:.?SC.P``:Y$#`!4`'`!S:6UU+3(P,30P-3,Q M7VQA8BYX;6Q55`D``^SINU/LZ;M3=7@+``$$)0X```0Y`0``[7W[<^,VEN[O MM^K^#[C9V4I297?;[7ZDLS.[)!W\];^>EB%ZQ$D:Q-'?OCE]=?(-PI$? MSX/H_F_??+D]'MP.Q^-O4)IYT=P+XPC_[9LH_N:__O-__R]$_O?7_W-\C"X# M',Y_1!>Q?SR.%O%_H(FWQ#^B3SC"B9?%R7^@7[QP37[S\_^,HXS\SL^"1TQ^ MFW_U1_3VU:F'CH\-RKR-UXF/JP+38+D.O8P4DOY^>O+GO[^Y.'EW=GKZ]M73 M@GSUPLN(S)N3T[?T#Q_8/V:G'WY\^X;\G^'W,B];I]7W3IY^.#FY."'_R]7_ M&@;1'S_2?]QY*4:D*J/TQZO8J3NY?OSDY.7W] M/Y^O;OT'O/2.@XA6J8^_*;5H*2*]TX\?/[YF?RU%.4P;N*?5:M!I]!4@GZ7\>EV#']U?'IF^.STU=/Z?R;LO)9#29Q MB&_P`C$S?\R>5X1EI&U7(07%?O>0X(483)@DKZG^ZPC?DP:?TP]]I!\Z?4\_ M]&_%KZ^\.QQ^@ZCDEYNQU*Z/C;(*I=>VP5[C)(CGHZ@?ZK:V(_BD[R39%@;4 M]:V;,(LS+^P%OJYI'?8$]ZOQC9[]FB:C`.Y7TS7-)NR0_O**_-0`CI\R',WQ MO(1.RU(X./8IYG>+LJO28[]1;DB=99PT:X0.3<=T[*$C$K.7_N;W&^S'R9R. M3#]\QLL[7&DQR+F:2.AU&P,5'R0E$"_Q-=84$J_]F+CZ578"G_ M=F%K+)/X/;RK2LIKA'Q,`KDAEN"4C>>=&J2.6UEI!:QE2,1H,(.CXR^WW_QG M+L>"`W1Z^OKD!U+XZ=E?7V\*[-/.&E=PSU.CV^][P5^\!K'&9I^1M* MC+/CD]-B,/RWXM>_TW`#+W&4#4,O3:>+VRSV_Q@\!6G+8`-Y&X0QADVYHQ5V M3B-3A&U&">71WZG&_]V65UHW\M'$C7QTZ$8^:MW(1YANY*.Q&WGS^O0#[>1O M]][:IR;8B"!B]%H+5X"Y>JR=^])L&(E29_:]+B;QTV^%MM>[^% MV=QON\<);_;>W.],FON=P^9^IVWN=S";^YUY<[]Y_>:MG>9^;]+<[QTV]WMM M<[^'V=SOC9O[A#CS#SN9!6B;^X-)TPZ^O^;^ M>>V%P2+`\_'M5-[>(BEK#2Z'6+4X+P*CR:6XVFU>"2(B"6-^?TT`THT%Q92^ M*6)S%B\"5Y^XU__NG`H*4&T>E"+[G9%/XLBLWTL$K75])="J]PNEG+>Z%EJ[ M[8GL\<8/;.\&)(W/5GRF*[81.8VPO/$E@M8:7PFT:GRA%(S&5T'CU^7H.EPA MC(@TC$%@\-5+YC/R%<4HT)*Q.0P(X=7'@8:`K)@#&SF`+.#`:7A` MY2TPX9*8:T:$NJ03'O!0A338B,%C`8=-30(JOB<.L`-O$3M+Y86W7HA3.0OD MLM9XH(-;,4$F"(,+&G1M-C3$$9.'$2I^]OX1)\-UFL5+G*2*>%$D:#-HE`.M M1XZ\E'.Z:*&UN=(4W&\@67[F5.XS.!%KKD("KO(0K;\[;VD%J'8;EU+H%(8; MD(\;0@FK1W_$8X3@S\X)(,?$K1KA#-(H,(Y\PL;JE%%Y-ELQ'"@U;-+#`'J= M+@IQ,/318^3#"ZJ!*A54ZM@9/=[H1X\WSD:/-YK1XPT0YZ$`)1T]]G5ZH/S` MF;YASYPU[)FF8<\@-NR96'%AJ_]4\$42$)@R75#.`3CN\3;_5`D(4F MUWMX>2?7>V2PA==[VL)@&*1#*+W>4Y??T=1M-[P:K9-X)=YG%(O89(\(7)TP M];^#X8@`5)L6N0@,`@S20#WLU`6L'B;A@#5.DE1_!=/P'"3N#`D1@-'HM_': M+.80"5H=/Z1`&P,')P6&%%)HW%!!!6'%'*,_U\&*CE[JX:$M976$$$-L#!)- M$3#,$./BAHI2"@8EKNG`E63/]&!T-HCF%;SS9\VQ1"--JV?6S4UI'&77JX&A MF#E6[N"[6A-4"#N,EZMUAA,S=R65MLD]#>0ZWR2B8#BFQLM= MBA_B<#Y>KI+XD2T%J'FEU+!)+`/H=68IQ,%02X^QS:U*`P4U%1C1AI6G98>>L-KR<7!<$N/D><6$4%C8&0Z?ZY^_"G`":G- MAV>&5!':FRH[H9B104*V*37A$<\$+C=V:I5!1?JB3B8^HF2DX=KE"0XP&8C# M8YX4H\3E0?-Y-?SB(T;%G4!,+00H>+N5>0RZ.^Y%)#!ZH9`5"V(UOYNDP<D]P--&;O7K03PFC>MGB#Z`0$J_G[5TT[]@.3@WD7LK^DZ M`%T6C[(@>Z99_Y-E?I3_+LWH(P4M*SKH63OBU\6,ZMR?B9)SSG1%VN91J8J( M+LJ544U[EVXFQ?ZK^_CQ]1P'N8"%!AQ_]8B)HUP>406GSB$/5G[%8?C?4?PUNL5>&D=X/D[3 M-;=T82!O-YS4P&Z&E1)A$"0R0)4`IA[Y-4:51/'&*BI+4@&T?LXD2]_ MM*3L4D<(L8>+F,(Y:N\_;!(]4Q76?L+6KBNN1>4:ED>;@Q,*`U MZ"@T`!')`*9L795I(J9ZA')E5--VN0"7S^KR-9]+\CM1-*.0M;T0)X7;7HSC M!$$P28=.NBA73+Z+M3FFXIXU="G`C#,U23>,X:"*^5*)`61+&YN.*VRA9N=, MV4$RD.GB,HB\R`](#XC30'$"H9NJDQ0A!L8(LX4H])QSKP=8:0X1%"]0I8Q* M;?3W4A_(^:=!FN(LU="P+60WL80(8#.Y1%T"#(F$L+AMB-O;T>P6$A6*Y0$C M1G"R]HDA@*G[T0GKI;I`-O21Y M)C$^.R4NL=U0U^I=[R[F-&Y^FRB"85T7M!P+B1*[O>O3'_!&'08AKQ.\\H+Y MS'O"\NP6=1&[:2QX<,U\%9N_@R&+`!2?@8*)H"#/@)U141AT&/A^O";DO,$^ M)D2]"_$$9X4CE;EDI8K5,)Y$(9X?ADG5W%T/\/)3#$,P`I&\MQKI.R6"^F:L@'.`&YP`M,4-'P M)#=+.[XK-6PRS@!ZG7`*<3!\TV/DEF\+#8BQ8WUN;C)_=[@"HEWYL$J1+,Z\ M\,ITV4/"C!DM!*3/*:A-FJC#:IE(W#Y=Y*!YYO"R8/R,!B"7?8`$6<<9B;)` MT6CHK0)"\>"?>%ZFVKN-%]E7+Z%3(NG2C5K)[FJ9B0'-93*5!AAZ&<'D%\8J M)>27J1/30@W-:0*,F&51)']-LW0S@_7]]7(=>AG1\Y;TM-X_\U?#Z-3U_='9 M#^^.?CA]Q\*POY`?3TZ/WGWX`0:#I9E'Y?Q5JX#(*2OAKDH>#',-0,K2QS*& M5:D^&#IV`"MZK#D,L9^M212X*CAJYC3?GA[]\*'PF*>G1V_>`5D` MK$V^-Z&+I.8DLC89JH1;IZ10$`P'5>C:I&.RH()$Y>J9BW4R^8J8@[4OPXFF M!\?#6>C4>W:#"Y0+<_#6Y&/TVO+D8WM]^BT<]?QK/?P%'5[-"0 M2L$1'0V.#\FE(5*NVT&B<*,(@U/E/MFU]TQWMO3=$I@B&:*5,"Y M9$TF>X1RY!MA;5>RW*B$P<("9VGF.8[P(M#N(FF4++LT`P-:KDVA`89Y1C!E MM+N+HS7=#,]B%"\6@4_B.1A\8S-68U\GE;:^KF#FUR2B8#BEQB=>7?!W'WW) M7BTO3@JMO7!Z%P;W;(5,3!`#>7OOF1O`WCQNKA!V3A-3A+(`G>5NB"-TC,I" MRI`+?3>A*_-O@:S,EZKIH'<,`M%M3L,#Z*H]%Q1":S0SE*!3#^R`2E M_'@..)+5#C0*+=-X9;F:HX.F2B,DITV%.E8)]XB3NSC%*J]FB-?*\=,NX?BD M>T0^`1.4\^#5D#`)Y+ M#URU6@#U,$(7!Y6O&81P1\B:,?J0P%F(I0FHP$;HRM`<'!=HQJ\@8\Z17B\G M3C&([G'DR[FAU+#\RKL.>NNE=YDX&%^CQRAX\;W4R*_XUW6*PZ#O@(QIG0_' M0#D.T^T`S`$<>>E\R(6E`BP4OF5'CK-G8.RZ3HJ)`3-.E<5$*&GYXJH,:NN^ M:EL,#(/DV`2W4XL)6YJGE?S+R:N3DU,2=R?HD>JATY.CDQ/V_RC-4TYZZ^PA M3MB]C"@N?QG0I.OS?!MY/RDIMQM&BY2;ROPYG)CM`5,$LCU*UF7`$$X"3#0> MQI&4:N]45#M]?W1V1N_KO&4D(_]Y>&U%\S'47&W M2;:S+I.V>FY!#;EQ8$$L"H:=:GS<$85*&M&+^\=!A/Q<`0:7;G#F!1&>C[PD M(@1/!YNK&Q=X$?B!+&`S4;3Z&J^Q(8UG>K5:8'AG#)5[V+=01+C0A,$\/C`U MCF!=3PG,I@*PEBVD^,2K%ZE@%@"#-[HS_/IE&XD:I%L7FA4QH0XLOAFBU:Z= ML1`,+AL'98:SRSBY*/*;\0FE-`=,NY5A-6[K8UXCFNM2`)BQM@]J+O)3Y[Z# M05]%+H5:?#&HW>&5S=EZ%`0D&X;&4,,,&9)2P%"Z-W3!H6OIY6Z#S!HP>'\9 M1$&&KX)'/&_?@N_&^SX%V>1]?T/KO.]>"AC>]X9NSOL(!:)T"#"8WER]O?:2 M:<+>09BSI;5KX@5H;&6T]"M7=K>BKC-(OL@NTP3#W$YP-4OQFW51B*S,7Y\: M5,NS1A7"*[ECHNHEDN# MIED#HBG%\HT:N/22/Y5HK.6::)+'$@U50%-._URBC'?@=@5KNZ8=HSPC34>[ MUUWB.P,U,&0TQZK:]H86UG'/D6IC.J6&(\Z91',*<8@<,XSC&MP"&L-Q5BD# M.*FT4V[)0S>)*%Q.*8,V$9\@!6P='K8V4W'**DVFA%#;)R8:8J`(8L85YLDY"\HI9(P*#&,TVRZH%F;V7$+G#P&/DYOXU`> M&,D5[(YB.N#-,4PF#88^6HC\^)6RK-F`V/0IB=/T.HD7TN.?#0F;?!%`JQ.D M]F=8YZ%X8&T>,`FZ>TA$8-!@NL*)1^^8%4^4Z=XB5\A;O9>L@]VXEBP3!N-0 M=`BY2\FE/+#DB[,2%=;)!V5#9:HS3R:!& MZ&.D"8:!G>!R]PESY2-TGZL?L1.=7J,$&`2]P2DF-4P?W[[8'%M2\U*C8_<& MA`'\YN4'A0(8\IF@Y*\\Y#J,:K4C:#!XQCET4\?O>!@U&CYA15TR>.)CYS'0 MD;.R(E^9N")QHL[>NJ03TO!0A;39B`$E#@=0LEI$JZ$D4!Q!(0[-3Y,#I,^- M&4;Q&B7K*8:T!G!IAJ0:8$8U(YCB=$-%,K3O"A\%)"<#?1&,5%*6VU1U'^F" MK$3:\B-O*LBM=]U$HF#HI,8G>KV-2A=4@D4@=;S-2;D@C"*F;HF`(X@Z;JZ( M4?@6&,R8Q%'<'([5'%'(VV2+%G:=-U)A,`S2(6QSZ7.0^F3J[T4X7J>@/,UE MG.#@OL@CZ3_/$B]*R:!+PK9/7A#14.\<+XC,S'N2U$6G$JQ>]^EN6N.>C[DZ M&%YVQ\PMO!,Y>HO'+XH@WL]_(`)`Z%H+%?7!I+/P7!.+`YO=<<`D"P*``^Y\ M+TFQ%E`7L/QT=PM8ZZ'NXJ]@/`@'23+%OV-^A.[0/08IO?E'+W;O,C7U+H\: M$7=7C,_%6TK*HS$":?M'C:20^:-&G*@=,GW,R13A>_8\FO;$D0RFX)5WT)2: MX$R[]-B2L1IIB^`UHNNZ`*RA2`1-=-9H#"B`+E-0E3<5SKTT\"7V262M/MJH M@MMXJ%$D"&:84J%K,Z:412N:C(%*HV/$%&`RZ"((UYGT$+]4VB6+6I!5/"I$ MP3*IB<^(2X7*GA[C^)7,Z!YH6H9'G'CWN#@4WCX/+MG'Z%6"M:P-I,81X!*MD4':9![,_[%.\]>: M9O$-I@T4A+AARRS>C7O9SZ?L/@^QO\IJOBVQ^^^`Z2=[-(Y_U:+Z%,IBE)0? M0U'5"^GOZ7_YU".NBB^BN^?.+M'F<\(K8DG`#O"2GT-,?Z"W7?1I8,U4[3XK M;&Y,\VEAO1X8RG<`R[\MO%'-;R2U4`W2.KV31?MO+8R_Z!1 MLNKPC0QHN&ZE!AA&&L'DW&F+>H#3":O2B&^7)1YD:O@M\L%;]Y?FAQ.ZP=:Q MU=^4=C@)X,L=5#PO,S5,X@@O5V'\C'&9M*%VEG#F/:G/T6Q3H-5%J*T-;RQ1 M]2X-6I_8VA)NV_2)**3T%`^ZRP6+-0&V8W5\1S^%O"2A!TU9)`VC8]!\;O35 MDNF")>$B]?`K`YFEEW%2UL,T&89>L)1%&AW+L'K2K(]YC?-G70H`$Y;T0+D+DZQRLF: MP>6G:D4&9G@'(XDA"28]X@+G_QY'[&CY9D4E?V@DFM>>0YM@@_1_VY5J^>SN M+JJ@=<9WFR+A>-V=V-'N#M^5Q7Y/@NO\)](SH/8'_MDTX\H2J;IEMMP8-7UY M/6CA;P?,@H>1F"!=!BXDV9K9,(X8C>M_V--YP3;ZZP2OV./,Q3##I5@QUK)V M+M#B14RGI?)AY@7S:\@>DS/DO<4[@B:]&B)HC,?JC1$ZD:%6LYCRLY0 M!9<8\UCQNS)J_/X`PL9K[[E7S%CIP0@86V:818N%$K1)O"E@:9RXRL6@4F]4 M+/K>8/;89VUN9EPAJB+<$E)OG)J;,Y)2SY:E@;CV'E!Y2L M,^R`R-IR`*PT;4MI32'.1_YMDPHR?=<(\^U#6V\6*]`&X5KE9!BZ55P;,4#5B<2+.<",'E9SE M,D3QG(UQ=7!Z;LDH,4--PI82_/A4#%BZ&YKD8C"H9WZ#1E(=70J`>3=*Q$IS M;7!9:;KA%EW'.:"C_Q)[Q]$C3G=QU4]9$``Z&QAJ0&M%*6"&_M[0=5?]@K($ M<.0FL79Q*VC@_[D.$GQ='"F_)@9E-/UX>;M!4F=="K"::;"S88U,A,;:T':= M.B/G=IH(J`>/;C'M[:*+9*^I_#*[&U%=5-YTT/8M3MZ-:Y/`%GNREC`4EID"YY.]@&J0L"`"5#0PUH+2B%.C3 M(#UTW31H498`CMS$5A]C=K4KOYNUN<)U29"S"V#L=LNP=KE%-I#U*\MR&O;^ MYK8RMG^8"&2=#$+ M$T`5S;]J8E!G7CQ$/M]C\7=$#R/#H(QYM$(OG031FOQN6KW%N74()"X49KRJ MJH!^L:NHQ(.8HG6S13IM^ZZ8MWT/.+:EYI,(A_Z+KOT^>B'M[-)Y>Z-9 M4HG=BK";H*6[<;ZL(C=`[DD+Z+@Z'_.;KKHSW[`FP\XRE`IMG9`^G:2 M/)->]XL7BL]^&"E:SFBY8HUTFWE)UKV%9="%DV]1"QZ1"+A],31O-@]0/XW2=Y'O*?KDJ2,:9JCP8 ME"W?.+XFLQOIT;RZB(L7INO@1,]+T[^#H9$`E/1A:3ASRL9A=`456E).GD5L M0A0^AYB+`.*$")?D84UVOA\0-2:D:8@#VVSQ1?-J+CG.\%*[^V6N;_E!\FYF MM1XH-U,&0\&NB+F94QP=LVALO-FO)1%858:3$U*_!ME#_G(+RU"8R>Y%;5<4 MD#-56F,-#UM)RX&R2KL#&SH?ST)?28GE\VF4V!$M%-;E[&ER[T5%JMEA'*5Q M&,R](L?W-<%-8\\\TW+1*[VP>EQ&YZ1W5+;5Y]9W61V-A]IW43`8Q[]+:[B; M7[6RCU"C=-:)ZN73KE=]`6T^`>ZAHZTJ[**:^1'IV^`^"A:!3X\AY^D>R$!Y M3+2IY9_V\!X:7X1+Z&\Z'E!E&IZ_0I]%D M=#.X@M'[>3-T[PTI%*P^(J$%WGA`0BH-AJ5:B)*4.G1J4FJ`&URV&A(@.O+^ M[O?`G.;VKN[-*W0[_C097XZ'@\D,#8;#Z9?);#SYA*ZG5^/A>'0+@Z/2^U,: M3VB@9_F$G)D9K1-R:B4P?#1%*C@AQ_2.$--D<7JE"\Y?2JWRD$+O>G9*W1],[T>WUI)7(#[^VK M,IESL>@D\8OF:M96&#L84:TF&N@X)U='H-PQ@T(:7>]FO4]"H18HF>/2R%HC MBPYNQ1"9(`Q::-`)G1]6E5$].%"5@C;%@`OQ MC(S7!7E="P%':F6@UZV$PZ*UD3]^1_WQY\_C&0WP;EF\1_TSF3N/)G`FSC24 MS9XUWKS28K38VHDU&G`X:#AD#;U"O4$--#=45POE)FH;FW[%0"!&8: M>LP.ZN#YVM%K?GB%;D97@]GH@LS%Z7(?F9=/;LG4?#R=;!WYR9=J?$S7#?(. M%LV_D/].,B^(%/E>.FG:7,;I8$I]4<=`S3G7NF,5+/[5E!'11@UU)PS3K0V: MJ0+AF'+ET$3O$%AFY,I^8.N*PQ%=6F3NBTUEOY#?W,P&8S*AW7XJ*Z';)QS? M)][J(?!O\"I.V!%PA1=3BENCE0'HBDH*61CTT0-L4V:C@2H5&'':+;ZGRSH5 MJ@ZS61--J_-8;P?5/XR$)Q:ZG-W3E#083 MZXFJBGAS2+-?ZO=`-&J65XB-C&BM"2MUP+#/$*A@/Z-20^44EBF"F[7*+/R$ M(YQXH<'>A:$Z!$[*C#+A9EL7/$H='GZZOI;Z,1.A]-1I?C&;J^ M&DQ@D/1V?9?B/]=D'!@]&EP(DHO;33^@!MW,-R"6!4,R#4`^HT`ICG)Y<'ZO M;9`V]I/+NR25.LZ3"8.EE9FS.GV%;K^+-Z8U+]MAF^7@\Z3:8P+P+<6ZCI%H,=6T2LI,Y=4(: M*8(A9!>TDNN,*=K(PZ#B#4XQJ<^'B\V+,^QX7_XB3?F(C>DPW:LLNT/W%N8V MA_,>!8&A\C;H52\9E26@L@A4^T*^X`>#]M*+2V9,-U<'<07-@,^FNF`HW!&P M[.9D\\HD#')>>D'"4JG65F9IV:/@QJE@,'Z7`USSYZH@ONZKC52--%*&!@BFC@5ZB!H:0Y5GXN MGVLR]PAT#*\2<9J-V7)Q)XE/#<9DF2P8?FD`2G*BLM2I>SH9)*<;]UP M)5G=W.UO:F/;MWLQ8+C;'SMW!(%>>CMF1:%Z63!8/<%?:YFXDC@B/_JX-G,R MP+G9R:4\>$S&J?IFE"YGBBP4>B^DI@7@4=] MR:G<9I]_2?%B'5Z1_IC.M%EA^I9D+X7Y5J9N,ICW*L8Y;[?';K;FB'!9'GU& MG12(0EHB#+=\ZS_@^3JD:UKE\M8@33'+`7$5>'=!R)X*_(P]>@)]/HU(]UPG M">F-9*`)U)U@3]^P&J#LHWH:HEX%P?7:;PIG=2K?U>F_)0MN,[;<-"X^OQE"581`V MV7K=5X"[KPR:=M]C?<3)79SB*UD,VP6Q+IDF8LX'7G"ZSHAYGX.(V+N\H4\> MA.6S\)=Q4CR('=U?T0>".P>EVY3M*!C=OCHD06C_@L'XK5U:P^WCLQ+I2U/[ M7(+86'`1T&?AHSE[B5"YV*#7L;:L8`J_?4ZH*R39D+G'E!R**T>:$' MZ+W(C5'BA6BVJ)RO1J<#/R,&9,\=_6O_@MTXUVTK0NQ9^Y;JG/L[-X6_.KE< M>LDS[2#9`T8I+0?%K""4U1)1'4B'R1\Z7&J&!5E0E18LX M83T[[]-D)%QG:4;FAG`2Y%0U55QQ2R\)54=/&4XB+QRNB4M:XH0M7L8D7`P> M\3Q??3Q_WF3]\4A'(8%DQ\%Q]Q]TTX?W57'BOKOKKP'LLWLR49ZUR@M14GP3 M2*\L7S&<"1Z)E@G93:HL`MC,G%R7@,,R$2S^.$DAA/[.Q*"DL2AA70419F^A MZXRL"3IA!P=4R)!*"AY+VM`43*&BB,DJZ>)B6?[\>4:J:?`4"-O!0`W.JF\? MT)U>ECM"5!_]G98`I-]+;16=UNA:7^(R0.PFJVS'ZKS#^7/UXT\!3NA=F^L]&YH',-.$YH8ZXY3?CCE"E!LKSB/-45+9N M=M\D%=1!WWV6$859^DPC`F5H;.T*7)IXQ*<_8&B)1_+)H#DW%?)6GT/7P6Z\ MABX3!C.JZ1"V236+,S+[]IC6GK84)^LEW>V,$U4><8&0M4U#* M2EA<)K]2SE%D,L%9?C_S*DZ%`4A#X/4RCO*S<,7;4/MZ?1A'\3*(=-U-*&;O=6$YR,U9*%X&1J>3`^.WWRM) M1QWO5QSH1M36]E4.A;G'-'MCL;.)]'SX`'CQCA MQ0+[&>TC]5,5KM9&)(Z@./7.^8,.KE!6Q,$X0ZT!H@>DJ<]CSAE*:D545, MVY9H[PCD3DS?')#%B])058XCEU?+G=A.OCA8TO=] M_LF.XHB7V(Q4+;LXU4#6%3%WHZ\FQ.*Z6N))OTP\F9:))^>UI%6^+FG5/E?\ M@RC(,#N*,29C>'0?T'L7^6U'WU\OU^R!$EUK=R\%WMBVA0V"=+JE//):M`C@ MI@D:A*SP8B#G3MP5B=EDJX:&RE879CL9U%BE-=*$1N%.J,4)6.Y8`A8?7`(6 MZ5;KIZ2V(&BZ/ULH@=@B;QA@M"?.-,",FT8PS2Y9'J%[J@.#<34G?H%7"?8# MUAW(SR$NTAO5!P-I-<^(\#T%K/3*N[6K MW96N<)HBKQ9QS&L?8?VK7CJTZ&B$5K3753[A.4(19NFDX7;,5: M=B%%*@RGKN$]LWG,0#D'Z%2" MS5&SAVEU1G90!S/"=LVM]]T5:^UDV0XKH8K-=E"F M&*J5A@CMP3GIXB@QC6XV/;S(-UUV;^FDT$35[FS;W)CF MY%NOYYRY/<#R'KA,+&GRE-4^=RF+Q*BU')G"S4E>#-`Y1A4Z\=7-P9*>/'55 MYP30Q%O*4YO4_@YOZB9$QQUV(?^%J!2HB9KXC-B`7LVXQWD:EHU(0:K!5R^9 M%Q]M5A>E?A-OV2V`\U%[-DX<^4_WUH8/L M?;F%^Z_K\CL'VN>:U;2G[I9_Q&I/RZ^&WF9>DBD7&?=D)'?VG>HT)AA'Z`[? M!Q&]M87N/"+L`YED;%LEG]@MQG%TS5I`=1!Y+U\ZI'ZHJ*I=]D3!9U[,J">W MCZSY_CS=8AZUO4R[[(TA.Q1D-V,F7T-;6Y;=2T% M#L'[0I=EX(;"X"T[[NAI%21,I^J]>W(1PB\=TC"AJ*I=#A."S\#I17NSC>]F M1/*E=#(R"5S@@#YOM.].)OS2(74R157MLI,)/O-B.IG<-C[C(FG/$,]?%RKJ M_@:8-8YFTG97?/.Y]"A2WN?:GY$F7D=4&:B9!Z2GX2D^Y/Q`E0BMFWKX1>MKV@?2K]-.VXC[Z-N[1`"J?^^^:COU\=U]'MHI M2ONFP]XRW[8Z2HN==O..(`ZJI_>JX)UV]DX(7EQ_[V/]H9\RT-6)8$_*1;?O M#..@.G[/2MYIU^^(X<5U_G[V;[T!^0'``Q,WPWQ'&0?F!GI6\XQ"@$X87 MYP?ZV=_C%-3_7U/:9F'E99_@,#+]\%>5S'?4':P6&W\=U!"SVRK=TQ$0,`.* M[8,A_2>4_\+'11ST_6U!'9)+V$T#V#UP\J_E0'92'^X.IYAE+KK!2R^@MSEK M:0:O@H7RZ;O.1;C*2&1JG"S[D$[?^<&*+4!KCT14Y:!:08B6M"=FUC,!2&P0 MF6^D9HV!'8RH6&>@`X-IYD`5DZ3Z#7*(0=5=>\1@OTT'Z^PA3N@#@%^B.4YJ M5R!I1IBTX?MOZ`A3,[D84`PZZ@PGRS>J\0P".NMA%@2C)?&6>VC.70/,^E!Z M(*@3NEW57BU&!>A[MD%WL+YG^R;9F^_I#^UE^IZMZT.QF`39V?!3X[M=38UE M-7;:J3W=`'3O&E"Q?"$ MU[T1%3N`1*$]!\JK^"M.\I^"92![''>_GW2_YK_;RM.OZ._F>[`\Z'Z-E)T6 M12MVVRN,O[[`SOEEM;+=.;E/'FSGE%3>WCIGZWLOLW.*C=1TS@<2_1S^>2Z; M67;LOMALZ;YORS9]X_8S'L<:]V":)A%[#_XH5K"[FXVM]SOU:[PVK;T\RF M^;$7TW]U%K;[ZZ47).B1"M!3='%>"+H_J+0[LBJAMC';!VFZ7N:F#:+Y9YP] MQ/,XC.^?)56JMO/H MUOR[!]LE5=6XM\XI^NC+[*8*2Z4OW#\'.-S7-=V]&+=)MB7HA/8^:^TRIL5* MK"YS6OBF\QYHV5!^Q,3'CSC-T**21@D1?\&#YR]Q2(H)@^S9]O#9_O+!#Z#B MJMS[$-K\K/,N;-]60:XV[&.ZZOM8B;_`'GP3I']<)AB/HPR3QLML]5_Q=P^V M]ZJJ<6]]5_31E]ES%9:V^RT5/5X06104PM`&WS[[KBIWMI?#!`8?/(@S`\85 MMY.C`=JOP>J>^S11.)[2X33<7XJ>G]<>*3W`\S$A5)0%C[C^%+QHEJ#3L#87 M-(->3>/4XLY99HZQ39-*B;CO0@NE5*W-*WD%_GRZZ MT,1S(,8ZA[^12%PN11<5H(T`Z;!2=G: ML2?#VQD[^7!+,LTP\O!6^(4F#DGJ$JI$!E_!G&;)Z?/ZY#%V^OB:LAOR`CG&Q1 M4ZUBL^>:@*\32B4/IB<;@.3F;SA#J1>2/NW7E6D&TT)S3[&'`FL[TX"!O+5H MPP1V%6:HA)V3QA0A=[#7]^-UE*4DBO5Q\$BOS/3BSCXG8IF7L2#_$X[O$V_U M$/A>*!LJI,+P1@P]5.[%XIH@J,'C!C_B:,VMU_)_MCDHM$'5:5+^S7F_E0#B M=E.+/\-H[L8D/)K?X"Q(&),O@M0/XW2=R!X&Z56"W4BBLVG-P,)8'0SUNF/F M`MI:"2R%Z*8,M"F$>*RB&"!>ZP(O@@C/SW%$?LAH-C*V"!3,XW,9O@I.R<=X@]1;"H4_'T>^]9:B7QK3?N\:)7'!*5XGHQ&(?,D MKQPUP"84IE?FOI#_3C(OB+(`I\KV,-$#USP=0'.M-9T,1Y/9S6`VGDYNT6!R M@;Z0W]S,!N/);#RZ==%\])Q:&&*V(G^=Q&0JDSU?QV'@/V?2IC/0@=5LYH#; M35;71*M"%:V8+J+*Z(YJNVBYTA":\OS/=;"B-3!*LV!)YDSTFMQB'5X%CX25 M:K_8KQA8[;N5#?REB**56:;WLCB$R_+H[5Y2(`IIB2X:_M9_P/-UB*>+\@)5 M>NT%N3T^TE5V*0*WM%C[0U?U66]MO85?VV\.I MZW?:NGX'NZ[?'4Y=O]?6]7O8=?W^<.KZ@[:N/\"NZP_0Z[IU;6SD6F<'9<)JS]T9I,U^&+&RZ90@9:773W^A.UH^ MF^3-\R\@+Z-[O.0;:*ZYA[P]BN^MOZ MQ3_TUF'63-X%YGI][\IOXN$EZ`:V`@KP)6O;HDF056Y M$!O`*MX^O2.H:M>@!-@`^T^4"*J!.J(&WV"[2\P&N)E4@`&V4.T4QO0N#.Z9 ME<-UDA!`H@4,J3"L-C%`>BB-,>G8'I-#:A(.+,!6:9U'&[(Y'W83-8N]=8H0 M6FP<35=TQ9,RT2<3MH`F'M`VFE`+=KNI(,N:#GTW+[2_1X&3="37I%X>R/>G M"U'.`:Z=U.*P&L@(*\`138W[UR![R'W\()I/X@RG1>J5CFTE+>>0&E%G!*S6 M+=,;#=(49ZD@;!0*6,YRV,!=M(0:E^!A>2)UA`HYIY4LKUUPU:JI3T?5>!5X M=_2!1C*6*0C+2P&J7@6X=E771%WS]P(O,/G^G`1R-51D1N;+FT&G`ZA1C*'R MF[JY(B*:J-%>$YP=H4T)[CN,IJ<`:@T1*D7?<)8U./;_>(C#.4Y2FN>H&9_* MI0!5M`*<\-Q\(?HMRH71(,L3&[(#/%F,KCT85"?AEUGKZ'0`M94Q5$5/J7)R MJ5\XWF,C?4KB-"7Q\B(0#AFU/P.J>A$J+G,VE4&YD*.ZK2;\]*A`E(H]/B<$ MJ)[EV-JU74FB4M1UG>?K7%>$!,I:WXA!K')%J>?3]2N"7=%D_4L#U*H[,(*+ MN#&M7CUOH@VFXXO$5?(-#FEY>L^#=11]THV7F1?O40X&DJ%078M&4953RIT4*D$:\@;1_3^ M;=\A3Z`-J-UZ@.XXY%5%N1_R),9>!I$7^0UCZ:65(%J3WQ4C=NMVX6Y*A,^# MKH9TY$95?(T;1VCS!;3YA"/*4/`D,*#_HB/ZHQ=2GW6-DR">MR-_$4&ZZ`.B M0R_8W)EHVO`T%F(_U,HA@1(K"0EF0/#"I?V?BS^(`$L/OUOD)2T/5$^OTG=L MGJ8V[^8"9?!]7(6Y0P>GQ2!63NU1;U<']D/V+CB>BY.X%.O9HF8UTP34IAT! M%.&J*7U_O5RSM3T[B`0YH>JRG`%52GBZ-!]9?X-E9Q9=6N"-\)P0O MB?/]#-\K[2M(_P+,WR2F=,?]CAA>$OO[FKY7_M=`_0OT`!+&!<7*LT/OWPG# M2^H!?4W?\PA0@7H!/6#K^=7.^\->$1U2[[!3$3`FQ+!ZSUZSEP+9YND"M`L` M`00E#@``!#D!``#M7>MSXS:2_WY5]S_P9NOJ=C_8X\<\,K.;NY)EV5&M+2F2 MG.Q\2M$4)&-#D0I(^I&__@"*E"F2`!H4*8`>I;8V$PT:1/>O&X_N1N,?__>\ M=*U'1`+L>S^^.ST^>61JX=TDZ"WTY/ M_OCOL\N3C^>GIQ^.G^?TJY=V2-NGGKQ_.Z/^`WPOM,`HV MWSMY_N'DY/*$_K,F_X>+O=^_LO^[MP-D45%ZP=?G`/_X[B$,5U_?OW]Z>CI^ M.C_VR>+]VTM(^PQT3JH'NEC.[TRYG9T?G MI\?/P>Q=*OQ8@L1WT1C-+?;ONW%_\]4,OL>.OWS/_OX]Q2A:(B_L>+.>%^+P MA0%&EG$SRD/#'D! MFEW8+A/PY`&A,)`-44S5\.!&-J'2>4`A=FRWVDA+NZA_V,PR$8,R&,Z'*S;1 ML(;@(8O)FQUNUPX>KES_J=IH"]2U#78]84MASS6K[?.3:+FTRS7.(P5F7*-OL:185N.`#(`DCKT\4'.HL]^.Z,;E$8 M-N&+5.^X%+4-:HSH3VA&)]CP94IL+V`;*<"D)Z.K4]<V06*)^&R]OO>;6H=]5H;/6`?7[*9N2:6-GNJ]%E$#9L M.6532R)L?$*B!M<=(.@2NOH&B!;)^:ED,@2.%=[%G@WL$M'5Q@V.JFSFZON" M)J:O;$QB-\C/P0B1V(CJY9C7^YZ9'=B$;:L> M:^*NT%VCZT1POGO/#3()GV/DI(T?F<&#!7>PIT,T>."* MW31YK`9.CW+*)@_98,%":$4#71$44&#B(=W0'[9(T'-()U#3X;N^LS5BET6*?"*3&OOE-]%8._=! MO#BF';GV/7+C[G]CM##2]U4&FT@WCET%R#E>^(_O9PB_I^,_9W]@C)P?G9PF MD:N_T)]^6X]AC!:8?=H+6;2P9.2T:7G+_$"S2M$ACN43.CM2Q-(^;>)LJ4(Q MV):T>+^*PR]'S@-V-UHT)_Y2592)V'P)(UGITB'L'8)N/,>Y?6HTS_]$+R(, M"DV!()R:AP*':QTPI'Q,:;?ETM]N`13ZF4E"+^-1IZSI:1+[E(,9RW`0"SW7 M%"C]+N1H2Q>(4#QW:_ M(9L(%9_?&@C"1Y-`D/&N;^']%;GN/SW_R9L@._`]-.L'082(:`'FD@"1^602 M,B`IZ(/G%]^-J`3)RQ5VZ3E;!$NA*1".S^;!P>%:X_9T;;^;`^TZGU"X2^50 M`$'YP3Q0Q#+0ATVL(UTZF2Y\(CPXY!H"D?AB'A*E'.L#8!3=N]BYM-))3]X5KGF M=G`?`Q4%1PO;7JTU#+EAD/Z25[7DY]\VPQO.K[!'&<+4$OP`2]SF"3F,>F?; MJ)P@H.G)&\NUT^="5Y+IM0!Q.ZI_)=D4CV;-#02DTU^9:%TNX#`8.JV:@ MP2Y[L&1W^B\6*G^T7<32W\.N3<@+W9G$V51\=(#DVGSR("#\*BR9!.*(H)6- M9U/[&97M$9)FVZVT.>HK0%+&GQF23U+7@C%R$%65>Q<-4)@P)9C3A%3:?/D5 MD('P;RI2%]AU$=WKDQO?6TP16:;I<\&0C`A+%5D*K*EJ?]J"!+6@JR(S,W!/ MYH[>\XIMV.G$/@P?$%E+03I76(3?/KX4&F4B&1 MMCA#!9P`W)L!TQ93P'V[QNA"E6FOC,.,\.G8UUC=K+GFCC`>7NB'MANW-`"V M@>\Y:B>O,@IM`8K*8/+Y-L.HNO8*4S7!?Z)9UU^NHA"1B3\/GZ@TZ#P@.G^) MZ?1%,Z#BSQ^^('(P`[/T/@A+T`VSET*$B(FI],4WJN$%D8$9:/6I%+T%IGO8 MS?+:>W;,TUQ<8J8:3 MD&LS@)$=J!2/3J<->S?`HN<>E%JY";S!]CUV,;N@0R?K.!:]=4]*OBF$]P!% MNF%/!QAI5=F887>948-#*B(:*&J-^3:48>"B:'3<)76M)5=UP2[C?'LH7HWY M.``"+WY*J;&)0"'FXW!2<+[K@!QKLNFP9O(=H?W+E[$ M`N*+G=&(2:"";\Q]`1>\G!F3;".-#HS1(_(B^7:!UQX*4&,>"F7+$'-N!CHJ MD]8N\U5C_@AE5$!35=N/R"K!$@D9%.'&W!Z[(&QZ\"03.BT=-2AZS*&$`M>8 M%P.&`S>6+!1(95M]1.3>#]`NUJJR)1E4VI4,*FQ,]N'6D,,(8LDD"\QO7\&^ M^1VM;A]>#34O/=3>S%CA0.L9'(Y]."RJ^'/?RMX$4*"\)$5`1`1%=A\>#7B2 M`+1.NVY+JQ)@J2&D`129QAP< MRLA(>#<#H#&K7NFA65H$NN,X47Q;%J)]7`<6[,?[%+(H90&K6B;DPI@/(WZK;J M`IP#ZP)8?]WJ[&^'.@&-[7=BK]*6[%L(.T%<7G1G0;WL_Z+(Z)+$T9O'A._^$CLP)Q*?775MA!XC51&0B MK.OB:ITH?/`)FZ2@#)2NB1\$(^+/1<']K4:Z'8YJ.)3PU_;`<++<>(ND"!^@%+6` M1+=S40U.*>]F6-4$N2XK>H,\.ER73@"=V1)[\4.4[-G59/""90E(K]NE*(?# MK\2725B.J4CI&%@1YTNZU+I^7)!*"J&$3+=7414YD!3,`*S`FL*\J-]CJ`H, ME]LWL\RM5X@;NHX#@,PVUNTRK`QED>/6@\DN,ZW98F7]X!L7"9UNOZ(RQ"`Y MF#&/]KT047&&Z^%N.!5Y`C@$NOV)JBA).#<+'NE.I-!0NZNP*AY&;C<&ON=O M3]Q21`0DVBNVJF(C9=\,E*Y\@O`BN>[LO$R)[064*2K5:QM[;*F]0'/:9FH_ M\W%3ZD1[]595)"N(R`QL,XLJ:"=A0,76'?8-;V5+N';*B;?UV3;:2[VJ8E9D MT`QS6:L1M>*$CZ2*FRS"4T*@O2:K^D9"R+JZ27U9FY2'%G$A0^U&-4`AY+B< M:Z:]2JORIJ.,S;9/B.DEPS0GZ,(.L,/'D--<>P5752R%;)LQ8^:'>(G=*!1E MUG`)M-=JW16='.L-59+\E6Y$'UCN_R,=[0(E^2'YU!"!^XCUHMJ)]G*L8&RJ M<&>2/>7&/HB6]X@,YX712V9`Q6[TE7'=`2]_%XY;@'DRGRBDP2EWI*^*;-.X MRX1G<,X<>P_WRO6?."ES'X$I<]W.Y"?KZF;XJR'OG6_84KJ_7$*E]PS!!D2/ MKX^8`GWQP"WJ;U:GCA/AQ?1-?RF25OLRYPFF_A@YON?@^%'DUP%/_=JLM9FOZ4X8K$U/F@3##'6[ M1!0^AY(V@].I# M)IP\M9^E,:==^M2=PKE'7=M=].U7/W;#DY6-&L[C&X14!K_:A+([DTCTJ624!F['`I4]7*,>\I82Z,T_WNHT%"5'G\Q^U9480 M1"?32[3^-Q46R[MYE=BZ-I67?;&02AQT1W:WCG5GT.YSMJD'!#/FGR(SQ8J& M*FI31JT]G;=SDT,)X2='_Z(H%5<^CN90TNO)3%*"*'V+.&:(8?R MK1_MIJ:%A-MTJ4U66"K`6*XR]TO5_K3G*.]KZE`1;PLFD])U%3B?<&BUIT3O M84H1BLWT#4/RP'F5W<*&5'L.];ZW"CFAO<4C"O\Q=155$?6B/UR(Q((T50-B<22/ M+>PR&Y1UH3T+?J^S`%^(IF*?'I.2TG(JF!=(M6?5[PMKCM#:OV.`YT_5D0>J M,T^_@<1"1Y:JRK*BD1=(4LLK=@=%OC'/X@XP%NH' M59>G62H1CY?EC@Y7\>7@WC,B#@[$3[))2:%0-^9&K!UJJ9P,@379UK`;Z(QS M;R:JX576&`I=8U[!^J#CR^+-;NY*I-3U/;J3B>AOQ==P=EG2R_L%WR$T7GWJ MD7#;MXM,!'298_]B+H]'VV4F-4($^[.\IYVO56J]0'5HW_?7U76HBO3>IL9T MJ$0)>:'"BU]75%65`CE41_;M:JQ+1SCRJJP2??LJ M&U(2QG(M:M+S#-CA3*+5RHT/ZK:;'M3[WMPG2[OLX<*2BZK0#J!JLH_WOZ$N M"47IF'$Z2:O%CVPL.%]NMX*"TYQ745'2Y07RLRR;`D8F\4F,1ZXA%)+F7'@[ M0E+*N!FH#'S/H1R].J"]V6:UZ--)`N*5A7#G;&J$FJH$JHX@O@K M#A^21ZG9S?]0E*8ICT<*>H-"V)RK31D/"X?A`11/_C]-BZ[@UZX\Z-QJ**0[*PO:142I MFWZM+PEX6*J>[G6^>K$+!Z]XL]=I\<+#<^RPG)/UO1EJ5"/:GT./#%.J;1>4 MC=\;DF6ED6@N$5FK;N9?^M`$JQFU8B?1>QS?AX[.[8F_>M! M_ZK?[0RF5J?;'=X-IOW!M34:WO2[_9[.HK%%K@#U&04T.L_0.\X?+;%Z.6+Y MTW,+#3#=%)4F'VZ9VP]YB/KY:-[A01@>6J]:+8_,);%X+JRJ,PP1A;R8XSESR-;=O@E;X8LG8"ZS49OARF\RWTWGZ M8OF"6])G/DPE>U/H0K.IE>.3/W>I2L0,,TJJ1(QLNE?-E.SE+(1G>6/Z?&R- M>S>=:>^2[OK8&8SN``<3N@GL#P6W(CDU-J-#O>X)0,3ZD3S:8'Q3%G MC!7D9(8YTC7806P/O>;2F]W1_R:AC;V0NSL]SQOE#_%9K-MCQ['8$.,-ZAW] M93SM].DVM>(&E7_@$8Q94+"SL.K\>=T4_]+EW+1L,Q.\;5:1\E@Y,8 MA9!"YZX/+=AA83,HM?T>A%BGS0!PRN_YX/(PPT[2VF#)C2[FG"RWDX^%\/S) ML=6['=T,O_5ZUD5OT+OJ3ZW136>@U]6QN8*6K/A=/X`$XN64>AT:I8-+\BE@ MK@Q@#_J=&"`$BWX+)0F987R3Z#Y`?T2TQ]XC<[F46UXQ,>;TV)K<74QZ/]_1 M'9W5^X6Y''4^/)IC`Y*MS*/0FH.]/2C("L8GT?U\J`230H:UA'=3#`:2ER', MSSBMD)]A_37M\F^'5(TZ6+EC29"](,1+.E,++FCFV[4M]:*<3S.2KY,"@>P5 M%6I+3((Q4R\@?Y&45/>KO,I0@<5A!GJ<$>87'-Q5FV4K=:7_C M5GWFW4%L9B#/S>T"@PWO0?L3MJKXJ@K'#$BO;$SBB\:9#/>^1QF-EJ]+"A]/ M(+GV-V)5P502BQE(IO,+5;W,%).\O23#$42L_1'6JE,N0"1F8+BYQ@J>4/D4 MVI],545+QGQ#=S[++BFN1Q!*`J(@2NUOB8)A`+-DDL7T;.)1WEC]G3@Q#FPX M4D+M#WTJ&Q!0%F8`]_J6>C:HL:[$1^?K?AR,QX^(;:>DVY!*G6E_UE/]BE-U MF9D!^@`]99@FOD?_Z*#,E@ILONH]:7]]4QGNJM)J4Q!CRKPSNP#-(_>&3B!K6&0)854[:TUX8Q>UWU`VUOOSM8K[AG15N[);<3]_-Y%IT4;WVW5,4TE'>8H^.>CEF`+MI0?HK M__6-RQM6^KG*KFF7[EMV:;Y>YDTRUN+]7)&]0F_IFK!,[O6Z+F>:>568S0,0 MK."G[*@J)S/ZJBV,!3,/#.5.R^R[*TG%[!?U&;-ZW[H/E["KU;4)L25*L:X+ M&H4//L%_HMD=G7E)ALG8KWWQDK[3,R+806/;6]2B-#5\6_?9M!ZEJ@T$0];C M]5TUNLTON>(^K_9LIN:C4O?$"L'19LN46AC-S@" MUUT\*]08@,2@DL_0UNF'+-N;69M/???1J;IJ\225>*><(NRI#>3:R2RXH->& M.))S;&034$Q`@5HQBHO#`Y#(M#4#C7)=XB&0&?YF3Z<7!:Y+\^)E2K_=><:B M1R,AQ"W""<1/YH1G(FYLH)?^TL;B1WOEQ&;@IJ"?8&=]ALG739?.7,1T9+=H M>8\('[="0]W>"`4MS.<C>X2(=SS"72C(9).&[T?F^RT)!,MUM=R]T>A;)R"^R/^ MCA5_R,I^Z>#].'@_#MZ/@_>CB5O,%R^;/_Z$$6&7/U]NV-5/L0,$2M\BM*`L MF>$&*5V2BN.6.404NS$#3C7EY<$,X]@(/\EF>'V/'DV#F,53Z7%/1*3;?U)) M?7E(\J5BQBFB;*!G5>`[,\6[TA1\9VV![[P*?.>F>%N:@N_<1/C*2W]MAO]Z M6!-X.>%=M.7LKBR5#)C`5Z;/UT?M1T3N_0#E7IG6<92-TS24@!>0Z%Y!P4A+ MV6ZC1R9_,ZS<&5.H3:[BC$D_8=%O6/%'OGL_#"?U;A`MV64#GT@2[DK:M>IF M,Y=/,Q:Z`0K7%8%N_$!P=,\UTS:/B26:+^Q0PIK.%8EWIPMY_A)[`%LH;:E[ M6Z]F#@)FS3"(7Q%>/(1HUJ&`VPM$E8UN3I,L[F!(-ZVA[])>+-?K4)L3,! MG]*:.PJLLD#/'IL]:K\0H':DV0Y!L7';M5*LG:(7I],7N:.6K2'>6['+( MG[%&B/Q`P`YT7GFI!_6"NTA)=&;,]-F1#>=]*G]O@=D5^]@C(C@W2^BT'ID: M@1#E%\\2H_4"J'*)[7Z>(%,N@J?6D[I#6&?G6)MO\\T''CSI-] M3>%N;U+Z6C!7`.FUG@J;F3.4)-?^W6'9%#3#6 M[KR_JB6[#NE_NA/*#$[_.UQ^5.7'C*R_P^7'P^5'_:D'A\N/B5/D>PF MZ[_CLB9,)JOI"[JW+_#,R9J%JNX#^[)V/7EHP0:AWUO*97&`JKB'8BK=FZ7= MYX,,\^UW<^;*40L]G(7WADIKI^_DV_SNBJ>G8XIL=WCOXL5ZRF'7+`84S.D3 M."$4&L-3ST@&,[C%SC$F0P"DC9B4N3"C*R%[+AD M20IE;0W#@J=?^6UU"2<[)AYP-F1C>CXFLTLZO!^X,376L*2=;E\\7S6RVRPN M@PV=3EZ_]P4HT"^FA/Y5!?IESP(]/0%*]+6A[O"\JDCS+#8NTP]`D7Y0E&C] M1ZV*$OVP9X%^!`KTHZ)`/YDBT(][%N@GH$`_*0KTLRD"_;1G@7X&"O2SHD!_ M,$6@GTW,B,F\([H.CM*!LG?"UH-^B0-.'5D01ZF3MN3*5)",N9!>(L>ETMD- M4FXGNK?<.V$J$4U#\YY2K1(ZI*1402=\G4\X,V4M/>O>\\L1K8U5DTPW*4,2 MKR@;54WJP:5Z*HKA0:AUGSW@]1P5A&$&?.EC]9GGN?EHE3;6G0,,SQSCLVI( M\45N>">IYE-6[R4;YSD_48[S)#U;F:X/$9]#Q.<0\3$TNG!C7,2')>(.[*7L MNNI6JQ9)?GO@9H1RTC%)[YKFVIDA]C*%X0B]V8C-SY'MXCE&L_YD*/3DE#74 M?8`LUX'L48//7D,'Q('O@47*::O[$">7JI!),_;TY:5@.JP,Y`*M[V^_-DEV MQ9TGF\R*V\RQ[[I7/F%_*5A;&_I>6]QNSG4VN>Q%W5*/Z5[LFY80QI3 MQVVH*B=0KA#!_HS:$PGUWY[;53S7<37=OC>*F9+X3COTPXZ3TCXN!`Y$ZMTI=VY^I>M:FRL`U1EAV% MU7M>8;+V.Z8FT=SD5?HQ[>[B-DU>`KC>ACY2\4WX[TY_"UBIM+)5@+4>5GF=`F8_=%X]X"\-\VTWK9VTB+^M6NG0G"@!9.VJJIIT?GO+)X0 M*'FH&S*6.@6X,5Y!@C=F>)"CQ3#_D&SV5/<2CW`M7--@2Y*^IF);G5 M$]WCZ$(V<,\9"0=_$"44\_KCMKN(VE?DTKCXZWU>R=>)ZITH?/`)_A/-[CPJ M]TS>.KN_&&QK,3.*#/>)#0!$.D5D>299(DT8(/@ZC(FZ:9HPWZP)9!9\,TU@ MEP%"3:"9UX8,-('=T3;9!(I;G?NZ=K\\N9RJ6H&>,4(-H9FWFIHT!)V8MZ\\ M5LS]AM\-'UO%LD[K*)9ET7]9F4\=BF=&;D;]K.H1X%=VO!FT"EV[BCTYR[3L/L6''E-2*Q M96`3=L'TD9.Y<@;.7-ET=,A+.>2E'/)2S,J-,#@O)78/BG-2,DU:)//,J,W( M18D'Q(W!94<-C;WM1]H%#2D3=#KD'9,UZI'T+=V2+J.E3-:Y9KH=:27ZD9-T M*5]F[+!O[6>0R+>;Z?83`41>QI<9(J_1=]6GAS?L!=CYQ7:C_3@0\Y]L=QRX M1JFW7+FN;$QB?CI!$"W7/'>\V2T*'_R9[_H+P/%@+Q]O>4BX$2C>H.ZMN;T+ MA(]I-?5![5'B/:I.@TI;Q/`-*FIZA^L2/^(9\F9C.CWL267+/ZU[/_Q&E%>$ M:U.)GTV,_[66)$>1>'+QHFV/S'M<>R MW]846X[M&U3F,0Y^OR((T1,DHBH3[E&5RS^M/13^-A19A*M!:EPEE4!DMTTE M=P"^J3U>KE=Q&T6RH=WMSY'MXCE&L[[GT#'A1Y2]N\/9F,J(6ONS&HX5P1 M1SAY>]^%JM,*Y0)N^9[M>[LC8^"#3/JV>;7>NMG[,QB@&?+*)T4N09,CA[*] M3Q?5.2\*Q5JS4FA(XATC^A.3'@E?IE2P`14*:R%)Y3W/I_)^/K;&O9O.M'=I MC3KCZ3=K.NX,)IWNM#\<3`Q)Z.7Q*H_ARRDUKHC#^9PJ*@FR1L)GI;RUYH05 M*#*YY4#$N1DY\G0U84?1Y-DE.@?=T?\F(5UJ0HQD1O8A;V0_'%O=X:#;&U#C M6AM69W!IW=%?QM-.?S#M]XPQ-1S\7F`78&=B,A/RNUN960^"XY!H;UC2M\&) M]GV/3G'H=8#L2TR`PM1[(5&+(LIJ/$C(S,`+H'@RPFFHRUC2O MV2X*9!GG6XUTIS2!="P_I16Y-,.M=&O_VR?=*`@I2R00SV-E;E[FTEB9[O5:(=D$0[BA)M+"V@DD0[>Y7H!4BB%\I+E%$BO=BK2+L@D795 M16K&LL]ATHS#QY:7F/GJ1HBP'^P%$F02BJG:<@45PGM3BL__=%G,/U8C(8GN MC;!3(J>7"-_0>S5`W;&:.63$'N+Y$VK\H#)QWS`Y,NQ==T;7H\[HY_Z M76O<&PW'T_[@>O,T5K40"4>=2D8K><-82&&"C[U=P0ZI2`]Q#B,=4@;'.39# M>]4KVQ5[!P4D;<2DR(49$8X)6N2')WW1BD]B&#(\;^5"GG:HU(E&R[FD*'IHEH$SOJV`[Z,8^(N7 M!'#!!*?0A6;;JX!LSBB5Q:5DMKV2]-NO__B[!#]W_RR7I0>"3>-6 MZCIZN6=/G5\D%5GX5GK$-J:(.?07Z0]D>E#R\7//9E"F,_*"H31HYE9J5>I( M*I=SR-0NVZLMKVNU;@U^\E5_(JZ^KES]-EN\7BU'Y/,,V]=> M=V+77`U]ZG?T@;&\4"\T;+:9M6A-C*^_=U>UN3J;LR="W?_(-XUKY/X>-'GG MZG-L(0EPLMW[TIRQQ6VU^OKZ6GEM5APZJS9JM7KU\U-?\_E*`>/MTB3VUS3V M^LW-3=6G1JP)SN6$FI'H9I63)\C%:\E`)0)^8KL,V?H.O\'6%;:9+ZH!<8>5 MI+)>!JPD8C5PC,_%>F7FO%2!`/SU9KE6+S?K$;OGEF<(+=95ILB=^*)#0DH5 MV[%MSTHWU&"TRE8+7`6F,G!A2O1UO;!^'86EB M"]OLP:%6%T^19X)/OWG()%."C9+$$)UAQKNANT`Z?EM@U)V1;3O,9PA+>-EB M0:!;0\'?[CC^M]0Q\1ATE_B'YU$O4SRG5V%8>%Q7V384FQ&VXF.$6CY;22+& M?4G(P9L%)?RPE-O&UJP4_=:DL1=6W/R+;D`)9TI:PNVIQ#6R#U#8R^6C4 MYA@S-W!^!DWL=@B@?G3$H=\[`[6KJ)K2E=IR7U8[BJ1]4)2Q=G;XME.'B(*- M<\P(:"[R_BZC&(IF3BBDGW>D_OODH5D[S1U,!PN^6.&,,5@RF,20M#(AT<;R M6'E25(!C\"`-ALI('O<&ZGF<;/NY@]SY@^F\BK#8\(BAN,@)14?6/D@/_<&G MDX4B6+"'82GZ(G;N)9]Q89%K.JY',7RI5Z1'185.W3]5+VJ>92&Z&DPU,K-A M,:8C6-;HNN/!6L2>#1V3Z`2''3LGKQB#JS@&C8JD]1[5WD.O(ZMC2>YT!L_J MN*<^2L-!O]?I*2?;PX?4@0C.5GR9^7C!R'0*-J M$&M.?(FN8QZT_7*(),_PG3)$()YL0HV01PQ#,P[#M1_D.PJ/\[[K_8#S#"6C ML=R#L'.Z`><1.S.*%G.BC_#"H3RB1POV)$'L]E;<[3=\\3YX',G##[T.#(3A M8,0C_*FZ6K$6IK/"N`VIT)2PH8G"W1,7?_/`(N6%+UBB!"E6*G9S,AV%?%1[;FLP=T(PD90_^.KE M=%V<)]L\)$/-EZG6#\A4I9\CV2>[79D/@C%/IO8"+:PAABR1Y.:!+)!\LH"E M[25LPR.@B\%(),.9.PXGCT%LEV';_>DDH><;B7PX91OBY'V>S'EW@E(65>SY MO'GQV?MX%CY!3\D$=H#(P2C&))$V9R0.9TQR3<1=#'FRZ9:S=Z>/($>,:"(# MSS/-A^T!=]1B<.@B:O,,>RZX'A"A_A&Q)XRX]ZWM].?[!8F!3^P![`&\WV!P MNDW:;O*,>RZX%$1M*':'F/ISXR&0)V2(T4YL0^R#=M26!(U)?FMGH(4@J8CR M_="7O9#=5!)#F=CJR`/E6OC)(I'VP M\%D''N.'Z8WU0Y^]:@@!:R:V.-X$+&Q"VFKC#%T.(/C4LL14)^[F5,QWU!?# MFG__1`!KD-=MVCS#O(8IOL@3,(B!2FRJ9`)U7L5E'?>(@?$VFQB2Q*Z(\'C( M&9BWCHK$X,G++`8IL8.1X_#(&:K4@R0[RW`!70Q(8I,A=(8D-$ MR"&&(7D6(NO(R?_G:."_^#W5$9Y*_OW66W[9\KX$2"SXJBLHFU,\]D)*X?PM"_*T'B'W52/E(`".,5Q]N M-2/Q=F"L5H]ALHDF^YH,5;#Y`VWM<_E'-1)ZW[Y&QCKL#S*ULVGEJ`;#T-G7 MX-W1]H/L[:X;V38WO&M$P(4EVXG*SZ/9Y<&^^[^B^*$$5 M_JT-PCJ>/+.D"?'"\/R--3MFNJ047>56YX5ZE??J$$V49*"&!F\M.'6<"S(*GH,6YP-;/(F+L0BC[,^4L=; MW)<"6018\FE[DZ7M31&UK=>RU-VB%$C?5I:ZK2)J>Y&E[441M;W,TO:RB-I> M96E[51QM/T:O7>EI@UUU4RGOKJ_JV-DJ9Q'?76N-.?K7:#?IM8+*TAM1!X>Y=<*,T?'(]F*[Y#?7>]_3>CV7X3R-20B=U=S07T=]>] MX[G,@85??5?E9'%A-&VD:]HHGJ;-=$V;Q=-43M=4+IZF[71-V\73M).N::W":#3'Z2)U(_'R\*/T4V[6]CP`%2B#T[!ACA@218%0TF)IGY;74\2OWS MV2$R8IXW30CVFUA$F@3O`KLOZ10;A.T:9CDV9HBN?I1I:C[KU/\%`S]A,ILS M;,@OF*(9YF_$<&S_(?W.B8I81]VW5N&Z;,\&OR(7=W'P_Y#B!2(&%$/X&*,E MOPL2K2MR<.YASE\+;US[GAV^H@W0X6^9)<$;"M)-S6`N')A#C^IST'N>%@DXSCJ"TZNQ"'*RUU$E`2*IX&6 MD[T(&*:<;XD#)V0I'%IIT<^_5;)B<:3RL18!I;3K&`J(LOC!OF<73SVS3U[" MEQDD>N3!M8M@.G^!N^&9,*^M3\8/8666,#('7Q',\1]0\C\'$!]E*83"C:TN MMAV+V&GJIY(*9\!>UPK7Q\'BMGZOE,*Y)9;H05><8`KFQ5.]-G*)#E&D2TR/ ML[/-L(50EO:1L?E8 M#S0H*CW&F.>=`KH;-CJ.M<"V&VRTP:BT9SYK>[5A@96VOS7WBJBQOD@NNZYG M!4]+E.4"U@O8>'#H%(,V%(^V.O]?T]3^TQC,84#GJ]*C/N;UU[D0V;8?)R4? M^69PO?<0#^_QX"$E^F9S)%&:?T=OQ]<^S,=Y1KW^:R9I;A;0B^7@P?0M4_;@ M?V=0=C6%\9EV+S'-J"S6=[9G)V,=$??K,`@6,(4U4K/:),^!%NP=DNZJP4$\ M^/A?4$L!`AX#%`````@`PD;H1R#;%>P``N[$%`!$`&````````0```*2! M`````'-I;74M,C`Q-#`U,S$N>&UL550%``/LZ;M3=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`PD;H1-$;/K[@#@``6*X``!4`&````````0```*2!$'P` M`'-I;74M,C`Q-#`U,S%?8V%L+GAM;%54!0`#[.F[4W5X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`,)&Z$1R^(_,XQ,``/U%`0`5`!@```````$```"D@3^+ M``!S:6UU+3(P,30P-3,Q7V1E9BYX;6Q55`4``^SINU-U>`L``00E#@``!#D! M``!02P$"'@,4````"`#"1NA$A1HY_.,[``!KD0,`%0`8```````!````I(%Q MGP``&UL550%``/LZ;M3=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`PD;H1!F#.!H9)P``P)<"`!4`&````````0```*2! MH]L``'-I;74M,C`Q-#`U,S%?<')E+GAM;%54!0`#[.F[4W5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`,)&Z$3_CLIM80L``*5K```1`!@```````$```"D M@0L#`0!S:6UU+3(P,30P-3,Q+GAS9%54!0`#[.F[4W5X"P`!!"4.```$.0$` 7`%!+!08`````!@`&`!H"``"W#@$````` ` end EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!,"'?^XP$``$,7```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F,U.XS`4A?=(O$/D+6I< M._S-J"D+?I:`!#R`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```/__`P!02P,$%``&``@````A`+55,"/U````3`(```L` M"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7 M^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X M8<'%#U1?````__\#`%!+`P04``8`"````"$`+K7Y<_$!```Z%@``&@`(`7AL M+U]R96QS+W=ON_#^$T5`VTTXNP%P%U.?IH[M:?/]T^^KU+^4>QVXVQRKOT ML39=2N-7:V/3^8.+BV'T?;ZS&<+!I;P,6SNZYL5MO>7EU4-; MF_#0DICJ^3CF1_]_\V&SV37^?FA>#[Y/?WF&_3F$E]AYG_*F+FQ]JDTI17NZ M0[+(FHW]AYSLAZZ<:R2'5\IR>(7DR,V<&G961&J8YU90Y MF924TN_184)RY$)9CEP@.5?*:JZ0&&)E-<10CK8Y!-WA2V5W^!*Y(]J1+#"2 M9=9(CNFXSXPK>'A?(SNT1Q=/KC80"`*!\_N$*BYY"5LU*Y]*_$_34DH?1+A! M=EO9TA2W21B0D M)&FK(2B'M8'-$-@\*[!+Y$XS4TH?*0S/4**=?(*C3QN9!)%)VL@DB$S1!H/` MU-'F`L2"=J=@HTC;&H+>L#8R&2*39T5FR3L0@?"`*=J9(S!S1!N?`O&IC2M, MJ]QCS<^AA>3V[(OO^@T``/__`P!02P,$%``&``@````A`(S)MJ^J`P``H0L` M``\```!X;"]W;W)K8F]O:RYX;6R4EEUOJD`0AN]/NO(T'/ZYEJ6RBK(X2O.,=>5/5LKWO=^_[C9Y\?J3%*JI@6;PHY;I@45PN&:M6J:*K:D=914DF M;Q5NB^]HY(M%,F>#?/ZV8EFU%2E8&E60?KE,UJ7&*HA*[VF2*^08K:(WM(JA/)V MZN"7WM+U#O\FM^(Q89MR'\27TL=3DL7YAG\5K/UL5@8DL*E?/25QM83WJJHV MS\8L>5E6NX<@KR#]VD'8I_Z4LKJ\G2,4.D5)5B75)[6SK?M)#BWDKMM0F29+ MQ6T"_Q1VK/'$L8KE.@/B!&1`^^;$="Q"@S$A88#B=12O?S>>>E'!H-%-%@92 MJ8T^G440FB%Y($X84'=(78_X9HA46DBE=3Z70Q7+#,9TB%3`],:1]K&*1D?$ M@6TG*,"X0A%U\W'V.@WLD6,/;MC@1:%;H:^:874,V=F?T)0:`M8;/:^.0YM M0^C#@QUNG>?;#<=($ M*F^`!'?DF][8MB`QS_6Y(S@>@Z0)/&HJ)0_>Q)T10OO`U-"&QL"0884.ZHHF MLJC18-H/``6HAI)'^'O@`\92^R&7T,AF.%L83$T@\S+@T-*]$`94$P@]AS@- MH^>4(9TVIE43!YT@>/3$'[IN$C'P/,` MBY_DX^))-_!4P.);0DY4%'#?>L<)X;DP!*`O'>04'X`&YAD61_EXQLVC=`[W2_[!+VAU M.Y7=[;KW'P``__\#`%!+`P04``8`"````"$`J(_@_$H&``"=&```&````'AL M+W=OR^?8>B;'%&&UNY26SITY#_S'`XHA\^?COL%U_+ MIJWJXRK@=RQ8E,=UO:F.SZO@G[\_?XB#1=L5QTVQKX_E*OA>ML''QY]_>GBM MFR_MKBR[!5@XMJM@UW6G^^6R7>_*0]'>U:?R"'>V=7,H.OC:/"_;4U,6F_ZA MPWXI&`N7AZ(Z!L["?3/'1KW=5NLRJ]Z*9[VH/L;5\7Z;+O_,C%_J-9- MW=;;[@[,+=U$IYK-TBS!TN/#I@(%UNV+IMRN@D_\/A;WZEB"MR%.-@)/=?W%HK]M["5X>#EY^G,?@3^;Q:;<%B_[[J_Z M]=>R>MYU$&X-BJRP^\WWK&S7X%$PTM;2N]S`!^+LX5#8UP"/%M_[_:[7I M=JM`AG-04WU="X_L9OC]Y/L?W_>>1"/D>$19>!3#7^3&R,*P:;^XQR87$(::/FHP4TV%$Y"&"&15% M)`4SGS`JE$P3(O>)6#-AS.A$)`_\/%^>A8D\@2>?."3JY0D1A8R$-_4!I;F1 M-"U]@/,P%IR*0X24D8[E919(7/@><18FXD:S_4I/'.+$2^19V&R\LC4$H>`=]]<>3>)[":17R.0 M/-N6>$7_>G6T,(D>2:S$(2YZ7#`%V]HE;?K8I#YAF-0QR;S,!R#Q8J-I\'Q" MA+$)Y3@(4F?>H\["1%V(YYXX9%AX4H4QD9\B@$%NDO!G/A!I%C.R.>8^$$I( M[C?RDD/G,C]R/4W$D9*8#,P0.R5C8PB28H1SQCA9OAE"%"Q?J!S8BSE"I!32 M>%90_+C=U&>G9T\3D63L9&"&$+)(FHAD5XH0KJ6(Y1B#H1MQS8:SHJ!\L'C, MP![)D149*Z[,.!-8),8^O>%9G1_ MR=$`"NZ/ZP!+LQW`?&FN7_"ET7XKX8[QZZ>>R+O-9#/LY-<9+-3V`O.%NLX! M"24IEG#'7!?JF"$-0Z_]&-+TMHU\&,?9D%K%;V6I;0CF*[0T7HJ&K)#$OC4! MXT:.)-VBT^&^[MN<#X;VL!EZ'F8>D3S($6#",!QG@(-GFX'YTESK@()'%E#" M_?8"2L@T11$@#%VB&;(0LA^(0Q8BP?5;:]#V`IXZ^UXG8?.XOM5SUT$@E60O M2P;&!5"PV$A!0I`BA&NE(S7FUY"D;J0AB870>M)H(RL*]IQ0CQ['H;2M@2?V MADC72""1HQ?[Z27<;S8^1#&/Z/MLBA&MA>83D<@*5P)>%LB*S[$9+B,>OYFQ MMDN8+]/U%$@F[6RX8]PK$YIH4')*,RAO);B/Y502+A:CX8J]7'&%IG*;01./^.!D@5Q%Y"*_O)AI=W9>EE#!,*$7? MDS/"28T296L7<4@)7:;L(+ZPVEKO?PFG5)WZNM.10]E\URFY7[?+M;U MBSW1E5`W+E7EP?@Z@V/A_N,.?@8HX704SGZ#Q;:NN_,7>P9Z M^6'A\7\```#__P,`4$L#!!0`!@`(````(0"D%CE-?`4``$X9```9````>&PO M=V]R:W-H965T<\OCKO\_ED;E?^?_\_?IMYGMUDY;;],A*NO*_:.U_7__\T_+,JK?Z0&GC M@86R7OF'ICDMPK#.#K1(ZX"=:`G?[%A5I`V\K?9A?:IHNA6+BF.(HV@:%FE> M^M+"HAIC@^UV>49?6/9>T+*11BIZ3!N(OS[DI_IBK8(>7^B.,TNML4;RWR19Q6KV:X)P%PH`[5SGH?S M$"RME]L<,N!E]RJZ6_E/:/$EN[2]V/S%SO_1O/]H8%V3R`CGMAB^_5" MZPPJ"F8"/.&6,G:$`.#5*W(^&E"1]%/\/N?;YK#RR328)!%!(/U*OU*3"+\3A*:1PW&L.[X4_'J6?)$>`)G.C0"D!N:IK2])'#&`J%_A<3'P M148,2==!602I09&H`@ZZ$+4&3W7WUU/G8MTM3F(C=:F1M2=D#G1L!9KC1'<\ M+F^^2`^`)+BU+_.6&KWVW8!H,?![PL`%=[T(?)$9@UD$J5&U1Z[:SW7WU]UR ML>EV8J0N-?W4N\"TQ"$R+?/KKH7:]#TU?"O17(Q;-XNZ6X-P-]Q*2O4O=9(D MIEN%,CGF*.A*HGN^"V1(@JOOV8:,$LE)Q\!]UZ0CCJ.[QTRL,HIN<4:)^ATG M20=[O00/T0X-X,Y"C1*U\QZYNL"9U*O$C?YSM5X!&S?\U@^B$5TP2#<..,A& MGDT<)1K7A8>XAX;`UUW;$GQ*=+L+!O9N=&&(=]W-1+F6HGX%NNCT*;P+>FB( M>A9YI*C->^*@#[X+>D*M3Y]-'R62T'/<9/!=T!-JW:V-'B6Z#+US?X,-ZHV; M>;%*#\'>X2A1O^-DYKC5XX<`*%8985CD42+5>QS@9-[_<:`0&RB\?@4(M1Z( MS2$EDBVYLN7D#QE]!(YL"5^EAV!C2)A>^7I+7-?"0S3$0S3L+G3)`B5J6X)< M(1@DO-&$`0+.S*T?EJ)^!;KH-`SANQ@HU&;Y30PID[:AH\P>=D$H8@XMZ+$`-_(+@SM M`.X^@C'66\?.#(,ODHO!;$>/X5I.$"1SP,DP*Y!,`!XHPL#X)MU MFUP)/B)%_3ETY7\7^L@`^A*3/DK4(P(^DH\(/@8V08PL2&^@;-W%BE1Z#C1\EZK>=S+KV:"6('Z*@6&6$ M8>%'B507)D'<[='U$`P"7A_\>.A)N)MJ.?A*I+H`)SZN)ACD&]D$FX#VWB>6 M(KT)W:#J%7@(@G"F?9L^2M0V86(V01YKRU/?@E9[^@L]'FLO8^_\R!K!X4G[ M:7N<_H3%@7C[!9QFG](]_2.M]GE9>T>Z@Z51D$#RE3P/EV\:=A)GRAO6P#FV M^/,`_[>@<#(;!2#>,=9O_`0``__\#`%!+`P04``8`"````"$` ML9EIW44%``#C%P``&0```'AL+W=OOM%=:K?;CF1(G004<`6UZ__V./:Z-#>3" MOC1-:-JT. M:<$KMO._L\;_LO_YI^V5UZ_-F;'6@PA5L_//;7O9A&&3G5F9-@&_L`J^.?*Z M3%MX6Y_"YE*S]"`?*HLP6BR689GFE8\1-O64&/QXS#/VQ+.WDE4M!JE9D;:0 M?W/.+\UGM#*;$JY,Z]>WRUW&RPN$>,F+O/TN@_I>F6V^GBI>IR\%Z/X@<9I] MQI9O>N'+/*MYPX]M`.%"3+2O>1VN0XBTWQYR4"#*[M7LN/,?R.8QCOQPOY4% M^B=GUZ;SO]><^?77.C_\GE<,J@WK)%;@A?-7`?UZ$!_!PV'OZ6>Y`G_4WH$= MT[>B_9-??V/YZ=S"@2`C;'+X_L2:#BD*8($I$I(P7D`#\]@:X&PNJ>A!LH'(G\HP#ZUU3"IH%$$>1)2=#^T. M*AI8G_<]31;;\!UJFBG,(V+@K\80C0@A&YT2I-%-:;C(G\P"+)A%T44JC_A! M)).(R6IMTK!(Z!P2`=[Y<2?U*(EU\LB+&%A.+<\@+&8(,UV>`$.W=*+2Q)0- MF1&SDHH30I:+$@Q"C-X>V'%0W;- M:4)U?%2.F`DU7]D9W&868%>Z64MD1@Q9R*)'P5HG9@D7_M\9KMNT`NS2NA5' MC*(E8[3K.;0"[-(F6@ZJ14FT7?PH,;V$Q5<@Y";`/,HM+&ARNQ$TK*[N:&E4*6X$ M(?>=L)91\EFV1H9\;>46O6ML=X);`ZPI$SOQ#-T";=>\;ZDRY,Y'W?'R!K?C M;;='G*!A=6M.$W?&%0BY*8G'=3NN-LU7"5H7U%9O5'UC5:`I0S?+X\B0R;G> MJD#:Y>Y-A>QUG^5SI&]T`[.&($6=!$NSUUK4T2R?DVB[Y?JCID!:-34>9%,[ M+G>[XZ(A=W,'38'6BL"C1APL1/A!GZA^S-R%/D".J2T\Z^ M8_?;+(>+!ARNMZLHD$4_.FF.R?V@W='-GG`R34""UN]Z/ M_F"ALZQ.HFWJOLLJD#K0T-&]E)9)B?1 M#GUO?U4@F]Z8L+4$<&TZ8]HDVJ4W?:74X^'/IC?K@_1XUXI7D26K3^P75A2- ME_$W<8]*X"BJ/]5WO`_RBC?47\`5ZR4]L6]I?K\M\S7*8SN"YB_JKN^K&WGW_^=KU87[.RRHO;WG97CFUEMT-QS&]O M>_N?OS__M+.MJDYOQ_12W+*]_3VK[)]??OSA^:,HOU3G+*LMB'"K]O:YKN]/ MZW5U.&?7M%H5]^P&5TY%>4UK^+5\6U?W,DN/ZDW7RUHX3K"^IOG-Q@A/Y9P8 MQ>F4'[*D.+Q?LUN-0[S\=BNL=0KSFE[S^ MKH+:UO7P]-O;K2C3UPOH_N;ZZ:&)K7X9A+_FA[*HBE.]@G!K3'2H.5R':XCT M\GS,08$LNU5FI[W]R7U*_(V]?GE6!?HWSSZJWK^MZEQ\_%+FQ]_S6P;5AC[) M#KP6Q1>)_G:4+\&;UX-W?U8=^+.TCMDI?;_4?Q4?OV;YV[F&=F]`D13V=/R> M9-4!*@IA5D*E<2@ND`#\M*ZY7!I0D?2;^OLC/];GO>T%J\W6\5S`K=>LJC_G M,J1M'=ZKNKC^AY`KDVJ#"`KB0?9TW5DR^+#@J4'B5?W5"YD]PDB-^5!,6W!'M4+-,H@GV24O0U[!DI109._OGB^ M^[S^"HTY$!,-&8.(&T*63H9-\`7XV0LKVK!KD-#J@!+W=8RWMTE7PC+=YD81 MOB!4YKZ[#9WV)BJ16+\.1=>O)WB]GZ@(6T3+$Y;`_#PE#`NNIU_X01M7I18A M$ZK4A=CL@MU.)^(^X6V$(W9F^GW"=QQ7N`^J#"MD?O82UK/W?$_/+4(&=E+; M85\GXDDBX0BM]G";^=E+6,]>^%U5L/;(!+1LH/9&[G@=?CY2EW"$EGNP)'<) MF[F;E4>FS3TTKL=XGV782,ZZC\G95CYH[7N=PY0LL]7)*[A,W< MC:4=(8.E#WP1;@P@1H!+GB.TY*%""RJO:#U]SS=*&Q'$I!=/(PF+Z!*DE M/"X:GS[XS>%#4+.#@]W6F#X$,!H3%M$%2(N;+P`-41=@3)C(1:@5,-B[!+`" M,,8XH@N0)M<3,&\*N6B-NI#!8D*HF4.N'_J!^01!@<83I:<=##..Z%JDY?6T M\*/(18/4-9BSB"!8T?+I#8:1`<0$C&='`F8[L7P"7R!`TOJ.'CX'J9![&YNP M<[;^UEAO,1&L`KS3.**W0+K?_!:@5_9;X/E&A2.7,U15X7@:25A$ER"=;[X$ M],F^A.$#D8M0LZ6W@?DL2L!X@6D5S39D5]K??`%HEKH`8XU$*N3>;@5LC2;% M!+`"9KNR*RVP)V#F3$+CU(4,9A)"[4P*-NYV\'F+$XHNP+#F>3/)&[-HCB3 M"&(U3)LT16EGD@O?!/?_/#`\;Y%C*]I<7.:((HC5,^W8%`5[(N"S2KCK5K'> MDD6>[0T]V_.-SSD10:P$C,,@"1M%EP!A%FQQ29M=,&>4AQ"37SR-)(0T6]QW M'BVC15;MC5EUUUVU*2."6`$8AT$2BM()Z":(W@'#JF?.J#'+[NY`0B;]./8F MD820=D9YCN]U)=.U+#)M;VC:(S.*LUMT/(K#-@.CM#/*>21@D65[8Y8]&$J3 M?AQ3'%8`1L$F^#LG=!\H\!=YMJ+U#>WYG0'A,B*(22^>1A(6T5:1;[@V_]RD M:%W"\/LE@E@)TVY-4=HM'7;36Q>PR*K],:ONNDL]F/3AF.(P&A-"&@&;1T/5 M-[QYWDQ2[S([8OF5_I.5;?JNL M2W:"D,YJ"TF5>%P'?ZF+NSJM\EK4<,Q&_?,,QZHR."<"9VELZU04=?.+O$%[ M4.OE?P```/__`P!02P,$%``&``@````A`"$8SW:4`@``^@8``!D```!X;"]W M;W)K&ULE%7;;N(P$'U?:?_!\GMQ'"X!1*A:5=VM MM"M5J[T\&\(,9GSIDS8T]FMQM5HU=AK-1-CFDO MP4@T7!>R6>;XU\_'FS%&UK&F8+5N1([?A,6W\\^?9FMM7FPEA$/`T-@<5\ZU M4T(LKX1BMJ=;TJ!8J%K*5["Z08*3Y]6C;:L$4- MOC=TP/B..RS.Z)7D1EM=NA[0D9CHN><)F1!@FL\*"0Y\V9$198[OZ/1^C,E\ M%NKS6XJU/7A&MM+K+T86WV0CH-C0)M^`A=8O'OI4^+\@F)Q%/X8&/!M4B)*M M:O=#K[\*N:P<='L(AKRO:?'V("R'@@)-+QUZ)JYK2`"^D9+^9$!!V";\KF7A MJASW1[UAEO0IP-%"6/:C_L:X'YWB`4:>;IO1$-V*@JAUFT"&.E/O7*'MP MCLRM1-0*B*O56_V5V=(VL!\/A.V@<':AROO[Y8MQ7=FEK*Q MJ!8E7(:DET'C3!Q><>%T&Z[Q0CL8.N&Q@G>,@#L.DP6C4FNW6_CQV+VUYG\! M``#__P,`4$L#!!0`!@`(````(0#F$:*.0@,``-$*```9````>&PO=V]R:W-H M965T/W^/87MV_E87URAK)1;6VB>/9%JL2 MD?+JL+;__'ZZF]N65+1*:2$JMK;?F;3O-Y\_K8ZB>98Y8\H"ATJN[5RI>NFZ M,LE92:4C:E;!FTPT)570;`ZNK!M&T[936;B^Y\5N27EEH\.RN<9#9!E/V*-( M7DI6*31I6$$5\,N7ZI[Q)1UF"QYP57[ZVI;97)\MNA$@W= M%S#O-Q+2Y.3=-B[L2YXT0HI,.6#G(NCEG!?NP@6GS2KE,`,=N]6P;&T_D.6. M^+:[6;4!_>7L*,^^6S(7QR\-3[_SBD':4"==@;T0SUKZ+=4_06?WHO=36X&? MC96RC+X4ZIX!)T+/$\NOA/ZT6Q^!8N+\VIC>J2*;E:-.%JP]H!M\7?HF:!X&'DA0/V'0J@P+U)V%L8:##..=IUZ>E. M0\2/J2,B:F8MXIT?DC`B/4&KV*'B"L;09)R.3XM--I\,V5"#;,0+HD4\0#,$ M4/KY1[Y&>@!_GMXTF1:;9"3VS8&WJ!G/!%.;4AAL\2UL6FRR!<%PT:&F2\T/ MO7``OT/!.+R!-KL%38M--!)_+&9<;*@9'QECFU(8;/K6M*IU7*B3C]=)%$]]U:)WS@M6'I?O7G]E3 M[#I2D;H@):_ITGVGTOVR^OVWQ9F+%WFD5#G`4,NE>U2JF7N>S(^T(G+"&UI# M9,]%110\BH,G&T%)T295I1?X_LRK"*M=PS`7CW#P_9[E-.7YJ:*U,B2"ED1! M_?+(&MFQ5?DC=!41+Z?F*>=5`Q0[5C+UWI*Z3I7/OQ]J+LBN!-UO*"1YQ]T^ MC.@KE@LN^5Y-@,XSA8XU)U[B`=-J43!0H&UW!-TOW6O@A4_6$W!;&B3;L".\Q<-_5[H)4CV1ME9VX!?PBGHGIQ*]0<_?Z/L M<%30[2D(TKKFQ7M*90Z&`LTDF&JFG)=0`'PZ%=.3`8:0M_;[S`IU7+IX-IE& M/D8`=W94JHQI2M?)3U+QZA\#0AM%OXX$5VRK9#="F966@; MX('&JU!H0E_H[0'H]&BPUM.QKLU"T$H+493X=AD;.PY=L>.I'1_E;^WX*#\S M<=!V-3CX,,_2B6V=NJ$87IO/]>JDI1OVZ#$>2%@;#,SPM81!AS=W$>E=Q/8N M(OL,83D!&T'\;C]&T_/D[/3!@^;\RAI1NVL[[NQ_JODVS]&`^<7QN,T1^B.!H( MW)CX[0K-OG:'87N7(>LS(#@`/C8DRX/(]N#SWFNPK1VA#]ZV\K7!F-E'/@Z3 MP-M=(-YD>_LJ?1%"G,+<.\Z!XTYZY.Z[@MM#^/,+ED,)AYT\`O.=<=0_Z#Z[7S=6_ M````__\#`%!+`P04``8`"````"$`.;N`LY$#```5"P``&0```'AL+W=OG>D76DT MVLNS20Q8G<21;9KNOY]R3"`V.S3S0HASZKA.G4I<\R]O3>V]4B$9;Q<^FH2^ M1]N25ZS=+_Q__G[^//4]J4A;D9JW=.&_4^E_6?[V:7[BXD4>*%4>,+1RX1^4 MZF9!(,L#;8B<\(ZV\&3'14,4W(I](#M!2=4'-740A6$:-(2UOF&8B40!,RWG%0($NNR?H;N$_ MH=EFZ@?+>5^??QD]R=%_3Q[XZ7?!JC]92Z'88),V8,OYBX9^K?02!`EDKUS#2E[Y5'J7CSGP&A,Y4AB"GSQH7U`O.Z)?!C0# MXJ'&IB*7JO^LZ%!M3?*D618^O'=03PF-\KK$.)P'K^!N><:L;C%9;D/6`T1[ MJ7F+8>'*B^R0S8#0C022+KK`K[&N_^^9(7T-UND/^Z[,0M0KB5&6.UK6]O,X M2NRL"OOY3?S&?CZ.MT1`OSPN0H,7/C3)R`.G6BN#`9\OF-C.?/TAHO@0L;F' ML/1!LF-]NODP?";NFZ6#`#?2@'%DJU@93-[[AW"8);';:F-$GN/(;==B#(BF M892D4WN3C85(=9M>64P]VS\$%%\B-C<0UCZ4EO? M8S;J(-O&*'1M-)C,V)BB'.=9:I=B;4/"*([3S(84-@2A#.6NE18DR:?Q%%T; MQM*:V5KO>ZG!KD;72X,Q&J,4(;<(ZS$`(X3B:Y>9C^08`/KCW"G`9@S`493E M/]&FYR;G+(BA">YKU$&N1N>CLC*8P<&PO=V]R:W-H965TL3(RB>68!BT3EF;E*3+_^?OE86,:7,1E&N>LI)'Y M0;GY;?_S3[LKJU_YF5)A0(221^99B&IKVSPYTR+F%JMH"?\<65W$`D[KD\VK MFL:INJG(;==Q`KN(L]+$"-MZ3@QV/&8)?6;)I:"EP"`US6,!^ODYJ_@M6I', M"5?$]>NE>DA844&(0Y9GXD,%-8TBV7X_E:R.#SGD_4Y6<7*+K4Y&X8LLJ1EG M1V%!.!N%CG,.[="&2/M=FD$&LNQ&38^1^4BV3ZYGVON=*M"_&;WRSF^#G]GU MMSI+?V0EA6I#GV0'#HR]2NCW5%Z"F^W1W2^J`W_61DJ/\247?['K[S0[G06T MVX>,9&+;]..9\@0J"F$LUY>1$I:#`#@:129'`RH2OZOO:Y:*6O'8\` MW#A0+EXR&=(TD@L7K/@/042'PB"N#@+?MR">Y6Y\X@?WH]BH2"7X'(MXOZO9 MU8"I`4Y>Q7(&R18BWS)#'4VN4ZE"CC+(HXP2F3#ND`6'_KSMO4(,'!L,:1`VJ&DD@8RNI,^+?&.68,DLBRZE/.$%5XE8D77H?$[B+2&18.A9 M1[JW"9NXR(N84/$2SUEO)K);+2&6X,B$8U,SKY,0$B,&YJC!K!IIO;H"9'Y= M)7B0Q;QPNYG_>O#A)#U$B$2 M/!32%A>%($8+"6#]3U++IT%GJ7T]UQ(\I/8'-4",IG8LF$G?Z7S:=O7&(%PB M0X*',H*!#,1H&<3R_&XGPG"R'@1\>'Y!%'HH93V0HD&]D73;LO7J0`;6]W4_ M%'I(/[(X]+@UFD\00#,:@7WN11Y'T--Z_A,._4>#-+4S^YN#>[D+M'W7%B% MC,QN[JU3]'N_R`O)V`Q73NMM.G,$Z8?/1-\'SC>S[V,+7#E#+R8(@L4GG_S$ M"MIEV<]\X(`S)7QBA6X[5;H""/JZ`HN1V2GTO9'3 MH#GDBZS.11?K+[;AR&F0[KEO!>UJ[/7<'3C=O)ZKN_IN.QX[#=(2`BMH[;@O M0=K28L>#_<3HT3<:.PV:EH!;"GSC+FA]HK_0/.=&PBYRNT!@P317FZW,HZLV M(\T?L).HXA/](ZY/6I\_,`%["/7S#'M&"F_% MC@7@(V/B=B)W.W(/I#8$^_\!``#__P,`4$L#!!0`!@`(````(0#QRU7,7@(` M`$X%```9````>&PO=V]R:W-H965T_N^?N MS.KNH#KR`L9*W9ZDGU3TA_?'V\6E%C'^XIWNH>2'L'2N_7[=ZN] M-L^V!7`$";TM:>O<4#!F10N*VT@/T..76AO%'2Y-P^Q@@%?C)M6Q-(YOF>*R MIX%0F&L8NJZE@`C76YZ>$O;UX)K;5^X]&5I]E#UAL;)-OP%;K9R]]JOPKW,Q> M[7X<&_#5D`IJONO<-[W_!+)I'78[1T/>5U$='\`*+"ABHC3W)*$[3`"O1$D_ M&5@0?ACO>UFYMJ2SVRB?Q[,$Y60+UCU*CZ1$[*S3ZE<0)2=4@*0G"-Y/D"2/ MLC2?+ZZ@L)#1:/"!.[Y>&;TG.#08TP[?V75?3H(1M/*2E. M.[JPV)Z7=1;G*_:"-14GS7W0X'72))."83932IC&94IO%_D)&&))+Y,GX[R.Q_@GAQ2;.+U-/%G^1#W*#!=D[VLKUZ,TW))C6\G M;H@<-,O1<8(_AOAORV&N0]L5F`8^0-=9(O3.SVR"&Z>WTW':I..)F#[@.`^\ M@2_<-+*WI(,:M\;1'`V;<"#"PNEA'*JM=CC(XV.+_RW`UL01BFNMW7GAC]ST M)US_!@``__\#`%!+`P04``8`"````"$`L/_L6*<#``!C#0``&0```'AL+W=O M\"`W#5%[#(38; MGK!'D>QS5FA#(EE&->A7.UZJ(UN>7$.74_F\+^\2D9=`L>89UV\5:1CDR?3K MMA"2KC.(^Y7T:7+DKA[.Z'.>2*'$1G>`+C)"SV.>1),(F!:SE$,$:'L@V68> M/I#IB@S#:#&K#/K#V4&=?`_43AP^2YY^XP4#MR%/F(&U$,\(_9KB$"R.SE8_ M51GX(8.4;>@^TS_%X0OCVYV&=`\@(@QLFKX],I6`HT#3Z0Z0*1$9"(#/(.=8 M&N`(?:W^'WBJ=_.P-^P,1G&/`#Q8,Z6?.%*&0;)76N1_#8C45(:D6Y/T0'T] M#]N-!V0PO,P2&455@(]4T\5,BD,`50-[JI)B#9(I,!\C,SJ:6/\7*L2()`_( M,@^AW"$*!?EY6?3CT2QZ`4^3&K,\QQ`;L3HB,!4@K]$(D9]J?-_UHQ0$HQ3, M`FI;FH&N445&D]C9U9[O=P?-O"4"S+E>!((AR98?XX;7Z#(8R'_KF8U8^1"6 MMOXMVA#L:IO8.R\-9FQ,BSN#GCV_T@7!7>\9@AU=Q,G5TF!\GOD0 MEK:AK0T+OP<'@[^X<)&KT:GBI<$TWG5=[YQYTM:%I6]DZ_/K0K"KJ\V)J3># M\7GG0UC:\%YS#HW+WN$B5Z/KG<$TWIUX4\6P]&M3:U[R5QKVS^9;`ENA<"G[_B#FVK<..].VM MES7(YZ`78NN[Z4(@YH"W],7N@5>#6NOZL?77.E5;:4A;?!.OK12/\),WY8*3 MYL"WE)+V.C*E2`S(ZZ0/8NN[Z>8@UUP=-:AQQK5ZY0'8VB#$&[Q#M/N"#)NL MU-X9D-<['\36Y]P@%W+[SM7A6K.$'A:#:+USDH]-[@E@U+%J-(Y'G^[:4]^( M-3VM:?ER)K=LQ;),!8G88[^*%WPSVO32#UWLGISQ)?;8.!XU$]#BEG3+OE.Y MY84*,K8!RK@S`@NE:9+-@Q9EU6BNA8;FMOJZ@Q\S#+HSZ"W"8".$/C[@!LW/ MH\4_````__\#`%!+`P04``8`"````"$`Y'96S1P&``#7&0``&````'AL+W=O M7QTVY;X[5*OQ9=>''AU]_N7]MVN=N M5U5]`!&.W2K<]?WI;KGLUKOJ4':+YE0=XKC?U#`#+7O05MM5^(G=%2()EP_W@T#_UM5KY_P>=+OF M];>VWOQ1'RM0&_*D,_#8-,\:^G6C_PM>7H[>_C)DX,\VV%3;\F7?_]6\_E[5 M3[L>TAW#C/3$[C8_/U?=&A2%,`L>ZTCK9@\$X&=PJ'5I@"+EC^'SM=[TNU4H MDD6<1H(!/'BLNOY+K4.&P?JEZYO#?PAB)A0&X28(?)H@C,T.(DP0^'P+PA>2 MQVDV@'FP5`USKB"T8%SA*A!M#2-4Y5RBBA-:^@XFA-+SS$&77?+NDF78XDG#LRT>TVLP M**,0<98(K^\4!,(SQ5ABHU":LYR"89=WZ4FOZG.#,5F.1*R\^BPH`OIQ9@N% MDM.=VUD96D,)Z;G=6QCV>T+2-PV#09)))/2.A!9K02$BC>U$*TTA!JEQEBGHNJ/TNAB6 M1(E@F=6?$IQE&@P[/DS>KD_?-0P&*%B,GU@,J4<0,HG8->UFV08;^X;TALX-!I,K)&Q8/'4+BF",1]?:RBSK8&/OD+8E M&.5<9U`1_//3Z@(2`B!)Y;-\8T!36Y.^;QB,6:\JBZTH`_?B!H!2N^`9[V_S M^-@SI,<@-QBD"*UL+)]!3%@5?)9E#&@JH--),;<&8[J*D$EJ:]XHB,:#B$QQ M;LN#*N@YQNT5R\=.$7LCYP9CDIMP)GSZ!8$D/!&175F4W2RKX-CEW787^U9A M,)>S9J3#,)U\T-!ND)$2DKD$FQZQDR5FX=OJCE'#)3: M>5<0VPYB1+R)(41U3YZ^4`8T/7HX!RY<*`;C$O2JH+@)H?0NV,C[VV8QMA'? MR'*#<6F.=+R-H40])YEV1A+C0TCB%5UN,%B7,HO\9-/G<63[*B4XRT[$V$X2 MWTX,!HDE$6=R='@C$`G'\U396J#T9OF)0"-P.V%BYVWJ$#%(#_J(BM*1=`0B M5`RW1N>M&*6G6_ODXX?0:-H)$]O'##W$(#T&)\M8,,]S"A/'8"3<',EK_1#N MS@G!:0UG>,LC:A-DB*)=X*WDE7.2B8.8*^[>N55`P``50L``!@```!X;"]W;W)K MXR7'%&K*PWPBW[Y&+^Q2B';F MNCPK28VYPUK20$O!NAH+N.TV+F\[@O.^4UVYON=%;HUI8RN'67>-!RL*FI%' MEFUKT@AETI$*"^#G)6WYWJW.KK&K\;>\R5K=@L:85%6^]J6W5V>SKIF$= M7EN[\YLZ]IUC'."N&`G:M`S\<\=:6\#^@/)3M^\MOB)=M][FC^C38$TH8ZR0JL&7N6TJ^Y_`LZNV>]G_H* M_.BLG!1X6XF?;/>%T$TIH-PAC$@.;):_/1*>0:)@X_BA=,I8!0#P;=543@U( M!+_VUQW-1;FP@\@)8R]`(+?6A(LG*BUM*]MRP>J_2H0&*V7B#R9P'4P0/"X) M41C=X!(,+G#=N_C.Q`_CY`H65XVKC^D1"[R<=VQGP=P#9"=^JZ@YE#4EV44SMT7J$,V2%(E\?O&"8JGGMZ^.K?PIP>)"W`' M0DCM=D+9:6%/;.M(&!WL^T&D2@)5/$@FNF(UIM`0(;A3Q/'PI!A"/GEN%.L/ M3I5DVH=G!G>Y3<.!89_B7%=3VK"3CF4FQ M`>?K3TZ5)+SX$EQNTW"FM^!(L8%CE"A5DLLXE]LT'*C]#?'T:@/(6)W20?/^ MI!H1Z&C&'C!>.:16[M/URWS+TD&C)E9X>6*-:W1`8POX#Z!:MC5`<^U'2C/, M_"@(8+$R\ET9&B_PDNE1HP/*1?GJN0_GG;/99NX`@V8<4/GL-1&POMN&U>VY[\/,.]0,-QC&4/*HBZ6G)/. M`:U+HFY;4D2Y,\'!^5`B2Q([%*EFD985G`_]8=Y@/@TP`P3S*'F4?I+Y_=>^ M5+&J2,E))P,,T!>+M6M?UE[7_UI[UY?_^NEVE'S,IOEP,O[CL\[ZQK,D&_>)?DL'0_2T62<_?'90Y8_^]>O_O-_^C+/9PGOCO,_/KN9 MS>Z^>/4J[]]DMVF^/KG+QCRYFDQOTQE_3J]?Y7?3+!WD-UDVNQV]VMS8>/WJ M-AV.GR7]R7P\8]S--XPS'P__-L_VW4_;FUO/OOHR'W[UY>RK@TE_?IN-9PGS M2`['L^'L(3D>NP&8]Y>O9E]]^4I-7?,WR?O)>':3TW20#:I/_S0?K2<;>ZUD M5!_%U5P\W-4G MT=EH?[OTC;-L.IR(V(/D()W57NZR'0/;DJ-1>EWMY<55.LIK[^S/IU,6DQP- M\SX+^CY+ITO[?]%N;^RUMSK5GH^UJ;;_:?)=-AJU?QA/[L=)+TMSV'.0'.?Y M/)M6WWIQ,JG^5.[H+Y/1?#Q+IP],;51_.S9]D2?GV=UD.D,XDMXLGW$R@PF_1_ M:"6]FW2:Y4F^=H_/3DX M/.D='B1ON^^Z)_N'2>^;P\.+7K+VH7>0/']9':X[OUY/MCHFK+6Y!(9*\SR; MU2:_G^8WIC#Z^D?VM_GP8SK*QO6&9]/L+AT.DB%Z[S9+9NFG^MYU^Z:I\F2: M]3,ZNAQEK62[3<3]+T$C)8#*_G%W-1TD:7J')\XWJPO;14-.T M/ROW6&T3)I9]0J/F;*O4WV1V`W?TO2PU+_T@N\J0M=5+NIC,D,+5';V;C*_; MLVQZFS0/M)_>#>EE^"-C0;R[.6V3?'(UNX<-DT'V,1M-[DQ-]"?Y+"](UD>A MST?(P"!);R51/Z8S-+G(^?QU:VMOI[77V;'U/N>?&YW6SNY>G3Q8FBFF0&31 M_MI(;HRU\626)5LU?CH>S]`:67\V9^UW4]?!TZ:UW6GM[?HY=3JMS9W:GI[: MUC13RE&[^5G@X]$PO1R.AK/A"OZ[2Q_$?%5:P)_3.<3D\70R@ODBIP3F6?;& MY60\%V_-)A#_:MC'%:@V=>L*G+)BEF$AIB/9S782V%P3T[R3M1-MS'9M8R++ M3F&:\;RVP$5N73&'@F57-#I+'\25>3*89[@=`[CVR3-UU,`;\I*Q8A@WZ14- MI+R',S<5;5D?K8#.Q@.#!Q+'Q#LU6KWX^:>??ZINDFG^F\F(M>0O3!R0C&4] MH%F\ALB=W7B^L8X7P2Y-$[0D1.ELM/`K]-\D=S8EG<]N)E,3]?$D_#B4O46& MQ6[+;8ZW4UJ]K^VQ*>\N9R.WF&9L6YS69# MG*B7R^RFO)/,%"\:]6@XQCP-6?K9)#W7.W=76K-9\A29_ M@D5X>G=C['.#[JYV4.'L@J,?:=@*[%2P^5/?<#+PU-9/%)/E$R\+T^.3;FK= M/.&FEJLF&SVYWD7WXO#]X0E>W.E1.XCFR4^W=;*\.S8>6$%`R]GU1/\ MKQR?KB:A^S@;2Y;/_5<%;=M%,<"AP1W/ME9K.'^\#S5H*2INVH M92*=#FZ'8XOX9L./-=MUGN7HDK[S1DM.475TIR[DDZR>@R?1U71RF_C6DW&- M"')UB`5FWJ^M#A8?^Y56G[\G2F.MZ3B;S/,E?7R-HDRP\\XUZ#]`M?Y-BOVJ M=N979OZ1=[/7_+@UZ^97=YGA36?:IX]#@1/F7/MW&UWTLR>W%-^X4:KS//0J M/V$/G&SAP[Q-\V'_22T/AB,\X!KB\%TVO+[A]W8*T))>9W*5%;-YP[I"R!J' M7C)*83(6!7*_V_LF.7IW^MW2(,LBI2N"F#PI\Q12@($8?FQT2$5#MQM5RG0' M?YWGWJ?!J21@FF!\$+%8_-$P$PMG`KLTA>3>#U\>,XE%?Q&'5>5A./Z('I556"X/9W,4 M/`3.97>>QH'A%;WQ).[[S&B[2M1(#^(]00/\Y_%U56EQY7S)U;283OI9-O"\ MC-+'+F33_C#/S"@KXD#2Y8W7&/H`=3,`6L1`XZ4O7<&:7\++Y"GS\;K*!"!9 M"P+P4B0P_K#(ZQ&0R.C0U+"%Z%X/QXH4M+H'+'UUVBO>9:G&,(:V5M_KS>_N M1B;XN.X#[/%HDL\%[S&.35PZFU4L!<*CC6\B)BHAPEW-U)Z,VS;UXX)/F*Z/ M)NK(XJ/\G-P/9S?!ZHF68[``[70CI-%93[X^/,&9?%>ER^GT.AU[Q*BEP#V? MC(:#PB`0`^3$2.X':%7$/]&KS%=$0"="*):/?G$SE"(4QB'?YX@T!]%R^UMS M4,3L?YNG4^%@["UR]CY]"`#FMH*,R7R$J5@OQ&#&'V&\OPU4S>VZ*'?MC[IK& MNR4JT!S6_O'W_]4[W/_'W__W2RWO9/(QN[UD-1V7,=E:3[JYX139[9T#\+#; MFC,O>2BE"Y[7Q^#OB5%)A0CH4]>]]G]K65-!H[9`"8V78!8)9.V"5H=T7DTF M,\W:?/6LESR;S MJ?YOGC][Z6@3!K1AF,MH/D!&M*"T<*Q:6FE.P&%:9\Q:&&FLA)M81>ZX'BR\ M,`:XSG,E.2!8DB97Z1`7-U!<[VOB2,Y\)"^$-OH[S`:'BG00-#DO-:@\-*)H M%\)00^8U'`\`*A05N2$F&`&\0@1`_G]?U`]C`9J/3'^N?UE)Z&VN)[WCKT^. MCX[WNR<727=___3#R<7QR=?)V>F[X_WCPU[U#;R+L*-G*`>#TU8$DI+XSQ_D M$/J3XJS'GZ=S$/K(J4L9?$$,()SV&;ZZ4S["H??&F=.!)1=,B!LYM8FE/2-^ M&(M!+5GE[`:)NRD;LIZE"5EFP9]B_\^,(UH&TD;[9KAJ M\*@\(+'8/WHDVOJ:=)T[VB/:<8*+XC15#OX[K<0:_!C7)#OH;`"L$=,^D+Q( M5\5?E>^?90(BI55JC%W8Z&XQ=\8?_.CN)V2C%I^AT;!(F;E-QY@BEC[DA*G*V^S8=D#3=>FE# M.(6@X:^&G[*!X]KMEPQHZ3F7",-\&%)WJ=01*@M8KRT3+^`:T`F^1YLE.6ZR MG+&U9V?[O6=X+9>CX;7Q@)OT$$L9)?9?-+IS&J+6,8GEW4`,&BNAB2H3,7(* M.!(4/9J&4)T?''^;YLQ8D!Q9_6P93A'$`1IZGL\!_<+T\FSZ$J&%6TMU+CAB*5HO;"E#DY2::.#AK2;A,`.;X/SN M>@KY"\,^AH%IPZ^W]")?G!]NX0T\'RTBR"TNJS0'3Z)DN16X53)I1#]L10X+ M3=APC'TZDH/[D-SYN'@0>Q1=22"E14(&)W1ZS?ZZB#Z,7!G3*6BI#F8*U4NO M"^T-4S<+A`$)NW+E?6N2U.3#6)AMJ9>&8&!D1KS68IZROECUT<,Z)2:2@)R0 MU.W+(AF0C.:HDKT1[>$]?TP'V& M_:0R\VDRGRDY7%L$`2@C,F/5!4`6S1A=,R2)"'<:"YH$BB\L!3S[+2"4!+*,&VWR.TA@LAJ8VK^3*5$G!U.@X MV$9;AFQZU8&;,!H9F004%D*G)M$VRR8[4^/UEZDND2EVR:K*/7HE:QQ<P>)5AMBT:],"7I]33S6LCD'R)%4$@8E M=ZB!V[2?P>@;9,/(FYE=703+(.T$(9,(9.6W2?@18>ZF`T#5EOB M>^F/AAD[/9;P,FD6Z=;,HI-2M&>KM4[JY`$*]/L[SG1DXE.+R=* M4D%[]#)RX9-;@?6,,&@0N?QPOY,L;]P(.T529OI-B)KAHLB_<1L)3N<8D-#E M7')K&XI%Q,&<$96T)U?X`^`09,.9"IM[,\&5&&0`X:9NYG?\3'#N&"%X#NI8 M]162SVQ\34>\U."3XCTF>(UMR@]^9\?QO.XM,H/_85C7;(K_QG+;*NHT=CES M/EW\;=\O-/\]/)H2TGYE)"DK"?-0A"2D<3/+!0]D]-)@P8HI$ M+K$$(>JT<6=6+(:.D@3_F'E`TWPIUCUVTXFMF(HLHJEXR3@5?KZB< MV5<^GE.);:BP7(Q"324!1HP>"$"U+F52&338%-PFLM4XV"W606@@F&/$CT3S MV>7,X*:I=XKB*Z3""&_NB1YNX+B<5[6GSA53!%]T#DCM,!"I+F=@P$*DD@*? M&'4UKTH(8W2)D*[A$EAB@`%B``>*H/M\36EW_&;5(D89 M"!)SAVX'8JW0+2@WNZP03Y!*?6'2M?=P"@+`+%E;,-&>6M+?*4]!DG(700!0 M@EW7^*2/2J__RV6`+(A2U(>QQ7P":^!7FGZJ^5O%-^E_]G#]^GTQ]0HX/?4__' M?2E@J>"'U^EL*;,\,?,LGD:&T+G#_":4K,VR_LT8&.;:A/B*I0VM--85^Z*T ME0Y#SPPI%2T!%]Y5-$L0HQ!Y2CEE0HV:]>+S1]>$0Z`M,#//;=8:1EX,;DY` M+]BJ,C=%=ZY.$`^W1G5LMNJO\\&U=;V`;+IL#L9#\+F),4702GK(NDREE*^` M1R93Z2]E#]!1+D0<$_.-AM2;6M!.C+*,QM*"^.##.VD-XE!4?$8\J+(I[XVA M#H+:HTXR:(K1\`H/N*)!XZ+U.Q[^P$K#B[&5:(F\PW"Q?9U(TB$RE%,RR90Z MDY8A8E7,9I5>_%L^':,,2/5`&E2V:J';`:-T`(T::`>#1=/;!EM)E\?!G=$B M.+$0TMP*,E.Z.%VL*=M^C*B\4_%&V1K<>N`-LH>I.N'PG'N*9B M#:^`]T0`BXOQ7N)2`B&9\-]CD_EAQDPD6RZ3_^^_\1'010.9Z2-719/B2-H$.^K]*>"@+$>2Z0=D:0 M=7)D02ZC^7<$IR\Q2Y7BG;B0^IXX=!*B0)[G.WO;K3SWA:^]P#F9+6*,)+$16W"PN]+C?4_3E/0C.O)$+`1UB;@@YPNS\ID8D0&T!^3*.0[!#W`NTN>=`:F) MS7=,7@Q0UI22&44R=8&CF)*$=+ M3(IR'BCI@V0_2`NXW<>9>;"D\J6+3DVO1RM2G#8\*Y>;R36W8RA5WW6A%2&Q M:V4.AXR&X>_,0SI*@0NJ%OC?%6]O]M7.BA[,7U(!_P):7AVGQYD'S*J4H"D9_M\2F.*MD3RNZ@OO2WDN M38U0UAP#BB7Z`9"7'3/,VQ1,$#)HBV`9^DCI"]TX:T;1CP5S8_D\!'8-"RR;L=C^`%D%[&IKJAKQ^M, M[91RMHQ7L"V^>C@X@B.BV>S']/=;%Y8E/9W^=5,G0Z?#CY9E<46.T1,$"=I8YW MX%1IHM('EF.4=[&"O=]I8C__=*R1:[QOOR*&]&S9LEH#>SLYKI+6WG,TH9K$ MZCODPO]M3C&`>3C25%)T*HISL*AQGZFV\F98H&)5%L[FTJ>LGYP#(XVYD924 M!">X4%]^9DNF1CA!+S(Q&-O%:97YSW M:UU^2G>4=YEW+!-S;_4","*R*Y>T+P,BPC>L]JE;:$(N"\D,N>SQM-6 MU%_EZ.?5'X`MJS\=R2[[H$7:"B>P`#50>T$1"93U$4P36((T!Z#!EQ!:612^ M,1L:?Z'-(R(V1^H"WSAV0;$(O95PNM&US51XT)A6ID#I>'>_CO/D,/Q[LP M'-Q%U6^65`%$<6$I(O'+8B[`+)3"*)_X_82'0_15BO?$FI)V&00A;$-R"O>" M=?V:G/@K5&9;),K'GN6LS/`JH>H M1W/'KF3FHEYZ;B`27JOE8\$BCRA)290KV-W>:'-N\O>&A"4E2.>IQF^(GCL-OL9*FJ:17A]*YC?!HMH918 MW6F88H6N+K@(6LSN9RFBHR';!(+6K>$*%%]9O:7&&J4<]E&'(M$FM6X9@\>NUJ M@JKI/*7@/+N=/(#A@):&!+SSG0_'^2AC M?M&FP&WG$^[MR8EQ6E;5]OUD^H/WFY47I\'SW1T[!PZ4V)E[`9)370>H*@!,B'HD/<:PC*29EP&5P'8K\(S$H)&=UNM-!XS8G^ZF MAMAS"1OQG"S$G:'T$UEK^(D?<"'(*=9):EM[;<\!Q*YVJ(VHZR66K; M(7VLNU!LG](^L;\K[FW8;I=@O^B=O[,R<8W6'8^3[A3?N)6\QR12V3:N;`\G MXOU)_=]NA[0SGKT]!<*J))TEBFP[BFP:RWP.*2LOKO4`^$Y4EUV_*\*=)EW8 MF3(WX0'4!:F0!!=0_6J6XQ*"P'//$^._)HS/`7?&'J8XGCO61-4(O3%28U/#\NG7GL`$S50`V_'69IX*8)51.5J*Z,@1[Q_I&.\P2UJR6`S&L9CL_[FA1#%WU>/V%*E MIE,K,&OY+8S-1U^G=&0X&7I8'UG! MST^YTF?A_5B6YT[].X?9O;)T3.=VBSQP:-`VM]32F'V$IHX0TIB#Y42,?I%! MTVI2S)V\8(,6C@14V^][!K&# MF-J7P#'V@^!82MEMJRV&TCXNW^9JYSUUTGYKW,Y`=\U'DBV&*C]F#@HT0ZX. M8B\LP7SN6`QAKOY2G;/;V?M_$8:55],V*M@QOK!^(K.6HY5J!7RYP&]3[O_S M3P7*[VI@T3SXOL'F``HJ8[B>?*A'/+!"W#+;$^FO4GY208I%$U)?5N'7)F@' MKRK`HX";576'*9[BMDO-'F`CGCW"V MP3C.36QA^LX7W-AJ;;_9<];WS1[_WHD6]XGZ:*EA)Q>XW>FXKO'&-[<[L>N2 M,5]IQ1?[EJYEU<&;<:9#UB(&MX3$&!?M03FX+4/^`K'C+26^5->FV"U=4@+` MM];[^K^DMW?_TN7@H91`C`GT1QF5\K/Q;L-BS'Q.E#:>D8,_=A=!=1TBI^TY MFU)`1/6]2WHLJ@D3_^-QPEV]+>X.'O>VSGPC.8 MKMPT1#]KOT.]#A)"-*YBL%K!KDN*2#<>@T4-IT+8?U<9=X$XAU/,131QI&HO MG*_RY.MPC::<#IR8._)7+N6A=*MV"#M!%C0L40D^L5E_;-S\8K.($1%"4`1GC&26U-J?8Q9OR3_7D=JB`TL``PIF4YK>,@N] M<>6N"7702>F,/?5C='>EI%Q/QW?=Z6078VT:)X-\C(8\3@=.:TB%T3>5+V15 M+.5M3QC'P!X$R66`<&1%QJOAE,`WG.*&2*69^`@1?_B2\TW@4<4@`THFQY38 M^+)Q'0REZGP4C3+SGI>![D)^&R2K*B`4$"P1D*TVEQ$&+T1VY3>O1#LN(:/) MV@5GG?N"/E]^H3.E@E!B10,YHP_C$E)V`:KRUEUTDGQG!8!`#K/DE,WA'3CR MG6J,]I6'AP-4&(MJ2CA!;0ZXWE8#0W?31'_N6_WFPAO)H9U!^YU,K<`J`=4P M@_G[\#TAC*Y3!GR!G^Z4C%`IOSA:.^A1IC*)YF42"7CR=\'0M8XQ@(0!PT02 M*1V,05XD48Q1>-L:2$0,Q'(5K@LO+%;'H1P\N*;I,7P)L).D:4(!"2O%(NPT MV6:'5Y"7CG">E(H;F52U`<%1.XA3/3"(8=>A]2:"N`-+_KBP0DL5^M+#X[J"0G=8@ M86^9,[=Z[C7&_R9$REWX%W6DJ?_([;:#O,:U0[`Y9Q(\.0>\/7THZHK#(0ZO M"RP_$O$0H@@9=(P:.3%;0@@.7C42`66>(R17C=QB,P!'03#%1;('1#O/ ME)>G-SQC3\XX?^"4TF$L\'KDTHG/ M'L4H*1ZYLY(.B,!^+^"O2IIQ_@&">'T32PEJ<$1O?HESR`7.U36](_7RA>KX M(PZ^L@*M^OH:D5!K>Z=V>WOMKC]9_[>3R0^N(JG:S3:5P:(&ZFD:O>"S7[[W!:X"/T2YR! MLO.0X4]S*EY!OY/.FS>[22"!:Y\5K;6JEK\0R/E(-E]_SM+-F*'#@D(]2)S` M1:A.=R7_![$R8`V>MZ#%ML166QN,&Y"SW3!2Y3Z,ZN6??'K***?OZ:RD"N$IWX M;$YXU2;U?&M])SR6[I)\<][$++=J7$()/-MKYZK,5XDI4'Y]OEGJ0)30BA18 M6WBH!IW8OYU^"ISBIV&^%N,8W&[P2COIO-YN[6[OA/N[/&LM>\&GG6-=7Q>[ M/4I("]DB$EUE)N92Q91EEERWFL;SU^L;N^O)D3MV`!VEZ*CU,R]!ZXC4#\XW M=GR,[V%Q):%M&\-)J92./2@]H=H<6&99V:I47?B*`T%1H2%:\*E]5@?901B MW(-H3Q^[U.QSQST$-)BX5TN(3)CBL/(=@%QR^YK*/57(HL\RK!DX0=2F#B`./?T3,Y/["D0-EF# M]9AK0,Q]M:I"TK*&=1ZCQK"PD/$,Q7>&O$A'66HW'-X-E+Z[73!4:$P$6V3IT)5Z)AX6UW M@G!K@[4\$+CZ\Z4()$2RN%LT#8$19D(QI-W/DI+96O"HN&K1((G2S3LNZ8HP MB:>PP`L:RN:!!A/*ITU+7R:=37?TN23RHL?E2VL[Y=M80ENMM191WNY&K>5N MERAME%N7L4BQK)J#Z=T7&B19$I7-84>JBL;N!4@/PQ30&5@BIAYG?RA4P'1)7JU4+#HE"-T5LT MW6!ZU6E0=;MLT;%F(D@[/*N3+ZOUZEJ#8J6:-$M%\]6+I7EXE!=#H.LN[*(R5>J[3(W#:[66$@$P#"7? M)V#:U0D#__6^Z9X??G/Z[N#PO/?"X**+[ZO-A`NQCD=`H2=V=N#ORJX.(N+5 M_3E#1ML(2-9"GG:`V+IN6(E%KEH,IQ=QH^D7LH47/&&*7*%5C[NC``3 M/A%%PS68B20QU6&-WQ$D=G$E-@)$B/%KE6N)1MJSYJI*-C1/-7/(R=0EK;EGT).Y[J>FG8VS+$Z=8Q"R4"^ M>?/:F8`&GO!Y4!?HB.E-OX?:.COL0E+8O0[<\]J[S:6QG=_XK/0+-S"Z6-TG MJ)%:(2"8`/.FS<$HS,B"V8BU:LHC3I6.EI,9<`NS=N_MX`QS>>-FU3AAJ7&< M=:NY"TQ:=VW=D2Z[M\1<8(8K0(;2@J1V-C5M_=6]CAZR\^$('T@[1/=Y^ M;?Q5@AL6]!L.9OP2A@7R1"0J*)+YU<><8E'=1*GQ4<%6P'L6_8YV*]9-0F*:A=AVK4' M:QT7155?V%?8.J#?V4Y"RUDI]_6M7T M`HDIU5;ZP&OB0K-R&OB2:#8Y[IV:-CGYEG_$1H%Y2H7$CU0^*C-.C9@\8P"^ M&8P),K"[QT1IJ(X]2VY_1_:O3Y2A6RY+KCQQAVB MIG*5FP#BD?_"R:0N;1XNG)=_;V^N4,39;NH1_: M7.DJYQ<+H+Y"!YWUK=>TD#:/G80[(W;6_2&IFJR>D+DH%$I%52T^9'>?I*Y$ MF4^JK4YU/IP*R)O.9%8^(V('@9Y3N5K=Q>"V/?&:,DQV@`YKHL:;9Z M"[I*12Q$:M5-\BU*>K#:XMWDOOK3-^2TJ[]!="L.J_X>F"8)QNOI)J?VZNK% MDJH\/WS'%S`/J%%0L0CU"B<]2A:.3T]ZU6F=^\\EG!FJ[#"?"G]_&T"=IF=NCW+\,ICA'7-D?` MF:$%`ZD;R8/\[ZC7R+"9$O\.H"'_K^J8JM%XL;B^NZ-UR]MW"CJLYY^Z%E4_ MG3V6PFPEBT"ZQ"PL2[7_8&W;S5E,Z3`'67N<'GOFOEN_$*$([=>H#W$6I_`+L/P`#83S=YB&(KLH.Z%::P.("B2B$>W?L]J<_4.5^9C(6+'5 MAY-]"J^ZQ^3$Z]_VP6>49Z^28<'37>SM!WZQ2Q";OIU^HAJ@7S#.N2^/Q#@4 MX^':ZSN9AEH?RP-P57>XKV)!$PY=ZBHEC-[>V?J#^0/;FW\0VPH#=\V"4G_$ M#Y/.%MGJIT3D@83[6ZNCXNHD:RE@$S,BW^V*0L7_?TKOD-`%B=4E_DK,QKXH MG7GC)KUC<_ZL^8H-#&,T>[(X1WT:PL_%4T>I\E\^SS#-W0IIG^KE;M5I9OO#OA$LI6J[]J;=IXD0>F\31;F%75[J^BNY[AM4H] M,REFYGFRT_E5,WS2S.HTYN2$JV6/Z+'FMWC7'VG2N>J'@].(5O0W4ZLM=[U; M5"\2]?WM?GRK8CC0!SM.4<%%K3RZV*Y$+#X$HV)N.RX),X+H2'>' M:UMA7G]A#!)KGTFQ*V),DLD%N&^E4,5:(->:QSCSE6!Z1Y.+MXI2U-!\QXPT M^FWZ5VY"I^Y7`>79MHG]/+XO40SBWI[R0C$0SHUR#D6Z(4&L0,S[H",3QAX*R].-06? M=,/=H6'4,6D9&UF5RJ4=0,Q$%B'_ZME08E\>;4E'18W.-''W[#T>M@5:\;*B ML'L8D'@1,$LOUF:;("+DPQ_->7=YG24K18#UY2^7$V)&5KNO#(,V)4[+]C4< MEW??VD&5R]^M:9,W^G[EZ=?GW;-OCO?Q$<].SU7A574)O\YTQ^D=ITC(95B] M6/W+FF;!GM@?`J8R;UUZ5TP;CKXNQH&Q\`\6RGOL!3.G[.,"&[**^"96+E+B M,RU8]4QWLF;UG%%Q@%N5474$YD1WMG.E*YF[?EJEZ>%<-=G57[OY ML-:R1S2UM!M=7'#X_NS=Z?>'A\E;OD5Z=$PA\KON2;7G?:DE_^EE=A'<`*5B MEWD]ENI[\A!LJWU!C1H2RHFV-SIK?WYIR1_S,]AQ'4%R1Q,C6NE<7<30OMH' MF$.E%E8`(8F:"YP'`1[)8>YL.'LC;1"Z<-44JL07CNINM=&7C,8+)6^X&W"- M$^#PIMG#0!,[8,#W\ESFS"K[-:)-RVX[YLO7;650JM-S"GUQPKQH6DBAM[_U M!VKSZ_.]-V!4VR;VSW=?M[8ZNS%X_D5^E@\5.-F[L>D/$%/`NKN[&;O]A:=\ MJ_S3`5CK?7C;XXP!CG!R^!?^MQ8[4JSO+L.:)8?N'JQ'0L8G]0K4CY^:T:$-W!':`=:!A!<[KZ)BJVA`&/$MU$YY8=;?PVC M<)1Y3@0CT'L?M33CJ!\@A4XQO=W?V=[9W7M#V098K6'H]U,.>.BN6CQ?I%JZ M&KMC'VF8C\V,66)@D-X"9^,T>Z](2Y,A_+&,P>OC@*+UFB\`HASJ&%B]3 MM-&IRI!MU/;+IJIJST8'\&7#([KIUUZ=BI,-M5(-`=+W<UUX]:[RGN8174!(8+SJN2J@_[BV6 M*MWAA35490.,CD->H/35E[59GW=W2K6'K66'D3A_^X35QO-"U7X;3M@L[;%2 MD%_M:DG1RM+N#NJ5)09G5/OMV<6GL6;)59LZ;-:=#',ZIW9K<43M'H=1JT,N M\;26+J710:IV^A3.#31I`R.Y0V6FQ%0U9,>]:CQ]&,&V5LI"3O2]5;EC2^?= M*X+<\"D>^55!IR:QA^KPX!_QO!\'#73'GYD1F3QI^D=O)URAICQK+YWT`L-' M?=5RGQVI3O3=H_?C4],5IU]]NU'I/3:_I>K-O]@^"`5U2Y=(??A[7.\;JB*; M(II2)5O2Z;S:V'NE>+HZ^7*KS5>=737:7M5HY]7&FT<;Q?$V5W75V7RUN:V^ M5K;:8$2;ULJYLSQUU[#"1RE]ZA-AIT5B;BG-ZZDHO$R7R_/G[*L++N6DK*F8 MWSS06A%`2!2U0XXIFAQ+3"91PU2'*$V\^HA\5BA?Z9U6'S8MICB7OF0]KIIA M53%#:3JD,N.%"4O7C=EPE[)PG0,EWV)H6%LG,*H37NA9+N'C?7(LTG7)?9Y- M79:VISI:G-=6[*-Y6HM9]3J=7WB32$@<>GK=.)G8,(Y([J9IUB]>!Y*Y#@%A M&]O]$MYW+H)+&LL77"H+@5^Y`]$5]*S(?W.1@TOB3@HAJ]%[VR_*GWO)DS>- MBZJ-FRUDN).GC%7KXRES]^.(*+6Y!QZ._+;[Z^:^8JS%FH[3<6TRGJ?#X2XB MY>IT*RV$AE>;1.Z/*UK"BXO3N;B?U'H*'VHJV)]_-;)U:/DFR,EF,PM4QM3U MC;51PXYLA[Z`;QH'#0TCVVTV-UP<]`CXH#9FX."].&:SQHC$C8+>/.12^8T^ MUU+I-*?7'=9#2X;B$U^Z59TXX6@L@<+SKYDF&2#Y?%9#57WYQ>-E5]57@G/C M"JJJ3\^65%55VQVJM$K?)4R*VJIJF_/F^JIJ,^M*/:E:I_JP,*)XZ<*BP"[S M\A'2Z@LR"()!7>'HRJ9!$;6?H$1+^[A"C;[7Y^$Y&OIO[ZU4Z]^KDUN4_9J- MK3PV>.KIRWGOSZ4N&WQEV4FR]CA;O]7YN,P=_JNN[`DY^?(0U=>/%]+O/:7? MJTT4J;D$-AAR*8F/0Z>_@`&K;^R3>=2]1TFW^N3Q[/`3>GU;[36.MU]]HKG; MHI+_B+KVNIGR%16W;EF9%RNRP#`T0VA82#^8;G9,QQEU@OY]V5<)^*3^BU+!/ M:7`0A&PO>SL\G7]W;/G:E_L<.<$_EP?O.WKFNVO@K7C/\SUO]Z9%U-=VT66O[;< MP+?G^HN]T[^[^?6OKG?1BVM_?K3M2`,1_FZN/T;1]JK7VZT>;<_:O0VVM@_? M;(+0LR+X&#[T=MO0MM8[W,ES>\-^_[+G68ZOQQ*NO)6($,\*G_;;BU7@;:W( MN7=<)WIALG3-6UU]>/"#T+IW`>KSP+!6J6SVH2#>K,>2+JY]O>>Z44[;17L_6BN#[--6OS-A_5>T23VC1% M&)Q-(]Q";?+`)`LW'K?)^JG$)D[7N%[7*?QQNI@5Q^V2IJL8%P4.3]&5^8KH M"1_NY[II0@T9]/M(*W581\IFRS[H.YNRR_'9+!N9(W,BU3(N%HM^0X4C4R:5 M-0K-=Y/W9Z-3OK(JZY(R?*X,P(23RZ(#J7LDOR)8QC(O M+XUWCF?OM$_V5^V'P+-\Y)6.:>S7W)"\)^Z1+YTZ7[YTFC,RI3."=L"EJQ%2X;(Y>6MN;QE>@DR41050DUS.>E`Z.UBMI2/=#F;R18Z-.%/ MLM!W8_R3+-2$?TMIG"9%TI`%,I.G10Y.J?IO)[/9;#JXG$ZG,V,T,`Q&\GT2 MT8Z_MI]MG&5)HZF(8`P(9J/I['((0/K&E*DZ*X(1`)B,Q]/Q8#8TX#\KR]TC MD,WI6%?M58)`D5<)`D5>95U]3T+E3S(%%C@4YRI!H,BK!($BKTXD5^")).M@C31Q6:-,$^]#\(U'.%)#UL,IC!'C+?=7+OV M)@(30N?A$5^C8(L&!5$$QT-NKM>.]1#XE@MO>^D>Z>N1/>&($1PO7;V7M&Z3'=I7`*-R&V] MX81#/U.2A$.^*-9#+R3N$]R#N9IY6G`'B(DT)`3WD&%COD`L:B/90\Q&LH.@ MC60/41LA=SA8.6A@TUSVN_'BW&B>HX+),!+(J8-6E: MH0=>V:[[&;O2OV^R1AC6EF^NGS?D1!LX^PG/1,'S>/`M',!)WL9-;_P!=%7M M!.?15.RD6=NM^_)I[]W;HB_D^ M#")[%;%3MMAQQ"H\HPH\@T20")Y3]!L5^H$G83Y.T0^KKZ7^`%Z4ZH?@$M8O M,Q[PY+0DJ,$%-*B/X9&)`-;84@3@!!4(\&2ZA`,(3Q4(8.TB10`!FB,`.$>B MXI0\&)!J!C&0JP3]7:F$&I-:R:GLT,JJ\@OZCUAI MX$9(11@`CY*LR/L$.#*A'(*J"DFB8:BJ1%(,JFID'@U#52620%!5(:DG5)5( MBD%5C22N4%4B"01@1$F%I)Y052(I!E4U,G?%2%6))!!454CBB5'');)'ETWC M152R?CH=M5H_U9XWM0NI@ZI)$_@]W3V>/<4S1_`%FTN1J31>OFBE:Z?:8Q`Z M/\,D$R]C7,%BJAWJ>-EKY*SHEJ^AM;VSGV$J&A]\?=X%SD05[^T?(12A'!;*6N M^FF_BYS-2[/Z(9Q$E>ER0L$80.?SNNC`*;-41*>P(QL+#19V_@$=LQN//'`9 M33E5N"3)UWL^F!?)2F@Z<%=&5NUH())9<),%.6@H>UFJG>#>:OYD(9;#'_3$ M4KQY`E6563F`H5@*.-G.[1YQ%W36)&ZWB=I6.75=.A5I&_FCPP6J8\%ELD-* MG54Q'LL`EJW$P<@KL:37I3%=!ZZ\W>7'`9X_8'1A&NF->-]TH0\A57 M3N)3!D\=MCH>5;.)=>M,.@ZP^4!0.=K*9+6#:0>%=SJKQP&^3E9?4;)CJ4G7 MH>DTBH<("^;\<"K":[=5BAYO$3_4)();**_2>I]WMNF6VOH`U*:,XUNA1?=* M3$VT_1\L:K>K+<0CE3D`O^%3@%\RJ'00173B$`<0\AZA+9Y&`4/6^4?<\%77 MH?#S0N%*4`NNJDNM`2>2]BTA2_3O62AN@Y>KM30FE`R^XCU#)6XN7`J9U#Q: MA+)?'#<@2D<(6H\.XJ.;.:ZD%"R`:TZJ<-5H$]*48MG'>FLIK&JZ:J98S2D4 MBDO14:D2M9)L$D5-'$U7!&JHY@=W?F@0(K5--UB-[Q4L"C4!USQ0SY;KE:-7 M1QT-K4VM!@".]^.9ICYH.7RO+6AKP/T2@[;0NB@)`=JC`*+3YR@T:=H4TDI` M>%'KW%Z%[-:&'UBL^25DYOPZCT]9?: M1K.B^9&>I.(I4#DEXR*L4->:%V>A+DTTS"I1O_5KO0 MWJVP$F7G96*)N=\[+MP,&`\DXM53*SCY.O`6\<;D>I=CLK*S*H>8DD06Q'I3 M62`A'FZ'$&94%K3A366!^EC6"*PELN#F3HUE9:L3\#`/3A8,%4UQ9:/+B.=^ M+,B]4>9'=F4PX1Y,%L%%9>5^Q")%9(')367E?@3'45E@H+`BWIK(R/QK@.")K+,C]9:D?^5C%R_A$<%%9N1_Y6!T)QBJ5E?N1 MCU4TN2FNW(\@E?!EP!=-9>5^Y.N$(5@GJ(VY'WGNQX+<'U94/N*'@A$?2\E] M!^\(1[CZ),)1+"7W&A_E(\$HCZ7D_N+CVQ",[UA*[BF01RPRX`MQBS(?C7AV M#4%V%]8Z'0WX@,%Q1@0&/+YRM7?AL:(!/I247::*EV,0@_"F!$*2'NW5D[:$ MNPYF@OA\P&%41-#M\]:U?"L*PA<-+TW-Q/%.'PN*^V,09!SQ$H;P4030G^`1 MKO!T6`UX209QCB`\Z-Y$3)8+/#TX)6\B!O:.T?#QAPUN$S&P=RR&+ZK8/XF( M^>!O]YF'^%J*0[>(B(^._V2O^I^#Z@XB0.R>"^VJG M2V/MW>@N^W*NY^__S.Y8#\&4_.I[YTL0,1%S/7__$1\%`%D, M)U)"N?FX@]O+PZNV#YVY_I_;Q63V_M8<7DS[B^F%,;+'%[/QXOW%V%@NWK\W M9_UA?_E?H`R?"'T%CQ0^X8G+[,G0:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN' MK0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X? MTSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6* M]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@>WLRH3Y!0TW2 MV\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;: M7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IE ML40-R#[6E_`;U69]>\W!&Y#%-Y;P]?O/R\1?E>%G$ M__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B6^0('?`( M=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$ M8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S M"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",G MD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L>FT1.[P:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[^`''*]U]EQ+' MW:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YL MM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F& M*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$ M:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8 MI#[2>B_[J&:+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H M":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/ M994FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY M[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U% M1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8 M_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE; M+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@ M8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:&PO=V]R:W-H965T(LM0R+?PR&*@E.6"7IH6*LMB60UT5"_ MJGBG!K:&OH>N(?+AT-U0T71`L>I5S4&#:CB0K4GP7)KLI]M>KOC^_.3NJLV>D M*G'\)'G^E;<,F@TV&0/V0CP8Z)?<;$&R?Y5]WQOP7:*<%>10ZQ_B^)GQLM+@ M]@P$&5U)_IPQ1:&A0.-%,\-$10T%P"]JN#D9T!#RU/\?>:ZK%$_FWBP.)B'` MT9XI?<\-)4;TH+1H_EA0>**R)-&)!#).)"&\;C$+9_.W67Q;42\P(YJL5U(< M$1P:>*?JB#F"80+,@S);QZCU?U)!HR&Y,RPIAM,.*A38\[B>1L'*?X2>TA-F M4;L"E_>._&;D16 M21@O+[1LW?@TFKE596[\*G_GQL_S'1$35X0Q9P*']W4Q)BG%4\>+BZYM+`;\ M?O'+5;!]$Y&]B=B]AG!T0K'G9KU/ITF"?IQKB")7Q<9BEKV/T2*(%FY\Z\1G M<7R1GYW'%\MX,77S8>:8&BQ_/)^$\1BW^NQ$L1>N8;)D6U;7"E%Q,--B`G6- MN^,@NXO,.;S8WX0)W([K_0P&7[_OCPDP>#I2LF]$EKQ5J&8%O"KP8G!;VM%E M%UIT_?7?"PTCIW^LX`O#X-X%'H`+(?2P,+=K_&:M_P(``/__`P!02P,$%``& M``@````A`*)C))DD`P``"0H``!D```!X;"]W;W)K&ULE%9=;YLP%'V?M/^`>"]@0CZ(DE0-5;=*FS1-^WAVP`2K@)'M-.V_W[4= M2$P6FKPDP#T^/O=+^[>J=%X)%Y352Q=Y@>N0.F49K;=+]_>OI[N9ZPB) MZPR7K"9+]YT(]W[U^=-BS_B+*`B1#C#48ND64C9SWQ=I02HL/-:0&B(YXQ66 M\,JWOF@XP9D>5)5^&`03O\*T=@W#G%_#P?*.%8,:6L!`'PZU14+0UP!+_I_SW-9+%T1Q-O/`U&".#. MA@CY1!6EZZ0[(5GUUX!T1AU)>"`9@?I#'*:;C=%X\C&+;Q3I!!^QQ*L%9WL' M5@W,*1JLUB":`W.;F='1Y7HI5I@?,VF!@ M2W089".2%J%*`?(ZC9!Y7^,(:OA_]UM):E!?TLR><&TP82LX#NQX8L>C<-S% M+7W@VZF^85T*#/4_L2%"<<>K[5P;3*QUQ=%D9(>3T_!L'!S#EJKH%E4*;*L* MXXD][=I@8,%V!8QL1#*$L+0!R?6.*;"M[=PQ@YF:2D:S?B'M,+K@V.0650IL MJPKC_I(W&)C\HF-#",NQZ2W:%-C6=NZ8P1C'PLFL7TH[/+W@F&IP)Z?'\,I7 M8%M5&/=WI,$,.3:$L!R+;]&FP+:V<\<,YN!8>&*)WK3):1A%Z+A[+%4(#J[K M+=-H6U<8]T^+`VC(M$&(K:_7$(9+"DWW8]\.('.&PO=V]R:W-H965T&ULE)==;YLP%(;O)^T_(.X;,/EJHI"J4'6KM$G3/J\=KN]<\[?^^&%U9/Q9[`F1#C@4(G3W4I9+SQ/)GN18C%A)"GBR M93S'$B[YSA,E)SBM7LHS+_#]F9=C6KC:8+#MEB;D@26'G!12FW"280G\ M8D]+<7++DR%V.>;/A_(F87D)%AN:4?E6F;I.GBR?=@7C>)/!N%_1!"NM5E:#?E!Q% MZ[+-#Y*11)(49LYUU(QL&'M6KS[!+1^"B$J@@HB_ MIS#W@8KB-6':OT\A'ZMI^\:=E&SQ(9/?V?$SH;N]A$A32(/*QC)]>R`B@6F` M6*-@JEP3EH$%?#HY5>L)THA?-1U-Y3YTQ[/1=.Z/$"M#/V^P]8.JX'+PC*+$%=BXL70):T@Z,K"J)NY(>ML4U;$ILL9UM M-9N6&&Q6G<1=R=G$J`($!]KPQ%5JB\XJP*C6&'A6L<07-'U\:N<=/+%([]/M M'01991C5FO?YM$];T\=WU0F`](YN\-GE6FO:L0.[7B]H^OC43CT\?TIMSF]@ MERS2&H//JI[X@J:/SSH@5*U($5GE&Z+V3H"JDN);,J^T'S<:3 MX-;OXX3Q7I%'I;;R>#;65:SZ.=`8>;3+^(+F;&/6\56'!C2\';Y.'7.Z.=87DI55;[AA$IK:ZN<>_OD0Z+7\$8BWC,G3A>KDFO]2ZW\` M``#__P,`4$L#!!0`!@`(````(0"_/QK&O`(``,\(```9````>&PO=V]R:W-H M965TJA(]"VVDJE>83B*,1,U5 M)NOM"O_Z^7#U"2-C69VQ4M5BA5^%P3?KCQ^6>Z6?3"&$1 MB(J9B6I$#4]RI2MF8:BWQ#1:L,Q/JDH21]$UJ9BL<6!8Z#$<*L\E%_>*[RI1 MVT"B1&0Z)`,XGGCHFK$A8`OZB2;FM`(NS%7_%Y/XW1)GB%!WF+N`B;V M3V>33O:(!P@R?O"LTN$';@O3)/YB7+`0-&Z5&8=HF<9(.,M.W!?>7J: M=8",L'Q]B;`#]X4'60?(".'D$F$'[@O3).F2#%4.F!%9N\Y_]%Z=W]<.W%<> M9!T@<[^]WGB5TDLD';@O.4@Y0,Y*4NBDXVUZ=%\4&L-)PBUH1,3TI'>=S]BC M^^*#D%O,>]RFR_@L``/__`P!02P,$ M%``&``@````A`"*'A/`,!@``41D``!D```!X;"]W;W)K&ULK)E;??YZ.A:^^%$&IA?+6L$_>^$N.+\TM-6R M_:FF%>+$/>_<8WCV&]HW/]8^W__[S]U[&+W&!]]/"J1PCAO:(4DN3JD4>P?_ MY,;%\.*?Z3_[,#JY"7V-7DKQ)?+=79IT.I:,1^1.;O3Z=OGDA:<+23P'QR#YEHIJA9/G M]%[.8>0^'ZG?7W73]81V^@7D3X$7A7&X3XHD5^(-Q3[72_42*=W?[0+J`1OV M0N3O&]J#[FQK6NG^+AV?=>"_QU?7A?@0OG>B8#<,SCX--DT3FX#G,'QEH;T= M0Y1<@NQV.@'3J+#S]^[;,9F'[UT_>#DD--L6=8CUR]E]:_FQ1P-*,D7#8DI> M>*0&T-_"*6#.H`%QOZ:?[\$N.32TBJD5GOTX:0=,2BMX;W$2GC;\GWHFP9,K M63)]9LFUHE4M5W0J]5$-.].@3]&`FS6K63Q]9O'58E4OURM5JGFCK3H-+>\I M&^.L-\6:99EVC:5^L,NZ'#"ZR&3,WY"A0>:MH8L_:`TUG,O0Q1^TAFX&7(8N MI(Q1LW3+9E-Y:UCK(I4NLE2[J)OE_TLTC"R17?S^"!C"@^Q"-OVCTUKBJR%= M7"TW<>_OHO"]0#6`R#8T&E992 M3/>&+_<50[\K?:$%[64Q38Q1(AY%!%N]3+:E@B<5M%7044%7!3T5]%4P4,%0 M!2,5C%4P4<%4!3,5S%6P4,%2!2L5K%6P4<'V"I3(!-()Y,Z_X00FPYP@YK#) M@5E-76'JU7HY[XM'&2!26D">@+2!=(!T@?2`]($,@`R!C(",@4R`3(',@,R! M+(`L@:R`K(%L@&RO2@+2!=(!T@?2`]($,@`R!C(",@4R`3(',@,R!+(`L@:R`K(%L@&RO2DYQ#:#?U`X<4V0XT.03>:S/DN^X?[-\K M]*C@VPHFDOI#S&N3$Y.IB)V&4;>4&X8,$FDM3F@')L@3D+;,NI:V\](=&22$ MNB#4`]*76=?2U;ST0`8)Z2$(C8",9=:U="TO/9%!0GH*0C,@@M`*R%IF?9?6:\K"W\@@(;V]%LJYC5ZJ`32XN3:0T#:G-325]G4PAT@7E#U@#($+)&0,:0-0$RA:P9D#ED+8`L M(6L%9`U9&R#;ZZS<)-.;\"],,HO.3S(G])8C_/3(2;7VL[UI"U*>@+0EN?9R M);],.CS(-'DELZ9L@KM21+2M!Z0OR8U"@UPAPZXIFZFA%!&%1D#&DMPH-,D7 M,JI*CZ=21!2:`9E+$S5#=MI3]; M*4*%)!I9+;4 ME4YWI8@8W1Z0OB0W"@URA0Q;=E$U0S2HK$T0GKLQ.W#SXX(5O['149_7)[4.Z,U)XDTYTTW-0E1L.O3I2SU1><>B- M`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`(012".`1)"(8A2$.0A2`/P2@$10C& M(9B$8!J"60CF(5B$8!F"50C6(=B$8!N"70BZA_3:Q'0/R3P0)*^+['61OFXY M?^]$D@==BA3_&[I4890N[6[>:M"\VFNT6;NZN0PT>#"P+GV0`4@$$H,D($.0 M%"0#R4%&(`7(&&0",@69@5SIS7OB9OC4WY]-KT37H'$WO(?9`!2`02@R0@ M0Y`4)`/)048@!<@89`(R!9F!S$$6($N0%<@:9`.R!=F!=+M$+LTVAUVFM8^R``D`HE!$I`A M2`J2@>0@(Y`"9`PR`9F"S$#F(`N0)<@*9`VR`=F"[$"Z72*79IO#;H]6S&N7 MB>UZF?5T*W=>GFZKZQSV>E19[^5I=^E6DZ9H$9E[:M1DY;<-9;4&-X.'8SLD?1!!B`12`R2@`Q!4I`, M)`<9@10@8Y`)R!1D!C('68`L058@:Y`-R!9D!]+M$MT2]8B8URX3*^7DO8Q$ M-*('3XU2]#A!CGZT84J M3[Y^?;S__?9)3G!24*B8KAMR#ZZK1RJ(KTA-&OYL7?CB?:8-ZT^4++L'N M#^`2@<2:-)O[=FNMF_K5]640)X'7$"0]$->?M>M`/)EI['+?V.7%99#*_!#$ M]O<(I#B0(PV-34/ZJ*YNVHVP4C4YA)&FO$2JQ9P3,KDW]U-ID*Q?JE)NLU9O M!\7%G^+SB,W$6UQSXB*APZTO;86)F#K=>;]9M0@P:IN7P='VC$5YV-(I.%D.Z!01Q0;9H=N^;%PV&\&(2^@W)$H= M.M+;F6W09OHR:"QW85QJ=:>5CK]P5D<:&]O&]!!N7E_>U(+F)BX0,JL*EN7, M_JV)5=5GPH1K=!C:S9N@VM@S3M[0#IQ:H4H&=(J(8H//^1F5_A9?0 M:DB4$F6,E=-J1%08U)9*U+&4FUNJUH&LF7G`_9ZK,=2QGBZ>? M?W7U6[J44L\AA*-4H_(MF;$JH3[1@"@BBHD2HB%12I01Y40CHH)H3#0AFA+- MB.9$"Z(ET8IH3;0AVA+MB&0Q%;F5Y52R7@6KR+@LJM+7S[FO654,*VOV%Y<, MNG;FG5`T$B&ZD55OX@+Q8&7/1'WU&(WHO*3@`5%$%!,E1$.BE"@CRHE&1`71 MF&A"-"6:$L$ MN>H:F2?7_F"9U5S#1[NK(.[NMR%L;T_ M(BH<.M+8V#:F;[3:4C-I!7T[<8&D.3^SJFYV0F9UF9O_6^7@?Q2^'&G08E5?M ML&9B+,I#&4Y70<<-Z!01Q08=AG*MW:J%E=6$?D.BU*$C.A'.QW[L(< M$DY4&-26*?7(#;AU;.]OP*\OK^NMH-0[L2;[TZ0WE.MA^?/O)9Q5T7U@J9G( M#%O:]Z`PT#-6Y5%N4%/_E8QZAGE`JX@H-DA&F>W3A%9#HI0H8ZR<5B.BPJ"V MS`NEPPX&X-A:W>Q35J_+Q'8=C(>)%]S/F2JXE4^_8<[>5C.1JQYUABV?E@TJ MW5[VB/I$`Z*(*"9*B(9$*5%&E!.-B`JB,=&$:$HT(YH3+8B61"NB-=&&:$NT M(Y*'?'6Z2[GMWE:PBH1W*S(N#_HRGI]S7[.J2EC6[/&+0?6W+Z$V-0H>/PM& M3<\XBI4]"?2)!D0144R4$`V)4J*,*"<:$15$8Z()T91H1C0G6A`MB59$:Z(- MT99H1R1R/:3;)E+D2E:1<)$K[2I2+@^FE^U\N:J"X`ERU?5#[U1Z*"FZB:#> M#";FGESM*)V7!F6?:$`4$<5$"=&0*"7*B'*B$5%!-"::$$V)9D1SH@71DFA% MM";:$&V)=D0B5R12Y$I6D7"1*^TJ4BYR+=OY2H$& MM(J(8J*$:$B4$F5$.=&(J"`:$TV(ID0SHCG1@FA)M"):$VV(MD0[(I$KLB9R M):M(N,B5=A4I%[F6[7RYJI+P"7+5%61/KAJ5YO2>^IOJ4)M``UI%1#%10C0D M2HDRHIQH1%00C8DF1%.B&=&<:$&T)%H1K8DV1%NB'9%H$UD3;9)5)%RT2;N* ME(LVRW:^-E6U^01MZN*TITV-KD3^A_)$O14^KZ;^GE_D*E;VVKM/-""*B&*B MA&A(E!)E1#G1B*@@&A--B*9$,Z(YT8)H2;0B6A-MB+9$.R*1*Q(I7#624VE9KB@B'JR<7($&4F,,SL$144R4$`V) M4J*,*"<:$15$8Z()T91H1C0G6A`MB59$:Z(-T99H1R1R18I$KF2]"M:O8!4I ME[-K.9XG5RDRI33S!PL3/6/5<@^_]JL=@[7I@;.RY^"(L6*BQ#F6 M]RM8+QLZ*QL^9:R,*'>.Y?#!8O/(6=GPA1?+S\6OEE_>]`=;ZDU!88HTDB=( M[%[TC)67#U@-C%7),:)C3)0XQW+O!`\"#)V5W:^4L3*BG(XCHL)S]'M:U6?? M?@'1T.5<3_4&N<7$GK&2Y0M[-'V#KAP:$$5TC(D2.@Z)4CIF1#D=1T2%Y^CW MGRH8GM!_NK[H]9]&\@![62#AHDM#6TE]TG4IT,!8F57X5D->=QG4<"(&BHD2 MA]Q.X7&:H6U.K\'7+JZ#R\;4A;%[G1'E1".#KG3DQL5-<+8J/!\_(ZI,=D)& M=%7-RXA&LCSN#AX+_KV&MI*+'7ML?:*!0?9!F/T?;/F/X43TBHD2A]Q.561$ M[Y3,?.HO!5H7[>"^,W5A[%YG1#G1R"");!T+S\K/@:K]G)`#72KRKQL[+=D#CD'"LR8P[(CI5&,`6D M+HR-G!'E1".#Y/"L8^%9^9E1E8\3,J,+)5YF-/)'1SL8^;V&MO)&!]#`6*D+ M-7?%U`ZNF"(7JV3%S"!\4N58D1GM:,8,!@S"9BZL[?"<:&20-V#*L?RTJ+O^ M$]*BBP1>6C0*!DQP#=EK:"MOP``-C)691IKM=L4T`J^8L1.'7.8J$F!V70^- M^D4PYE(7Q?9W1I03C0PZS"*MX**T\'S\A*A[V!,2HF]YO81H%(R38![KJ8>@ MY1K5&R=``V-E9I&&O$>8\SJ\8L9.'#J:$!W+CHB+*V0$C64NLDU23C2RZ'H_ M/S4N&L%P*ZS!?E;U,J).WR=D9&_NWY\9)/=G=A=[1'VB`5%$%!,E1$.BE"@C MRHE&1`71F&A"-"6:$`:H>>LK(+[1`.BB"@F2HB&1"E11I03 MC8@*HC'1A&A*-".:$RV(ED0KHC71AFA+M",2N6H%E,J8(E>RBH2+7&E7D7)Y M25W9SI=K6%XY7NJ2:0=RU:BT_SUC54)]H@%11!03)41#HI0H(\J)1D0%T9AH M0C0EFA'-B19$2Z(5T9IH0[0EVA&)-I%;T2991<)%F[2K2+EHLVSG:_.T@I2Z MW@U/I1KY3['BU3#&L?P4*]&`*"**B1*B(5%*E!'E1".B@FA,-"&:$LV(YD0+ MHB71BFA-M"':$NV(1*Z'=-LY4>1*UJM@_0I6D7*1:SF>+U=5A'O[?8+<4D&N M&@4S?W#%W3..WMGUX&@/?$"KB"@F2HB&1"E11I03C8@*HC'1A&A*-".:$RV( MED0KHC71AFA+M",2N2)K(E>RBH3+V95V%2D7N9;M?+FJ^N`)H(V=4'5TZ9&OUB`;6JK\H*? M08%C4#P;."M[PHT8*R9*G*.KNM3;P1\J#)V5#9\R5D:4.\=2^+#6-7)6-GSA MQ?)SH2J5Y5R$?__VI@58^8`%9CN-1`5V+WK&RLL'K`;&JN08T3$F2IQCN7>" M.^NAL[+[E3)61I33<414>(Y^3ZOB9[FG?W$OIFNEGNH-*I>U-"HOP*KWV\MY MN[P`2Q095'*,B1(Z#HE2.F9$N75T[^\:$16>H]]_JA1Y0O_IRJ77?QJI:SRW M"-'"!9@I>9868-4=AG1IJ9@^,$@FX/V;NJZE/RB/%('^DM(-ILF>L2L.B3S2PL5$(Z*":$PT(9H2S8CF1`NB)=&*:$VT(=H2 M[8A$KDBDR)6L(N$B5]I5I%R^/%.V\^6J;O-/D*NN"GAR/10*G%QK>(%GZV#E MY`HTH%5$%!,E1$.BE"@CRHE&1`71F&A"-"6:$+Y[JAT2I$U5!21=43KG),I=;]$BU)=H1R=C10CM4P,(^ MDI%TD*+=;QE)9"6Y'>DF&4E>@^PGF:+*P?TI2E763QA7NA#OW3V8VKS\.#:N MM-7A0>?P-0W]UB&,[9,!4>30D<9B8V5+7GYQ+7$Q;$M#HI0H,\C6[>1+5$'= M+J?3B*@@&AMD]KAU$;X;>D*?*=',H2/=,_<;JU_4KV[*_P63P<(%M?VU)%H1 MK0TR_55C?VWHM"7:$DSV20>0W6+VK!W""# MK!S<&V3MTQ9J]N;^0HU!4ND_LI,]8W4X\X1?9>J[,#:5`Z+(H2.-Q7YC3HV("J*QC6WGKT8@]@E]ID0SAX[TT#QLK!XT MMG!A;!5GNEM:AN M26Y'NDD^;1LV&([EDB*EH_RA%2ZU_:UR@KS).WQ\PB!9]#RR[SUC9<[;,@B" MLT+?A;$I'A!%#AUI+/8;:U^$;QU/7!C;V)`H)XI][ M;^BT)=H1R8#3ZI.:F5XRK0==)`-.6Y16X+M6>F5FU:;6._ZZEV3`>0VV+L)7 MK,NGIO7B=TF1+-##K^M;NYWU8];&O! MP$NB%=':(--!C<8-EK@W]-H2[8ADN&BA''JH%=1X9;A`2C)2#!>O MP5K833):RK'U:'GW\O7AX;5_]WKW\?WWA^SNZ?_O@A(U-J(R5\ M]OSP^<.Y/$K?V3__+EH_>-A-3;5I_T`4-K74IGV=)MS44@'E7%`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`````/__ M`P!02P,$%``&``@````A`,-@+'S_`@``YP@``!D```!X;"]W;W)K&ULE%9=;YLP%'V?M/^`_%Z^DS0HI$I7=:NT2=.TCV<'#%@% MC&RG:?_][L6$04I3]H+@YOB<>^ZU?;.Y>:Y*ZXE)Q44=$\]VB<7J1*2\SF/R MZ^?]U36QE*9U2DM1LYB\,$5NMA\_;(Y"/JJ",6T!0ZUB4FC=1(ZCDH)55-FB M837\D@E940V?,G=4(QE-VT55Z?BNNW0JRFMB&"(YAT-D&4_8G4@.%:NU(9&L MI!KR5P5OU(FM2N;0550^'IJK1%0-4.QYR?5+2TJL*HD>\EI(NB_!][,7TN3$ MW7Z\HJ]X(H42F;:!SC&)OO:\=M8.,&TW*0<'6'9+LBPF.R^Z]0+B;#=M@7YS M=E2#=TL5XOA9\O0KKQE4&_J$'=@+\8C0AQ1#L-AYM?J^[\Y4A(K.2@MJC\&Y+5)&:XVM3NJZ78CQ=&"?@-:-11WCQQ'D%%0P*>M[U]OG"H0#HKTRJ,U71C`J M8U4PE5L3\-LD0F^U=J=%@K$(ECR`QEVVB8MB$@XL^/ZZYS?Z!@-U[VV&/6)D M$VCFVT0P=`+,];1^\,^:D3:@&=(`F2^-X%:Z+W$7`:>#9-YHYG(LU=8YN,9] M_$ZM<>%8MHL,=Y`?^-/%78UE+[<5P6.I+C*4\L+5M!3>PH.#@@[#A;UZUR"N M&ZMVD:&J'P33JNNQZF6#"!Y+=1%S!0P/GP>'X-R.'T`]+BNTR\82I]#8SAN' MP0/44/8=-42?J76A"4?_=9_@$3NG-J$E5&:PWQ?3?8$Y,3(R>SNT"\\\F;L$ M:S,07IX)F[%B[NZ*R9Q]8F6IK$0<<&3@1=A'^W&V\_'"/(^'T&HY`)H4\? MH.ST?U&V?P$``/__`P!02P,$%``&``@````A`*0]9[VT!```?!```!@```!X M;"]W;W)K7_^2W[-/<]UN7-(:]H0U;^.V'^Y_7//RUOM'UA M9T(Z#Q@:MO+/77>)@X`59U+G;$0OI(&_'&E;YQU\;4\!N[0D/PBGN@KP>#P- MZKQL?,D0M\]PT..Q+$A"BVM-FDZ2M*3*.XB?GXW%.9%SRV^./1U6;24T6,W`KI`!NIJ7@2+ M`)C6RT,)"OBR>RTYKOP-BC,4^L%Z*1;HKY+&F7PX<`N?`\J^TIOOY+R=.X@W1$HXL+BPWM"6`$K M"C0C''&F@E80`/SVZI*7!JQ(_B:>M_+0G5<^GHY0.)Z"M;!4.<)3.88C/(]0));'C3"0JRN2E>1=OEZV].;!#H`%9)><[R<4 M`UF?)+P,7J$^"F6S=6V0;;'K+7@Q M<-ID"*1#(#.``!1I69#Q#Y#%6;BL/J"M!,*9D!BBV6(@I?$05('R4S$ MD@'U]P$R.,O*AYHTLC-8^ZVR,5,8#M*C3;0V!TD=)#,12QO$\P':.`O4+JR@ M(0[;D6^E4?A(G#;1XAPD=9#,1"QQL*&'XJ(I;W2JZSR]LSB1T-?'M95(!`W9 M4#RQ%>^T4>^6.$CJ()F)6'*@,YAR[O?POAEP8SMDB4#(?30[!TD<)'60S$2L M^&9V?+R+A2#F![L89[$#E\A@K8?[0AOUZA('21TD,Q%+"S\`&1WY\5IS8SMD MB9AK[2")@Z0.DIF(%=_B1^+CQG9\$HFFLH5BA!:#TI4&6!Q-Y!C0R+\5C^:# MBD^E41@*WEDTAA^;.-,TD"=+$8*]]/R2"VM;DX(B-1=P.(_L=^^4!5[H+9"X M4*J@$']?A.5EJ^"ST"@<.(*<%/4V(OFV.CXC#75W5$!WU3+D M1+5DJ"$+:G3?1//!I-CQ00(%:^5)0Z;CL/R4HTH=%O4W6*?,(K?5\2EIJ/MO MN9.CUA*MIB\\M&B,G>*45E;^%&3F3T'0N`RNJ5WH&=)W'R;6$(FA^6J/;:I1CM!#;%-UM-A:Y%"VO2O+T M79/V1':DJIA7T"N_!L'&7B\UK.]H&[$3!_B6W]WX#AWB.(:SY!U\$L,YS,4W M8;R1=\`A41C#V<9UV$8Q'!+NX-,8AO,=?!;#H+N#SV,8,(`'^L5P][OD)_)[ MWI[*AGD5.<*BC$7[:N7M47[IZ$6TL3WMX-HG/I[AED^@Q8Q'T.N.E';]%_X" M_7^#]3\```#__P,`4$L#!!0`!@`(````(0`S:ZKX=00``&(/```8````>&PO M=V]R:W-H965T&ULK%?;CJLV%'VOU']`O!_`8$B"DASE`NV1 M6JFJ>GEFB).@`1QA,IGY^VYCP_B2CC+M>0EA97MEK[VV;\NOKTWMO)".5;1= MN<@+7(>T)3U4[6GE_OE'_F7N.JPOVD-1TY:LW#?"W*_K'W]8WFCWS,Z$]`XP MM&SEGOO^DOH^*\^D*9A'+Z2%7XZT:XH>7KN3SRX=*0[#H*;VPR!(_*:H6E

+'HFZKL**/'W@,Z7R1J:U[X"Q^8ULM# M!0IXV9V.'%?N!J4YBEQ_O1P*]%=%;DSY[K`SO?W458=?JI9`M<$G[L`3I<\\ M]-N!0S#8MT;G@P._=X8%'%AZ>%M3U@)%04:+XPY M4TEK2``^G:;BK0$5*5Z'YZTZ].>5&R5>/`LB!.'.$V%]7G%*URFOK*?-WR(( M22I!$DH2>(XDV`OG,8J33[!@R0)/R8*\>1SC9#Y[/!6('/3`4Y+,/(2#S^21 M2`IX3GD\6!%?5'J"(PQZ[64=(K3T7Z`_2AFSM6.,B-T8P9N!T^Y-(#.!7`%\4#3)`L._ M@RS.PF6-"6T%@&>#1(QFBT`7N9L"QB%["\DL)%<1349DRXA@)MZ?0Z,9?-#* MA695S`CU/+0JHDF!?+Z#(YP%6A4*IHB+],RW(@A_ M)&X*F<192&8AN8IHXF!2J^(^]H<'#QK&_]X*)`9G%56F'U/0.&QO(9F%Y"JB MI0R3_?&4>;">LD`@Y3&;G87L+22SD%Q%M/QFG\F/!^OY"01#.TXE18DQ"W8B M*,23B/V$*,/F1G]EDAL/JP`*<8`-XGRB@>IHJOCI1EEN/VX4'JRK$@B&54]1 M93:*"`H7[ZHL))-$H9"`X_G"$)FK8S0)B\](X,&Z!($8QB3Z#-Z)(-48"\DD MD7`A1C@Q2')UB*8`P41371";GL75[YH8V&:7Z(Z%X.(X-]-D("7EAE&!3GL:CZ^.[XL-=AGBT(41`FDDABDTA M(DIU27(I4"8A+(1$.`[P3"?*M5&Z$KXS*DK^FU-B>X5-8URKMGP#`(2"*%X8)>4WCG=NH5G<(,2AM"'=B>Q( M73.GI%=^.YC#A)O0Z>:R&;PT\"V_T7"/33Q,X81U!X]2.*[8^`:G&\C3_F&+ M4S@"W,'C%/;9.WB2POX&N#]E!#><2W$BOQ;=J6J94Y,C:`R&I:<3=R3QTM/+ ML`0]T1[N-L/7,]QE"9R*`P\Z[4AI/[[P/YANQ^M_````__\#`%!+`P04``8` M"````"$`:N&:9)`9``"\JP``&````'AL+W=OMVN_@\OO&IJZ6*\E46[S?R9K=?78[2N+J.$[9[NZ9;[^' M`BGPX,]6+&^_3*9_/`!I'`$"0)I^_X]_/7P[^V/W]'S_^/W#N??N\OQL]_WN M\=/]]R\?SO_[G^%_79V?/;_GWYZ_ M[G8O9U+#]^/[Q MM+O]M"_T\.UB=GFYNGBXO?]^;FJX?GI-'8^?/]_?[?S'N]\?=M]?3"5/NV^W M+W+]SU_O?SP/M3WXO1OJWO\'JG^XOWMZ?'[\_/).JKLP%\J?>7.QN9":/K[_ M="\_0=?L9T^[SQ_.?_&N6^_R\OSBX_M]"_W/_>[/Y]'_/WO^^OAG]'3_*;__ MOI/FED1U*?CU\?&W+C3YU)$4OD#I<)^"^NGLT^[S[>_?7MK'/^/=_9>O+Y+O MI?Q(W4]V_>G?_N[Y3II4JGDW6W8UW3U^DPN0_SU[N.\^&](DM__Z<#Z3$]]_ M>OGZX7R^>K=<7\X]"3_[=??\$MYW59Z?W?W^_/+X\+\FR.NK,I7,^TKDWXE* MCA1<]`7EWXF"KSR[7.?^1Y!_^TIFLW=7R^5B=;46.W+Z55]R?2CIK5]74OK/ M_ISR;W].SWOG+2Y77:L=.>.F+R?_#N7DY$<*>/*)V)_)DQ0I^YXD-_ M_*ON*/VPJ^67KIH/YU)>>MJS#")_?/3FF_<7?TB_O^MC;B9B=,1VB.@Z>5>M M[T+@0NA"Y$+L0N)"ZD+F0NY"X4+I0N5"[4+C0CN""TG/(4?RV?\[](6E>-C)WRV1AES=,IN3%!BV-9.X01FE:Z;3 MM3T$#<5\2``)(1$DAB20%))!B#-6N=_VAZ`A.SXD@(20"!)#$D@*R2`YI("4D`I20QI(.Q:5 M"QGP52[>/%9U%>DT&7'&JJ4S5AV"#FF"!)`0$D%B2`))(1DDAQ20$E)!:D@# M:<>BTM3M%:@\'1^L]N$Z&SV-ARN23PI((2DBQ:2$E)(R4DXJ2"6I(M6DAM0J MTKGHEJ/NUL!\_L[N2+U^=\"L;&66/'S\;[K-(.E(3K=9.=W&1@T%?5)`"DD1 M*28EI)24D7)202I)%:DF-:16D4Y=MU0=I^XGWG6Y2>D!ZSAI7ZAO:[Z38U MV7NNW/0T+CL8]GQ200E)$BDD)*25EI)Q4D$I21:I) M#:E5I#/7+5O'F?O)=,VLH>H82+FDP)22(I(,2DAI:2, ME),*4DFJ2#6I(;6*5'IFIVT0[,/U!D%/>CZP=&\!V*A#>D@!*21%I)B4D%)2 M1LI)!:DD5:2:U)!:13H][I[!\9%LQGV!GL8C&/9#.S2A^/9#TY(YE[&\9&V:YBZI*"`P6,"DD1*28E MI)24D7)202I)%:DF-:16D4[/:9L`,VX"].2,9.X-`ALUY,(G!:20%)%B4D)* M21DI)Q6DDE21:E)#:A7I]'2+\Q-ZCUG+J]Z#Y?UV!O))`2DD1:28E)!24D;* M206I)%6DFM206D4Z%Z=M`G0/,,K,5^7"D#.2N3=I^H*C8G%FU>VO-1@U#HD\* M2"$I(L6DA)22,E).*D@EJ2+5I(;4*M*9.VU_8,[]@9[&O8CDDP)22(I(,2DA MI:2,E),*4DFJ2#6I(;6*="Y.VQ^8KN+?6;)3M*J:N41(#1H6DB!23 M$E)*RD@YJ2"5I(I4DQI2JTBGY[3]@3GW!WH:M?*6Y),"4DB*2#$I(:6DC)23 M"E))JD@UJ2&UBG0N3ML,F',SH">]`%VY]\]LE.TJIJ[1FC1@5$B*2#$I(:6D MC)23"E))JD@UJ2&UBG1Z3ML?F'-_H"<]DJW<>S8VRJ;'U#7J8P&C0E)$BDD) M*25EI)Q4D$I21:I)#:E5I-/3+=+'BY[C"]"Y6=./5S8]C5IY2_))`2DD1:28 ME)!24D;*206I)%6DFM206D4Z%Z=M!LRY&3"0C$OV=S-6[OVS(4JZQRC*WCK0 M%^6NBG_R`>'2=]Z3OBAW*WR(TA=E=P'U19VVX)MSP3>0OBAW5VN(TA=E5^WJ MHA;NRN=X2^W#]?)F('U1[O)FB-(796=V^J).F]0O.*GO:6E^)[_[S=\MR2<% MI)`4D6)20DI)&2DG%:225)%J4D-J%>EKIP)SV&G)',G:DL#E%V)`,%C`I) M$2DF):24E)%R4D$J216I)C6D5I%.CSNI[_9@O>7^MX->OM[?_7;SV,'D>T/F M\L()\]J0!>?Z/:D!SD2-R&=40`I)$2DF):24E)%R4D$J216I)C6D5I%.D3O7 M?UN*N`20-X;L^YJDQ4[NUW9R;Q[C'J+6AX>`_(%DMCXJ:*?I^O+=54%W^?-% M]_OE)WS`N%;H7L/0C10R81]=A%T%]%=OHN11-SLL]"0?ZE%!.Y_75^\N'[JK M7YS/EVO=!?OHE2E]^3OGP[\U>7WPV::O1]T^7O:]&#\D!R,:-& MM"L+<_E]U/CR!U*7?V7GI?KR)4I=_O%UDBP\W"^/GI;VEZZV))\4D$)21(I) M"2DE9:2<5)!*4D6J20VI5:1S<=J21%HE=QSZQG8@.\#Y/77;9+:?K9UO MQL!L%K"LBQ;;@N'KGFRNQ44/U*>O*2+DM.*[>^68I;-10?+]\::A[HO*0R#G&RT/0<*G^4$Z. M',IY5\[$+ABB5OOWQJW7R_5F[;1#.,0L#A^XB!0/=/1\R1`EL\[15=E9XW[* MD`Y1]HP9*1_HZ!F+(>KH&LJ&561:E+# MNEH5I7/1+8[^_YVZ7V+9T?EF::A[H&/4#9R.M^VCI.L/^?"'@C*+&A5$K^ZK M[Q;G?WS\BUYM8D:51T/E]GSQ0$?/EPQ1NE^@5^.,V5#0GC$?Z.@9BR'JZ!G+ M/FKT,U9#07O&>B"U!'9'RF:(,F_8G&S35IU/?Y*Z]>:Q3](_'W_\U1:+/*T] M[+$LS;)5?3\84C,VD-\7'$4%I)`4D6)20DI)&2DG%:225)%J4D-J%>D<=8OJ M<8Y^,O*:-;C*A2%IY7'O="9=V^4ARG9K4,"HD!218E)"2DD9*2<5I))4D6I2 M0VH5J?2LW&V,X^G9A^O]BIY&G6!+\DD!*21%I)B4D%)21LI)!:DD5:2:U)!: M13H7I^W)K+@GTY.^WW)E-^#,WI&-.G054D`*21$I)B6DE)21'J*'A?5)`"DD1*28EI)24D7)2 M02I)%:DF-:16D4[/:9L5*VY6]*1&,A,U(I]1`2DD1:28E)!24D;*206I)%6D MFM206D4Z%]WR^H0O?;,:'R]?5H9&#;\E^:2`%)(B4DQ*2"DI(^6D@E22*E)- M:DBM(IV+J>7^V]ZGSA7_ZK"\'ZTR\?<^;)0=T0X%!PH8%9(B4DQ*2"DI(^6D M@E22*E)-:DBM(IVY;B5^0B\R"W?5B["6WZY`/BD@A:2(%),24DK*2#FI()6D MBE23&E*K2.5B?=J*?Q^NO_Q[TG.SC7OWQ$8-_<(G!:20%)%B4D)*21DI)Q6D MDE21:E)#:A7I])RV";#F)D!/>FZV<;?!;91-CZEK]$T5,"HD1:28E)!24D;* M206I)%6DFM206D4Z/:=M`JRY"=#3J)6W))\4D$)21(I)"2DE9:2<5)!*4D6J M20VI5:1S<=J*?\T5?T].5W%N_&QME.TJIJY1$@-&A:2(%),24DK*2#FI()6D MBE23&E*K2*>G6XF__DM_;1;NXR_]GD:MO"7YI(`4DB)23$I(*2DCY:2"5)(J M4DUJ2*TBG8O35OS=7S!P5OP].5W%N1NYM5&VJV`3(&!42(I(,2DAI:2,E),* M4DFJ2#6I(;6*='I.6_&ON>+O2745KO@9%9!"4D2*20DI)66DG%202E)%JDD- MJ56DE*#'#F]@H-$O*O>NE^>L@]<;9P;H8&-&@J&I(@4DQ)2 MVM/HNC)2;@N.+]6Y$578J.%22U)%JDD-J>W)7*I.I+M=\+9$B! MQHDT4?(K5MTS<1-_(3GH"TG$T#(AZXE(L2UHJE[,G&_0Q$8,5:>L)R/EMN!? M7'5A(X:J2]93D6I;\"^NNK$10]6MJD>G][3MABMN-_2DGG3V-NZ=.ALU7)1/ M"GJ2=Q\,42&C(E),2EA7RJB,E),*UE4RJB+5I(9UM2I*I^>T'8@K[D#TU+VO MX#`2SB[M+VV9^]Q]E+SP;VAXWY(MR"?1A^IG^_[IS2_7RX63^]#6-%0>D6)+ M1\Z7Z/-M-O/9W/E94EO1<+J,E%LZ>K2+6E(^=K MG/.MN@'/V?=N;4UR/OUI.6U#Y(H;(CV-'KW=DGQ2T)/JN:;Z45T1"\:DA'6E MC,I(.:E@726C*E)-:EA7JZ)T+D[;$+GBADA/W4LX1SW7^31L;=3PZ?-)04_C MWQ%@5$2*20GK2AF5D7)2P;I*1E6DFM2PKE9%Z?2X&R+=M&8V?]>]8_OXLT17 MW!OIJ7O1Q2A3[@V1/FK4'WQ2,-2U,`/JRMO,-VMG@1BR7$2*28E;^^5LL5@Y MT^*4Y3)23BK5TQD_;=KGB MMDM/3H=T-_-ME.V0IJ[1MVO01\E[:KIIW&SE>9?.YR5D11$I)B6Z[KGG>0MG MU$A9*B/EI$+7+9^>A;NJ*EFJ(M6D1M<]G\W6[C2R5:5T>MUMFY_T8N[-7!F2 M7CPD;MO3Z+/JDX*AX'C6:NH:%8Q8,"8EK"ME5$;*207K*AE5D6I2P[I:%:5S MX6[$O'YPY9[,E2%G`NO>%^BC1EW,)P5#7?UL=;58+B_7S@`5LEQ$BDF)6_M\ MOEQ=.K6G+)>1:N.L6$N6JT@UJ4'ME^N5YUQ[J\JIC&_<[9[CO6\? MKO=U>AIOO9%\4D`*21$I)B6DE)21Z4G= MZYE=.OU^:Z.&[RZ?%)!"4D2*20DI)66DG%202E)%JDD-J56DT^-NK^R_J&;= M"X[N?G]^>7R(=_=?]AN>/UL5;+CSTI-TF?&JP)G*;VV4S9RI:]37`D:%I(@4 MDQ)22LI(.:D@E:2*5),:4JM(9^ZTK8X-MSIZ&K7REN23`E)(BD@Q*2&EI(R4 MDPI22:I(-:DAM8IT+D[;ZMAPJZ,G9Y!SUJ5;&V6[BJEK?$.;42$I(L6DA)22 M,E).*D@EJ2+5I(;4*M+IF=SJ>-,@QZV/C2%GD',FCEL;93-W*#A0P*B0%)%B M4D)*21DI)Q6DDE21:E)#:A7IS)VV9;'AED5/:I`S42/R&1600E)$BDD)*25E MI)Q4D$I21:I)#:E5I'/A[B^\?:K`K8>-(:<7.7M;6QLU=!F?%)!"4D2*20DI M)66DG%202E)%JDD-J56D,^?N1OQD;LF+!RPJH)JR>LF;!6FTGFQ?/7W>[%OWVY_?C^8??T9;?= M??OV?';W^/MWN?\A.Q,C/GO:??YP?K-97W>#JS3WHD8NZWE_95'V>E-H_'>26VLSDR/[9$AR9RY']OB^.+.3(_JU#.+*4(\O) MGV@E1_:/H[AEUE)&'M*=N.JUE)%'1J>.2,O)TXI31Z3EY&FXJ2/2DK>47*Z:.2%O+,_U31Z2M MY0GSB2,K*2,O`Y@Z(F7D]]"GCDA;RZ]`3QV1MI9?R)TZ(FTMOQXZ=43:6G[] M<.+(0LXCSYE-'9'SF,>2W,_!4MI-7MP4S*F+LZ.")M+7>/IVJ3MI8_#CQU1#YO\J=JIXY(3LVK`-WS M>%+&FRSC21EO\G/@25O+V[:GSB-M;=[Q[)YG)FT]FVSKF;2U>5+0+>-)&6^R MC"=ES!8SRDA;>Y/Y\:2MO-+6WF1;>]+6WF1;2Y')$E)@,KX;=J=:3!IY MLHVEB2=;V),6]J9&3__*N^Z>7F16Y-'$Z^[A0QZ1)PNONV<'>40>#+SN'OWC MD5^\ZU\F>T:7K(GXFRZ]4]YUI`G_97']2S=+X)EONLX_X?*:V^ON);8L(6^H MO>[>/\LC\G+9Z^[5L3PB[X6][M[ZRB/^U:6TX]25R5.WTEI31VZ6DDAYG1EK MNUE))N7E6E-'I"GEO4Y31Z0QY95"W9!B75\;/B@1ZCI$UAZM7[_;K77YM[V`(X@ MPVAKVCLW58Q9T8/B-M,3C/BEU49QATO3,3L9X$TXI`8VR_-SIK@<:62HS"D< MNFVE@!LM=@I&%TD,#-RA?]O+R1[8E#B%3G%SOYO.A%834FSE(-U3(*5$B>JN M&[7AVP%S/Q9S+@[<8?&*7DEAM-6MRY".1:.O,U^R2X9,ZU4C,8$O.S'0UG13 M5-<+RM:K4)^?$O;VQ3NQO=Y_-++Y+$?`8F.;?`.V6M][Z%WCM_`P>W7Z-C3@ MJR$-M'PWN&]Z_PEDUSOL]@(#^5Q5\W0#5F!!D2:;!1M"#V@`GT1)/QE8$/Y8 MTQD*R\;U-2W/L\4R+PN$DRU8=RL])25B9YU6OR*H"*8B5[!VPQU?KXS>$VPW MHNW$_?`4%1*_[05->.S&@VN*XX@R%NOWL"[*Q8H]8&CQC+F.&'S^P20$0]&D MC&JG*WNP5\;Z!BO7<6,63,R+Y67^MDAY+.)+/O]GR0\Q_2'$O8Q0GB?^J!\Q M2)5BSA/B*";2G![3@[$3&"[1%N4R$4?I"#I!&B$OI7WX65[ZX?I/G_W!8".5 M^WGGJ*WE13(6$\?)C^.EP'3P`8;!$J%W?JI]K])NNG";F>_IW_OS:A-N`$L? M\"),O(,OW'1RM&2`%BGS;(G&3+Q*<>'T%(9ZJQU>@?#:XQ\/<'SS#,&MUNZP M\)BY3G'(ZW5YV*[M.Z'EY]_>GZO MFR_MKB@Z!R(FR);]S=5 M^X7TO.6BRLJ#BQ&>FCDQZLVFS(M/=?Y6%8<.@S3%/NN`?[LKC^TI6I7/"5=E MS9>WXT->5T<(\5KNR^Y[']1UJOSIM^VA;K+7/:S[F_"S_!2[?S,)7Y5Y4[?U MIGN$<`LD.EUSO(@7$.GE>5W""K3L3E-L5NY'\93ZGKMX>>X%^K^_-.7Z]_)0@-J0)YV!U[K^HJ&_K?5'9:`CY?4>","K4Y6Z-$"1[%O__WNY[G8K M5RT?@]!3`N#.:]%VGTL=TG7RM[:KJ_\0)$PH#")-$`7LS75O;I`%$NK7]RGK MLI?GIGYWH&C@*]MCIDM0/$'@T\*0QK#42RN%)>H@'W64E0O5#HMH(3U?7X0G MGQ=?0=+<8)(S&(I(3PB=":`W<(2%VQS/BWZBHL&:BDZ"YI;@![)GY8LP]MBW MTNN^#(;KA`2(,Y^$!J]"6&I=Q8`@W&"!-C==8/[%SCDE4=_$]1OS@OHA!EXO MZG<-03@NIQP5S(CKA:9OXCHN!PV0(V+"7D<5A(K7'KDN?'%!PY#RN\Y+@SFO MD/%"C.'E+:V:[WFG]O7`ODQDT^[&9L=MV?1-G!XKK@0Q2"^(?*D8_Y0`E!3> M*#QA&/\(0WT39Q@S`1%C%U_`.2($%_$0>M$EC@(JS9;Q>G9[-&,G6%DE!H3? M+3SEQTSAE"#BR(_'"4`$%,P?;I##"6[/%C5F!ENBC[AR#3>@%D2LLU,"B6/? MLA)*[BYC$#CH87`-`T-8#6?8(D!?G>#"!S[MHA"3,P4 M0::ZA)2Q/Y618I9"1&JL`\I4CW.+Z8TTX_"W&:H)0<08@DL?*FR29ALB`A7% M8ZU0=GJ0SV>GT;Q#N/GJS1N`D%XHXY@!4@(02D9C&5!NS#MN*#CK%0U9ATW5#OC&6+, MA^%F>X+RX!\=V:FP`0\BL!&4''.-&^3.V(5@NB1BAE\8C.D8WU.A&L,0@O(N MQ^C1O!]X9@WH-$_\R#($''L&88\]R_(HO[M,0TY-(V"Y2PP&Z0D_\'V6_I0@ M5*#D"*#CM38M$6[`GGA#,\!,#0I)*:6MC,J<$(@+8-*L+'2+U\)X] M\WHTVS"+<=9CAQB0G<%1))-DM(SS$*KC78XAIXXA!-]3&9"I00G2,$1*$2*6 MP8B@[/1XGZ^>1K,.D9,21-")G1X?DQ&C'^8A$+P.6XR+/<)\8V8=3OU#R/&A MP>39-I`'X04BG#(EF`BD7EX:-G>YB)RZ"&Q.Z"1.#,A(V3\735-M.\E#!`U] ML:/O\A*)+@#U.*1(R+$'C8((LO,XZ91K$%J+S$YF9OJ,K7ACM1N>,VQ%(@;% MOO(8HH>@W3+S:/9W\=9A6B4&9"C`\!Y+#<<.`<@PMK:R1$IUE['T:,Z-?75B M0*>VED&TC-C@3"E&!=*3%QDR>[F^=U!G;$4RST@,Z,00-O'29P6;4HSRI;CX M1*>8LNY;=C.3*;H%U92WN$*0Z9T0M@PA&ZLQ("NS@6)-631V8#PE0'H83]#37.E""$?@"S1BFEQTSGQAQ"CZ`) M9C,F45.S88,^O0HA_."PY@J[/[-`.YFF<\"\*SDJIH MMD5:[/>MD]=O^IQ''R<,GPYG4!^E/G9@GR=P-M4?Y"R&"W`T=,RVQ1]9LRT/ MK;,O-A#2>PR!4(.'2_BFJX_]"&PO M=V]R:W-H965T/T^YSTV)\N;5UFC%ZZ-4$V& MHR#$B#=,Y:(I,_SSQ\/5-4;&TB:GM6IXAM^XP3>KCQ^66Z6?3<6Y1>#0F`Q7 MUK8+0@RKN*0F4"UOX)=":4DMW.J2F%9SFG>+9$WB,$R)I*+!WF&AS_%012$8 MOU=L(WECO8GF-;50OZE$:_9NDIUC)ZE^WK173,D6+-:B%O:M,\5(LL5CV2A- MUS7D?HTFE.V]NYLC>RF85D85-@`[X@L]SCPG&<"UYU)//_?8N(+ MZ7+=4TM72ZVV"`X+H$Q+W=&+%F"X#^3Q?<3W$D(T9W+K7#(,IQR*-[`M+ZLD M3I;D!5K)=IH[KX'/7A/U"@+5]"5!&<.23O=V3W9B1W:]=J7<^0=Q5\0DFLW# MTY#D$H@3PU8-2T_CWM=SO09VL8\WZ16C>)-+R$X\)B?QP=>3O69(3N+I:3:( MSF^M$X_94?HWVVN&[(-BE#J]A.S$8_)Q:J\9DI,X/9UZ=@G;BDX]3>\V0G,2STZEA)IS/=N(Q.TJO>U^?VFN&['=2 MPP2^`-VIQ^SCW#O1$)[$AP+]4?-CVX\WR77)/_&Z-HBIC1O)$8R$_FG_NKB- MNX'?_P#3NJ4E?Z*Z%(U!-2]@:1C,@*S]O/YG#"`H# M$!=*V?V->Z/T;_K5'P```/__`P!02P,$%``&``@````A`,G^:0]O`@``Q04` M`!D```!X;"]W;W)K&ULE%1;;]L@&'V?M/^`>*^Q MG;L5ITH6=:NT2=.TRS/!V$8QQ@+2I/]^']"2;*FF[,4V^'#.^6XL[T^R0T]< M&Z'Z$F=)BA'OF:I$WY3XQ_>'NSE&QM*^HIWJ>8F?N<'WJ_?OED>E]Z;EW")@ MZ$V)6VN'@A##6BZI2=3`>_A3*RVIA:5NB!DTIY4_)#N2I^F42"IZ'!@*?0N' MJFO!^%:Q@^2]#22:=]2"?].*P;RR278+G:1Z?QCNF)(#4.Q$)^RS)\5(LN*Q MZ96FNP[B/F5CREZY_>**7@JFE5&U38".!*/7,2_(@@#3:ED)B,"E'6E>EWB= M%9L))JNES\]/P8_FXAN95AT_:E%]%CV'9$.97`%V2NT=]+%R6W"87)U^\`7X MJE'%:WKH[#=U_,1%TUJH]@0"S>09XM./&/@C'B1$[&*ODKX#*G*O(DK^PP/O,,IFEHQM( M2'#D`]Q22U=+K8X(F@8DS4!="V8%$+\=$9APV+4#EQB:&KP:J,+3*I^G2_($ MJ6,OF$W`P#-BLH@@(!J50>UV90=VRBX?SLHF;.3>Q#B;+`V4:3(#8SK,85A8-?A>WBD+X^,_6[@N M.;1*Z@*OE;*O"Q`F\0)>_08``/__`P!02P,$%``&``@````A`-E6ISN&ULK)E;<]HZ$,??S\SY M#@SO!6P,-IZ03KC?[[=7!TSP%#!C.TW[[<\*6<+6/^4D;5^"_N+E.4?_[%:S/]TP M^_7QWW\>WOS@6WAPW2A#"N>PFCU$T<7.Y\/MP3TY8;U0*.=/CG?.<@4[^(B&O]][6[?A;U]/[CGB(H%[=")J?WCP M+J%0.VT_(G=R@F^OER];_W0AB6?OZ$4_KZ+9S&EK=U_.?N`\'ZG?/S3#V0KM MZPW(G[QMX(?^/LJ17)XW%/MK6L&)D%FY^Z= MUV,T\]\ZKO=RB"C=)>H1ZYB]^]EPPRV-*,GD]!)3VOI':@#]S9P\5AHT(LZ/ MZ^^;MXL.U6RQD#.U0J5HDLJS&T8MCTEF,]O7,/)/:VZDQ5)V-V_MOM-62D;<8S;6<6]R5JEDE*U/=%F3 M`T<7L8SQ&S*&:`U=_$%K:)QY&NGB#UI#LP*7H0LIHULEK51FJ;PWK!7A2A>Q M:SFG&87_<]3UV)%=_/X(Z*(&V85L^D?3FN=/Q?4A:SB1\_@0^&\9FKDHN>'% M8?.@9NN4(O%X\9&0#]ROGC=ZT)C*$Y.I9FE0Z5$*:9+X_JA7M(?\=WJPM[%- M#6T4B[JP8$\QDVVHH*F"E@K:*NBHH*N"G@KZ*ABH8*B"D0K&*IBH8*J"F0KF M*EBH8*F"E0K6*M@D0)Z*0%8"5>??J`0FPRI!Y+#&@6%>J\+0S$HA71=U:2!< M&D":0%I`VD`Z0+I`>D#Z0`9`AD!&0,9`)D"F0&9`YD`60)9`5D#60#9)DJH% MFF+^1BTPF6J69I7$K*"GLU^+;9)3AY$VJ4L362!`FD!:0-I`.D"Z0'I`^D`& M0(9`1D#&0"9`ID!F0.9`%D"60%9`UD`V29(J$,KIWR@0)D-O'JK#1(44T^FO M<2/C7H5($UDA0)I`6D#:0#I`ND!Z0/I`!D"&0$9`QD`F0*9`9D#F0!9`ED!6 M0-9`-DF2JA!:3:4JY/WUNE@_,.MK(8@$UC@II4M#G1FDD7!K`&D":0%I`^D` MZ0+I`>D#&0`9`AD!&0.9`)D"F0&9`UD`60)9`5D#V21)*N^TO?E$WIEU.N^< M4-Y%2NM`&D":0%I`VD`Z0+I`>D#Z0`9`AD!&0,9`)D"F0&9`YD`60)9`5D#6 M0#9)DDHR[4E32>:[AAS;7D8';_NMYO,M]3L/?9'6@7S/P$32N>?$8"JW;40I M_3JH2R-1(`U.:'LE2!-(2WHEIFQ-!+2$Q":`IE)KZ1T)2T]ET9">@%"2R`KZ763UBQEW;>61D)Z MDQ1*51N]^5/5]DY5T>9=E!6S3I<5)V91UD<=2(.39`T!:7%B7;]774NX#:0# M7ET@/?#J`QF`UQ#("+S&0";@-04R`Z\YD`5X+8&LP&L-9)/T2B69OJI\(LG, M.IUD3N@3AJBG.B>F]:N-9P-Y,A;EDTO9N0]RZ87+?*19=.+$_G,LNE%B'QEV?1B0UXS M;5J<(F^9-JTLD?=,FY:%R$>F36LZY#/3I@49\I5ITVJ*>%YFC`[`+LZ+.W2" M%^\<9H[NGHJ`CKUH91WP(S1^$_D7FJSH",N/Z.CK>GF@HTZ7OKT7*```9```` M>&PO=V]R:W-H965T7WX^LNVQ5 MDEVR1(JZWZ]O'D=)7!/;*=LSV?OO3T,`"`*+HUBS9QY&SF)W`T0W`*()01_^ M]>_'[Q=_'EY>'YZ?/EZ6"L7+B\/3_?/GAZ>O'R]7R_C_KB\O7M_NGC[??7]^ M.GR\_,_A]?)?G_[W?S[\?'[Y_?7;X?!V(1:>7C]>?GM[^]&\NGJ]_W9XO'LM M//\X/,F5+\\OCW=O\L^7KU>O/UX.=Y^/2H_?K\K%8OWJ\>[AZ5);:+Z\Q\;S MER\/]X?.\_T?CX>G-VWDY?#][DWJ__KMX<>KM?9X_QYSCW]_EZIW]];V\1\P__AP__+\^OSE MK2#FKG1%><\W5S=78NG3A\\/<@>JV2]>#E\^7K9*S59??IP;*'UP^'G M:^;OB]=OSS^[+P^?AP]/!VEN<91RP6_/S[\KT=YGA43Y"MKQT073EXO/AR]W M?WQ_FS__3`X/7[^]B;]K;Z5BK,BGL5(M5,NUQO4Y5:D:(_)IC)3*YUN1 M2A];13Z-E4:A5"W6SVB3NC$AG\9$S;7KB;9L&#WY-'KE>N8&3FA*GSY66CYM MI4]Z[<;(RZ>1+]4+C5+QIJ*<=J*@DD2I#AH5KCH@RAE_GU)-XTW^L*46WW=_ M)1MFZ@];;.F=Y=K@*KGH*A7?Y9"2#2GUARFV]KYVLF&D.J2M<*9WG6HGZ\R2 M\V;]G;=J_5KR'%N^KI5JQP`^46S9-I/ZP]0X4^'W#@CT(G;KMBH5'_84NN%4TUVID0_5UX+T6W-?* M^N]*0C*-2PG%?R(NE1D5E[::MQI4&\<8K98:-\4@!E,!J](!B4!BD"Y(`M(# MZ8,,0(8@(Y`QR`1D"C(#F8,L0)8@*Y`UR`9D"[(#V8.T6D3.R=:'K3:EZ-<6 M'=OR/.M%J$PY_T2$*C,?+V6N3D?.\\=D`@D!NF" M)"`]D#[(`&0(,@(9@TQ`IB`SD#G(`F0)L@)9@VQ`MB`[D#U(JT5T2]0FHE]; M=&S+\ZP7M[(F\>(V/V-@GT>5]#$\;5C=:E*3A^TT8,O5\`$T%;)J'9`()`;I M@B0@/9`^R`!D"#("&8-,0*8@,Y`YR`)D";("68-L0+8@.Y`]2*M%Y!QM?=AJ M4XI^;=&QD@H[AI$$C=CRHE%6BF=$HY+VHU$3;?BXU&F#=$`BD!BD"Y*`]$#Z M(`.0(<@(9`PR`9F"S$#F(`N0)<@*9`VR`=F"[$#V(*T6T2T1W=JB7UMT;,OS MK!=ZDFGP0D^OV`LJ"?;V[>'^]]MG&>!D"9*K15"+-:FJ.MN$0;D:/--V4R';DQ,8ZH'T4ZVLZ9I? MHT$J9$T/86@$,DZULJ;KONE)*F1-3[.&/%?*@Y'GRAR720K7^DQ)^S[3I%XR MB]ER.9S/M$"YZOP%E:#Z$51BD*XFU>JQW%+MIMRX+@9V$FCU0/HI<>U9N@Z" M9V`**QX+*Q:*@2N'J1';WB.0<4I.%#0Q!>F[:MS4*V%N8)J:D:(\1TJO.<.1 M2MIWI";ULG5D/^/&<0*L' MTD_)B?8=:"%)=ZKT8%&]H/#^"^H_3&VF?@49I^1$N1,M9&ZR7*Z6;\(8FZ9V M0L>J=P=G>/8H[KO6H+235HO!C;:-1+:74BD8&R,JQ41=@VQ/K172E>WP2Q MDU"O1]1WZ(0/!D8J[=5TN&ZAS,V.G&7;:&.#:I(521\(,!5,K)1S>#F8=J:> M;6^,5KF*?\#A.I'H.5RCNE_W\-'I6/S'2Z^7:\5J)0V>B%(Q4=>@ZG%=JD MR^1ME79WQK?ROHJLG<-R/"YOK:CK^]R/697[ MRL;LZ:=Z]9H^C$V-I/ZN9Y6KX2.A4=$I,AVU;V5FT7D0C.!&*;J$,4$<5$7:*$J$?4)QH0#8E&1&.B"=&4 M:$8T)UH0+8E61&NB#=&6:$>T)Y+8A&\E-LER'"ZO_RF7XW+9`I"5\V-3)=2R ML?FWR;E1R%EHPU:.IOD.N<;'V&=@"TY5U ML*H;.C.V]4=$8X=.%#:QA>F%5EU2)K6@;:?.D!3G>U:ER<[PK,ZJ>9[5*%U" MR[Y[NNMBH-H(.,'6&X%F5)\MZ]N^-QSK; MYCE*\KEP. MTY]_R^%'*WY6U*"Z#)"9N@>)@;:1RO9R@ZIZ1[_:)!I1*B;J&B2]S+9I0JD> M49]H0%M#2HV(Q@;5I?=F;COH@!,K=7-T6;DL$]MUT!^FGG'?9[]*;+XO9U)F M9M.@[(,^48:P=@[+\;CLI*0]W^=^S*HL(2<6^[6.=V]#ET=UDTQQ M_:M2"L:[6R-U%P"F[J^S_W`5JG#;&"?7N6H M[[$$R4"#&ME9OEP+WR$Z*1>NVI8H6A11*B;J$B5$/:(^T8!H2#0B&A--B*9$ M,Z(YT8)H2;0B6A-MB+9$.Z(]D80KO";A2M;.89TM>>'JTH=GA&N M.M.8?9*79VT5P3*/N!&X7,.#72IE8[/C%"V*B&*B+E%"U"/J$PV(AD0CHC'1 MA&A*-".:$RV(ED0KHC71AFA+M"/:$TFXPI$2KF3M');C<1E=J>O[W`]7E3D\ M(UQUHM$+UVSN46_$E/>&)H)M(':((J*8J$N4$/6(^D0#HB'1B&A,-"&:$LV( MYD0+HB71BFA-M"':$NV(]D02FW"DQ"99.X?E>%QBD[J^S_W85"GF,V)39Z2] MV-2H(4_2Z6*Q7`L6BVWUI54UX+H7,AV#`L4@7Q@Y*1OG,6UUB1*GF*U7D,/H M.2EKOD];`Z*A4\R:#Q*`(R=ES8\]6[XO5!XVZXN_E\;0V5S/11I)5M_6HJV^ M"1SZ`U*1D5>G,;TF-<@E>-IEC>3)V]Y-QZ"&0Q%13,4N44+%'E&?B@.B(15'1&-/T6\_ ME:T[H_UTTU"7 M*''(50JO.'JV.)T7E:,2@L?&OC-C:ST@&A*-#&IHRY7"33!:C3T=SR.2,#S' M(T=Q/]=ID*0LWV\=HLC:,CMVCQMH_5T7X M5J=MI+*]@BBRMKPE3M@RL5-T#5P.OR'9=5*V&1*'G&*.9_0]RA9`Y9E2H1), M`7UGQEH>$`V)1@9E-A>./2G?,RH; M`109*15([HFI'CPQQ@?DD3S'',UI1*G'TC-\[^\Z&>Y M'`>8JFL'R$D_H0M0PX$S;+TR)!H9E,XBM>"A=.SI^`Y1Z]HS'**7P9Y#-/)G MD7HPC[4K6LKK)T"1D3(O@2O';V+XC1334)BD0W0-;(\H-.`15''@+#N/ M0&IDI:Z/?:U2J`3ST]@*',<-WR-J-7>&1_3BS_.(1K+,LE5L5X`Z1!%13-0E M2HAZ1'VB`=&0:$0T)IH038EF1'.B!=&2:$6T)MH0;8EV1'LB.9T!CFS=YK`< MA\L!#=3-<;D)3;(0JK"A)1!_ALM[$]S4BYL/3]<51+N MC-%5Y^R\T56C3-2UU6YUE9)V$T:'*"**B;I$"5&/J$\T(!H2C8C&1!.B*=&, M:$ZT(%H2K8C61!NB+=&.:$\DL0E'2FR2Y3A$`T)!H9 ME$W:>U*^8U0^Z`S'Z/21YQB-E.\SC@FFR;;Z#J)R3.;=+U%DD%3W>'!#+:>G MP$Z7=A*'7)UR/&!J;GO*3?`"J._,.!>@_"&E1@:E/:4<],&QI^,[1"5!SG"( MSIEX#M$HZ"E!7VU7M9374X`B(R4CK7*([*GDT`6E+DTG#IUTB+9END2E4`TJ MW7=FG$-0_I!2(XMTSKY>"(\#&5L!YNSEV.ZS'**S`IY#-/*>0$LX6N%8SL?+ M3&:_0Q01Q41=HH2H1]0G&A`-B49$8Z()T91H1C0G6A`MB59$:Z(-T99H1[0G MDL-J4W?;(&W=YK!V#LOQN!Q82WN^S_WQ0RWSL^.'?D@_^ULMZHLJ^C'=]5C9 MB^//^+=&ZN2W6IR,;8\.4404$W6)$J(>49]H0#0D&A&-B29$4Z(9T9QH0;0D M6A&MB39$6Z(=T9Y(`EN'A'Q81TI@D[5S6([');"IZ_O<#VR5(V!@GWEV6E5G M&KSA62,U);L'F$;P+-`VBB)E;[Y#%!'%1%VBQ*#,XJQ'U'>*V:H&N8R!D[)5 M'1*-B,9$$Z(IT8QH3K0@6AJ4N>T5T=HI9F\[>,3<."E[VUNB'=&>2&(]#0IK M3&*=+"],S<,.OL+>=E+WY MCD$91T5$L5/,.BI(JW2=E#6?T%:/J.\4L^:#EW@#)V7-#VEK1#1VBEGSP;IL MXJ2L^2EMS8CF3C%K/E@9+)R4-;^DK171VBEFS0>-LW%2UOR6MG9$>Z>8-1\T MCIR-KB)7GF+=,-FZI34Y'5W+9>*I96,L",Z@@>3(=!9A`R^O*X5)R].;PVO, M3AHD2U=WYUA,MHV49$]S=N!UG`W;[!%1[-")DKI!285@D90X*[:L'E&?:&`- MZ]6W')E8"U=[0VJ-B,9$$VO;KK5KP>@]I2/J.27#_51M)3](2F2R*]"2R3+B=:";I25Z!;"?Y M+8*L<7^*.B]%+8E\LYRP+7YKD&0@3E2R;:32-%GX+>2.,V,M1T2Q0R<*Z_J% M!<]5B;-A2^H1]8D&!MDLBIQY':RCAE0:$8V))@:9YJD5PN.HIM29$*:$VT,<*#H#O.C+4<$<4.G6B1KI$R,V65\Y>N3&:0ZSG#MO@^T<`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`I9JZE%OWBKHD7W+)J4:EKBX=3Z8*#594,\E^[CPMU1BR=Y:75,*J*4X^ M#C*!Q9:T4^X-J_;+:[[;8QOEE'*K6BBO@5K2/KF>N%4-E]MNJFURFT:U3&[# ME%3I\E,$O'O)AC?5BPQ>D;<4397KYQ5)Y$N#Y5Z2)&%3)06I)+F]IDH9\XKD M@YLJV\LKDLIMJD0MKT@6MJERK+PB"=2F2H_RBN0^FS)ZY%V2S9A-M2>02K(G MLZFV!O**;,ULJNV`O")[+YMJ5R"O=*KE9B3K85Z1?7=-M=&.5V07G923=^56 MRKG-+4?VP3;5WDM:Z\@5M=^25V2_:U-MN^05V?8J,9)W17:_2JWS6E2V9LJ5 M/!TYRJ6I3A1A.7*B2U,=+,(K4DW?E5LJYS2U'3M%IJI-;:$T.TY$:Y%V1TW*:ZM`6ZLBA.4UU M=@NOR-DY4NN\[BT'N\B5/)VXT91?0J2M?J,I/V-(/FXTY3<(R>4(^F97SF/G M%3D]OJG.AN<5.?B]J8YUYQ7YA0HU'.6.;24UN,FI_J)UE0[&KY\^_+C[>AC= MO7Q]>'J]^'[X(G-H\?C*^.7AJ]H9H?_Q9G[1Y[?GM[?G1WEE=GGQ[7#W^2`G M_18+,D=_>7Y^L_]0!?Q\?OG].$]_^G\!````__\#`%!+`P04``8`"````"$` MSD=:RP($```>#0``&0```'AL+W=O-^\?OR8?(=;A(ZSPM M64TV[AOA[L?MSS^M;ZQ]Y@4AP@&&FF_<0H@F]CR>%:1*^8PUI(9OSJRM4@&W M[<7C34O2O%M4E1[V_857I;1V%4/:D2/+KA6IA2)I29D*R)\7M.$# M6Y4]0E>E[?.U^9"QJ@&*)UI2\=:1NDZ5Q5\N-6O3IQ)TOZ(@S0;N[F9"7]&L M99R=Q0SH/)7H5//*6WG`M%WG%!3(LCLM.6_<'8H3Y+O>=MT5Z$]*;MSX[/"" MW3ZU-/]*:P+5!I^D`T^,/,D M$-GI@&M/LOQ^DD5/`E>=2;CTY^B_U7BJKIU-QU2DVW7+;@[T/E20-ZG<22@& MWL$?557MV+<,`ZH#.R/F8_C4%VQ&&(D&T@ M:8]CX#0&$@/P0)&6!9:_@RS)(F4-">T5$"P[B0%:KOR1!!TP+#E.D-,$24S$ MDC%_%QF29>-"_VIW,![5?M_'F!8&(VTZ1&N;(*<)DIB(I0WR>0>+)`OT+E10 MBYNCA9WY7@4%_R9.AVAQ$^0T01(3L<3!/C?%W1]WP^Z1P9V&X=E[A80+U6<8 MH96MZ*`"<*!;\ZB1?PJ!HKF][*2"@J#C788^_-D1B::!7"Q%,!P>5R2#;44* M"?N=@X-H-!X.*@"F^U"$XP0Y*23`WT[?7&.EO[335W-N)B>X*&CVO&?J;7+' MJ#D\34TYR6&K4HCV*0I'Y3RH`-.G'E$O.SGE3CVBS$;2DXDK)HTE2YZ3C/%] M)WUX-PSYRV`[?X4$,$7U[D$1MEOBH(),9S1B+AOW6L^MS,)=KXVJDVB><;/! M.]Z4]4-N20Y;K4("F$A:+<;C/E1!IF,]8CC6(^"*030:.HDF,H)0I&MKV0A' ML/\ON".Q%?>093#&2YU$U]>'/LITN(="<$A+G(Z3(6K5;4AT=Z!8Y$JT.BVJ M8TA%V@LYD++D3L:N\B0H]X%&]2EUA^5@&.%[>7J]A^,8WJEWXNR"]I>Z$U=TIRAIS];I*TZGRK;@1KP`LX93(! MY]/N8P&_0PCL>'\&8^?,F!ANY`/T+YOMWP```/__`P!02P,$%``&``@````A M`(O]EH+=`@``"`@``!D```!X;"]W;W)K&ULE%7= M;YLP$'^?M/\!^;T0R`<)"JG25=TJK=(T[>/9,0:L`D:VT[3__>XP8;A)N^P% MP7'^?=P=Q_KZN:Z\)ZZTD$U*0G]"/-XPF8FF2,G/'W=72^)I0YN,5K+A*7GA MFEQO/GY8'Z1ZU"7GQ@.$1J>D-*9-@D"SDM=4^[+E#;S)I:JI@4=5!+I5G&;= MH;H*HLED$=14-,0B).H2#)GG@O%;R?8U;XP%4;RB!O3K4K3ZB%:S2^!JJA[W M[163=0L0.U$)\]*!$J]FR7W12$5W%?A^#F>4';&[AQ/X6C`EM16L`D#:K#,!#K#LGN)Y2K9A>+N7ALQ+95]%PJ#;T M"3NPD_(14^\S#,'AX.3T7=>!;\K+>$[WE?DN#U^X*$H#[9Z#(S269"^W7#.H M*,#XT1R1F*Q``%R]6N!H0$7H#(-(=W;<6WN!$(2C^VU MD?5OF]0Y"BQ6)^V6&KI9*WGPH-^0K5N*TQ,F`'S49!$&E6^)!'4(LD64E,"@ M`K^&RCYMHN5L'3Q!-5B?8[,F(S,6"Z4FP.-&.S]+8!C#V`NMX?)T!HP-Q1!_KR4>M.OJ)!,`@Y MIDX^;+MW[7*KN2KX)UY5VF-RCSL5%\(0'?;]-D+EK^.S9`M<\"(8WL`>;FG! M'Z@J1*.]BN>`.?%C E-[E],+(%H;"-I8$-W-V6\,?EL)DF.)FYE.;X@`3# M/WSS!P``__\#`%!+`P04``8`"````"$`)%5^KQ\$``#1#0``&0```'AL+W=O M.;^DOL^*,ZESYM$+:>"3(VWKG,-K>_+9I27YH1M45WX8!(E?YV7C2H6T M?42#'H]E0;:TN-:DX5*D)57.H7YV+B]L4*N+1^3JO'VZ7CX4M+Z`Q+ZL2O[: MB;I.7:1?3@UM\WT%OE\0SHM!NWL9R==ET5)&C]P#.5\6.O8\\V<^*"WGAQ(< MB+8[+3DNW!5*,X1CLRZ!KZUS(,?\6O%O]/:9E*][*`S\OW"CQXDD0(:`[>\)X5@I)URFNC-/Z7TGJ'"F1 ML!>!YR""O7`:HSAYAPKN5>#9JR!O&L+P68G1]X]B(3#^'@/74DO00\ M51T/=L27W>W"VN8\7\Y;>G-@!4#_V"47ZPFEH#ND)'NJXZ>I&T515D;(;H1D.F)8@7I^0R)"!:8J-$R9BY!5^5J2\,_, M*8HR-T)V(R33$<,<+&K=W,_S$>3.P_#=:XE@Z)URA1(KLHTDA5C-QJU"M&%3 M:]GM>FW<35D4X@!;PIF2@7H,5[`?/.Y*D$U7$L&P1#575E8;20IG;ZY&R*X7 M"J4%'$]GELE,'V-8F+S'@B";%B1B!9-8"T62]&!&R*X7DBG$"">62*8/,1R( M^]!H@_;$P_$OA].)F-YZR(@G1%9G-SU+SZ>'](`&2$R8X7`.D6WQ34MGO4T( MT[8X=7]U3L+=TXZTAZQ,9V8:FYZEA]I#$6P#RB,:[80#2Y[>*(CBF=52<2$6 M14EMZ5E><.6=J2;MB6Q(53&GH%=Q>4U@ABI47:Q7H5@@%KX6%^Y[>)C"!>`. M/TKA-!WC*YRNH,[Q!VN7;A?94PY7Z>[?,_QT(G`)"SR8.4=*^?`BOD#]&%O^!P``__\#`%!+`P04 M``8`"````"$`[V3-[CZ['25Q=1RE;/?M MV^^!2!`$_FS%GA_VWS^<>^\NS\]V MW^_WGQZ^?_EP_C__"?]U=7[V_'+W_=/=M_WWW8?SOW;/Y__^^-__]?Z/_=.O MSU]WNY'[\X?SKR\O/VXN+I[OO^X>[Y[?[7_LOLN6S_NGQ[L7^<^G+Q?/ M/YYV=Y\.C1Z_77M/'_O/GA_N=O[__[7'W_:7KY&GW M[>Y%CO_YZ\./9]W;X_UKNGN\>_KUMQ__NM\__I`N?GGX]O#RUZ'3\[/'^YOD MR_?]T]TOW^1U_^DM[NYUWX?_0/>/#_=/^^?]YY=WTMU%=Z!\S=<7UQ?2T\?W MGQ[D%:C3?O:T^_SA_-:[::^6YQO^S^BIX=/^/?PY>N+I'LI MKTB]L)M/?_F[YWLYH]+-N]GA,.[WW^0`Y'_/'A_4I2%GY.[/#^O M'\[GJW?+]>7=^)_#O1R9&& MB[ZA_#O1\)5[E^,\O`3YM^]D-GMWM5PN5E=KL2.[7_4MUT-+;_VZEC)\#ON4 M?_M]>MX[;W&Y4F?MR!ZO^W;RKVXG.S_2P),KXK`G3U(P-'G=07J2U*ZMR>[K M#M/3&57_9]CK\0/5N517W]#DE0>J$^')_^G;SLU5>.STR-GK7N(XA\-HOND%S&(/^WY9[R.\?YY=7[R]^EW%_W\=L&./9$5L=H4:FZM9W(7`A M="%R(78A<2%U(7,A=Z%PH72AW!UX@RNI3.XAJ`A39``$D(B2`Q)("DD@^20`E)"*D@-:2#M6*PTR=N( ME:;IA;*>F:MH.Q>=2"[T:=Y"?$@`"2$1)(8DD!2207)(`2DA%:2&-)!V+-:) MER6O=>+56FD^?V>6Z*]^]U$]V4GIQ!D@*V>`#$$ZGIEL56>CH:O\.H!5*7 M,9,+4,"HD!218E)"2DD9*2<5I))4D6I20VHMLG.AEJ\GY*);[4I_^BQO5/F3 M0^7:O9,-4;JA;QIJ"D@A*2+%I(24DC)23BI():DBU:2&U%IDIT>M4T](3[>L MM=+3D3540+X'"D@A*2+%I(24DC)23BI():DBU:2&U%IDYT(M1L>Y4+.S-ZU> MU$+5F9WU9+_A+)WBW-9$Z2'CDP)22(I(,2DAI:2,E),*4DFJ2#6I(;46V9E3 M"U(WF9N>6'-XZS0S^'NL0X24[1=--''1UG)F9()"D@A:2(%),24DK*2#FI()6D MBE23&E)KD9W(TPH5,Q8J>G+FC6Y9ST29]`P5#DT!HT)21(I)"2DE9:2<5)!* M4D6J20VIM/;8$_CU1?))P6DD!218E)"2DD9*2<5I))4 MD6I20VHMLG/A%BK>O/J:L8;1DS.*W&JLB=)#QB<%I)`4D6)20DI)&2DG%:22 M5)%J4D-J+;(SIVH+)XRBKA1AC2)4)[8SD$\*2"$I(L6DA)22,E).*D@EJ2+5 MI(;46F3GXA^K8:B'.)T:1D_.*'*+YB;*C**NK]%=,F!42(I(,2DAI:2,E),* M4DFJ2#6I(;46V9ES:QC'I^2SH52AS_*FI]%9WI)\4D`*21$I)B6DE)21J%G#"':TK'5AWM*&:,)YYNT7SV1"ED^B3`E)(BD@Q*2&E MI(R4DPI22:I(-:DAM1;9Z5$K_'%ZWKH\ZBH%DK=1DE9.378S&^H))LI=YYH8 MD\BAF::`42$I(L6DA)22,E).*D@EJ2+5I(;46F0G\K0RQ(QEB)[LMZ254['= MFBB="Y\4D$)21(I)"2DE9:2<5)!*4D6J20VIM[+?"M?.;&9KHH:W0E)`"DD1*28EI)24D7)202I)%:DF-:36(CL][HK@C5/. M^;!4&-U>U\Y\9=-'':W(FQB3R*YS::8I8%1(BD@Q*2&EI(R4DPI22:I(-:DA MM1;9B737#C^Y$0]+!'U*-_..G'&&]]$A2C?T34--`2DD1:28E)!24D;*206I M)%6DFM206HOL]+@K@FZ<'9Z0?OGZK$G$YKD MK;G*])AMRHH9E$VH?O3J35X<\7Z@M@K[_`%IQ>:Y*+ M:G009H[:'WW74#XQU/<`OV^H/J4:-32S3?OHW1FW.OK%\L3QL>!$7)-]^&8V MVQ]^U]`Z_)[LPS?S4OOPW;GYVPZ?4_9%3_;AFWEO?_A=E'7X/5F'?V5F3?;A MJ]GUZV?QBWXR/GJ8MJ>EH2W))P6DD!218E)"2DD9*2<5I))4D6I20VHMLG.A MUADGY*);EHQKM(M^I2+W,S/PKIRYV-9$F1$[--04,"HD1:28E)!24D;*206I M)%6DFM206HOL])RVGEEP/=/3Z.UY2_))`2DD1:28E)!24D;*206I)%6DFM20 M6HOL7$PO7DY]TQB6+OJJW\@//ZB*@'PTK&FKR=S@_)[4I,^,L[7SSAB8*-U7 MR+XB4FP:CKMWWKD2$Z6[3]E71LI-PW'WSCM+8:)T]R7[JDBU:3CJ_LI9330F M2G??6GW9Z59+C_&=\6T3M&X!8]TP.U*?/@^)G.-^.03I0_75.E9=)G+;'-IY M5\[$+M!1J\./B:S7R_7UVCD/H8Y9#!=<1(HU'=U?HJ/D&AX=E9DU'J8,J8XR M>\Q(N::C>RQTU-$]ECK*[+$BU9J.[K'144?.::MC#ONS+R2U0!I?2!.++DFJ M7G4M5+@SI>](/@'2%\.VCY)/'33YI*`GJ8?KJ)!1$2DF)>PK951&RDD%^RH9 M59%J4L.^6BO*RH4J-UBY>-.@/O1BIZ@G5?/"'=7<8Z8;FCWFFH[NL=!11_=8 MT];:GWTE2::/7DG_V?_XNQ++:+1+S=\= M[3W)KO5%LB7YI(`4DB)23$I(*2DCY:2"5)(J4DUJ2*U%=H[4HOKU=UY93B(7 M':G+8#0ZG4G7MF\XRIA/"D@A*2+%I(24DC)23BI():DBU:2&U%IDIT<5#<;I MZ6[&)W_?;-E7+>P;C"G]'*8@FSY*O4\/J71N:%L3HX>>3PI((2DBQ:2$E)(R M4DXJ2"6I(M6DAM1:9"?RM(+.D@6=GIQQYJP^MB;*I*?K:S3T`D:%I(@4DQ)2 M2LI(.:D@E:2*5),:4FN1G1YY3_U'QIGJYS#M,2/(NS(URGZ<=5''Q]D08Q() M"I:@D!218E)"2DD9*2<5I))4D6I20VHMLA-Y6C5HR6I03\XX62M\X* MASK*Z-WJVJFS;99=U/%WJR'&W`Y!@>E)1X6DB!23$E)*RD@YJ2"5I(I4DQI2 M:Y&5R)5;:SE^.SR$VT65GIQQYA953)0^\3XI((6DB!23$E)*RD@YJ2"5I(I4 MDQI2:Y&='K>`\9/TL%"QZFAT@]N2?%)`"DD1*28EI)24D7)202I)%:DF-:36 M(CL7IQ4J5BQ4].0,%:>,N#519J@,%0Y-`:-"4D2*20DI)66DG%202E)%JDD- MJ;7(3H];J/C)4!GJ$?J4;E8=64,%Y#,J((6DB!23$E)*RD@YJ2"5I(I4DQI2 M:Y&=B]-J#2O6&GIRAHI;"C)1.HD^*2"%I(@4DQ)22LI(.:D@E:2*5),:4FN1 MG1ZU9G?GW6_X#:E5M_:76?=X]N847C=]U-'9FXDQB41A(6!42(I(,2DAI:2, ME),*4DFJ2#6I(;46V8ET:PUO7D"M6(;HR1F"3L5V:Z),YE!S"!@5DB)23$I( M*2DCY:2"5)(J4DUJ2*U%=N9.*T.L6(;HR7JWZJ)&Y#,J((6DB!23$E)*RD@Y MJ2"5I(I4DQI2:Y&=BZDRA'?J@Z8KEB`TC;XRU)/\-H@9+EU#]7S9\)F'=^V4 MU8.^H43IAB$I(L6DA)3V-#JNC)2;AN-#=8K+A8G2AUJ2*E)-:DAM3]VAVHE4 M"WZ^KYWX\->J*QN,:TD]C1_^TC1.9%]OZ)Y`F?@304'?2!Y?TVSN?-:4M.1WEU&R@T=V5UA M[VYV=3E;KIQ;7Z^=!6+(=A$I)B5N[Y>SQ6+E3(M3MLM(.:EP>_>\M7>-VV5W_D:GH6)7 M-:EQ>E]>7RVN/.>]IK7:V1E7M8_Q1/9X+5/]31WG:>2>G`'IEII-E!F075^C M=]>@CY*OS:EIW&SE>9?.]1*RHX@4DQ*[[[GG>0OGKI&R54;*287=MUP]"W=5 M5;)51:I)C=WW?#9;N]/(UFIEI]Y_/EROW;Q"G;)>1 MZMI9L99L5Y%J4H/>+]?D)UK70\%G_$[JO,I-'W6T^FUB M]&CV20$I)$6DF)204E)&RDD%J215I)K4D%J+[$1.E7O>]/C0FB6?GJSJ]^S2 MF=QL393)7-?7J`@;,"HD1:28E)!24D;*206I)%6DFM206HNLS%VYE9PW/CYT MZ,=YV'5VZ/HI83[GJR!Y%GE/.WYHH/61\4D`*21$I)B6DE)21W5 MYUEBU3O=VNKV0_AY\;<-O( M%K64FMC/^EJV3+6Y75[?W,I39!-M9(MZJ'QBRTJR(,\S3VV1+,C3M5-;)`OR M8.?4%LF"/&8XM46R,'ELM\OYS:U\SVZBC6Q17Y"N5W22?:R!;UV^I36^3U=)4T]PCF^7G:B=[F\GHFC^!V M)O<=^9G^B3:R1?U9K*DM<@[DM^ZFML@YZ!Y@<8]M)M=H]YP)MDA^NB(MMLCK MD4]]IO8CKT?^]L/4%KEVIE^/)_N1OQP[T<:3_IN,5?7<0(``,4%```9 M````>&PO=V]R:W-H965T#/-JHQ%I"F_??[@)9F:[5E+[;!AW/.=V-U>:]&<@?& M2CTUM,AR2F`2NI53W]#OWVY.SBFQCD\M'_4$#7T`2R_7;]^L]MKH8)_W3:*.YP:7IF9P.\#8?4R,H\/V6*RXE&AMHPBDE"A1?^PG M;?AVQ+COBP473]QA\8)>26&TU9W+D(Y%HR]COF`7#)G6JU9B!#[MQ$#7T$U1 M7RTI6Z]"?GY(V-N#;V('O7]O9/M)3H#)QC+Y`FRUOO70CZW?PL/LQ>F;4(`O MAK30\=WHONK]!Y#]X+#:2PS(QU6W#]=@!284:;(RV!!Z1`/X)$KZSL"$\/OP MWLO6#0VM3K/R?%DL3Q%/MF#=C?28-.@I)VY;\&B1N+7(T(3'KOQX(9B4Z-7BU6X6U=YOF)W MF#KQB+F*&'PF3)$0#$63,JH=K^S!7MGGPUNYBAME,+$HSBZ>;?PF4OV/B`'Y\%8`0PJT59YF8BC=`0=(8V00^G0K>4B MP^V_E]>?"RY2EA]W#JM9Y57R%5,=QR9VE0+3PSL81TN$WOF1\"5*NVE:-Z4O MY9_[BWH3QH>E'SA%,^_A,S>]G"P9H4/*/#M#8R;.85PX/8=>WFJ'XQ,^![PN M`5LE]X%W6KNG!0JS=`&O?P$``/__`P!02P,$%``&``@````A`(A*6V-N`@`` MP04``!D```!X;"]W;W)K&ULE%1;;]L@&'V?M/^` M>*^Q8R=IK3A5NBI;I56:IEV>"<8VJC$6D-N_WP>D+&LK-7NQ#3Z<<[X;B]N# M[-&.:R/44.$L23'B`U.U&-H*__RQOKK&R%@ZU+17`Z_PD1M\N_SX8;%7^LET MG%L$#(.I<&?M6!)B6,& M4E_"H9I&,'ZOV%;RP082S7MJP;_IQ&B>V22[A$Y2_;0=KYB2(U!L1"_LT9-B M)%GYT`Y*TTT/<1^R@K)G;K]X12\%T\JHQB9`1X+1US'?D!L"3,M%+2`"EW:D M>5/A55;>33%9+GQ^?@F^-V??R'1J_UF+^JL8."0;RN0*L%'JR4$?:K<%A\FK MTVM?@&\:U;RAV]Y^5_LO7+2=A6I/(2`75UD?[[EAD%"@22;>!E,]&(`GDL)U M!B2$'OQ[+VK;57ARG61%.@,TVG!CU\(Q8L2VQBKY.V`RYRER3$X<\#YQY+-D M.D_S['T2$OSX\.ZIIWP3\$Q[07!Z>`T,%(*A(FZ>S%](!=($T0,ZE M?:\6\_>*ZTYY#S''IYWS6N;I/+H*X8:1"3TEN6[Y)][W!C&U=>/@"A1WXZ2N M)JZ0+_>+*`O#XS\[ MN"HY-$J:`+A1RCXO0)C$RW?Y!P``__\#`%!+`P04``8`"````"$`VCOTG<$) M``#=+0``&0```'AL+W=O8UVZ^+F_PM M.]"5Y_RX7Y_HW^-+IW@[9NNGLM%^US&[W7YGO]X>VI7"^/@5C?SY>;O)9OGF M?9\=3I7(,=NM3S3^XG7[5@BU_>8KY,^G&Y+K5`/%>QYU1AU2NK]]VM(= ML&EO';/GN_:#,4Y-N]VYORTGZ+_;[*-H?&\5K_F'<]P^!=M#1K--?F(>>,SS M;\S4>V*(&G>@]:+T0'QL/67/Z_?=*'5XS#()^5`V)=?'HDAG,.^_/I8^F(L](6K M&#?#7L_N#Z_PCS$0,O3EVL%TJJ5;1L)L?5K?WQ[SCQ9M+[0XB[ M$S%0K=@Z*CX+"HH&IO+`9.[:U)[6>T&1_/W>ZHYN.]\I^C;<9H(VAFHQ%18L MU)CL3`=S'2QTX.C`U8&G@Z4.?!T$.@AUL-)!I(-8!XD.T@;HD'MJ']$2_AT^ M8C+,1V)V)Q6P!Z6_;&,PZFK^J`U$DQF0.9`%$`>("\0#L@3B`PF`A$!60"(@ M,9`$2-HDBG]H<_@=_F$R=VW:PNL8,FS-(Q-NTPPT6W-:;5([#<@J0SH%U,>)E..5*X2R]`RFDEE=#'R:Q.Q2&=`YD`60!P@+A`/ MR!*(#R0`$@)9`8F`Q$`2(&F3*%XSZ'AWQFTW+(,^O6XWWR8Y12NE4&>V!(LR M')ZG,A5U?97"=(BSZL1H*I!9HQE'%BTTN2D,9`R6\G-I)9RY0"T'D2L;-N5E M1)7RGK02\DO4\A$%LF%37L9'*1]**R&_0JT(42P;-N2'VK::2"LAGRI:JKM9 M,HP'DVO=7:74]'@674Z,"E%=08[5TL)V*HU$NYE`RA8SE$\%O@"X>K_,J0># MWF`TT.9A(93*RD;9S$'D"G2Q/T]8T88LE^50>WXLA97LT4<4"'2QQU!87>QQ M):QDCQ&B6*"+/2;"ZL*MJAFC.D556H4I'+]#*0>0B\E!KB58^H@!1B%HKM(H0Q8@2U$H5 M*]47+!MO^J)Z]%X;U%5.3]V(X)RP^@SYPZ+H:X2!%GA3;E65%$M_S$1#\F>C M(40UEV?/D>_WGT1U9=,0=X2X#`)7H(O]><)*C0N(:NC1%PUECX%`%WL,A=7% M'E?XP%HJSU\SE-A%55?3@[IZG2G[J2:/N^N)+^RM\^RP::T1AVC)46-LZ1M)IQ*[O*$<[4,N?20LS,0DA+'0>1*QNRS=\V;%/+^CUI(:27 MJ.,C"F3#2AHJL*&T$-(KU(D0Q;+A)Z-.I(603A4=U;WLQ-]T[S]D4;Q`(&=V MPGZ^8-'7S+N-D78$F4HK,:@9HCE'=C.QJN5%0P<;NH@\U%JBE8\H0!2BU@JM M(D0QH@2U4L5*=0^K?USA'EXN:;JG0G8S@Z*?H[4R"_N%B#FQF??6J+$OX;F( MRYME!F58W4'/UGR_0'$'D2O1A?X\;F57_8U&EFEI][*40F+%^(@"B2YT%ZK= MF<.NV>MK6_-**HG^(D2Q1!?Z2[3^^FS#T\ZPJ52B_M35PHHL5ZR6JB:CY-L5 M:B2"4P/0#-&<(R5RH:&##5U$'FHMTZ.A/32T9TVJM%,]SDH[38__0T`RZM:BQ*%%>(HECLI%,ZG/#<5J`9 MHCE'S6:BW1RD<4(`I1:X56$:(848):J6*E^N)<$>=KFVM=MQ$3 M/F$'"PI$+8'5:F93;M5,8!'-A1;/5OMVK]<=:!O4`MLYB%Q$GJYN6;U^5U-? M8CL?48`H!/6^T1]I)]85MHL0Q8@24.\.^H8V=O;.IMS:*H]7[V!6;Y[ML^-+ M-LUVNZ*UR=_9^Y7T_+V_K3%_^7,T?J#Z'_E7NS`9C=/R_*'Q!\,>/U#79UK0 M%5:#PBM4-QBSR@!>H6/_F!WL\0J=VL?L7(Y7Z-`]9L=JO$)OLCZ4ARUMS!-Z MP[6L4.GZ-;+GR=T';KQ\_?=I?LNC\]:"_HEDN[[W!7Z M$9'N^]P5^OV/[OO<%2JPD5KY[JS6#]6SJ$UYI5-?HI=KW]8O6;@^OFP/16N7 M/=/BZ)8_#QRKUW.K?TZ\N/N8G^BU6GKZTGN+]!IU1E6^[@UE9L]Y?A+_D#,Z M]8O9]W\#``#__P,`4$L#!!0`!@`(````(0#_$9FT,@$``$`"```1``@!9&]C M4')O<',O8V]R92YX;6P@H@0!**```0`````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````"&>TO9W%Q(RQ(U.[G$Q!F--X1O&[%0`FB[ M?R_KVCJC)X_D?7EXOH]BV>HJ^03G56U*1+(<)6!$+979E>AILTH7*/&!&\FK MVD")#N#1DEU>%,)243MX<+4%%Q3X))*,I\*6:!^"I1A[L0?-?18;)H;;VFD> MXM'ML.7BG>\`3_)\CC4$+GG@^`A,[4A$/5**$6D_7-4!I,!0@083/"89P=_= M`$[[/R]TR5E3JW"P<:9>]YPMQ2D027R/GNR&Y'EZ>[=9 M(3;)R56:7Z?Y8D,F=#:G9/9:X*'5WV&UL M(*($`2B@``$````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````````````````G%9-;Z,P M$+VOM/\AXMZ2KV:[%:$BX"1(!%APNLK)6_F><8>6[M_W26=/2MXG*5CI7?=53HLC;)UG#Z-E26>7MTJ'2YHNJ9)EK*Q M\L:X%*S MS2:.F)5%+SN6"K7?[8Y4]BI8NF;KJ_SH4*D]WNW%I4[7653JXP_X+0?!NF;D M>1)'5,`J]44<%1G/-J*#7B.6:&K3J(&ZD$4O12S>]*ZF-G^U,*(),\&QOJ$) M9YKZ,:'-&2V3YM.XX+JV%W=[%HFLZ/#X#Z2MKW0>*6>EG+&RIT5,4P&R2EC] M4XV3G(M"_YT5SWS+F.":"H!ZLAHVL/> MQJ>%D$@>C)J:*Q6UXEK0H8H$]@9!J8!\$3NMJQUG3>7'-9B>:R$W1!:9&([A MFHB$"AP2R MB`/#Q,0W5L;$05+8#<`6"QO7.2C=EC30@5S3EE-&4`TC0'//L5`05C+P2NK\ M!PF0`PFV0$*I&N2X(2BR/5=>R]LRN@E+@C*4H&J=2Y@)L&&[TA@_(+##\ MN6U".-\+2O52:*]+T,)WO!5"9`*EF=J0&]A?NN;V0 M/:GS=DY?RCE7?8+I8P(MYGAZRF91'[W/>Z`&$>3*SNS+MC2?:PVD6D]S,2?WY#\WHQ.GSWR9X\RB M@AVN_M-)+=S"M;2&2_%@_YC0YG#K%TGIQ-S2](FM#YC/AO*A\E"_QO3>\+H[ MZ,(;I#&GJ1_O+OTO````__\#`%!+`0(M`!0`!@`(````(0!,"'?^XP$``$,7 M```3``````````````````````!;0V]N=&5N=%]4>7!E&UL4$L!`BT` M%``&``@````A`+55,"/U````3`(```L`````````````````'`0``%]R96QS M+RYR96QS4$L!`BT`%``&``@````A`"ZU^7/Q`0``.A8``!H````````````` M````0@<``'AL+U]R96QS+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`*+)3R,[!P``[24``!D`````````````````^1\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/'+5`@``3@4``!D````` M````````````9CD``'AL+W=O&PO=V]R M:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*;F!H9W M-0``2Z<``!0`````````````````MDD``'AL+W-H87)E9%-T&UL M4$L!`BT`%``&``@````A`+SONV;2#```]WH```T`````````````````7W\` M`'AL+W-T>6QE&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`( M````(0"(K5--OP(``/@&```9`````````````````"&3``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`*)C))DD`P``"0H``!D` M````````````````%Y8``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+\_&L:\`@`` MSP@``!D`````````````````69T``'AL+W=O$\`P&``!1&0``&0````````````````!, MH```>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,-@+'S_`@``YP@``!D````````` M````````F<(``'AL+W=O&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`#-KJOAU!```8@\``!@` M````````````````N&PO=V]R:W-H965T&UL M4$L!`BT`%``&``@````A`/<17,*C!@``FQP``!@`````````````````Q^L` M`'AL+W=O&UL4$L!`BT`%``&``@````A`,G^:0]O`@``Q04``!D````````````` M````I?4``'AL+W=O&PO=V]R:W-H965T M*```9```` M`````````````![_``!X;"]W;W)K&UL4$L!`BT` M%``&``@````A`,Y'6LL"!```'@T``!D`````````````````JQ@!`'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`'-R MF+%N%P``!I8``!D`````````````````3B0!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-H[])W!"0``W2T``!D` M````````````````0$$!`'AL+W=O XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
7. RELATED PARTY TRANSACTIONS (Narrative) (USD $)
9 Months Ended
May 31, 2014
Related Party Transactions [Abstract]  
Bonuses paid $ 120,000

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SIGNIFICANT ACCOUNTING POLICIES (Details-Earnings Per Share) (USD $)
3 Months Ended 9 Months Ended
May 31, 2014
May 31, 2013
May 31, 2014
May 31, 2013
Numerator        
Net income attributable to common shareholders $ 1,307,549 $ 993,230 $ 2,802,568 $ 2,641,791
Denominator        
Weighted-average number of common shares outstanding during the period 16,193,976 16,024,467 16,117,198 15,984,819
Dilutive effect of stock options 261,102 311,141 244,497 322,799
Common stock and common stock equivalents used for diluted earnings per share 16,455,078 16,335,608 16,361,695 16,307,618
XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
4. CONTRACT PAYABLE
9 Months Ended
May 31, 2014
Contract Payable  
Note 4. CONTRACT PAYABLE

On May 15, 2014 the Company entered into an agreement (the “Agreement”) with TSRL, Inc., a Michigan corporation (“TSRL”). Under the terms of the Agreement, the Company and TSRL agreed to transfer the rights of the intellectual property under the Exclusive Software Licensing Agreement dated June 30, 1997 (the “License Agreement”), under which TSRL licensed to the Company certain Software Technology and Databases (as defined in the License Agreement), and pursuant to which the Company paid royalties to TSRL to the Company.

 

The Agreement calls for the Company to pay TSRL total consideration of $6 million. The Company paid $3.5 million on May 20, 2014, comprised of cash in the amount of $2.5 million and the issuance of $1 million worth of the Company’s common stock-- 164,745 shares of the Company’s common stock based upon the April 25, 2014 closing price per share of $6.07. Future payments under the Agreement, which is non-interest- bearing, are due as follows:

 

April 25, 2015   $ 750,000  
April 25, 2016     750,000  
April 25, 2017     1,000,000  
Total   $ 2,500,000  
Less Current portion     (750,000 )
Contract payable, net of current portion   $ 1,750,000  
EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\W8F8S83'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/CA?0T].0T5.5%)!5$E/3E-?04Y$7U5.0T525$%) M3CPO>#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C)? M4TE'3DE&24-!3E1?04-#3U5.5$E.1U]03TQ)0S$\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I%>&-E M;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/C9?4TA!4D5(3TQ$15)37T5154E465]486)L97,\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/C)?4TE'3DE&24-!3E1?04-#3U5.5$E.1U]03TQ)0S,\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C)?4TE'3DE&24-!3E1? M04-#3U5.5$E.1U]03TQ)0S8\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C9?4TA!4D5(3TQ$15)37T5154E465]$971A:6QS1#PO>#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C9?4TA!4D5(3TQ$15)37T5154E465]$971A:6QS3S$\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K M#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV M95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!) M;F9O'0^)SQS<&%N/CPO2!296=I2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)S`P,#$P,C,T-3D\'0^36%Y M(#,Q+`T*"0DR,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A(%9O;'5N=&%R>2!&:6QE'0^)TYO/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO3QS<&%N/CPO2!#;VUM M;VX@4W1O8VLL(%-H87)E'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO'!E;G-E2P@;F5T(&]F(&%C8W5M=6QA=&5D(&%M M;W)T:7IA=&EO;B!O9B`D-#$L.#'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XR+#4R.2PS-S$\6UE M;G1S(&1U92!U;F1E'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO2`H;F]T92`U M*3PO'0^)SQS M<&%N/CPOF5D(&YO('-H87)E'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\W8F8S83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2`S M,2P@,C`Q-#QB'0^)SQS<&%N/CPOF%T:6]N(&]F(&-O;7!U=&5R('-O9G1W87)E(&1E=F5L;W!M96YT M(&-OF5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PP,#`L,#`P/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XU,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2`S,2P@,C`Q-#QB M2`S,2P@,C`Q M,SQB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XR+#`X.2PS,C<\&5S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W.#$L-S'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W8F8S83'0O M:'1M;#L@8VAA2`S,2P@,C`Q-#QB'0^)SQS<&%N/CPO2!O<&5R871I;F<@86-T:79I=&EE'0^)SQS<&%N/CPOF%T:6]N(&]F('!R;W!EF%T:6]N(&]F(&EN=&5L;&5C='5A;"!P3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S&5S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V-#0L.30U*3QS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S MF5D M(&-O;7!U=&5R('-O9G1W87)E(&1E=F5L;W!M96YT(&-O'0^)SQS<&%N M/CPO"!B96YE9FET'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO M6EN9R!F:6YA;F-I86P@2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L M97,N(%1H92!I;G1E2!F;W(@82!F86ER('-T871E;65N="!O9B!T M:&4@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2`S,2P@,C`Q-#QB'0^)SQP('-T>6QE/3-$ M)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/'4^17-T:6UA M=&5S/"]U/CPO<#X-"@T*/'`@2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E6QE/3-$)V9O;G0Z M(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/'4^4F5V96YU92!296-O9VYI=&EO;CPO M=3X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^5V4@2!I2!P=7)C:&%S960-"G-O9G1W87)E(&%T(&YO(&%D9&ET:6]N86P@8VAA2!D;R!N;W0@2!C:&%N9V4@=&AE(&)A M2!O9B!T:&4@7!I8V%L;'D@;V-C=7)R960@;VYC92!O65A'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU65A65A2!U;FQO M8VL@86YD(&EN=F]I8V4@65AF4@ M'1E;G0@;V8@<')O9W)E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU'0M86QI9VXZ M(&IU2!L:7%U:60@:6YV M97-T;65N=',@<'5R8VAA7IE('1H92!A9V4@;V8@8W5S=&]M97(@8F%L86YC97,L#0IH:7-T;W)I8V%L M(&)A9"!D96)T(&5X<&5R:65N8V4L(&-U6UE;G0@=&5R;7,@=VAE M;B!M86MI;F<@97-T:6UA=&5S(&]F('1H92!C;VQL96-T86)I;&ET>0T*;V8@ M=&AE($-O;7!A;GDF(S$T-CMS('1R861E(&%C8V]U;G1S(')E8V5I=F%B;&4@ M8F%L86YC97,N($EF('=E(&1E=&5R;6EN92!T:&%T('1H92!F:6YA;F-I86P@ M8V]N9&ET:6]N'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU MF5D($-O;7!U=&5R(%-O9G1W87)E($1E=F5L M;W!M96YT#0I#;W-T6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^4V]F='=A'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X M<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'1E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IUF%T M:6]N#0IO9B!S;V9T=V%R92!D979E;&]P;65N="!C;W-T2P-"F%N M9"!A;6]R=&EZ871I;VX@;V8@2X- M"E=E(&5X<&5C="!F=71UF%T:6]N(&5X<&5N2!D=64@=&\@:6YCF5D(&-O;7!U=&5R('-O M9G1W87)E(&1E=F5L;W!M96YT(&-OF5D(&-O;7!U=&5R('-O9G1W M87)E#0ID979E;&]P;65N="!C;W-T6EN9R!A;6]U;G0@;6%Y(&YO="!B92!R96-O M=F5R86)L92X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/'4^4')O<&5R='D@86YD($5Q=6EP;65N=#PO=3X\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^4')O<&5R='D@86YD(&5Q=6EP;65N="!AF%T:6]N(&%R92!P6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL M6QE/3-$)W=I9'1H.B`Q M,#`E.R!B;W)D97(M8V]L;&%P'0M86QI9VXZ(')I9VAT)SXU('EE87)S/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$)W9E6QE M/3-$)W!A9&1I;F6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SY3:&]R=&5R(&]F(&QI M9F4@;V8@87-S970@;W(@;&5A6QE/3-$)V9O M;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^36%I;G1E;F%N8V4@ M86YD(&UI;F]R(')E<&QA8V5M96YT'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU6QE/3-$ M)W9E6QE/3-$)W9E3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V)O'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R M;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^-RPW-36QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUL969T.B`U M+C1P=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!T M('-O;&ED.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U M)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[(&)O'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^-RPW-36QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@ M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^-RPW-36QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-3`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-3`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W9E6%B;&4L(&-O;G1R86-T('!A>6%B;&4L(&%C8W)U960@<&%Y'0M86QI9VXZ(&IU2!O M9B!S86QA'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^5V4@=71I;&EZ92!&05-"($%30R`W-#`M,3`L)B,Q M-C`[/&D^)B,Q-#<[26YC;VUE#0I487AE'!E8W1E9"!F=71U6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^ M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^56YD M97(@=&AI2!T87@@'!E8W1E9"!T;R!A9F9E8W0@=&%X86)L92!I;F-O;64N(%9A;'5A M=&EO;B!A;&QO=V%N8V5S(&%R92!EF5D+B!4:&4@<')O=FES:6]N(&9O M6%B;&4@9F]R M('1H92!P97)I;V0@86YD#0IT:&4@8VAA;F=E(&1U"!A'0M86QI9VXZ(&IU2!A9W)E96UE M;G0@=VET:"!%;G-L96EN(%)EF5D(&]V M97(@,3`@>65AF%T:6]N(&5X<&5N'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU2`Q-2P@,C`Q-"P@=V4@86-Q=6ER960@:6YT96QL96-T=6%L#0IP M2!F'!E;G-E(&9O2`Q M-2P@,C`Q-"!T;R!-87D@,S$L(#(P,30@=V%S("0R-2PP,#`N($%C8W5M=6QA M=&5D(&%M;W)T:7IA=&EO;B!A6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2P@86YD#0IW87,@)#(V+#@W-2!A;F0@)#$L.#2!F;W(@=&AE('1H6QE/3-$ M)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/'4^16%R;FEN9W,@<&5R(%-H M87)E/"]U/CPO<#X-"@T*/'`@6QE/3-$)W1E>'0M86QI M9VXZ(&IU6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E M6QE/3-$)V)O6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M8V]L6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`T,B4[ M('!A9&1I;F6QE M/3-$)W=I9'1H.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^,2PS,#6QE/3-$)W=I9'1H.B`Q M,24[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^.3DS M+#(S,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3$E.R!T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C(L.#`R+#4V.#PO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,3$E.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/C(L-C0Q+#6QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M/"]T6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$ M)W9E'0M:6YD96YT.B`M,3!P="<^5V5I9VAT960M879E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W!A9&1I;F6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG M:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/C$V+#0U-2PP-S@\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/C$V+#,S-2PV,#@\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$V+#,V M,2PV.34\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$V+#,P-RPV,3@\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X\+W1R/@T*/"]T86)L93X-"CQP('-T>6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/'4^4W1O8VLM0F%S960@0V]M<&5N2P@86YD('=A2X@5&AI'!E;G-E(&ES(&EN M8VQU9&5D(&EN('1H92!C;VYD96YS960@'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU&5S("A4 M;W!I8R`W-#`I.B!0F5D(%1A M>"!"96YE9FET(%=H96X@82!.970@3W!E"!#69O"!C&%B;&4@:6YC;VUE#0IO65A'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M2`R,#$T+"!&05-"(&ES'!E9&EE;G1S(&%S(&%L;&]W M960-"FEN('1H92!S=&%N9&%R9"X@5V4@87)E(&5V86QU871I;F<@=&AE(&EM M<&%C="P@:68@86YY+"!O9B!T:&4@861O<'1I;VX@;V8@05-5(#(P,30M,#D@ M=&\@;W5R(&9I;F%N8VEA;"!S=&%T96UE;G1S(&%N9"!R96QA=&5D(&1I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2`S,2P@,C`Q-#QB2P@4&QA;G0@86YD($5Q M=6EP;65N="!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$ M)W=I9'1H.B`Q."4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^,3(T+#`T,CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M,30U+#@Y,SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F'0M86QI M9VXZ(&IU'1U6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C4Q+#0V-CPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,C,L-C0V M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/C,T-2PP-#<\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$)W9E3L@;&EN92UH96EG:'0Z(#$Q-24G/DQE MF%T:6]N M/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXI/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ(&IU M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R M+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^)#PO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,3`S M+#4Y-CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2`S,2P@,C`Q-#QB'0M86QI M9VXZ(&IU2`Q-2P@,C`Q-"!T:&4@0V]M<&%N>2!E;G1E M2!A;F0@5%-23"!A9W)E960@=&\@=')A M;G-F97(@=&AE(')I9VAT&-L=7-I=F4@4V]F='=A2!C97)T86EN(%-O9G1W87)E#0I496-H;F]L;V=Y(&%N M9"!$871A8F%S97,@*&%S(&1E9FEN960@:6X@=&AE($QI8V5N2!T;PT*<&%Y(%134DP@=&]T86P@ M8V]N2!P86ED M("0S+C4@;6EL;&EO;B!O;B!-87D@,C`L(#(P,30L(&-O;7!R:7-E9"!O9B!C M87-H(&EN('1H92!A;6]U;G0@;V8@)#(N-0T*;6EL;&EO;B!A;F0@=&AE(&ES M6QE/3-$)W=I9'1H.B`W-R4[('!A M9&1I;F'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H.B`S)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3@E.R!T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^-S4P+#`P,#PO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(&IU6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,2PP,#`L,#`P/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(&IU6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,BPU,#`L M,#`P/"]T9#X-"B`@("`\=&0@3L@;&EN92UH96EG:'0Z(#$Q-24G/DQE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXI/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E3L@;&EN92UH96EG:'0Z(#$Q-24G/D-O;G1R86-T('!A>6%B;&4L M(&YE="!O9B!C=7)R96YT('!O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\+W1A8FQE/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^3VX@2G5L>2`R,BP@,C`Q,BP@=&AE($-O;7!A;GD@96YT97)E9`T* M:6YT;R!A;B!E;7!L;WEM96YT(&%G'!I65A2!F;W(@=&AE('!R979I;W5S(&9I65A&5R8VES86)L92!F;W(@9FEV92!Y96%R2!F M;W(@86YY('-T;V-K('-P;&ET2!O8FQI9V%T:6]N M('=O=6QD(&)E('1O('!A>2!I=',@4')E6UE;G0@86=R965M96YT(&9R M;VT@=&AE(&1A=&4@;V8@;F]T:6-E(&]F('1E'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU65A2!T:&4@0V]M<&5N65A2!F;W(@86YY M('-T;V-K('-P;&ET2!O9B!T:&4@86=R965M96YT M(&ES(&%T=&%C:&5D('1O('1H92!#;VUP86YY)B,Q-#8[6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="]N M;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE($-O;7!A;GD@:7,@82!P87)T M>2!T;R!L:71I9V%T:6]N+B!-86YA9V5M96YT(&1O97,@;F]T(&)E;&EE=F4@ M=&AE(&]U=&-O;64@;V8@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI M9VXZ(&-E;G1E6QE/3-$)V)O M6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M8V]L6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q-24[('1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^-SDV+#,Y,#PO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M/"]T6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^,3(O,C0O,C`Q,CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/C$R+S(X+S(P,3(\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^,38L,#(Q+#,P.3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P M861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXD M/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W!A9&1I M;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^-2\Q,"\R,#$S/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^-#@P+#DQ,SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C@O,34O M,C`Q,SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z M(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I M;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^,"XP,SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU6QE/3-$)W!A9&1I;F'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W!A M9&1I;F6QE/3-$)V)O6QE M/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&(^-"PP,#$L,C$R M/"]B/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/@T*/'`@'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M M86QI9VXZ(&-E;G1E6QE/3-$ M)V)O6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@8V]L6QE/3-$)V)O6QE/3-$)W=I M9'1H.B`R)3L@<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`R-R4[('!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^,38L,#6QE/3-$)W=I9'1H M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN92UH96EG:'0Z M(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,34E.R!P M861D:6YG+6QE9G0Z(#4N-'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/C`N,#0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T M:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,B4[('!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^,38L,30Y+#0V,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D M:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXD/"]T M9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,38L,38U+#$W M,3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^.#`X+#(U M.3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU2!B92!G2`R,#`U+"!T:&4@2!B92!G2`R,RP@,C`P-RP@=&AE($)O M87)D(&]F($1I6QE M/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^07,@;V8@36%Y(#,Q+"`R M,#$T+"!E;7!L;WEE97,@:&]L9"!1=6%L:69I960-"DE33R!T;R!P=7)C:&%S M92`T-C8L,#`P('-H87)E6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V)O&5R8VES92!06QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C M;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@ M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W9E6QE/3-$)W=I9'1H.B`R)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M)3L@<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('!A9&1I M;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^-3,R+#`P,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN92UH96EG:'0Z M(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3`E.R!P M861D:6YG+6QE9G0Z(#4N-'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/C$N.#(\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T M:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,24[('!A9&1I;F6QE/3-$)W9E3L@;&EN M92UH96EG:'0Z(#$Q-24G/D=R86YT960\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M,3`P+#`P,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE M9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU&5R8VES960\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^*#$V,"PP,#`\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^*3PO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,2XS-CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU6QE/3-$)W!A9&1I;F6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXI/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)W9E2`S,2P@,C`Q-#PO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^,BXX,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)W9E3L@;&EN92UH96EG M:'0Z(#$Q-24G/D5X97)C:7-A8FQE+"`F(S$V,#M-87D@,S$L(#(P,30\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^,S$T+#`P,#PO=&0^#0H@("`@/'1D('-T>6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!C96YT97([(&QI;F4M:&5I9VAT.B`Q,34E)SXS+C,Q/"]T9#X-"B`@ M("`\=&0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^5&AE(&9A:7(@=F%L=64@;V8@=&AE(&]P=&EO;G,L(&EN8VQU M9&EN9PT*8F]T:"!)4T\@86YD($Y14T\@;W!T:6]N2`S,2P@,C`Q-"!I2`S,2P@ M,C`Q-#H@9&EV:61E;F0@>6EE;&0@;V8@,RXQ-"4L('!R92UV97-T(&9O2!O9B`S M."XY-24L(')I'0M86QI9VXZ(&IU2`S M,2P@,C`Q-"P@=&AE(&]U='-I9&4@;65M8F5R'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R M;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/"]P M/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E&5R M8VES92!06QE/3-$)V)O6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W1E M>'0M86QI9VXZ(&IU6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@8V]L3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@8V]L3L@;&EN92UH96EG:'0Z(#$Q-24G/D]U='-T86YD:6YG+"!! M=6=U6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUL M969T.B`U+C1P=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUL969T.B`U+C1P M=#L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=W:61T:#H@,3`E.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C,N-SD\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('!A9&1I;F6QE/3-$)W9E3L@;&EN92UH96EG:'0Z(#$Q-24G/D5X97)C:7-E9#PO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W!A9&1I;F6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^,2XX,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^-#4L-C`P/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W!A9&1I;F6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^,RXY,CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E3L@;&EN92UH96EG:'0Z M(#$Q-24G/D5X97)C:7-A8FQE+"`F(S$V,#M-87D@,S$L(#(P,30\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^,C4L,C`P/"]T9#X-"B`@("`\=&0@6QE M/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^,RXT-3PO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^5&AE('=E:6=H=&5D+6%V97)A9V4@2`S,2P@,C`Q-"X@5&AE#0IE>&5R M8VES92!P2`S,2P@,C`Q-"!R86YG960@9G)O;2`D,2XP,"!T;R`D-BXV."P@86YD('1H M92!I;F9O6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE M/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,3`@ M'0M M86QI9VXZ(&-E;G1E&5R M8VES86)L93PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$ M)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$ M)V)O6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$ M)V)O&5R8VES92!06QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3`E.R!T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$N,#`\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[ M(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W=I9'1H.B`Q,"4[('1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,2XP-3PO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG M:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`Q,"4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^,C$R+#4P,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`S)3L@=&5X="UA M;&EG;CH@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/C4N.#8\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/C4N.#,\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,RXR.#PO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,3`S+#4P,#PO=&0^#0H@("`@/'1D M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^,RXR-#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^-"XW,#PO=&0^#0H@("`@/'1D M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE M/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U M8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQB M/C,N.3`\+V(^/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&(^)#PO8CX\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQB/C(N.3`\+V(^/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&(^ M,RXU,CPO8CX\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V)O'1087)T7S=B9C-A-SDX7S@Q9&9?-&(R8U]B-3,W7S`U-C`V,3-A-C%C8PT* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W8F8S83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ(&IU2`S,2P@,C`Q-"P@:6YC;'5D960@:6X@8F]N=7,-"F5X<&5N2!A;6]U;G0@;V8@8F]N=7,@<&%Y86)L90T*=&\@=&AE($-O6UE;G0@86=R965M96YT(%1H92!O=&AE&5C=71I M=F4@3V9F:6-E'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2`S,2P@,C`Q-"!C;VUP87)E9`T*=&\@=&AR964@8W5S=&]M M97)S('=H;R!A8V-O=6YT960@9F]R(#$P)2`H82!D96%L97(@86-C;W5N="!I M;B!*87!A;B!R97!R97-E;G1I;F<@=F%R:6]U6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#%I;B<^/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5V4@;W!E2X@3W5R(&]P97)A=&EN M9R!R97-U;'1S(&-O=6QD(&)E('-I9VYI9FEC86YT;'D@869F96-T960@8GD@ M;W5R(&%B:6QI='D@=&\@9&5V96QO<`T*;F5W('!R;V1U8W1S(&%N9"!F:6YD M(&YE=R!D:7-T'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&(^ M)B,Q-C`[/"]B/CPO<#X-"@T*/'`@2X@1'5R M:6YG('1H92!C=7)R96YT(&5C;VYO;6EC(&1O=VYT=7)N+"!W92!H879E('-E M96X@8V]NFEN9R!I;B!T:&4@<&AA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W8F8S83'0O:'1M;#L@8VAA2`S,2P@,C`Q-#QB M'0^)SQS<&%N/CPO'0^)SQP('-T>6QE/3-$ M)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI M9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@8V]L6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C M;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@ M'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@8V]L6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\ M='(@6QE/3-$)W=I9'1H.B`Q M)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`R,"4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^36%Y(#,Q+"`R,#$T/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I M9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^-"PT.#`\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=W:61T:#H@,B4[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E M)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,3(E.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/C(L,C6QE/3-$)W=I9'1H M.B`Q,B4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M,C8\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T M:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXD/"]T M9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^/"]T6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/DUA>2`S,2P@,C`Q,SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^,BPV-S,\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXD/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/CQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2`S,2P@ M,C`Q-#QB'0M M86QI9VXZ(&IU65E M)B,Q-#8[2P@86YD("0R."PP M,C@@86YD("0R-2PW-S(@9F]R('1H92!T:')E92!M;VYT:',@96YD960@36%Y M#0HS,2P@,C`Q-"!A;F0@,C`Q,RP@'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2`S,2P@,C`Q-#QB'0^)SQP('-T>6QE M/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@;W(@ M86)O=70@2G5N92`R-BP@,C`Q-"P@=&AE($-O;7!A;GD-"G=A2!W87,@=&AE(&]W M;F5R(&]F('1H92!S=6)J96-T#0IA:7)C2!I;G1E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W8F8S83'0O:'1M;#L@8VAA2`S,2P@,C`Q-#QB'0^)SQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^3W5R(&-O;F1E;G-E9"!F:6YA;F-I86P@6EN9R!N;W1E2!M86YA9V5M96YT)B,Q-#8[ MF5D#0IC;VUP=71E'0^)SQP('-T>6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5V4@2!I2!P=7)C:&%S960-"G-O9G1W87)E(&%T(&YO(&%D M9&ET:6]N86P@8VAA2!D;R!N;W0@2!C:&%N9V4@=&AE(&)A2!O M9B!T:&4@7!I8V%L;'D@;V-C=7)R960@ M;VYC92!O65AF5S(')E=F5N=64@870@=&AE('1I;64@=&AE('1R86EN:6YG#0IO'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`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`N M-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE(&5S=&%B;&ES:&UE;G0@;V8@=&5C M:&YO;&]G:6-A;"!F96%S:6)I;&ET>0T*86YD('1H92!O;F=O:6YG(&%SF5D('-O9G1W M87)E(&1E=F5L;W!M96YT(&-O6QE/3-$)V9O;G0Z(#AP="]N;W)M M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V M,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^06UOF%T:6]N(&]F(&-A<&ET86QI>F5D('-O9G1W M87)E#0ID979E;&]P;65N="!C;W-T65A&-E M<'0@9F]R(&]U2!O9B!T:&5M(&%T('1H:7,@<&]I;G0I+B!!;6]R=&EZ871I;VX-"F]F M('-O9G1W87)E(&1E=F5L;W!M96YT(&-O2`S,2P@,C`Q-"!A;F0@,C`Q,RP@2`S,2P@,C`Q-"!A;F0@,C`Q,RP@'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!W:&5N979E'0M86QI9VXZ(&IUF%T:6]N+B!$97!R96-I871I;VX@86YD(&%M;W)T M:7IA=&EO;B!A'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W!A9&1I;F'1U'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^-2!T;R`W('EE87)S/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$)W9E6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^36%I;G1E;F%N8V4@86YD(&UI;F]R(')E<&QA8V5M96YT'0M86QI9VXZ(&IU2!T M:&4@'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O3L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O2!T:')O=6=H(&-O M6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="]N;W)M M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM M87)I>F5S(&9A:7(@=F%L=64-"FUE87-U2!L979E;"!A="!- M87D@,S$L(#(P,30@9F]R(&%S6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C M96QL6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$ M)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@8V]L6QE/3-$)V)O6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@8V]L6QE/3-$ M)W9E6QE/3-$)W=I9'1H.B`R M)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!T('-O M;&ED.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[(&)O'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-3`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG M:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q)3L@<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@8F]R M9&5R+6)O='1O;3H@8FQA8VL@,7!T('-O;&ED.R!L:6YE+6AE:6=H=#H@,3$U M)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[(&)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M-RPW-3'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M&EM871E(&9A:7(@=F%L=64@9'5E('1O M('1H96ER('-H;W)T(&UA='5R:71I97,N/"]P/CQS<&%N/CPO'0^)SQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^5V4@=71I;&EZ92!&05-"($%30R`W-#`M,3`L)B,Q M-C`[/&D^)B,Q-#<[26YC;VUE#0I487AE'!E8W1E9"!F=71U6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^ M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^56YD97(@=&AI2!T87@@'!E8W1E9"!T;R!A9F9E M8W0@=&%X86)L92!I;F-O;64N(%9A;'5A=&EO;B!A;&QO=V%N8V5S(&%R92!E MF5D+B!4:&4@<')O=FES:6]N(&9O6%B;&4@9F]R('1H92!P97)I;V0@86YD#0IT:&4@ M8VAA;F=E(&1U"!A3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQP('-T>6QE/3-$ M)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@1F5B2`S,2P@,C`Q-"!A;F0@,C`Q,RX@06-C=6UU;&%T M960@86UOF%T:6]N(&%S(&]F($UA>2`S,2P@,C`Q,R!W87,@)#$V+#@W M-2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^3VX@36%Y(#$U+"`R,#$T+"!W92!A8W%U:7)E9"!I;G1E;&QE8W1U86P- M"G!R;W!EF5D M(&]V97(@,3`@>65AF%T:6]N(&5X<&5N2`S,2P@,C`Q-"!W87,@)#(U+#`P,"X@06-C=6UU M;&%T960@86UOF%T:6]N(&%S(&]F($UA>2`S,2P-"C(P,30@=V%S("0R M-2PP,#`N("A3964@3F]T92`T*3PO<#X-"@T*/'`@2!A9W)E96UE;G1S(&9O2`S,2P@ M,C`Q-"!A;F0@,C`Q,R!W87,@)#,P+#8R-2!A;F0@)"`U+#8R-2P@'0^)SQP('-T M>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^5V4@ M2!T:&4@=V5I9VAT960M879E&-E<'0@=&AA="!T:&4@9&5N;VUI;F%T;W(- M"FES(&EN8W)E87-E9"!T;R!I;F-L=61E('1H92!N=6UB97(@;V8@861D:71I M;VYA;"!C;VUM;VX@6QE/3-$)V9O;G0Z(#AP="]N;W)M M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V M,#L\+W`^#0H-"CQT86)L92!C96QL6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$ M-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M8V]L6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$ M,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$ M)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/CPO='(^#0H\='(@6QE/3-$ M)W!A9&1I;F6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@3L@;&EN92UH96EG:'0Z(#$Q-24[('1E M>'0M:6YD96YT.B`M,3!P="<^3F5T(&EN8V]M92!A='1R:6)U=&%B;&4@=&\@ M8V]M;6]N('-H87)E:&]L9&5R6QE M/3-$)W=I9'1H.B`R)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q M-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3$E.R!T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$L,S`W+#4T.3PO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`R M)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3$E.R!T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/CDY,RPR,S`\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@ M,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^,38L,3DS+#DW-CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,38L M,#(T+#0V-SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,38L,3$W+#$Y M.#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,34L.3@T+#@Q.3PO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/CPO='(^#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^,C8Q+#$P,CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M,S$Q+#$T,3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,C0T+#0Y-SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,S(R+#6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@'0M86QI9VXZ(&IUF5D(&]N(&$@ M2`S,2P@,C`Q-"!A;F0@,C`Q,RP@2`S,2P@,C`Q-"!A;F0@,C`Q,RP@2!)'0^)SQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^26X@2G5L>2`R,#$R+"!T:&4@1D%30B!I65A6QE/3-$)V9O;G0Z(#AP="]N M;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF M(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^26X@2G5L>2`R,#$S+"!T:&4@1D%30B!I"!,;W-S+"!O&ES=',\+VD^+"!W:&EC:"!E;&EM:6YA=&5S(&1I=F5R2!I;B!P M6%B;&4@=&AA="!W;W5L9"!R97-U;'0@ M9G)O;2!D:7-A;&QO=V%N8V4@;V8@82!T87@@<&]S:71I;VXN($%352`R,#$S M+3$Q(&%F9F5C=',@;VYL>2!T:&4@<')E2!A9&]P=&EO;B!I2P@;V8@=&AE(&%D M;W!T:6]N(&]F($%352`R,#$S+3$Q(&]N(&]U2!C;VUB:6YA M=&EO;B!O9B!P2P@;V8@=&AE(&%D;W!T:6]N(&]F($%352`R,#$T+3`Y('1O(&]U65T('-E;&5C=&5D(&$@=')A;G-I=&EO M;B!M971H;V0@;F]R(&AA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!A;F0@17%U:7!M96YT(&5S=&EM M871E9"!U6QE/3-$)W9E6QE/3-$)W!A9&1I;F'1U'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^-2!T;R`W('EE87)S/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ M(&-E;G1E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^ M#0H\='(@6QE/3-$)W=I9'1H M.B`T-"4[('!A9&1I;F6QE/3-$)W=I9'1H M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!T('-O;&ED.R!P M861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)#PO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[(&)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-3`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F'0M86QI M9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)A8VMG6QE/3-$)W9E6QE/3-$)W9E M6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E M6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V)O6QE M/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`T,B4[('!A9&1I;F6QE/3-$)W=I9'1H M.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M,2PS,#6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^.3DS+#(S,#PO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=W:61T:#H@,3$E.R!T97AT+6%L:6=N.B!R:6=H=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/C(L.#`R+#4V.#PO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=W:61T:#H@,3$E.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/C(L-C0Q+#6QE/3-$)W=I9'1H M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W9E'0M:6YD96YT M.B`M,3!P="<^5V5I9VAT960M879E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$V M+#0U-2PP-S@\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$V+#,S-2PV M,#@\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$V+#,V,2PV.34\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$V+#,P-RPV,3@\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\ M+W1R/@T*/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQT86)L92!C96QL M6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)W9E M6QE/3-$)W=I9'1H.B`Q."4[('1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,3(T+#`T,CPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^/"]T6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^,30U+#@Y,SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@ M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU'1U6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/C4Q+#0V-CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^,C,L-C0V/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C,T-2PP-#<\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E3L@;&EN M92UH96EG:'0Z(#$Q-24G/DQEF%T:6]N/"]T9#X-"B`@("`\=&0@6QE/3-$ M)V)O6QE/3-$)V)O6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXI/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE M/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2`S,2P@,C`Q-#QB6QE/3-$)W=I9'1H.B`Q."4[('1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^-S4P+#`P,#PO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^/"]T6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(&IU6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@3L@;&EN92UH96EG:'0Z(#$Q-24G M/D%P6QE/3-$)V)O M6QE/3-$)V)O6QE/3-$)W9E3L@;&EN92UH96EG:'0Z(#$Q-24G M/E1O=&%L/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U M)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W8F8S M83'0O:'1M;#L@8VAA2`S,2P@,C`Q-#QB'0^)SQS<&%N/CPO'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@ M'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q-24[('1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^-SDV+#,Y,#PO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,3(O,C0O,C`Q,CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$R+S(X+S(P,3(\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^,38L,#(Q+#,P.3PO=&0^#0H@("`@/'1D M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^-2\Q,"\R,#$S/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^-#@P+#DQ,SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\ M='(@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D M:6YG+6QE9G0Z(#4N-'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG M:'0Z(#$Q-24G/C@O,34O,C`Q,SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,"XP,SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W!A9&1I;F6QE/3-$)V)O M6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(&IU6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/@T* M/'`@'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B M;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)V)O6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUL969T.B`U+C1P=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN92UH96EG M:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`R-R4[('!A9&1I;F'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^,38L,#6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUL M969T.B`U+C1P=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUL969T.B`U+C1P M=#L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=W:61T:#H@,34E.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C`N,#0\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,B4[('!A9&1I;F6QE/3-$)W9E6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^,38L,30Y+#0V,#PO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^,38L,38U+#$W,3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I M;F6QE/3-$)V)O3L@;&EN92UH96EG:'0Z(#$Q M-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^.#`X+#(U.3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG M+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/CQS<&%N/CPO2!O9B!T:&4@'0^ M)SQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU2`S,2P@,C`Q-"P@96UP;&]Y965S(&AO M;&0@475A;&EF:65D#0I)4T\@=&\@<'5R8VAA2`S,2P-"C(P,30N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O M;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS M<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N M/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@3L@;&EN92UH96EG:'0Z(#$Q-24G/D]U M='-T86YD:6YG+"!!=6=U6QE/3-$)W=I9'1H.B`Q)3L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\ M='(@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M,2XP,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z M(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@3L@;&EN92UH96EG:'0Z(#$Q-24G/D]U='-T M86YD:6YG+"!-87D@,S$L(#(P,30\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^-#8V M+#`P,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z M(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&QI;F4M:&5I M9VAT.B`Q,34E)SXS+C4W/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU&5R8VES M86)L92P@)B,Q-C`[36%Y(#,Q+"`R,#$T/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/@T* M/'`@'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2`S,2P@,C`Q-"P@=&AE(&]U='-I9&4@;65M8F5R'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`X<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS M<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N M/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E&5R8VES92!06QE/3-$ M)V)O6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@ M6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L3L@;&EN92UH96EG:'0Z(#$Q-24G/D]U='-T M86YD:6YG+"!!=6=U6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`R)3L@ M<&%D9&EN9RUL969T.B`U+C1P=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUL M969T.B`U+C1P=#L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,3`E.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C,N-SD\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[ M('!A9&1I;F6QE/3-$ M)W9E3L@;&EN92UH96EG:'0Z(#$Q-24G/D5X97)C M:7-E9#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z M(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,2XX,#PO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@3L@ M;&EN92UH96EG:'0Z(#$Q-24G/D]U='-T86YD:6YG+"!-87D@,S$L(#(P,30\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^-#4L-C`P/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,RXY,CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9E3L@;&EN M92UH96EG:'0Z(#$Q-24G/D5X97)C:7-A8FQE+"`F(S$V,#M-87D@,S$L(#(P M,30\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,C4L,C`P/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,RXT-3PO=&0^#0H@("`@/'1D M('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="]N M;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE&5R8VES92!P6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L M3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)W=I9'1H.B`Q M,"4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^,2XP M,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG M:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N.B!R M:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$N-3`\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@ M,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/C(Q,BPU,#`\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,38E.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/C,N-30\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E M)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^,2XU,3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/C(Q+#8P,#PO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^-2XX-CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$Q+#8P,#PO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^-2XX,SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^,RXP,3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/C$T,2PY,#`\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/C,N,S@\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)#PO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^,RXR,SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^-"XU,3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^,3,V+#`P,#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^,3(L,#`P/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^-2XU.3PO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/CPO='(^#0H\='(@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V)O6QE/3-$ M)V)O6QE/3-$)V)O M'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&(^,BXY,#PO8CX\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/CQB/C,S.2PR,#`\+V(^/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/CPO='(^#0H\+W1A8FQE/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQT86)L92!C96QL6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M8V]L6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)W9E2`S,2P@,C`Q-#PO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q M-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`R)3L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=W:61T:#H@,3,E.R!T97AT+6%L:6=N.B!R:6=H=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/C0L-#@P/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I M9'1H.B`Q,B4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U M)2<^,BPV.#0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E M)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,3(E.R!T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/C(V/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q M,B4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^.2PT M-C,\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^,2PT,38\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^."PU,#,\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\ M+W1R/@T*/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA65A65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`S,2P@,C`Q-#QB M'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W8F8S83'0O:'1M;#L@8VAA2`S,2P@,C`Q-#QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA2`S,2P@,C`Q-#QB2`S,2P@,C`Q,SQB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(&]F(&-A M<&ET86QI>F5D(&-O;7!U=&5R('-O9G1W87)E(&1E=F5L;W!M96YT(&-O'0^)SQS<&%N/CPO M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W8F8S M83'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!A;F0@97%U M:7!M96YT+"!G'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6%B;&4\+W-T6%B;&4L(&YE M="!O9B!C=7)R96YT('!O3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\W8F8S83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2`S,2P@,C`Q-#QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`Y+`T*"0DR M,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M3F]V(#$S+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^1&5C(#(X+`T*"0DR M,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M36%Y(#'0^)SQS<&%N/CPO2`Q,"P-"@D),C`Q,SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\W8F8S83'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M&5R M8VES86)L92P@96YD(&]F('!E7,\&5R8VES92!0'0^)SQS<&%N/CPO7,\&5R8VES86)L93PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)S8@>65A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W8F8S83'0O:'1M;#L@8VAA&5R8VES92!P&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)S,@>65A&5R8VES92!P&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S,@>65A&5R8VES92!P&5R M8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S&5R8VES92!P&5R M8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S,@>65A&5R8VES92!P&5R8VES86)L93PO M=&0^#0H@("`@("`@(#QT9"!C;&%S&5R8VES92!P'0^)S0@>65A&5R8VES92!P'0^)S,@>65A'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2`S,2P@,C`Q-#QB6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA'!E8V5T960@=F]L871I M;&ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO&5R8VES92!P&5R8VES92!P&EM=6T@6TUE;6)E'0^)SQS<&%N/CPO3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\W8F8S83'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\W8F8S83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2`S,2P@,C`Q,SQB'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W8F8S83'0O:'1M;#L@8VAA2`S,2P@,C`Q-#QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`S,2P@,C`Q-#QB'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. SHAREHOLDERS' EQUITY (Details-Dividends) (USD $)
9 Months Ended 12 Months Ended
May 31, 2014
May 31, 2013
Aug. 31, 2013
Total Amount $ 2,258,688 $ 3,520,285 $ 4,001,212
Record Date 11/08/2013
     
Record Date Nov. 08, 2013    
Distribution Date Nov. 15, 2013    
Number of Shares Outstanding on Record Date 16,073,894    
Dividend per Share $ 0.04    
Total Amount 642,956    
Record Date 2/17/2014
     
Record Date Feb. 17, 2014    
Distribution Date Feb. 24, 2014    
Number of Shares Outstanding on Record Date 16,149,460    
Dividend per Share $ 0.05    
Total Amount 807,473    
Record Date 5/09/2014
     
Record Date May 09, 2014    
Distribution Date May 16, 2014    
Number of Shares Outstanding on Record Date 16,165,171    
Dividend per Share $ 0.05    
Total Amount 808,259    
Record Date 11/08/2012
     
Record Date     Nov. 08, 2012
Distribution Date     Nov. 13, 2012
Number of Shares Outstanding on Record Date     15,927,806
Dividend per Share     $ 0.05
Total Amount     796,390
Record Date 12/24/2012
     
Record Date     Dec. 24, 2012
Distribution Date     Dec. 28, 2012
Number of Shares Outstanding on Record Date     16,021,309
Dividend per Share     $ 0.14
Total Amount     2,242,983
Record Date 05/07/2013
     
Record Date     May 07, 2013
Distribution Date     May 10, 2013
Number of Shares Outstanding on Record Date     16,030,433
Dividend per Share     $ 0.03
Total Amount     480,913
Record Date 08/12/2013
     
Record Date     Aug. 12, 2013
Distribution Date     Aug. 15, 2013
Number of Shares Outstanding on Record Date     16,030,894
Dividend per Share     $ 0.03
Total Amount     $ 480,926
XML 19 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
4. CONTRACT PAYABLE (Details) (USD $)
May 31, 2014
Contract Payable  
25-Apr-15 $ 750,000
25-Apr-16 750,000
25-Apr-17 1,000,000
Total 2,500,000
Less Current portion (750,000)
Contract payable, net of current portion $ 1,750,000
XML 20 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. SHAREHOLDERS' EQUITY (Details-Options Outstanding) (USD $)
9 Months Ended
May 31, 2014
Number of Options  
Awards Outstanding, ending balance 511,600
Exercisable, end of period 339,200
Weighted-Average Exercise Price Per Share  
Outstanding $ 2.90
Exercisable, end of period $ 1.90
Qualified ISO
 
Number of Options  
Awards Outstanding, beginning balance 532,000
Granted 100,000
Exercised (160,000)
Canceled/Forfeited (6,000)
Awards Outstanding, ending balance 466,000
Exercisable, end of period 314,000
Weighted-Average Exercise Price Per Share  
Outstanding $ 1.82
Granted $ 5.61
Exercised $ 1.36
Canceled/Forfeited $ 1.00
Outstanding $ 2.80
Exercisable, end of period $ 1.78
Weighted-Average Remaining Contractual Life  
Outstanding, beginning of period 3 years 11 months 12 days
Outstanding, end of period 3 years 6 months 25 days
Exercisable 3 years 3 months 22 days
Non-Qualified SO
 
Number of Options  
Awards Outstanding, beginning balance 48,600
Exercised (3,000)
Awards Outstanding, ending balance 45,600
Exercisable, end of period 25,200
Weighted-Average Exercise Price Per Share  
Outstanding $ 3.79
Exercised $ 1.80
Outstanding $ 3.92
Exercisable, end of period $ 3.45
Weighted-Average Remaining Contractual Life  
Outstanding, beginning of period 7 years 10 months 6 days
Outstanding, end of period 7 years 3 months 14 days
Exercisable 6 years 1 month 13 days
XML 21 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. SHAREHOLDERS' EQUITY (Details-Options Outstanding and Exercisable) (USD $)
9 Months Ended
May 31, 2014
Awards Outstanding 511,600
Weighted average remaining contractual life - awards outstanding 4 years 2 months 9 days
Weighted average exercise price - awards outstanding $ 2.90
Awards Exercisable 339,200
Weighted average remaining contractual life - awards exercisable 3 years 6 months 7 days
Weighted average exercise price - awards exercisable $ 1.90
Stock Options One
 
Exercise price low $ 1.00
Exercise price high $ 1.50
Awards Outstanding 212,500
Weighted average remaining contractual life - awards outstanding 3 years 6 months 14 days
Weighted average exercise price - awards outstanding $ 1.05
Awards Exercisable 212,500
Weighted average remaining contractual life - awards exercisable 3 years 6 months 14 days
Weighted average exercise price - awards exercisable $ 1.05
Stock Options Two
 
Exercise price low $ 1.51
Exercise price high $ 3.00
Awards Outstanding 21,600
Weighted average remaining contractual life - awards outstanding 5 years 10 months 10 days
Weighted average exercise price - awards outstanding $ 2.28
Awards Exercisable 11,600
Weighted average remaining contractual life - awards exercisable 5 years 9 months 29 days
Weighted average exercise price - awards exercisable $ 2.11
Stock Options Three
 
Exercise price low $ 3.01
Exercise price high $ 4.50
Awards Outstanding 141,900
Weighted average remaining contractual life - awards outstanding 3 years 4 months 17 days
Weighted average exercise price - awards outstanding $ 3.28
Awards Exercisable 103,500
Weighted average remaining contractual life - awards exercisable 3 years 2 months 27 days
Weighted average exercise price - awards exercisable $ 3.23
Stock Options Four
 
Exercise price low $ 4.51
Exercise price high $ 6.68
Awards Outstanding 136,000
Weighted average remaining contractual life - awards outstanding 4 years 8 months 12 days
Weighted average exercise price - awards outstanding $ 5.49
Awards Exercisable 12,000
Weighted average remaining contractual life - awards exercisable 3 years 3 months 7 days
Weighted average exercise price - awards exercisable $ 5.59
XML 22 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
3. PROPERTY AND EQUIPMENT
9 Months Ended
May 31, 2014
Property, Plant and Equipment [Abstract]  
Note 3. PROPERTY AND EQUIPMENT

Property and equipment as of May 31, 2014 consisted of the following:

 

Equipment   $ 124,042  
Computer equipment     145,893  
Furniture and fixtures     51,466  
Leasehold improvements     23,646  
Sub total     345,047  
Less: Accumulated depreciation and amortization     (241,451 )
Net Book Value   $ 103,596  
XML 23 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. SHAREHOLDERS' EQUITY (Narrative) (USD $)
9 Months Ended
May 31, 2014
Fair value of options granted $ 130,781
Assumptions used  
Pricing model Black-Scholes option-pricing model
Dividend yield 3.14%
Pre-vest forfeiture rate 6.25%
Expeceted volatility 38.95%
Risk-free interest rate 1.36%
Expected life 5 years
Qualified incentive stock options 466,000
Non-qualified stock options 45,600
Weighted-average remaining contractual life of options outstanding 4 years 2 months 9 days
Minimum [Member]
 
Assumptions used  
Exercise prices $ 1.00
Exercise prices of Non-qualified stock options $ 1.67
Exercise prices for the options outstanding $ 1.00
Maximum [Member]
 
Assumptions used  
Exercise prices $ 5.61
Exercise prices of Non-qualified stock options $ 6.68
Exercise prices for the options outstanding $ 6.68
XML 24 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED BALANCE SHEETS (USD $)
May 31, 2014
Aug. 31, 2013
Current assets    
Cash and cash equivalents $ 7,757,972 $ 10,179,298
Prepaid income taxes 946,518 301,573
Accounts receivable, net of allowance for doubtful accounts of $0 3,219,743 1,910,615
Contracts receivable 124,270 203,913
Prepaid expenses and other current assets 119,180 192,173
Deferred income taxes 217,655 184,258
Total current assets 12,385,338 12,971,830
Long-term assets    
Capitalized computer software development costs, net of accumulated amortization of $6,385,815 and $5,801,578 3,358,632 2,891,169
Property and equipment, net (note 3) 103,596 117,987
Intellectual property, net of accumulated amortization of $41,875 and $11,250 6,033,125 63,750
Other assets 18,445 18,445
Total assets 21,899,136 16,063,181
Current liabilities    
Accounts payable 177,356 146,011
Accrued payroll and other expenses 349,464 311,209
Accrued bonuses to officers 90,000 60,000
Other current liabilities 19,859 19,859
Current portion - Contract payable (Note 4) 750,000  
Deferred revenue 234,671 89,227
Total current liabilities 1,621,350 626,306
Long-term liabilities    
Deferred income taxes 2,529,371 1,146,389
Payments due under Contract payable (Note 4) 1,750,000  
Other long-term liabilities 33,099 47,993
Total liabilities 5,933,820 1,820,688
Commitments and contingencies (note 5)      
Shareholders' equity (note 5)    
Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding      
Common stock, $0.001 par value 50,000,000 shares authorized 16,335,804 and 16,030,894 shares issued and outstanding 4,807 4,502
Additional paid-in capital 6,021,432 4,842,794
Retained earnings 9,939,077 9,395,197
Total shareholders' equity 15,965,316 14,242,493
Total liabilities and shareholders' equity $ 21,899,136 $ 16,063,181
XML 25 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
1. GENERAL
9 Months Ended
May 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Note 1. GENERAL

This report on Form 10-Q for the quarter ended May 31, 2014, should be read in conjunction with the Company's annual report on Form 10-K for the year ended August 31, 2013, filed with the Securities and Exchange Commission (“SEC”) on November 18, 2013. As contemplated by the SEC under Article 8 of Regulation S-X, the accompanying financial statements and footnotes have been condensed and therefore do not contain all disclosures required by generally accepted accounting principles. The interim financial data are unaudited; however, in the opinion of Simulations Plus, Inc. ("we", "our", "us"), the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Results for interim periods are not necessarily indicative of those to be expected for the full year.

XML 26 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
9. GEOGRAPHIC REPORTING (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
May 31, 2014
May 31, 2013
Revenues $ 9,463 $ 8,503
North America
   
Revenues 4,480 4,413
Europe
   
Revenues 2,684 2,673
Asia
   
Revenues 2,273 1,416
South America
   
Revenues $ 26 $ 1
XML 27 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
9. GEOGRAPHIC REPORTING (Tables)
9 Months Ended
May 31, 2014
Geographic Reporting  
Geographical revenues
Nine month ended     North America     Europe     Asia     South America     Total  
                                 
  May 31, 2014     $ 4,480     $ 2,684     $ 2,273     $ 26     $ 9,463  
  May 31, 2013     $ 4,413     $ 2,673     $ 1,416     $ 1     $ 8,503  
XML 28 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
10. EMPLOYEE BENEFIT PLAN (Narrative) (USD $)
3 Months Ended 9 Months Ended
May 31, 2014
May 31, 2013
May 31, 2014
May 31, 2013
Compensation and Retirement Disclosure [Abstract]        
Contribution by employer in benefit plan $ 28,028 $ 25,772 $ 89,784 $ 76,317
XML 29 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SIGNIFICANT ACCOUNTING POLICIES (Details-Fair Value Measurements) (USD $)
May 31, 2014
Cash and cash equivalents $ 7,757,972
Total assets 7,757,972
Level I
 
Cash and cash equivalents 7,757,972
Total assets 7,757,972
Level II
 
Cash and cash equivalents 0
Total assets 0
Level III
 
Cash and cash equivalents 0
Total assets $ 0
XML 30 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 31 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
May 31, 2014
Accounting Policies [Abstract]  
Note 2. SIGNIFICANT ACCOUNTING POLICIES

Estimates

Our condensed financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. Actual results could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized computer software development costs, valuation of stock options, and accounting for income taxes.

 

Revenue Recognition

We recognize revenues related to software licenses and software maintenance in accordance with Financial Accounting Standard Board (“FASB”) Accounting Standard Codification (“ASC”) 985-605, “Software - Revenue Recognition”. Software product revenue is recorded when the following conditions are met: 1) evidence of arrangement exists, 2) delivery has been made, 3) the amount is fixed, and 4) collectability is probable. Post-contract customer support ("PCS") obligations are insignificant; therefore, revenue for PCS is recognized at the same time as the licensing fee, and the costs of providing such support services are accrued and amortized over the obligation period.

 

As a byproduct of ongoing improvements and upgrades for the new programs and new modules of software, some modifications are provided to customers who have already purchased software at no additional charge. Other software modifications result in new, additional cost modules that expand the functionality of the software. These are licensed separately. We consider the modifications that are provided without charge to be minimal, as they do not significantly change the basic functionality or utility of the software, but rather add convenience, such as being able to plot some additional variable on a graph in addition to the numerous variables that had been available before, or adding some additional calculations to supplement the information provided from running the software. Such software modifications for any single product have typically occurred once or twice per year, sometimes more, sometimes less. Thus, they are infrequent. The Company provides, for a fee, additional training and service calls to its customers and recognizes revenue at the time the training or service call is provided.

  

Generally, we enter into one-year license agreements with customers for the use of our pharmaceutical software products. We recognize revenue on these contracts when all the criteria are met.

 

Most license agreements have a term of one year; however, from time to time, we enter into multi-year license agreements. We generally unlock and invoice software one year at a time for multi-year licenses. Therefore, revenue is recognized one year at a time.

 

We recognize revenue from collaboration research and revenue from grants equally over their terms. However, we recognize contract study revenue using the percentage-of-completion method, depending upon how the contract studies are engaged, in accordance with ASC 605-35, “Revenue Recognition – Construction-Type and Production-Type Contracts”. To recognize revenue using the percentage-of-completion method, we must determine whether we meet the following criteria: 1) there is a long-term, legally enforceable contract, 2) it is possible to reasonably estimate the total project costs, and 3) it is possible to reasonably estimate the extent of progress toward completion.

 

Cash and Cash Equivalents

For purposes of the statements of cash flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.

 

Accounts Receivable

We analyze the age of customer balances, historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability of the Company’s trade accounts receivable balances. If we determine that the financial conditions of any of its customers deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable are written off when all collection attempts have failed.

 

Capitalized Computer Software Development Costs

Software development costs are capitalized in accordance with ASC 985-20, “Costs of Software to Be Sold, Leased, or Marketed”. Capitalization of software development costs begins upon the establishment of technological feasibility and is discontinued when the product is available for sale.

 

The establishment of technological feasibility and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues, estimated economic life, and changes in software and hardware technologies. Capitalized software development costs are comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in our software products.

 

Amortization of capitalized software development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the products (not to exceed five years, although all of our current software products have already been on the market for 7-15 years except for our newest MedChem Designer™ program, and we do not foresee an end-of-life for any of them at this point). Amortization of software development costs amounted to $584,237 and $532,106 for the nine months ended May 31, 2014 and 2013, respectively, and amortization of software development costs was $200,585 and $173,094 for the three months ended May 31, 2014 and 2013, respectively. We expect future amortization expense to vary due to increases in capitalized computer software development costs.

 

We test capitalized computer software development costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:

 

Equipment 5 years
Computer equipment 3 to 7 years
Furniture and fixtures 5 to 7 years
Leasehold improvements Shorter of life of asset or lease

 

Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.

 

Fair Value of Financial Instruments

Assets and liabilities recorded at fair value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The categories, as defined by the standard are as follows:

 

Level Input:   Input Definition:
Level I   Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II   Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III   Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

 

The following table summarizes fair value measurements by level at May 31, 2014 for assets and liabilities measured at fair value on a recurring basis:

 

    Level I     Level II     Level III     Total  
Cash and cash equivalents   $ 7,757,972     $     $     $ 7,757,972  
                                 
Total   $ 7,757,972     $     $     $ 7,757,972  

 

For certain of our financial instruments, including accounts receivable, accounts payable, contract payable, accrued payroll and other expenses, and accrued bonus to officer, the amounts approximate fair value due to their short maturities.

 

Research and Development Costs

Research and development costs are charged to expense as incurred until technological feasibility has been established. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased software and databases which were developed by other companies and incorporated into, or used in the development of, our final products.

 

Income Taxes

We utilize FASB ASC 740-10, “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.

 

 

Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.

 

Intellectual property

On February 28, 2012, we bought out the royalty agreement with Enslein Research of Rochester, New York. The cost of $75,000 is being amortized over 10 years under the straight-line method. Amortization expense for each of the nine months periods ended May 31, 2014 and 2013 was $5,625 and was $1,875 for each three month period ended May 31, 2014 and 2013. Accumulated amortization as of May 31, 2013 was $16,875.

 

On May 15, 2014, we acquired intellectual property from TSRL, Inc of Ann Arbor, Michigan. The cost of $6,000,000 is being amortized over 10 years under the straight-line method. Amortization expense for the period of May 15, 2014 to May 31, 2014 was $25,000. Accumulated amortization as of May 31, 2014 was $25,000. (See Note 4)

 

Total amortization expense for intellectual property agreements for each of the nine months periods ended May 31, 2014 and 2013 was $30,625 and $ 5,625, respectively, and was $26,875 and $1,875 respectively for the three month periods ended May 31, 2014 and 2013. Accumulated amortization as of May 31, 2014 was $41,875.

 

Earnings per Share

We report earnings per share in accordance with FASB ASC 260-10. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted earnings per share for the three and nine months ended May 31, 2014 and 2013 were as follows:

 

    Three months ended     Nine months ended  
    05/31/2014     05/31/2013     05/31/2014     05/31/2013  
Numerator:                                
Net income attributable to common shareholders    $ 1,307,549     $ 993,230     $ 2,802,568     $ 2,641,791  
                                 
Denominator:                                
Weighted-average number of common shares outstanding during the period     16,193,976       16,024,467       16,117,198       15,984,819  
Dilutive effect of stock options     261,102       311,141       244,497       322,799  
                                 
Common stock and common stock equivalents used for diluted earnings per share     16,455,078       16,335,608       16,361,695       16,307,618  

 

 

Stock-Based Compensation

Compensation costs related to stock options are determined in accordance with FASB ASC 718-10, “Compensation-Stock Compensation”, using the modified prospective method. Under this method, compensation cost is calculated based on the grant-date fair value estimated in accordance FASB ASC 718-10, amortized on a straight-line basis over the options’ vesting period. Stock-based compensation was $103,498 and $98,495 for the nine months ended May 31, 2014 and 2013, respectively, and was $32,411 and $28,241 for the three months ended May 31, 2014 and 2013, respectively. This expense is included in the condensed statements of operations as Selling, General and Administration (SG&A), and Research and Development expense.

 

Recently Issued Accounting Pronouncements

In July 2012, the FASB issued ASU 2012-02, “Testing Indefinite-Lived Intangible Assets for Impairment”, which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September 15, 2012 and earlier adoption is permitted. We adopted this standard in the first quarter of fiscal year 2013. We believe adoption did not have a material effect on our financial statements.

 

In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity’s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.

 

In May 2014, FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. The standard will eliminate the transaction- and industry-specific revenue recognition guidance under current U.S. GAAP and replace it with a principles-based approach for determining revenue recognition. ASU 2014-09 is effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The revenue recognition standard is required to be applied retrospectively, including any combination of practical expedients as allowed in the standard. We are evaluating the impact, if any, of the adoption of ASU 2014-09 to our financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

XML 32 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED BALANCE SHEETS (Parenthetical) (USD $)
May 31, 2014
Aug. 31, 2013
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 0 $ 0
Accumulated amortization of computer software development costs 6,385,815 5,801,578
Accumulated amortization on intellectual property $ 41,875 $ 11,250
Preferred stock par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock par value $ 0.001 $ 0.001
Common stock shares authorized 50,000,000 50,000,000
Common stock shares issued 16,335,804 16,030,894
Common stock shares outstanding 16,335,804 16,030,894
XML 33 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
May 31, 2014
Accounting Policies [Abstract]  
Estimates

Our condensed financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. Actual results could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized computer software development costs, valuation of stock options, and accounting for income taxes.

Revenue Recognition

We recognize revenues related to software licenses and software maintenance in accordance with Financial Accounting Standard Board (“FASB”) Accounting Standard Codification (“ASC”) 985-605, “Software - Revenue Recognition”. Software product revenue is recorded when the following conditions are met: 1) evidence of arrangement exists, 2) delivery has been made, 3) the amount is fixed, and 4) collectability is probable. Post-contract customer support ("PCS") obligations are insignificant; therefore, revenue for PCS is recognized at the same time as the licensing fee, and the costs of providing such support services are accrued and amortized over the obligation period.

 

As a byproduct of ongoing improvements and upgrades for the new programs and new modules of software, some modifications are provided to customers who have already purchased software at no additional charge. Other software modifications result in new, additional cost modules that expand the functionality of the software. These are licensed separately. We consider the modifications that are provided without charge to be minimal, as they do not significantly change the basic functionality or utility of the software, but rather add convenience, such as being able to plot some additional variable on a graph in addition to the numerous variables that had been available before, or adding some additional calculations to supplement the information provided from running the software. Such software modifications for any single product have typically occurred once or twice per year, sometimes more, sometimes less. Thus, they are infrequent. The Company provides, for a fee, additional training and service calls to its customers and recognizes revenue at the time the training or service call is provided.

  

Generally, we enter into one-year license agreements with customers for the use of our pharmaceutical software products. We recognize revenue on these contracts when all the criteria are met.

 

Most license agreements have a term of one year; however, from time to time, we enter into multi-year license agreements. We generally unlock and invoice software one year at a time for multi-year licenses. Therefore, revenue is recognized one year at a time.

 

We recognize revenue from collaboration research and revenue from grants equally over their terms. However, we recognize contract study revenue using the percentage-of-completion method, depending upon how the contract studies are engaged, in accordance with ASC 605-35, “Revenue Recognition – Construction-Type and Production-Type Contracts”. To recognize revenue using the percentage-of-completion method, we must determine whether we meet the following criteria: 1) there is a long-term, legally enforceable contract, 2) it is possible to reasonably estimate the total project costs, and 3) it is possible to reasonably estimate the extent of progress toward completion.

Cash and Cash Equivalents

For purposes of the statements of cash flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.

Accounts Receivable

We analyze the age of customer balances, historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability of the Company’s trade accounts receivable balances. If we determine that the financial conditions of any of its customers deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable are written off when all collection attempts have failed.

Capitalized Computer Software Development Costs

Software development costs are capitalized in accordance with ASC 985-20, “Costs of Software to Be Sold, Leased, or Marketed”. Capitalization of software development costs begins upon the establishment of technological feasibility and is discontinued when the product is available for sale.

 

The establishment of technological feasibility and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues, estimated economic life, and changes in software and hardware technologies. Capitalized software development costs are comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in our software products.

 

Amortization of capitalized software development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the products (not to exceed five years, although all of our current software products have already been on the market for 7-15 years except for our newest MedChem Designer™ program, and we do not foresee an end-of-life for any of them at this point). Amortization of software development costs amounted to $584,237 and $532,106 for the nine months ended May 31, 2014 and 2013, respectively, and amortization of software development costs was $200,585 and $173,094 for the three months ended May 31, 2014 and 2013, respectively. We expect future amortization expense to vary due to increases in capitalized computer software development costs.

 

We test capitalized computer software development costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:

 

Equipment 5 years
Computer equipment 3 to 7 years
Furniture and fixtures 5 to 7 years
Leasehold improvements Shorter of life of asset or lease

 

Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.

Fair Value of Financial Instruments

Assets and liabilities recorded at fair value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The categories, as defined by the standard are as follows:

 

Level Input:   Input Definition:
Level I   Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II   Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III   Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

 

The following table summarizes fair value measurements by level at May 31, 2014 for assets and liabilities measured at fair value on a recurring basis:

 

    Level I     Level II     Level III     Total  
Cash and cash equivalents   $ 7,757,972     $     $     $ 7,757,972  
                                 
Total   $ 7,757,972     $     $     $ 7,757,972  

 

For certain of our financial instruments, including accounts receivable, accounts payable, contract payable, accrued payroll and other expenses, and accrued bonus to officer, the amounts approximate fair value due to their short maturities.

Research and Development Costs

Research and development costs are charged to expense as incurred until technological feasibility has been established. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased software and databases which were developed by other companies and incorporated into, or used in the development of, our final products.

Income Taxes

We utilize FASB ASC 740-10, “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.

 

Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities.

Intellectual property

On February 28, 2012, we bought out the royalty agreement with Enslein Research of Rochester, New York. The cost of $75,000 is being amortized over 10 years under the straight-line method. Amortization expense for each of the nine months periods ended May 31, 2014 and 2013 was $5,625 and was $1,875 for each three month period ended May 31, 2014 and 2013. Accumulated amortization as of May 31, 2013 was $16,875.

 

On May 15, 2014, we acquired intellectual property from TSRL, Inc of Ann Arbor, Michigan. The cost of $6,000,000 is being amortized over 10 years under the straight-line method. Amortization expense for the period of May 15, 2014 to May 31, 2014 was $25,000. Accumulated amortization as of May 31, 2014 was $25,000. (See Note 4)

 

Total amortization expense for intellectual property agreements for each of the nine months periods ended May 31, 2014 and 2013 was $30,625 and $ 5,625, respectively, and was $26,875 and $1,875 respectively for the three month periods ended May 31, 2014 and 2013. Accumulated amortization as of May 31, 2014 was $41,875.

Earnings per Share

We report earnings per share in accordance with FASB ASC 260-10. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted earnings per share for the three and nine months ended May 31, 2014 and 2013 were as follows:

 

    Three months ended     Nine months ended  
    05/31/2014     05/31/2013     05/31/2014     05/31/2013  
Numerator:                                
Net income attributable to common shareholders    $ 1,307,549     $ 993,230     $ 2,802,568     $ 2,641,791  
                                 
Denominator:                                
Weighted-average number of common shares outstanding during the period     16,193,976       16,024,467       16,117,198       15,984,819  
Dilutive effect of stock options     261,102       311,141       244,497       322,799  
                                 
Common stock and common stock equivalents used for diluted earnings per share     16,455,078       16,335,608       16,361,695       16,307,618  
Stock-Based Compensation

Compensation costs related to stock options are determined in accordance with FASB ASC 718-10, “Compensation-Stock Compensation”, using the modified prospective method. Under this method, compensation cost is calculated based on the grant-date fair value estimated in accordance FASB ASC 718-10, amortized on a straight-line basis over the options’ vesting period. Stock-based compensation was $103,498 and $98,495 for the nine months ended May 31, 2014 and 2013, respectively, and was $32,411 and $28,241 for the three months ended May 31, 2014 and 2013, respectively. This expense is included in the condensed statements of operations as Selling, General and Administration (SG&A), and Research and Development expense.

Recently Issued Accounting Pronouncements

In July 2012, the FASB issued ASU 2012-02, “Testing Indefinite-Lived Intangible Assets for Impairment”, which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September 15, 2012 and earlier adoption is permitted. We adopted this standard in the first quarter of fiscal year 2013. We believe adoption did not have a material effect on our financial statements.

 

In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, which eliminates diversity in practice for the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward is available to reduce the taxable income or tax payable that would result from disallowance of a tax position. ASU 2013-11 affects only the presentation of such amounts in an entity’s balance sheet and is effective for fiscal years beginning after December 15, 2013 and interim periods within those years. Early adoption is permitted. We are evaluating the impact, if any, of the adoption of ASU 2013-11 on our balance sheet.

 

In May 2014, FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. The standard will eliminate the transaction- and industry-specific revenue recognition guidance under current U.S. GAAP and replace it with a principles-based approach for determining revenue recognition. ASU 2014-09 is effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The revenue recognition standard is required to be applied retrospectively, including any combination of practical expedients as allowed in the standard. We are evaluating the impact, if any, of the adoption of ASU 2014-09 to our financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

XML 34 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
9 Months Ended
May 31, 2014
Jul. 08, 2014
Document And Entity Information    
Entity Registrant Name SIMULATIONS PLUS INC  
Entity Central Index Key 0001023459  
Document Type 10-Q  
Document Period End Date May 31, 2014  
Amendment Flag false  
Current Fiscal Year End Date --08-31  
Is Entity a Well-known Seasoned Issuer No  
Is Entity a Voluntary Filer No  
Is Entity's Reporting Status Current Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   16,342,804
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2014  
XML 35 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
May 31, 2014
Accounting Policies [Abstract]  
Property and Equipment estimated useful lives
Equipment 5 years
Computer equipment 3 to 7 years
Furniture and fixtures 5 to 7 years
Leasehold improvements Shorter of life of asset or lease
Assets and liabilities recorded at fair value
    Level I     Level II     Level III     Total  
Cash and cash equivalents   $ 7,757,972     $     $     $ 7,757,972  
                                 
Total   $ 7,757,972     $     $     $ 7,757,972  
Components of basic and diluted earnings per share
    Three months ended     Nine months ended  
    05/31/2014     05/31/2013     05/31/2014     05/31/2013  
Numerator:                                
Net income attributable to common shareholders    $ 1,307,549     $ 993,230     $ 2,802,568     $ 2,641,791  
                                 
Denominator:                                
Weighted-average number of common shares outstanding during the period     16,193,976       16,024,467       16,117,198       15,984,819  
Dilutive effect of stock options     261,102       311,141       244,497       322,799  
                                 
Common stock and common stock equivalents used for diluted earnings per share     16,455,078       16,335,608       16,361,695       16,307,618  
XML 36 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended
May 31, 2014
May 31, 2013
May 31, 2014
May 31, 2013
Income Statement [Abstract]        
Net sales $ 3,740,567 $ 3,094,779 $ 9,463,059 $ 8,502,994
Cost of sales 227,600 451,935 1,168,219 1,337,583
Gross profit 3,512,967 2,642,844 8,294,840 7,165,411
Operating expenses        
Selling, general, and administrative 1,204,312 903,589 3,378,950 2,689,632
Research and development 234,685 206,424 750,808 634,281
Total operating expenses 1,438,997 1,110,013 4,129,758 3,323,913
Income from operations 2,073,970 1,532,831 4,165,082 3,841,498
Interest income 8,017 9,203 25,000 40,005
Interest expense            
Miscellaneous income    4,694    35,488
Gain on currency exchange 7,340 (980) 35,477 96,662
Total other income (expense) 15,357 12,917 60,477 172,155
Income before provision for income taxes 2,089,327 1,545,748 4,225,559 4,013,653
Provision for income taxes (781,778) (552,518) (1,422,991) (1,371,862)
Net Income $ 1,307,549 $ 993,230 $ 2,802,568 $ 2,641,791
Earnings per share - Basic $ 0.08 $ 0.06 $ 0.17 $ 0.17
Earnings per share - Diluted $ 0.08 $ 0.06 $ 0.17 $ 0.16
Weighted-average common shares outstanding        
Basic 16,193,976 16,024,467 16,117,198 15,984,819
Diluted 16,455,078 16,335,608 16,361,695 16,307,618
XML 37 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
7. RELATED PARTY TRANSACTIONS
9 Months Ended
May 31, 2014
Related Party Transactions [Abstract]  
Note 7. RELATED PARTY TRANSACTIONS

As of May 31, 2014, included in bonus expenses to officers was $120,000, of which $45,000 was accrued bonus representing an estimated quarterly amount of bonus payable to the Corporate Secretary, Virginia Woltosz, as part of the terms of the sale of Words+ to Simulations Plus in 1996, and $45,000 accrued bonus representing an estimated quarterly amount of bonus payable to our President/Chief Executive Officer, Walter Woltosz as part of his 2014 employment agreement The other $30,000, paid in September 2013, was FY2013 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was approved by the compensation committee in September 2013.

XML 38 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. SHAREHOLDERS' EQUITY
9 Months Ended
May 31, 2014
Equity [Abstract]  
Note 6. SHAREHOLDERS' EQUITY

Dividend

The Board of Directors declared cash dividends during fiscal year 2013. The details of dividends paid are in the following table:

 

Record Date   Distribution Date   Number of Shares Outstanding on Record Date     Dividend per Share     Total Amount  
11/8/2012   11/13/2012     15,927,806     $ 0.05     $ 796,390  
12/24/2012   12/28/2012     16,021,309     $ 0.14     $ 2,242,983  
5/7/2013   5/10/2013     16,030,433     $ 0.03     $ 480,913  
8/12/2013   8/15/2013     16,030,894     $ 0.03     $ 480,926  
Total                       $ 4,001,212  

 

The Board of Directors has also declared cash dividends during fiscal year 2014. The details of dividends paid are in the following table:

 

Record Date   Distribution Date   Number of Shares Outstanding on Record Date     Dividend per Share     Total Amount  
11/08/2013   11/15/2013     16,073,894     $ 0.04     $ 642,956  
2/17/2014   2/24/2014     16,149,460     $ 0.05     $ 807,473  
5/09/2014   5/16/2014     16,165,171     $ 0.05     $ 808,259  
Total                       $ 2,258,688  

 

Stock Option Plan

In September 1996, the Board of Directors adopted, and the shareholders approved, the 1996 Stock Option Plan (the "Option Plan") under which a total of 1,000,000 shares of common stock had been reserved for issuance. In March 1999, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 2,000,000. In February 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 4,000,000. In December 2000, the shareholders approved an increase in the number of shares that may be granted under the Option Plan to 5,000,000. Furthermore, in February 2005, the shareholders approved an additional 1,000,000 shares, resulting in the total number of shares that may be granted under the Option Plan to 6,000,000. The 1996 Stock Option Plan terminated in September 2006 by its term.

 

On February 23, 2007, the Board of Directors adopted and the shareholders approved the 2007 Stock Option Plan under which a total of 1,000,000 shares of common stock had been reserved for issuance. On February 25, 2014 the shareholders approved an additional 1,000,000 shares increasing the total number of shares that may be granted under the Option Plan to 2,000,000.

 

Qualified Incentive Stock Options (Qualified ISO)

As of May 31, 2014, employees hold Qualified ISO to purchase 466,000 shares of common stock at exercise prices ranging from $1.00 to $5.61 which were granted prior to May 31, 2014.

 

Transactions in FY14   Number of Options     Weighted-Average Exercise Price 
Per Share
    Weighted-Average Remaining Contractual Life  
                   
Outstanding, August 31, 2013     532,000     $ 1.82       3.95  
Granted     100,000     $ 5.61          
Exercised     (160,000 )   $ 1.36          
Cancelled/Forfeited     (6,000 )   $ 1.00          
Outstanding, May 31, 2014     466,000     $ 2.80       3.57  
Exercisable,  May 31, 2014     314,000     $ 1.78       3.31  

 

The fair value of the options, including both ISO and NQSO options, granted during the nine months ended May 31, 2014 is estimated at $130,781. The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions for FQE May 31, 2014: dividend yield of 3.14%, pre-vest forfeiture rate of 6.25%, expected volatility of 38.95%, risk-free interest rate of 1.36%, and expected life of 5.0 years.

 

Non-Qualified Stock Options (Non-Qualified ISO)

As of May 31, 2014, the outside members of the Board of Directors hold options to purchase 45,600 shares of common stock at exercise prices ranging from $1.67 to $6.68, which were granted prior to May 31, 2014.

 

Transactions in FY14   Number of Options    

Weighted-Average Exercise Price

Per Share

    Weighted-Average Remaining Contractual Life  
                   
Outstanding, August 31, 2013     48,600     $ 3.79       7.85  
Exercised     (3,000 )   $ 1.80          
Outstanding, May 31, 2014     45,600     $ 3.92       7.29  
Exercisable,  May 31, 2014     25,200     $ 3.45       6.12  

 

The weighted-average remaining contractual life of options outstanding issued under the Plan, both Qualified ISO and Non-Qualified SO, was 4.19 years at May 31, 2014. The exercise prices for the options outstanding at May 31, 2014 ranged from $1.00 to $6.68, and the information relating to these options is as follows:

  

Exercise Price     Awards Outstanding     Awards Exercisable  
Low     High     Quantity     Weighted Average Remaining Contractual Life     Weighted Average Exercise Price     Quantity     Weighted Average Remaining Contractual Life     Weighted Average Exercise Price  
$ 1.00     $ 1.50       212,500       3.54     $ 1.05       212,500       3.54     $ 1.05  
$ 1.51     $ 3.00       21,600       5.86     $ 2.28       11,600       5.83     $ 2.11  
$ 3.01     $ 4.50       141,900       3.38     $ 3.28       103,500       3.24     $ 3.23  
$ 4.51     $ 6.68       136,000       4.70     $ 5.49       12,000       3.27     $ 5.59  
                  511,600       3.90     $ 2.90       339,200       3.52     $ 1.90  
XML 39 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SIGNIFICANT ACCOUNTING POLICIES (Details - Property and Equipment)
9 Months Ended
May 31, 2014
Equipment
 
Estimated useful lives 5 years
Computer equipment
 
Estimated useful lives 3 to 7 years
Furniture and fixtures
 
Estimated useful lives 5 to 7 years
Leasehold improvements
 
Estimated useful lives Shorter of life of asset or lease
XML 40 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
3. PROPERTY AND EQUIPMENT (Tables)
9 Months Ended
May 31, 2014
Property, Plant and Equipment [Abstract]  
Property and equipment
Equipment   $ 124,042  
Computer equipment     145,893  
Furniture and fixtures     51,466  
Leasehold improvements     23,646  
Sub total     345,047  
Less: Accumulated depreciation and amortization     (241,451 )
Net Book Value   $ 103,596  
XML 41 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
10. EMPLOYEE BENEFIT PLAN
9 Months Ended
May 31, 2014
Compensation Related Costs [Abstract]  
Note 10. EMPLOYEE BENEFIT PLAN

We maintain a 401(K) Plan for all eligible employees, and we make matching contributions equal to 100% of the employee’s elective deferral, not to exceed 4% of total employee compensation. We can also elect to make a profit-sharing contribution. Our contributions to this Plan amounted to $89,784 and $76,317 for the nine months ended May 31, 2014 and 2013, respectively, and $28,028 and $25,772 for the three months ended May 31, 2014 and 2013, respectively.

XML 42 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
8. CONCENTRATIONS AND UNCERTAINTIES
9 Months Ended
May 31, 2014
Concentrations And Uncertainties  
Note 8. CONCENTRATIONS AND UNCERTAINTIES

Revenue concentration shows that International sales accounted for 53% and 42% of net sales for the nine months ended May 31, 2014 and 2013, respectively. Three customers accounted for 14% (a dealer account in Japan representing various customers), 9% and 5% of sales for the nine months ended May 31, 2014 compared to three customers who accounted for 10% (a dealer account in Japan representing various customers) 9% and 7% of net sales during the nine months ended May 31, 2013.

 

Accounts receivable concentration shows that three customers comprised 23%, 18% (a dealer account in Japan representing various customers) and 10% of accounts receivable at May 31, 2014 compared to three customers comprising 18%, 13% and 11% (a dealer account in Japan representing various customers) of accounts receivable at May 31, 2013.

 

We operate in the computer software industry, which is highly competitive and changes rapidly. Our operating results could be significantly affected by our ability to develop new products and find new distribution channels for new and existing products.

 

The majority of our customers are in the pharmaceutical industry. During the current economic downturn, we have seen consolidations in the pharmaceutical industry, especially in this first fiscal quarter of 2013. Although we have not seen any significant reduction in total revenues to date, our growth rate has been affected. Continued consolidation and downsizing in the pharmaceutical industry could have an impact on our revenues and earnings going forward.

XML 43 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
9. GEOGRAPHIC REPORTING
9 Months Ended
May 31, 2014
Geographic Reporting  
Note 9. GEOGRAPHIC REPORTING

We allocate revenues to geographic areas based on the locations of our customers. Geographical revenues for the nine months ended May 31, 2014 and 2013 were as follows (in thousands):

 

Nine month ended     North America     Europe     Asia     South America     Total  
                                 
  May 31, 2014     $ 4,480     $ 2,684     $ 2,273     $ 26     $ 9,463  
  May 31, 2013     $ 4,413     $ 2,673     $ 1,416     $ 1     $ 8,503  
XML 44 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
11. SUBSEQUENT EVENTS
9 Months Ended
May 31, 2014
Subsequent Events [Abstract]  
Note 11. SUBSEQUENT EVENTS

On or about June 26, 2014, the Company was served with a complaint in a civil action entitled Sherri Winslow v. Incredible Adventures, Inc., et al. (Los Angeles Superior Court Case No. BC545789) alleging wrongful death and seeking unspecified damages arising out of a May 18, 2012 plane crash in the State of Nevada (the “Complaint”). In the Complaint, Plaintiff alleges that the Company was the owner of the subject aircraft.   The Company denies all material allegations against it, including that it owns or has ever owned any interest in the subject aircraft, and intends to vigorously defend itself.

XML 45 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
8. CONCENTRATIONS AND UNCERTAINTIES (Narrative)
9 Months Ended
May 31, 2014
May 31, 2013
International Sales
   
Net sales concentration percentage 53.00% 42.00%
Customer A
   
Accounts receivable concentration percentage 23.00% 18.00%
Customer B
   
Accounts receivable concentration percentage 18.00% 13.00%
Customer C
   
Accounts receivable concentration percentage 10.00% 11.00%
Net Sales | Customer 1
   
Net sales concentration percentage 14.00% 10.00%
Net Sales | Customer 2
   
Net sales concentration percentage 9.00% 9.00%
Net Sales | Customer 3
   
Net sales concentration percentage 5.00% 7.00%
XML 46 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
6. SHAREHOLDERS' EQUITY (Tables)
9 Months Ended
May 31, 2014
Equity [Abstract]  
Details of dividend paid

The Board of Directors declared cash dividends during fiscal year 2013. The details of dividends paid are in the following table:

 

Record Date   Distribution Date   Number of Shares Outstanding on Record Date     Dividend per Share     Total Amount  
11/8/2012   11/13/2012     15,927,806     $ 0.05     $ 796,390  
12/24/2012   12/28/2012     16,021,309     $ 0.14     $ 2,242,983  
5/7/2013   5/10/2013     16,030,433     $ 0.03     $ 480,913  
8/12/2013   8/15/2013     16,030,894     $ 0.03     $ 480,926  
Total                       $ 4,001,212  

 

The Board of Directors has also declared cash dividends during fiscal year 2014. The details of dividends paid are in the following table:

 

Record Date   Distribution Date   Number of Shares Outstanding on Record Date     Dividend per Share     Total Amount  
11/08/2013   11/15/2013     16,073,894     $ 0.04     $ 642,956  
2/17/2014   2/24/2014     16,149,460     $ 0.05     $ 807,473  
5/09/2014   5/16/2014     16,165,171     $ 0.05     $ 808,259  
Total                       $ 2,258,688  

 

Summary of the stock option transactions

Qualified Incentive Stock Options (Qualified ISO)

As of May 31, 2014, employees hold Qualified ISO to purchase 466,000 shares of common stock at exercise prices ranging from $1.00 to $5.61 which were granted prior to May 31, 2014.

 

Transactions in FY14   Number of Options     Weighted-Average Exercise Price 
Per Share
    Weighted-Average Remaining Contractual Life  
                   
Outstanding, August 31, 2013     532,000     $ 1.82       3.95  
Granted     100,000     $ 5.61          
Exercised     (160,000 )   $ 1.36          
Cancelled/Forfeited     (6,000 )   $ 1.00          
Outstanding, May 31, 2014     466,000     $ 2.80       3.57  
Exercisable,  May 31, 2014     314,000     $ 1.78       3.31  

 

 

Non-Qualified Stock Options (Non-Qualified ISO)

As of May 31, 2014, the outside members of the Board of Directors hold options to purchase 45,600 shares of common stock at exercise prices ranging from $1.67 to $6.68, which were granted prior to May 31, 2014.

 

Transactions in FY14   Number of Options    

Weighted-Average Exercise Price

Per Share

    Weighted-Average Remaining Contractual Life  
                   
Outstanding, August 31, 2013     48,600     $ 3.79       7.85  
Exercised     (3,000 )   $ 1.80          
Outstanding, May 31, 2014     45,600     $ 3.92       7.29  
Exercisable,  May 31, 2014     25,200     $ 3.45       6.12  

  

Exercise prices for the options outstanding
Exercise Price     Awards Outstanding     Awards Exercisable  
Low     High     Quantity     Weighted Average Remaining Contractual Life     Weighted Average Exercise Price     Quantity     Weighted Average Remaining Contractual Life     Weighted Average Exercise Price  
$ 1.00     $ 1.50       212,500       3.54     $ 1.05       212,500       3.54     $ 1.05  
$ 1.51     $ 3.00       21,600       5.86     $ 2.28       11,600       5.83     $ 2.11  
$ 3.01     $ 4.50       141,900       3.38     $ 3.28       103,500       3.24     $ 3.23  
$ 4.51     $ 6.68       136,000       4.70     $ 5.49       12,000       3.27     $ 5.59  
                  511,600       3.90     $ 2.90       339,200       3.52     $ 1.90  
XML 47 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
2. SIGNIFICANT ACCOUNTING POLICIES (Narrative) (USD $)
3 Months Ended 9 Months Ended
May 31, 2014
May 31, 2013
May 31, 2014
May 31, 2013
Aug. 31, 2013
Significant Accounting Policies Narrative          
Amortization of capitalized computer software development costs $ 200,585 $ 173,094 $ (584,237) $ (532,106)  
Amortization of intellectual property 30,625 5,625 30,625 5,625  
Accumulated amortization of intellectual property 41,875   41,875   11,250
Stock-based compensation $ 103,498 $ 98,495 $ 32,411 $ 28,241  
XML 48 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended
May 31, 2014
May 31, 2013
Cash flows from operating activities    
Net income $ 2,802,568 $ 2,641,791
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization of property and equipment 35,730 31,411
Amortization of intellectual property 30,625 5,625
Amortization of capitalized computer software development costs 584,237 532,106
Excess tax benefits from share-based arrangements    (70,806)
Stock-based compensation 103,498 98,494
Deferred income taxes 1,349,585 99,402
(Increase) decrease in    
Accounts receivable and Contracts receivable (1,229,485) (1,611,838)
Prepaid income taxes (644,945) 153,896
Prepaid expenses and other assets 72,993 13,284
Accounts payable 31,345 44,206
Accrued payroll and other expenses 38,255 24,973
Accrued bonus 30,000 (15,000)
Accrued income taxes    (403,735)
Other liabilities (14,894)   
Deferred revenue 145,444 35,324
Net cash provided by operating activities 3,334,956 1,579,133
Cash flows from investing activities    
Purchases of property and equipment (21,339) (19,259)
Purchase of intellectual property (2,500,000)   
Capitalized computer software development costs (1,051,700) (833,965)
Net cash used in investing activities (3,573,039) (853,224)
Cash flows from financing activities    
Excess tax benefits from share-based arrangements    70,806
Proceeds from the exercise of stock options 75,445 27,985
Dividends paid (2,258,688) (3,520,285)
Net cash (used in) financing activities (2,183,243) (3,421,494)
Net increase (decrease) in cash and cash equivalents (2,421,326) (2,695,585)
Cash and cash equivalents, beginning of year 10,179,298 12,701,075
Cash and cash equivalents, end of period 7,757,972 10,005,490
Supplemental disclosures of cash flow information    
Interest paid      
Income taxes paid 572,192 1,382,545
Non-Cash Investing and Financing    
Purchase of intellectual property with shares and notes payable $ 3,500,000   
XML 49 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
5. COMMITMENTS AND CONTINGENCIES
9 Months Ended
May 31, 2014
Commitments and Contingencies Disclosure [Abstract]  
Note 5. COMMITMENTS AND CONTINGENCIES

Employment Agreement

On July 22, 2012, the Company entered into an employment agreement with its President/Chief Executive Officer that expired in August 2013. The employment agreement provided for an annual base salary of $300,000 per year, and a performance bonus in an amount not to exceed 10% of Employee’s salary, or $30,000 per year, at the end of each fiscal year. The specific amount of the bonus to be awarded to be determined by the Compensation Committee of the Board of Directors, based on the financial performance and achievements of the Company for the previous fiscal year. The agreement also provided for Employee stock options, exercisable for five years, to purchase fifty (50) shares of Common Stock for each one thousand dollars ($1,000) of net income before taxes at the end of each fiscal year up to a maximum of 120,000 options over the term of the agreement at an exercise price equal to ten percent (10%) over the market value per share as of the date of grant (the number of shares to be adjusted accordingly for any stock splits or reverse splits after the date of the agreement). The agreement allows the Company to terminate the agreement upon 30 days written notice, if termination is without cause, the Company's only obligation would be to pay its President the greater of a) 12 month’s salary or b) the remainder of the term of the employment agreement from the date of notice of termination.

  

For fiscal year 2013, the Compensation Committee awarded a $30,000 performance bonus to Walter Woltosz, our President/Chief Executive Officer, which was paid in September 2013.

 

On August 22, 2013, effective as of September 1, 2013, the CEO’s employment agreement was renewed for another year by the Compensation Committee and provides for an annual bonus of up to five percent (5%) of the Company’s net income before taxes of the previous fiscal year not to exceed $60,000. In addition, at the CEO’s request, the agreement calls for a reduced granting of ten (10) options to purchase shares of the Company’s common stock for each $1,000 of net income before taxes that the Company earns at the end of each fiscal year (up to a maximum of twenty thousand (20,000) options over the term of the agreement) at an exercise price equal to ten percent (10%) over the market value per share as of the date of grant (the number of shares to be adjusted accordingly for any stock splits or reverse splits after the date of the agreement). A copy of the agreement is attached to the Company’s 2013 Form 10-K filed with the SEC on November 18, 2013 as Exhibit 10.9.

 

Litigation

The Company is a party to litigation. Management does not believe the outcome of such litigation will have a material impact on the Company's financial position.

XML 50 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
3. PROPERTY AND EQUIPMENT (Details) (USD $)
May 31, 2014
Aug. 31, 2013
Property and equipment, gross $ 345,047  
Less accumulated depreciation and Amortization (241,451)  
Net Book Value 103,596 117,987
Equipment
   
Property and equipment, gross 124,042  
Computer equipment
   
Property and equipment, gross 145,893  
Furniture and fixtures
   
Property and equipment, gross 51,466  
Leasehold improvements
   
Property and equipment, gross $ 23,646  
XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 66 183 1 false 34 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://simulations.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - CONDENSED BALANCE SHEETS Sheet http://simulations.com/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS false false R3.htm 00000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://simulations.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) false false R4.htm 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS Sheet http://simulations.com/role/CondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS false false R5.htm 00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOWS Sheet http://simulations.com/role/CondensedStatementsOfCashFlows CONDENSED STATEMENTS OF CASH FLOWS false false R6.htm 00000006 - Disclosure - 1. GENERAL Sheet http://simulations.com/role/General 1. GENERAL false false R7.htm 00000007 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES Sheet http://simulations.com/role/SummaryOfSignificantAccountingPolicies 2. SIGNIFICANT ACCOUNTING POLICIES false false R8.htm 00000008 - Disclosure - 3. PROPERTY AND EQUIPMENT Sheet http://simulations.com/role/PropertyAndEquipment 3. PROPERTY AND EQUIPMENT false false R9.htm 00000009 - Disclosure - 4. CONTRACT PAYABLE Sheet http://simulations.com/role/ContractPayable 4. CONTRACT PAYABLE false false R10.htm 00000010 - Disclosure - 5. COMMITMENTS AND CONTINGENCIES Sheet http://simulations.com/role/CommitmentsAndContingencies 5. COMMITMENTS AND CONTINGENCIES false false R11.htm 00000011 - Disclosure - 6. SHAREHOLDERS' EQUITY Sheet http://simulations.com/role/ShareholdersEquity 6. SHAREHOLDERS' EQUITY false false R12.htm 00000012 - Disclosure - 7. RELATED PARTY TRANSACTIONS Sheet http://simulations.com/role/RelatedPartyTransactions 7. RELATED PARTY TRANSACTIONS false false R13.htm 00000013 - Disclosure - 8. CONCENTRATIONS AND UNCERTAINTIES Sheet http://simulations.com/role/ConcentrationsAndUncertainties 8. CONCENTRATIONS AND UNCERTAINTIES false false R14.htm 00000014 - Disclosure - 9. GEOGRAPHIC REPORTING Sheet http://simulations.com/role/GeographicReporting 9. GEOGRAPHIC REPORTING false false R15.htm 00000015 - Disclosure - 10. EMPLOYEE BENEFIT PLAN Sheet http://simulations.com/role/EmployeeBenefitPlan 10. EMPLOYEE BENEFIT PLAN false false R16.htm 00000016 - Disclosure - 11. SUBSEQUENT EVENTS Sheet http://simulations.com/role/SubsequentEvents 11. SUBSEQUENT EVENTS false false R17.htm 00000017 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies 2. SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R18.htm 00000018 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables 2. SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R19.htm 00000019 - Disclosure - 3. PROPERTY AND EQUIPMENT (Tables) Sheet http://simulations.com/role/PropertyAndEquipmentTables 3. PROPERTY AND EQUIPMENT (Tables) false false R20.htm 00000020 - Disclosure - 4. CONTRACT PAYABLE (Tables) Sheet http://simulations.com/role/ContractPayableTables 4. CONTRACT PAYABLE (Tables) false false R21.htm 00000021 - Disclosure - 6. SHAREHOLDERS' EQUITY (Tables) Sheet http://simulations.com/role/ShareholdersEquityTables 6. SHAREHOLDERS' EQUITY (Tables) false false R22.htm 00000022 - Disclosure - 9. GEOGRAPHIC REPORTING (Tables) Sheet http://simulations.com/role/SegmentAndGeographicReportingTables 9. GEOGRAPHIC REPORTING (Tables) false false R23.htm 00000023 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Details - Property and Equipment) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-PropertyAndEquipment 2. SIGNIFICANT ACCOUNTING POLICIES (Details - Property and Equipment) false false R24.htm 00000024 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Details-Fair Value Measurements) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements 2. SIGNIFICANT ACCOUNTING POLICIES (Details-Fair Value Measurements) false false R25.htm 00000025 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Details-Earnings Per Share) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare 2. SIGNIFICANT ACCOUNTING POLICIES (Details-Earnings Per Share) false false R26.htm 00000026 - Disclosure - 2. SIGNIFICANT ACCOUNTING POLICIES (Narrative) Sheet http://simulations.com/role/SummaryOfSignificantAccountingPoliciesNarrative 2. SIGNIFICANT ACCOUNTING POLICIES (Narrative) false false R27.htm 00000027 - Disclosure - 3. PROPERTY AND EQUIPMENT (Details) Sheet http://simulations.com/role/PropertyAndEquipmentDetails 3. PROPERTY AND EQUIPMENT (Details) false false R28.htm 00000028 - Disclosure - 4. CONTRACT PAYABLE (Details) Sheet http://simulations.com/role/ContractPayableDetails 4. CONTRACT PAYABLE (Details) false false R29.htm 00000029 - Disclosure - 6. SHAREHOLDERS' EQUITY (Details-Dividends) Sheet http://simulations.com/role/ShareholdersEquityDetails-Dividends 6. SHAREHOLDERS' EQUITY (Details-Dividends) false false R30.htm 00000030 - Disclosure - 6. SHAREHOLDERS' EQUITY (Details-Options Outstanding) Sheet http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstanding 6. SHAREHOLDERS' EQUITY (Details-Options Outstanding) false false R31.htm 00000031 - Disclosure - 6. SHAREHOLDERS' EQUITY (Details-Options Outstanding and Exercisable) Sheet http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable 6. SHAREHOLDERS' EQUITY (Details-Options Outstanding and Exercisable) false false R32.htm 00000032 - Disclosure - 6. SHAREHOLDERS' EQUITY (Narrative) Sheet http://simulations.com/role/ShareholdersEquityNarrative 6. SHAREHOLDERS' EQUITY (Narrative) false false R33.htm 00000033 - Disclosure - 7. RELATED PARTY TRANSACTIONS (Narrative) Sheet http://simulations.com/role/RelatedPartyTransactionsNarrative 7. RELATED PARTY TRANSACTIONS (Narrative) false false R34.htm 00000034 - Disclosure - 8. CONCENTRATIONS AND UNCERTAINTIES (Narrative) Sheet http://simulations.com/role/ConcentrationsAndUncertaintiesNarrative 8. CONCENTRATIONS AND UNCERTAINTIES (Narrative) false false R35.htm 00000035 - Disclosure - 9. GEOGRAPHIC REPORTING (Details) Sheet http://simulations.com/role/GeographicReportingDetails 9. GEOGRAPHIC REPORTING (Details) false false R36.htm 00000036 - Disclosure - 10. EMPLOYEE BENEFIT PLAN (Narrative) Sheet http://simulations.com/role/EmployeeBenefitPlanNarrative 10. EMPLOYEE BENEFIT PLAN (Narrative) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - CONDENSED BALANCE SHEETS Process Flow-Through: Removing column 'May 31, 2013' Process Flow-Through: Removing column 'Aug. 31, 2012' Process Flow-Through: 00000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Process Flow-Through: 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS Process Flow-Through: 00000005 - Statement - CONDENSED STATEMENTS OF CASH FLOWS Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2013' simu-20140531.xml simu-20140531.xsd simu-20140531_cal.xml simu-20140531_def.xml simu-20140531_lab.xml simu-20140531_pre.xml true true XML 52 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
4. CONTRACT PAYABLE (Tables)
9 Months Ended
May 31, 2014
Contract Payable  
Future payments
April 25, 2015   $ 750,000  
April 25, 2016     750,000  
April 25, 2017     1,000,000  
Total   $ 2,500,000  
Less Current portion     (750,000 )
Contract payable, net of current portion   $ 1,750,000